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Summary 
Human campylobacteriosis represents an important public health problem and poultry has been 
identified as a significant source for human infections with Campylobacter. Nowadays, the 
implementation of effective controls to reduce the burden of disease in humans is considered a 
priority in many areas of the world. Consequently, the control of Campylobacter in poultry seems 
crucial for the reduction of human campylobacteriosis cases; this fact represents the fundamental 
inspiration for this PhD thesis. The term “poultry” is used in the title and throughout this PhD thesis 
as a synonym of chickens and broilers athough this term can refer to other birds bred for the 
production of meat or eggs. It was preferred to use the term poultry because some of the knowledge, 
information and/or reseach included in this thesis might refer to or could be applied to birds other 
than broilers. 
The research presented in this thesis belongs to a larger project on vaccination of poultry against 
Campylobacter, the CamVac project, funded by the Danish Council of Strategic Research (Det 
Strategiske Forskningsråd). The overall aim of this research project is to support a cost-effective 
vaccination strategy able to reduce the numbers of Campylobacter in infected chickens which in 
turn will translate in a decrease of the numbers of Campylobacter in poultry products and a 
reduction in the associated public health risks to the consumers. The aim of my PhD research is to 
explore, investigate, research and/or develop different aspects related to the effect of vaccination 
strategies against Campylobacter in poultry.  
In the beginning, a general and critical review of control strategies against Campylobacter in 
poultry production from farm to fork and public health implications is presented in this thesis. A 
variety of potential Campylobacter control measures are discussed with emphasis on vaccination 
strategies against Campylobacter and other zoonotic pathogens in poultry. In addition, information 
on Campylobacter risk assessments and the evaluation of the potential public health impact of 
controls against Campylobacter in poultry production are included.  
Next, this PhD thesis presents results from an experimental inoculation and vaccination trial 
conducted for the investigation into Campylobacter colonization of poultry and for the assessment 
of the effectiveness of a Campylobacter vaccine candidate based on the protein ACE393 (the most 
promising candidate obtained in previous studies). Moreover, critical reflections related to the 
design of clinical vaccination trials and adequate data analyses are presented. The potential effect of 
the vaccine candidate ACE393 in poultry is assessed in this research based on the enumeration of 
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Campylobacter in chicken samples using different methods. Accurate and reliable quantitative 
microbiological data are crucial for quantitative risk assessment models and for the evaluation of 
the effectiveness of food safety control measures e.g. vaccination strategies. Therefore, conducted 
investigations related to molecular quantitative microbiological methods for the accurate, fast, 
direct and reliable enumeration of Campylobacter present in poultry fecal material are presented 
and discussed in this thesis. 
The final part of this thesis describes and discusses the development and application of 
mathematical models and decision support systems that can integrate current knowledge to aid 
poultry producers in decision making regarding potential investments for the implementation of 
Campylobacter control strategies in poultry production. 
Results from our inoculation and vaccination experiments  based on a nested fixed block design and 
including 290 broilers indicate that the observed differences between vaccinated and placebo groups 
related to Campylobacter numbers could be attributed to “non-vaccine related” variation between 
birds within the same group and between groups. It is concluded that there is no statistically 
significant effect of the vaccine ACE 393 in broilers in this clinical trial under the experimental 
conditions applied. Despite years of extensive research, the availability of a cost-effective 
commercial vaccine against Campylobacter in poultry remains a major goal.  
There seems to be no international consensus regarding the most appropriate sampling protocol to 
obtain accurate Campylobacter quantitative data from poultry flocks. The sampling protocol 
(including methods, sample size, sample origin, sample matrix, time of sampling and other aspects) 
will influence the quantitative microbiological data collected and data analyses results. Several of 
these aspects related to sampling protocols are explored further in this PhD work. A comparison of 
the main quantitative microbiological methods used in food safety (traditional culture and real-time 
PCR) is presented in this thesis. Although chicken faecal samples represent complex matrices for 
the quantification of Campylobacter, poultry faeces are often the sample of choice for the routine 
Campylobacter testing of poultry flocks. In this research, several DNA extraction methods are 
evaluated for Campylobacter DNA direct quantification (without enrichment) using real-time PCR 
and spiked chicken faecal samples. Subsequently, the DNA extraction methods Easy-DNA and 
MiniMAG are selected to quantify directly (without the use of enrichment) Campylobacter present 
in naturally infected chicken faecal samples. Results indicate that there are no statistically 
significant differences between culture and real-time PCR in these experiments. Results from 
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statistical analyses of Campylobacter quantitative data obtained from colonization studies and 
vaccination clinical trials show high variability between chickens in relation to the numbers of 
Campylobacter in individual chickens suggesting that individual factors may affect Campylobacter 
dynamics in poultry flocks. Remarkably, a significant correlation is observed between faecal and 
caecal Campylobacter concentrations at slaughter suggesting that Campylobacter counts from 
faecal samples at slaughter might be a good indicator of Campylobacter concentration in the 
caecum of slaughter chickens and supporting recommendations made related to the sampling of 
chickens closer to slaughter time.  
Considering the relatively low profit margins in poultry production, Campylobacter control 
strategies that can be tested and/or applied at low cost are generally accepted but controls that 
require efforts and/or extra costs might not be welcome by poultry producers. For this reason, 
proposed controls should be backed up with strong evidence of effectiveness and a satisfactory 
viable cost-benefit balance. Mathematical models may provide poultry producers with valuable 
information related to the effectiveness of potential public health control strategies and the 
associated cost-benefit analyses. Even more, hypothetical controls such as the use of a commercial 
Campylobacter vaccine can be included in mathematical models. The flexibility of the 
mathematical models developed for this PhD thesis allows for the assessment of several 
Campylobacter control strategies in poultry and their potentially synergistic combinations. The 
models presented here integrate knowledge related to epidemiological, microbiological and 
financial factors for the control of Campylobacter in poultry. The selection of epidemiological and 
microbiological variables for model development can be complex. Challenges related to the 
selection of variables and quantitative data to be included in the models are discussed in this thesis. 
Results from the models include posterior probability distributions related to expected 
Campylobacter numbers in the flock (in logs) before and after the implementation of the decision/s 
and the expected cost-reward balance associated with each decision/s. Ideally, Campylobacter 
controls in poultry production should be cost-effective, reliable, easy to implement, easy to maintain 
and accepted by consumers. Consumers’ preferences will influence the type of products available in 
the market. Socio-economic aspects are therefore crucial for the implementation of effective 
Campylobacter controls and are considered in this thesis.  
The work presented in this PhD thesis provides an extensive review on Campylobacter controls 
along the food chain. Some of these Campylobacter control strategies could be integrated following 
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a “farm to fork” approach in mathematical models in future studies.  The critical reflections related 
to the design of clinical vaccination trials and adequate data analyses presented here may prove 
useful for other researchers. Results obtained from the colonization study and vaccination clinical 
trial shed some light on complex issues related to microbiological sampling protocols in poultry and 
in relation to the assessment of vaccine effectiveness. Moreover, adequate Campylobacter testing of 
faecal samples from chickens just before slaughter will support producers in the implementation of 
relevant Campylobacter control strategies to reduce Campylobacter contamination of chicken 
products and accordingly decrease associated public health risks. The mathematical models 
developed and presented here may assist the poultry industry in the implementation of cost-
effective Campylobacter control strategies under conditions of uncertainty. Even more, results from 
the mathematical models developed in this thesis could be integrated in risk assessment models in 
order to assess the public health impact of Campylobacter controls in poultry in terms of expected 
reduction of human campylobacteriosis cases. Hence, the food industry, scientists, researchers, 
government agencies and the society as a whole may benefit from the work presented in this PhD 
thesis related to the control of Campylobacter in poultry. 
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Sammendrag (Summary in Danish) 
 
Infektioner med Campylobacter, campylobacteriose, hos mennesker udgør et betydeligt 
folkesundhedsproblem og fjerkræ er blevet identificeret som en væsentlig smittekilde. 
Implementering af bekæmpelsesstrategier for at mindske byrden af infektionssygdomme hos 
mennesker er i dag højt prioriteret i adskillige lande. For så vidt angår campylobacteriose hos 
mennesker anses bekæmpelse af Campylobacter i fjerkræ for at være afgørende for reduktion af 
antal tilfælde: denne antagelse udgør den grundlæggende inspiration for Ph.d. afhandlingen. 
Forskningsarbejdet præsenteret i afhandlingen hører under et større projekt, der vedrører 
mulighederne for at udvikle en vaccine til fjerkræ mod Campylobacter (the CamVac projekt, 2010-
2014). Projektet finansieres af det Strategiske Forskningsråd i Danmark. Hovedformålet med 
projektet er at støtte udviklingen af en omkostningseffektiv vaccinationsstrategi til 
fjerkræproduktionen for at reducere antallet af Campylobacter i inficerede kyllinger. En sådan 
reduktion antages at kunne afspejle sig i et fald i antallet af Campylobacter i fjerkræprodukter og 
dermed en reduktion af de tilknyttede sundhedsrisici for konsumenter. Formålet med min ph.d. 
forskning er at udforske, undersøge og udvikle vaccinationsstrategier over for Campylobacter i 
fjerkræ.  
Ph.d. afhandlingen indledes med en generel og kritisk gennemgang af bekæmpelsesstrategier mod 
Campylobacter i fjerkræproduktionen fra jord til bord og konsekvenser for folkesundheden. 
Forskellige mulige bekæmpelsesstrategier mod Campylobacter diskuteres med vægt på 
vaccinationsstrategier mod Campylobacter og andre zoonotiske patogener i fjerkræ. Derudover 
diskuteres mulige folkesundhedsmæssige følger af bekæmpelsesstrategier mod Campylobacter i 
fjerkræproduktion.  
Herefter præsenteres resultater fra et eksperimentelt podnings- og vaccinationsforsøg udført for at 
undersøge på hvilken måde Campylobacter kolonisering i fjerkræ påvirkes ved vaccinering med en 
Campylobacter vaccine kandidat baseret på proteinet ACE393 (selvsamme er i tidligere studier 
fundet at være den mest lovende kandidat). Desuden, på bagrund af forsøget diskuteres forskellige 
kritiske forhold omkring samspillet mellem forsøgsdesign, gennemførsel og analyse af 
vaccinationsforsøg generelt. Med udgangspunkt i forsøget foretages en kritisk gennemgang af 
udformningen af kliniske vaccinationsforsøg og fyldestgørende data analyser herom. Den 
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potentielle effekt af vaccinen måles ved brug af forskellige kvantificeringsmetoder for forekomst af 
Campylobacter. Nøjagtige og pålidelige kvantitative mikrobiologiske data er afgørende for 
kvantitative risikovurderingsmodeller og for evalueringen af effekten af bekæmpelsesstrategier i 
forhold til fødevaresikkerhed f.eks. vaccinationsstrategier.  Følgelig præsenteres og diskuteres 
undersøgelser, relateret til molekylære kvantitative mikrobiologiske metoder for direkte, præcis, 
hurtig og pålidelig tælling af Campylobacter i fækalmateriale fra fjerkræ, i afhandlingen. 
Den sidste del af afhandlingen beskriver og diskuterer udvikling og anvendelse af matematiske 
modeller som beslutningsværktøj, der kan integrere nuværende viden, for beslutningstager. 
Hensigten med beslutningsværktøjet er at hjælpe fjerkræproducenter i beslutningsprocessen i 
forhold til investering i bekæmpelsesstrategier mod Campylobacter i fjerkræproduktionen. 
Resultater fra vores eksperimentelle podnings- og vaccinationsforsøg er baseret på et hierarkisk 
fastsat blok design med i alt 290 slagtekyllinger og indikerer, at de observerede forskelle i antal 
Campylobacter i tarmkanalen mellem vaccinerede og placebogruppen kan tilskrives "ikke – vaccine 
relaterede” variationer mellem individer og mellem isolater. Konklusionen er derfor, at der ikke er 
nogen statistisk signifikant virkning af vaccinen ACE 393 i slagtekyllinger i forhold til forsøgets 
forudsætninger. Trods flere års omfattende forgæves forskning, forbliver udviklingen af en 
omkostningseffektiv kommerciel vaccine mod Campylobacter i fjerkræ fortsat et vigtigt mål.  
Der ser ikke ud til at være international konsensus om en bedst egnet prøvetagningsprotokol for 
nøjagtig kvantificering af Campylobacter i fjerkræflokke. Prøvetagningsprotokollen, herunder valg 
af metode, stikprøvestørrelsen, prøve oprindelse, prøvematrix samt tidspunkt for prøvetagning, vil 
have indflydelse på laboratorieresultater og på efterfølgende data analyser og konklusioner. 
Adskillige af disse aspekter er undersøgt nærmere i ph.d. arbejdet, deriblandt en sammenligning 
mellem de to væsentligste kvantitative mikrobiologiske metoder, der anvendes inden for 
fødevaresikkerhed (traditionel dyrkning og real-time PCR). Selvom gødningsprøver fra kyllinger 
udgør en kompleks matrix til kvantificering af Campylobacter, er det hyppigt fæces der vælges som 
prøvemateriale til rutinemæssig laboratorieundersøgelse. Ph.d. arbejdet omfatter tillige evaluering 
af forskellige DNA ekstraktionsmetoder, der kan bruges i forbindelse med direkte kvantificering 
(uden præopformering) ved hjælp af real -time PCR og spikede gødningsprøver fra kyllinger. 
Efterfølgende er DNA ekstraktionsmetoderne Easy- DNA og MiniMAG valgt til direkte 
kvantificering (uden brug af berigelse) af Campylobacter i gødningsprøver fra naturligt inficerede 
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kyllinger. Resultaterne viser at der ikke er statistisk signifikant forskel mellem dyrkning og real-
time PCR i disse eksperimenter.  
På basis af de kvantitative data for forekomst af Campylobacter i tarmkanalen hos inficerede 
kyllinger, fra det eksperimentelle podnings- og vaccinationsforsøget, påvises store variationer 
mellem kyllinger i samme isolator (flok) i forhold til antallet af Campylobacter, hvilket tyder på at 
individuelle faktorer muligvis påvirker dynamikken af spredningen af Campylobacter i en 
fjerkræflok. Data viser yderligere en signifikant sammenhæng mellem antallet af Campylobacter i 
gødningsprøver udtaget fra kloak samt blindtarm på slagtetidspunktet. Kvantificering af 
Campylobacter i gødningsprøver tæt på slagtning kan muligvis være en god indikator for antallet af 
Campylobacter i blindtarmen hos slagtekyllinger. Fundet understøtter nuværende anbefalinger, der 
tilråder prøveudtagning fra kyllinger tæt på slagtetidspunktet. I betragtning af det relativt lave 
dækningsbidrag per kylling i fjerkræproduktionen, vil fjerkræproducenter i højere grad være 
positivt indstillet overfor bekæmpelsesstrategier mod Campylobacter, der kræver begrænsede 
investeringer, i forhold til tilsvarende strategier der kræver større investeringer. Af samme grund 
bør bekæmpelsesstrategier understøttes af stærke beviser for effektivitet og fyldestgørende analyser 
for omkostningsgevinst. Matematiske modeller for spredning og kontrol af Campylobacter kan give 
fjerkræproducenter værdifulde oplysninger om effektiviteten af mulige sundhedsmæssige 
bekæmpelsesstrategier samt dertil hørende omkostningsgevinst analyse. Endvidere kan disse 
modeller efterligne effekten af hypotetiske bekæmpelsesstrategier, såsom anvendelse af en 
kommerciel Campylobacter vaccine. Fleksibiliteten i de matematiske modeller udviklet i 
forbindelse med ph.d. afhandlingen gør det muligt at vurdere flere bekæmpelsesstrategier mod 
Campylobacter i fjerkræ samt deres potentielt synergetiske kombinationer. Modellerne, der blev 
udviklet, integrerer viden om epidemiologiske, mikrobiologiske og økonomiske faktorer tilknyttet 
bekæmpelse af Campylobacter i fjerkræ. Selektionen af epidemiologiske og mikrobiologiske 
variabler samt kvantitative data i forbindelse med udvikling af modellen er kompleks, og 
udfordringer heri diskuteres i afhandlingen. Resultater fra modellerne omfatter posterior 
sandsynlighedsfordelinger for forventede antal Campylobacter (log CFU/gram) i en 
slagtekyllingeflok før og efter implementering af en bekæmpelsesstrategi (er), samt de forventede 
omkostninger og gevinster forbundet med hver strategi. Ideelt set bør bekæmpelsesstrategier mod 
Campylobacter i fjerkræproduktionen være omkostningseffektive, pålidelige, let at implementere, 
let at vedligeholde og accepteret af forbrugerne. Forbrugernes præferencer påvirker produkttyper 
tilgængelige på markedet. Socio -økonomiske aspekter er derfor afgørende for gennemførelse af 
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effektive bekæmpelsesstrategier mod Campylobacter, og overvejelser herom gennemgås i 
afhandlingen. 
Afhandling giver en omfattende gennemgang af bekæmpelsesstrategier for Campylobacter i hele 
fødevarekæden, hvoraf flere kan integreres efter et "jord til bord"-princip i fremtidige studier af 
matematiske modeller. De kritiske refleksioner omkring design af vaccinationsforsøget under 
produktionslignende forhold, samt efterfølgende fyldestgørende analyse af data, der præsenteres i 
afhandlingen kan vise sig nyttige for andre forskere. Resultaterne fra det eksperimentelle podnings- 
og vaccinationsforsøget kastede lys over komplekse problemstillinger i forhold til mikrobiologiske 
prøveudtagningsprotokoller hos fjerkræ og i forhold til vurderingen af vaccine effektivitet.  
En adækvat undersøgelse for Campylobacter i gødningsprøver fra kyllinger lige før slagtning vil 
støtte producenters beslutning for implementering af relevante bekæmpelsesstrategier mod 
Campylobacter og dermed mindske tilknyttede risici for folkesundheden. De matematiske modeller 
udviklet og præsenteret her, kan muligvis hjælpe fjerkræproducenter med at vurdere 
omkostningseffektivitet af forskellige bekæmpelsesstrategier, når vedkommende skal tage 
beslutning om implementering uden at have kendskab til flokkens Campylobacter status. 
Resultaterne fra de matematiske modeller, der blev udviklet i denne afhandling, kan højst 
sandsynlig integreres i risikovurderingsmodeller, der vurderer den offentlige sundhedsmæssige 
virkning af bekæmpelsesstrategier mod Campylobacter i fjerkræ, i form af forventet reduktion af 
menneskelige campylobacteriose tilfælde. Derfor kan fødevareindustrien; videnskabsfolk og 
forskere; offentlige institutioner og samfundet som helhed drage fordel af arbejdet, der præsenteres i 
ph.d. afhandlingen i forhold til kontrol af Campylobacter i fjerkræ. 
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List of abbreviations 
 
AE: amplification efficiency  
ASC: antibody secreting cells 
C. jejuni: Campylobacter jejuni 
C. lari: Campylobacter lari 
C. upsaliensis: Campylobacter upsaliensis 
C.coli: Campylobacter coli 
C.I.: Confidence Interval 
CamVac: Campylobacter Vaccination project 
CFU: Colony Forming Units 
CPS: polysaccharide capsule  
Ct: threshold cycle 
CWC: Campylobacter whole-cell  
CWF: Compassion in World Farming 
DAG: directed acyclic graph 
Danish Kroners (DKK) 
DANMAP: Danish Integrated Antimicrobial Resistance Monitoring and Research Program 
EC: European Commission 
EFSA: The European Food Safety Authority 
EU: European Union 
European Centre for Disease Prevention and Control [ECDC], 
FAO: Food and Agriculture Organization 
FSAI: Food Safety Authority of Ireland 
FSC: Food Safety Criteria 
GBS: Guillain-Barré Syndrome 
GHP: Good Hygiene Practices 
HACCP: Hazard Analysis and Critical Control Points 
IAC: Internal Amplification Control 
ICC: intra-cluster correlation coefficients  
ICGFI: International Consultative Group on Food Irradiation  
ICMSF: International Commission on Microbiological Specifications for Foods 
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ICTs: Information and Communication Technologies  
IFR: Institute of Food Research  
IgA: Immunoglobulin A 
IgG: Immunoglobulin G 
IgM: Immunoglobulin M  
ISO: International standards 
KGy: KiloGray 
KM: Knowledge Management  
LAB: lactic acid bacteria  
mCCDA : modified charcoal cefoperazone deoxycholate agar  
MLST: Multi Locus Sequence Typing 
ORs: Odds Ratios  
PGMs: probabilistic graphical models  
QMRA: quantitative microbiological risk assessment  
R: regression parameter 
ReA: reactive arthritis 
ST: Sequence Type 
UK: United Kingdom 
USDA: United States Department of Agriculture  
UV: Ultra Violet 
VBNC: viable but non-culturable  
WHO: World Health Organization 
£: British Pound  
 
 
 
 
 
 
 
 
Campylobacter Control in Poultry 
 
xvi 
 
 
 
 
 
 
 
 
 
 
 
 
1. TABLE OF CONTENTS 
 
Preface  ................................................................................................................................................ iii 
Acknowledgements  ............................................................................................................................ iv 
Summary  ............................................................................................................................................. v 
Sammendrag (Summary in Danish) .................................................................................................... ix 
List of abbreviations.......................................................................................................................... xiii 
1. TABLE OF CONTENTS ................................................................................................................. 1 
2. OUTLINE  ....................................................................................................................................... 5 
3. INTRODUCTION  .......................................................................................................................... 7 
4. OBJECTIVES  ............................................................................................................................... 10 
5. CAMPYLOBACTER: PUBLIC HEALTH ASPECTS AND CONTROL STRATEGIES IN 
POULTRY PRODUCTION  ............................................................................................................. 11 
5.1. Human campylobacteriosis ......................................................................................................... 11 
5.2. Campylobacter reservoirs and sources  ...................................................................................... 13 
5.3. Epidemiology of Campylobacter in chicken flocks  ................................................................... 14 
5.4. Campylobacter control strategies ............................................................................................... 18 
5.4.1. Campylobacter controls in poultry primary production  ......................................................... 20 
5.4.2. Controls during transport  ........................................................................................................ 27 
5.4.3. Controls at slaughter, processing and consumption  ................................................................ 27 
5.4.4. Integration of controls against Campylobacter in poultry  ...................................................... 32 
5.4.5. Campylobacter risk assessments and evaluation of the public health impact of controls 
against Campylobacter in poultry production  ................................................................................... 33 
5.5. Vaccines against Campylobacter and other zoonotic pathogens  ............................................... 35 
5.6. Discussion ................................................................................................................................... 42 
6. EXPERIMENTAL INFECTION WITH CAMPYLOBACTER AND A VACCINATION TRIAL 
AGAINST CAMPYLOBACTER IN BROILERS (MANUSCRIPTS I and II)  ................................. 46 
6.1. Introduction ................................................................................................................................. 46 
6.2. Materials and Methods ................................................................................................................ 47 
6.2.1. Animals and experiments ......................................................................................................... 47 
6.2.2. Data analyses............................................................................................................................ 49 
6.3. Results ......................................................................................................................................... 50 
Campylobacter Control in Poultry 
 
2 
 
6.3.1. Results obtained from descriptive statistics ............................................................................. 50 
6.3.2. Results from data analyses (placebo group only) .................................................................... 52 
6.3.3. Results from data analyses (vaccinated and placebo groups) .................................................. 52 
6.4. Discussion and conclusions ........................................................................................................ 54 
Manuscript I 
Garcia AB, Bahrndorff  S, Hald B, Hoorfar J, Madsen M, Vigre H. 2012. Design and data analysis 
of experimental trials to test vaccine candidates against zoonotic pathogens in animals: the case of a 
clinical trial against Campylobacter in broilers. Expert Rev. Vaccines 11(10): 1179-1188. 
 
Manuscript II  
S. Bahrndorff 1,2*, A.B. Garcia 3, H. Vigre 3, M. Nauta 3, P. M. H. Heegaard  4, M. Madsen 5, J. 
Hoorfar 2, B. Hald 1,2 Intestinal colonization of Campylobacter spp. in broiler chickens in an 
experimental infection study. Submitted to Epidemiology and Infection, under review. 
 
 
7. MICROBIOLOGICAL TECHNOLOGIES FOR THE QUANTITATIVE ASSESSMENT OF 
CAMPYLOBACTER PRESENT IN POULTRY FECAL SAMPLES (MANUSCRIPTS III AND IV)
 ............................................................................................................................................................ 57 
7.1. Introduction ................................................................................................................................. 57 
7.2. Materials and Methods ................................................................................................................ 60 
7.2.1. Samples .................................................................................................................................... 60 
 7.2.1.1. Spiked samples ................................................................................................ 60 
 7.2.1.2. Naturally infected samples .............................................................................. 61 
7.2.2. DNA extraction methodologies for Campylobacter quantification with real-time PCR ......... 63 
7.2.3. Real-time PCR ......................................................................................................................... 64 
7.2.4. Data analyses............................................................................................................................ 66 
7.3. Results ......................................................................................................................................... 68 
7.3.1. Results obtained from the different methods used to extract Campylobacter DNA from spiked 
fecal samples ...................................................................................................................................... 68 
7.3.1.1. Results related to DNA yields and purity ............................................................................. 68 
7.3.1.2. Results related to real-time PCR ........................................................................................... 69 
7.3.1.3. Standard curves, amplification efficiency and linearity ........................................................ 70 
7.3.2. Results related to the quantification of Campylobacter present in naturally infected chicken 
fecal samples from data analyses (placebo group only) .................................................................... 70 
7.3.2.1. Standard curves generated for absolute quantification ......................................................... 70 
7.3.2.2. Comparison of enumeration by culture and real-time-PCR.................................................. 71 
7.4. Discussion and conclusions ........................................................................................................ 72 
Manuscript III 
Garcia AB, Kamara JN, Vigre H, Hoorfar J, Josefsen MH. 2013. Direct quantification of 
Campylobacter jejuni in chicken fecal samples using real-time PCR: evaluation of six rapid DNA 
extraction methods. Food Analytical Methods, August 2013. 
 
Manuscript IV 
Garcia AB, Vigre H, Josefsen MH. Towards the production of reliable quantitative microbiological 
data for risk assessment: direct quantification of Campylobacter in naturally infected chicken fecal 
samples using real-time PCR. Submitted to Microbial Biotechnology, under review, 2013. 
 
8. THE USE OF PROBABILISTIC GRAPHICAL MODELS AND EXPERT SYSTEMS FOR 
THE CONTROL OF CAMPYLOBACTER IN POULTRY (MANUSCRIPTS V AND VI) ............. 78 
8.1. Introduction ................................................................................................................................. 78 
8.2. The design of probabilistic graphical models: epidemiological, microbiological and quantitative 
considerations..................................................................................................................................... 80 
8.3. The Development of a Decision Support Model for the Control of Campylobacter in UK 
Poultry farms (Manuscript V) ............................................................................................................ 92 
8.3.1. Introduction .............................................................................................................................. 92 
8.3.2. Materials and Methods ............................................................................................................. 93 
8.3.3. Results and discussion ............................................................................................................. 98 
8.4. The Development of a Decision Support Model for the Control of Campylobacter in Poultry 
farms in Denmark (Manuscript VI) ................................................................................................. 100 
8.4.1. Introduction ............................................................................................................................ 100 
8.4.2. Materials and Methods ........................................................................................................... 101 
8.4.3. Results and discussion ........................................................................................................... 105 
ManuscriptV 
Ana B. Garcia, Anders L. Madsen and Håkan Vigre. 2013. Integration of Epidemiological Evidence 
in a Decision Support Model for the Control of Campylobacter in Poultry Production. Agriculture 
3(3), pages 516-535. 
 
Manuscript VI 
Ana B. Garcia, Anders L. Madsen and Håkan Vigre. Prevention of human campylobacteriosis and a 
decision support system for the control of Campylobacter in chickens, Denmark. Submitted to 
Emerging Infectious Diseases, 2013. 
 
9.  GENERAL DISCUSSION AND CONCLUSIONS ................................................................... 107 
10. PERSPECTIVE AND FUTURE TRENDS ............................................................................... 118 
11. REFERENCES........................................................................................................................... 121 
Campylobacter Control in Poultry 
 
4 
 
12.  APPENDICES .......................................................................................................................... 159 
12.1. Appendix 1 .............................................................................................................................. 159 
12.2. Appendix 2 .............................................................................................................................. 161 
 
13. LIST OF ADDITIONAL MANUSCRIPTS .............................................................................. 168 
  
Campylobacter Control in Poultry 
 
5 
 
2. OUTLINE 
This thesis’ content is presented in four main chapters: 
- Chapter 5 Campylobacter: public health aspects and control strategies 
This Chapter includes background information on Campylobacter, human campylobacteriosis, 
Campylobacter sources and the epidemiology of Campylobacter in poultry. A review on 
Campylobacter control strategies that can be implemented in poultry production from farm to fork 
is presented. A variety of potential Campylobacter control strategies are considered with emphasis 
on vaccination against Campylobacter and other zoonotic pathogens in poultry. In addition, this 
Chapter includes background information on Campylobacter risk assessments and the evaluation of 
the potential public health impact of controls against Campylobacter in poultry production.   
- Chapter 6 Campylobacter vaccination trials (manuscripts I and II) 
Chapter 6 presents research conducted as part of the CamVac project such as vaccination clinical 
trials in chickens and investigations into sampling protocols to obtain accurate Campylobacter 
quantitative data. Accurate and reliable quantitative microbiological data are crucial for quantitative 
risk assessment models and for the evaluation of the effectiveness of food safety control measures. 
The sampling protocol (methods, sample size, sample origin, time of sampling and other aspects) 
will influence the quantitative microbiological data and data analyses results. Some of these 
sampling issues are explored further in this Chapter. Experimental infections and vaccination trials 
were conducted based on a nested fixed block design (no blinding) to test a Campylobacter vaccine 
candidate. The design of the experiments, data analyses, results and important considerations are 
included in this Chapter. 
- Chapter 7 Microbiological technologies for quantitative assessment of Campylobacter 
(manuscripts III and IV) 
The assessment of the effectiveness of vaccines and other control strategies that aim to reduce the 
numbers of Campylobacter in poultry depends on the quantitative microbiological techniques used. 
Chapter 7 presents research conducted to assess the complexity of obtaining accurate quantitative 
microbiological data related to the numbers of Campylobacter in chickens. Assessment of diverse 
quantitative microbiological techniques and quantitative data analyses to obtain reliable estimates of 
Campylobacter numbers from chicken fecal samples is presented in Chapter 7. Chicken fecal 
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samples represent complex matrices for the quantification of Campylobacter, still poultry feces are 
often the sample of choice for the routine testing of poultry flocks for Campylobacter. Quantitative 
risk assessment models, the evaluation of the effectiveness of control measures and mathematical 
models require accurate and reliable quantitative microbiological data.  
 
- Chapter 8 Probabilistic Graphical Models designed for the control of Campylobacter in 
poultry (manuscripts V and VI) 
Chapter 8 of this thesis focuses on the development of probabilistic graphical models (PGMs) to 
support decision making in order to control Campylobacter in poultry. The aim of PGMs is the 
efficient representation and integration of knowledge obtained from sources such as empirical 
observations, epidemiological data and expert opinions in order to support decision processes that 
have to be made under conditions of uncertainty. In many occasions, poultry producers need to 
make decisions regarding the implementation of control strategies before they even know if the 
flock will be infected or challenged with Campylobacter. PGMs may include many variables and 
represent complicated relationships among stochastic variables in an attractive, efficient and elegant 
way. The relationships of dependence or independence between the entities included in the models 
can be represented and the strength of the relationships can be defined using conditional probability 
distributions (Madsen et al., 2012). This Chapter presents several PGMs that have been designed to 
integrate epidemiological knowledge and financial data in order to assist poultry managers in the 
selection of cost-effective strategies (such as vaccination of commercial broilers) for the control of 
Campylobacter in poultry. 
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3. INTRODUCTION 
 
The term “poultry” is used in the title and throughout this PhD thesis as a synonym of chickens and 
broilers athough this term can refer to other birds bred for the production of meat or eggs. It was 
preferred to use the term poultry because some of the knowledge, information and/or reseach 
included in this thesis might refer to or could be applied to birds other than broilers. 
Human campylobacteriosis is a general term used to describe bacterial disease in humans caused by 
several members of the genus Campylobacter spp. The bacteria Campylobacter has been 
recognized as the main etiological agent causing human bacterial gastrointestinal disease (Friedman 
et al., 2000; Lindqvist  et al., 2001; Adak et al., 2002; Lin, 2009; Hermans et al., 2012). Children 
and adults can be severely affected by Campylobacter and the socioeconomic costs can be very 
high (Samuel et al., 2004). Human infections with Campylobacter pathogenic strains are 
characterized by nausea, vomiting, stomachache, malaise, profuse watery diarrhea, blood in feces 
and high fever (Blaser et al., 2008). The incubation period is usually 4 days but can vary from 2 to 
10 days. Patients are advised to drink fluids and to follow antibiotic treatment when there is 
bacteremia or a serious underlying disease. In general, amoxicillin, tetracycline, erythromycin and 
fluoroquinolones are effective against campylobacteriosis if the pathogen is not resistant to these 
antibiotics (Moore et al., 2006; Wassenar et al., 2007). The disease is usually self-limited but 
complications may occur such as reactive arthritis, the Guillain-Barré syndrome (Carter and 
Hudson, 2009; Shahrizaila and Yuki, 2011; Baker et al., 2012) and even death (Gradel et al., 2008). 
Campylobacter is usually associated with sporadic human cases of disease, however, outbreaks 
could be more common than previously thought (Gillespie et al., 2003; Miller et al., 2004; Fussing 
et al., 2007). Outbreaks have been linked to contaminated chicken, water, milk and other food items 
(Allos, 2001; Frost et al., 2002; Black et al., 2006; Baker et al., 2007). The epidemiology of 
Campylobacter remains poorly understood partly due to its widespread prevalence in the 
environment. It is known that livestock, domestic and wild animals (birds in particular) constitute 
important reservoirs, in fact, they may carry Campylobacter without the development of clinical 
signs which leads to the hypothesis that Campylobacter may be part of their natural intestinal 
microbiota (Whyte et al., 2004; Young et al., 2007; Ogden et al., 2009; Garcia et al., 2010a; 
Jokinen et al., 2011). There is increased evidence that, in many areas of the world, poultry, in 
particular broilers and chicken meat are the main contributors to human campylobacteriosis 
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(Wingstrand  et al., 2006; Wilson et al., 2008; Mullner et al., 2009; European Food Safety 
Authority [EFSA], 2010b; Friis et al., 2010; EFSA, 2011a; Hermans et al., 2012). The poultry 
reservoir has been identified as one of the main sources for human campylobacteriosis, actually it 
may account for 50% to 80% of human cases. In particular, according to the expert panel in EFSA, 
preparation and consumption of chicken meat could be the source for 20-30% of human 
campylobacteriosis cases (EFSA, 2010b). Contaminated poultry meat has been implicated in human 
campylobacteriosis outbreak investigations (Pebody et al., 1997) and case-control studies (Studahl 
and Andersson, 2000; Kapperud et al., 2003; Neimann et al., 2003; Nielsen et al., 2006; Stafford et 
al., 2007; Doorduyn et al., 2010).  
Efforts have been directed towards the control of Campylobacter in chickens as a strategy to reduce 
the risk of human campylobacteriosis. There is a general belief that effective Campylobacter 
controls implemented throughout the food chain from poultry farms to the consumers will provide 
greater public health benefits than controls applied only later in the food chain because 
Campylobacter may infect humans via other pathways than chicken meat (EFSA, 2010a). However, 
despite a great number of research studies, it does not seem that an effective general strategy has 
been implemented in broiler farms to consistently produce Campylobacter free chickens (Hermans 
et al., 2011). The production of Campylobacter-free broiler flocks is possible but often expensive 
and difficult to achieve due to the fact that considerable investments in control strategies that are 
difficult to maintain might be necessary (Loc Carrillo et al., 2005; Wagenaar et al., 2006; 
Wassenaar, 2011; Hermans et al., 2012). Even when this aim is achieved, Campylobacter-free 
flocks might be contaminated at slaughter (Rivoal et al., 2005). 
The identification of important risk factors for the introduction of Campylobacter in broiler flocks 
may assist on the implementation of efficient controls. Strict bio-security may result in a significant 
reduction of the probability of Campylobacter infection of poultry flocks. Some studies have found 
a clear correlation between the level of biosecurity and flock infection with Campylobacter 
(Cardinale et al., 2004; Johnsen et al., 2006). Nonetheless, strict biosecurity might be difficult to 
achieve and maintain throughout poultry production operations. In order to reduce the public health 
risk, controls against Campylobacter should be implemented during the farming period but also 
during the transport of poultry, at slaughter and during the production of poultry products and by-
products. Some control strategies will aim to prevent Campylobacter contamination of chickens and 
their products while other interventions such as vaccination will aim to reduce the numbers of 
Campylobacter in already contaminated animals, their products and by-products.  
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Chickens might carry Campylobacter in numbers as high as 1010 Colony Forming Units (CFU) per 
gram of faeces (Stas et al., 1999; Sahin et al. 2002; Lütticken et al., 2007). Birds infected with 
Campylobacter will contaminate the food processing environment. The concentration of 
Campylobacter on chicken carcasses and Campylobacter numbers in caeca are positively correlated 
(Berrang et al., 2004a; Reich et al., 2008). In alignment with this knowledge, it can be assumed that 
a reduction of the amount of Campylobacter in the intestinal tract of chickens will result in a 
decrease of the numbers of Campylobacter present in chicken meat. In addition, risk assessment 
models indicate that a 2 log reduction of Campylobacter in chicken carcasses may translate into a 
decrease of human campylobacteriosis cases by 30 times (Rosenquist et al., 2003; Reich et al., 
2008). The assumption that a reduction in the amount of Campylobacter in the intestinal tract of 
chickens will result in a decreased risk of human campylobacteriosis serves as basis for the research 
project (CamVac) that is the foundation for this Phd thesis. The CamVac project aims to develop a 
cost-effective vaccination strategy that can reduce the numbers of Campylobacter in infected 
chickens by at least 2 logs (CamVac, 2012). The work presented in this thesis has been conducted 
as part of the CamVac project and covers the following topics: clinical trials of vaccines, 
assessment of quantitative microbiological methods and development of decision support tools for 
the control of Campylobacter in poultry.  
 
Nowadays, consumers demand safer food putting pressure on governments and food industries all 
over the world to improve food safety and reduce the risk of food-borne illnesses. Risk analysis 
(risk assessment, management and risk communication) is used by governments and public health 
agencies worldwide as a structured, science-based, integrated tool to reduce the risk of foodborne 
illness (Taylor and Hoffman, 2001). The food industry, government agencies and the society as a 
whole may benefit from the use of the assessment of quantitative microbiological techniques, 
vaccination trials and mathematical models developed in this thesis for the control of 
Campylobacter in poultry. Even though models are not perfect but limited representations of the 
reality, the models presented in this thesis may assist poultry producers in strategic decision making 
for the control of Campylobacter. In addition, efforts directed towards the control of an important 
public health issue such as Campylobacter will have a positive impact on consumers’ perceptions 
related to food safety, the food industry and public health agencies. 
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4. OBJECTIVES 
 
Human campylobacteriosis represents an important public health problem and reducing the burden 
of disease in humans is considered a priority in many areas of the world. Poultry has been identified 
as a significant source for human campylobacteriosis cases and consequently the control of 
Campylobacter in poultry is crucial for the reduction of human cases. The aim of this thesis was to 
assist in the control of Campylobacter in poultry. The main objectives were: 
 
• To provide a general overview of control strategies against Campylobacter in poultry and 
public health implications 
• To explore vaccination strategies against Campylobacter in poultry and to assess vaccine 
effectiveness in a particular clinical trial 
• To investigate several quantitative microbiological methods for the accurate and fast 
enumeration of Campylobacter present in poultry fecal material 
• To develop mathematical models and decision support systems that can integrate knowledge 
to aid on decision making regarding Campylobacter control strategies in poultry production. 
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5. CAMPYLOBACTER: PUBLIC HEALTH ASPECTS AND CONTROL STRATEGIES IN 
POULTRY PRODUCTION  
 
5.1. Human campylobacteriosis 
 
Human campylobacteriosis represents an important public health problem and the burden of disease 
is considerable even though the numbers of reported cases have decreased slightly in some areas of 
the world (Samuel et al., 2004; Ailes et al., 2008; European Food Safety Authority [EFSA] and 
European Centre for Disease Prevention and Control [ECDC], 2011). Human campylobacteriosis 
seems to be a particularly important problem in New Zealand where almost 400 cases per 100,000 
habitants have been reported (Baker et al., 2007; Baker and Wilson, 2007; French, 2008). The 
possibility that the high number of human campylobacteriosis cases in New Zealand may be due to 
an effective reporting system has been considered. Researchers have reported that the increase in 
human Campylobacteriosis cases in New Zealand is real and not only due to changes in the 
reporting system (McNicholas et al, 1995; Baker et al., 2007). The overall number of reported 
campylobacteriosis cases in Europe was 45.6 cases per 100,000 persons in 2009 (EFSA and ECDC, 
2011). However, it has been estimated that in Europe the true incidence of human 
campylobacteriosis can reach up to twenty million per year due to the effect of underreporting 
(EFSA, 2010a, 2011b). In addition to the personal consequences caused by the disease there are 
important socioeconomic costs associated with human campylobacteriosis caused by visits to the 
doctors, absence from work, hospitalizations and problems due non-diagnosed sequalae (Kemmeren 
et al., 2006). 
 
The most frequently identified Camplylobacter spp. associated with human disease have been 
identified as C. jejuni and C.coli (Nachamkin and Blaser, 2000; Friedman et al., 2000; Allos, 2001; 
Gillespie et al., 2002; Tam et al., 2003; Lin, 2009; Hermans et al., 2012). In fact, it was observed 
that of the human campylobacteriosis cases characterized to species level in the EU in 2009, 
C.jejuni accounted for 90% of the cases, followed by C. coli, C. lari and C. upsaliensis 
corresponding to 2.5%, 0.2%, and 0.01% of the isolates respectively (EFSA and ECDC, 2011). 
The disease is self-limited in most cases in adults and non-immune-compromised individuals. Still, 
complications may occur such as post-infection irritable bowel syndrome and reactive arthritis 
(ReA). The ReA syndrome can be characterized by conjunctivitis, urethritis and/or arthritis 
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(Altekruse et al., 1999; Allos, 2001; Carter and Hudson, 2009). Furthermore, the Guillain-Barré 
syndrome (GBS) may be developed, a neurological disorder that has been identified as the most 
frequent cause of acute neuromuscular paralysis in humans (Nachamkin et al., 1998, 2000; Jacobs 
et al., 2008; Van Doorn et al., 2008; McGrogan et al., 2009; Shahrizaila and Yuki, 2011; Baker et 
al., 2012). Reactive arthritis and the Guillain-Barré syndrome are considered to be caused by 
autoimmune responses to Campylobacter infections. Human campylobacteriosis may rarely result 
in long term disabilities or even death (Helms et al., 2003, 2006). Some persons are at higher risk of 
suffering severe symptoms (deriving in hospitalization and/or death) such as immunocompromised 
individuals, very young and very old persons (Helms et al., 2003; Gradel et al., 2008). Furthermore, 
Campylobacter strains that are resistant to the most commonly used antibiotics represent a 
challenge for the treatment of human campylobacteriosis (Moore et al., 2006). Recommendations 
regarding careful, safe and effective use of antibiotics in food-producing animals have been made to 
protect public health (WHO, 2000). In fact, a correlation between ciprofloxacin-resistant 
Campylobacter and poultry consumption has been observed. Additionally, associations between 
particular Campylobacter strains and antibiotic resistance have been detected (Kinana, 2006; Habib, 
2009). 
 
Human campylobacteriosis is hyperendemic in many developing areas of the world and the disease 
differs from campylobacteriosis in developed countries (Coker et al., 2002; Islam et al., 2006). In 
developing areas, campylobacteriosis is predominantly a pediatric problem affecting children under 
the age of five while adults are generally less prone to the disease (Oberhelman and Taylor, 2000; 
Coker et al., 2002). Humans that are continuously challenged with Campylobacter might develop 
protection against clinical disease and become asymptomatic carriers (Blaser et al., 1985).  A more 
favorable clinical outcome has been observed in human volunteer studies where humans have been 
re-challenged with the same Campylobacter strain (Black et al., 1988). Immune response against 
Campylobacter seems to differ between Campylobacter strains. Particular C. jejuni strains can 
induce immune response in the host to a higher degree than other strains (Pancorbo et al., 2001). 
Additionally, differences in human hosts’ immune reactions might explain disease outcomes such 
as the development of the Guillain-Barré Syndrome (Shahrizaila and Yuki, 2011). 
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5.2. Campylobacter reservoirs and sources 
 
Campylobacter is frequently found in surface water and other environmental niches (Hanninen, 
1998; Carrique-Mas et al., 2005; Sopwith et al., 2008; Jokinen et al., 2011). Campylobacter 
bacteria seem to be sensitive to heat (Waterman, 1982; Christopher et al., 1982; Sörquist, 1989), 
desiccation (Doyle and Roman, 1982), irradiation (Isohanni and Lyhs, 2009), freezing (Georgsson 
et al., 2006; Sandberg et al., 2005) and acids (Birk et al., 2010; Chaveerach et al., 2002, 2003). On 
the other hand, Campylobacter can survive in foods at chill temperatures of around 5°C (Lee et al., 
1998; Solow et al., 2003; Bhaduri and Cottrell, 2004). Campylobacters are considered fragile 
bacteria but paradoxally they can survive in the environment outside hosts for long periods probably 
by developing survival mechanisms (Newell, 2002, Murphy et al., 2006). In fact, the presence of 
highly mutable areas on the genome of C. jejuni could explain survival and adaptation mechanisms 
(Jerome et al., 2011). Moreover, particular environments (such as fecal material and some foods) 
might represent protective vehicles for Campylobacter. Biofilm formation can play an important 
role in the epidemiology of Campylobacter infections (Gunther and Chen, 2009; Garcia and 
Percival, 2011). Campylobacter bacteria are ubiquitous and can be found widespread in the 
environment and animals. Multiple sources of Campylobacter and risk pathways can be associated 
with human exposure to this microorganism (EFSA, 2011b). 
Birds are considered natural hosts for Campylobacter and may harbour Campylobacter in high 
numbers contributing to its survival and dissemination (Newell and Wagenaar, 2000; Waldenstrom 
et al., 2002). Molecular epidemiological studies have identified poultry as an important source for 
human campylobacteriosis but also ruminants and other sources (Sheppard et al., 2009a, 2009b; de 
Haan et al., 2010). Campylobacter is frequently present in the intestines of cattle and sheep and 
may contaminate the food processing environment and food products posing a public health risk for 
the consumers (Nachamkin and Blaser, 2000; Wesley et al. 2000; Dykes and Moorhead 2001; 
Garcia et al., 2010a/b). Numerous epidemiological studies have been conducted to identify potential 
sources for human campylobacteriosis, in fact, consumption and handling of poultry meat and direct 
contact with animals seem to be the most common and important sources (Kapperud et al., 1992; 
Eberhart-Phillips et al., 1997; Friedman et al., 2000; Studahl and Andersson, 2000; Rodrigues et al., 
2001; Stafford et al., 2007, 2008; Tamm et al., 2009). Several risk factors have been identified as 
significant sources in a recent meta-analysis such as eating undercooked chicken, direct contact 
with farm animals, environmental sources and foreign travel (Dominguez et al., 2012).  
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Source attribution models developed based on Multi Locus Sequence Typing (MLST) data have 
identified poultry as one of the most important source of human campylobacteriosis (Sheppard et 
al., 2009a/b; Mullner et al., 2009; Mughini Gras et al., 2012).  In general, C. jejuni is the most 
commonly isolated species in birds of around six weeks of age. However, C. coli is more frequently 
identified in older animals and particularly from organic systems (El-Shibiny et al., 2005). Poultry 
flocks and individual chickens might be infected with different Campylobacter strains at the same 
time (Jacobs-Reitsma et al., 1995; Stern et al., 1997; Rivoal et al., 1999). Furthermore, mixed 
infections can result in new strains through the exchange of genetic material (Jacobs-Reitsma et al., 
1995; De Boer et al., 2002; Hook et al., 2005). In particular, Campylobacter strains resistant to 
antibiotics may interfere with the treatment of human campylobacteriosis (Moore et al., 2006). The 
use of vaccines in food producing animals could alleviate the problems related to antimicrobial 
resistance (Lütticken et al., 2007). 
 
5.3. The epidemiology of Campylobacter in chicken flocks  
 
A harmonized baseline survey was conducted in EU in 2008 in order to estimate the prevalence of 
Campylobacter in broilers and on broiler meat (EFSA, 2010a). Campylobacter prevalence on 
broilers and their meat varied between countries (from 5 to 100%). A trend to obtain higher 
Campylobacter concentrations in broiler meat in geographical areas with a higher Campylobacter 
prevalence was observed (EFSA, 2010a). Broilers are considered Campylobacter free after hatching 
and in general, broiler flocks remain Campylobacter free for the first two weeks (Annan-Prah and 
Janc, 1988; Stern, 1992). Nonetheless, most chickens intended for human consumption are heavily 
and persistently colonised with Campylobacter representing an important public health risk. In 
modern poultry production systems, chickens grow to a slaughtering weight within four to six 
weeks, and during this relatively short period of time, Campylobacter may be introduced into the 
flocks and colonize chickens (Wagenaar et al., 2006). Prevalence of Campylobacter in broiler 
flocks can vary between 3 and 91% (EFSA, 2010a). In chickens infected with Campylobacter, 
colonization and shedding patterns depend on a number of factors, such as the bacterial strain 
(Cawthraw et al., 1996; Ringoir and Korolik, 2002; Conlan et al., 2007; Janssen et al., 2008). 
Several risk factors can result in the introduction of Campylobacter into the flocks making it 
difficult to keep chicken flocks free of Campylobacter throughout the rearing period. To increase 
the knowledge about why and how chicken flocks become infected with Campylobacter during the 
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rearing period, several observational studies have been carried out, focusing on different parts of the 
production processes and practices. Most epidemiological studies have focused on the outcome 
being the flock becoming infected, not considering the within flock prevalence nor the amount of 
Campylobacter in the infected chickens. Important risk factors for the introduction of 
Campylobacter into chicken flocks include season (Kapperud et al., 1993; Jacobs-Reitsma et al., 
1994; Refregier-Petton et al, 2001; Bouwknegt et al., 2004; Barrios et al., 2006; Zweifel et al., 
2008; McDowell et al., 2008; Ellis-Iversen et al., 2009; Jore et al., 2010), the type of production 
system (Näther et al., 2009), age of the birds at the time of sampling (Evans and Sayers, 2000; 
Bouwknegt et al., 2004; Barrios et al., 2006; McDowell et al., 2008), partial depopulation practices 
(Hald et al., 2000; Ellis-Iversen et al., 2009), human traffic and farm equipment (Ramabu et al., 
2004) size of the flock (Barrios et al., 2006; Nather et al., 2009), water from a private supply 
(Lyngstad et al., 2008), type of drinking water systems (Näther et al., 2009), the presence of other 
animals on farm or very close to the poultry farm  (Bouwknegt et al. 2004; Lyngstad et al., 2008; 
Ellis-Iversen et al., 2009) and general farm hygiene (Hald et al., 2000; Evans and Sayers, 2000; 
McDowell et al., 2008). An association between Campylobacter status of broiler flocks and health 
and welfare of the birds has been suggested (Bull et al., 2008). The increased risk of Campylobacter 
introduction in poultry flocks attributable to partial depopulation practices could be partly explained 
by a confounding effect with age (Russa et al., 2005). Nevertheless, partial depopulation was found 
to be a significant risk factor even after adjusting for confounding with age in a study conducted by 
Lawes et al., 2012. Human traffic on farm has also been reported as an important pathway for the 
introduction of Campylobacter into poultry flocks (Kapperud et al., 1993; Berndtson et al., 1996; 
Evans and Sayers, 2000; Hald et al., 2000; Cardinale et al., 2004; Hofshagen and Kruse, 2005). The 
number of poultry houses onsite has also been identified as a significant risk factor in some studies. 
The risk of Campylobacter infection increased with the presence of three or more houses on the 
same farm in France (Refregier-Petton et al., 2001) and five or more houses on the same poultry 
farm in the Netherlands (Bouwknegt et al. 2004). A strong association has been found between the 
presence of rodents in poultry farms and Campylobacter infection in poultry (Gregory et al., 1997; 
McDowell et al., 2008). 
 
The incidence and prevalence of Campylobacter in positive broiler flocks varies depending on 
geographical, farming and environmental conditions. Seasonality effects have been observed with a 
marked peak during summer much more noticeable in Northern Europe than in Southern Europe 
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(Nylen et al., 2002). Seasonality effects could be explained by environmental factors such as 
humidity, temperature and sunlight that require further investigation (Wallace et al., 1997; 
Arsenault et al., 2007; Guerin et al., 2008). The observed increased risk of Campylobacter 
introduction during the summer seemed to be more apparent in younger birds in a study conducted 
by Lawes et al. (2012). These authors suggested that broilers could be infected earlier during the 
summer due to increased pathogen survival in the environment. Seasonality effects have been 
detected regarding human campylobacteriosis cases (Nylen et al., 2002; Bi et al., 2008) and 
Campylobacter infections in chickens (Patrick et al., 2004; Reich et al., 2008; Jore et al., 2010; 
Jorgersen et al., 2011; Nichols et al., 2012). Human infections with the clonal complexes ST-45 and 
ST-283 (both types have been frequently identified from chicken isolates) increase during early 
summer (Sopwith et al., 2006; de Haan et al., 2010; McCarthy et al., 2012). Pathogen infection 
pressure might increase during warmer periods in some areas of the world (Hald et al., 2004, 2007) 
partly explaining an increase of Campylobacter prevalence in chickens and humans. Climate and 
environmental factors could partly explain seasonality effects (Louis et al., 2005; Kovats et al., 
2005; Tam et al., 2006). Remarkably, the increase in human cases can sometimes occur previous to 
infections in chickens suggesting that there might be a common risk factor responsible for the 
increase in Campylobacter cases. Flies can transmit Campylobacter to chickens and humans and 
they could partly explain the seasonality of human cases (Nichols, 2005; Ekdahl et al., 2005; Hald 
et al., 2004, 2007a, 2008; Nelson et al., 2006; Guerin et al., 2008; Nichols, 2010). 
The numbers of Campylobacter in broilers may exceed 7.0 log cfu/gr of caecal content (Rosenquist 
et al., 2006). In actual fact, the colonization level can be as high as 1010 CFU per g of faeces (Stas et 
al., 1999; Sahin et al. 2002; Lütticken et al., 2007). Campylobacter infective dose for chickens 
depends also on the colonizing strain. Transmission dynamics on the population are difficult to 
model mathematically (Conlan et al., 2007). Though, it has been suggested that once a bird has 
been colonized by Campylobacter, the rest of the birds in the same house will be contaminated 
within one week (Jacobs-Reitsma, 1997). Campylobacter colonizes the chicken intestine, multiplies 
in the intestinal mucus layer being able to re-invade epithelial cells (Van Deun et al., 2008). 
Campylobacter might be able to regulate gene expression of epithelial cells in chickens (Artis, 
2008). Several Campylobacter spp. genomes have been sequenced suggesting a significant diversity 
between isolates (Parkhill et al., 2000; Gundogdu et al., 2007). Characterized Campylobacter 
colonization factors and pathogenic factors can be considered for use in vaccine development 
(Jagusztyn-Krynicka et al., 2009). Campylobacter ability to control genetic expression for adaption 
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to different environmental conditions and the ability to form biofilms have been identified as 
important factors for chicken colonization (Kalmokoff et al., 2006; Van Deun et al., 2008; Gunther 
and Chen, 2009; Garcia and Percival, 2011). Researchers have identified Campylobacter’s most 
critical metabolic pathways and the genes that regulate them which could serve as basis for the 
development of new antimicrobials and/or new vaccines (Institute of Food Research [IFR], 2012). 
Campylobacter can be found in ceca, intestine and cloaca in very high numbers (Stas et al., 1999; 
Corry and Atabay, 2001; Sahin et al. 2002; Lütticken et al., 2007). The amount of faecal spillage 
during food processing will directly affect meat contamination with Campylobacter (Berrang et al., 
2004a). Moreover, poultry processing can lead to cross/contamination of chicken carcases. There 
are specific areas or processes in food premises that can be considered higher risk for food 
contamination and might become critical control points. Food processing areas that constitute 
critical control points in poultry processing plants are usually scalding, defeathering and 
evisceration (Stern and Robach, 2003; Takahashi et al., 2006). Automated defeathering represents a 
high risk practice since cloacal contents can cause contamination of the carcases (Berrang et al., 
2001). The concentration of Campylobacter on chicken carcasses and Campylobacter numbers in 
caeca are positively correlated. In fact, small amount of cecal contents may increase the numbers of 
Campylobacter on carcasses (Berrang et al., 2004a; Reich et al., 2008). 
A reduction of Campylobacter numbers in the intestinal tract of chickens will translate in a decrease 
of the numbers of Campylobacter present in chicken meat. This fact serves as basis for the 
development and implementation of vaccination strategies and other controls that aim to reduce the 
numbers of Campylobacter in the intestinal tract of chickens to achieve a reduction of 
Campylobacter in chicken meat which may translate on a decrease of human campylobacteriosis 
cases (Rosenquist et al., 2003; Reich et al., 2008). A decline in reported human campylobacteriosis 
cases was observed in the Netherlands and Belgium when the consumption of chicken meat was 
temporarily limited. Furthermore, a decrease on human cases has been documented in Iceland and 
New Zealand following interventions against Campylobacter in poultry (Vellinga et al., 2002; Stern 
et al., 2003; EFSA, 2010a; Sears et al., 2011). Therefore, it is possible that a reduction on chicken 
meat consumption and/or the effective implementation of Campylobacter controls in poultry will 
translate on a decrease of human campylobacteriosis cases.  
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5.4. Campylobacter control strategies in poultry production 
Campylobacter control programmes have been implemented to reduce the prevalence of 
Campylobacter in broilers in order to decrease the burden of human campylobacteriosis. On the 
other hand, it seems difficult to compare the effectiveness of these controls between different 
countries due to a number of factors such as the use of different sampling and testing protocols. 
Campylobacter prevalence and concentration in chickens and their products can be high posing a 
public health risk (EFSA, 2010b). Effective controls should be implemented along the food chain in 
order to reduce Campylobacter concentration and prevalence in poultry (Figure 1). 
 
 
Figure 1 Graph illustrating poultry production stages from farm to fork. 
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Campylobacter control strategies should be implemented along the food chain (Reich et al., 2008) 
and used synergistically in order to reduce the incidence of human campylobacteriosis.  The 
synergistic effect of control measures implemented at all levels of the food chain should be properly 
assessed. Campylobacter control measures at farm level may include the identification of the most 
significant risk factors, increased bio-security, use of effective vaccines, use of phage therapy and 
husbandry measures (e.g. chlorinated water and/or food additives) to mention a few. Campylobacter 
control strategies in poultry farms based on increased biosecurity levels aim to reduce the 
probability of Campylobacter introduction in poultry flocks. Other controls such as the use of 
probiotics, effective vaccines or novel antibacterial treatments try to reduce Campylobacter burden 
in poultry (Newell et al., 2011; Djenane and Roncalés, 2011).  
 
Campylobacter controls should be implemented during transport of poultry, slaughter and 
processing. High levels of hygiene should be maintained during poultry processing to control 
Campylobacter contamination of chicken products. Cleaning and disinfection of poultry processing 
plants should be thorough and effective. In actual fact, Campylobacter may survive in surfaces after 
cleaning and disinfection of the processing plant posing an additional risk to meat contamination 
(Peyrat et al., 2008). Decontamination treatments such as freezing can be implemented as a 
compliment to high levels of hygiene. Contamination of food products during transport and storage 
should be avoided. Effective controls such as high level of hygiene, decontamination techniques, 
freezing and the use of new technologies may assist in reducing Campylobacter numbers in 
chickens, their products and by-products. Some controls will aim to prevent contamination of 
Campylobacter free products while other measures will intent to reduce the numbers of 
Campylobacter in already contaminated animals and their products. Decontamination technologies 
should be a compliment to preventive control measures and good hygiene practices (GHP). The 
food industry needs to comply with legal requirements and the implementation of “Hazard Analysis 
and Critical Control Points” (HACCP), an internationally recognized food safety management tool.  
Nonetheless, food safety is everyone’s responsibility and consumers may get infected with 
Campylobacter at home via different routes: directly from contaminated hands or insufficiently 
cooked infected chicken, direct contamination of raw foods from chicken carrying Campylobacter 
and indirectly through contaminated kitchen surfaces and tools. A large number of food-borne 
disease cases may be due to unsafe handling of food in kitchens (Zhao et al., 1998).  Kitchen 
hygiene should be improved 30 times in order to reduce the incidence of human campylobacteriosis 
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(Rosenquist et al., 2003). Eating raw chicken meat may translate in human exposure to 
Campylobacter up to 1010 times higher than the exposure level when the product is properly cooked 
(Uyttendaele et al., 2006). Consumer education is crucial to prevent human campylobacteriosis and 
it has been promoted by governments in many areas of the world.  
 
5.4.1. Campylobacter controls in poultry primary production 
 
Campylobacter control strategies implemented during poultry primary production, defined as the 
on-farm rearing of poultry, are crucial for the control of this significant public health issue. The 
identification of important risk factors for the introduction of Campylobacter in broiler flocks (see 
Thesis Introduction) will assist on the selection and implementation of efficient controls. It is 
interesting to notice that estimated Campylobacter prevalence in the environment around broiler 
houses from different farms seems to be quite similar independently of the biosecurity level (Hald 
et al., 2000; Hansson et al., 2007; Ridley et al., 2011a). Therefore, Campylobacter must be carried 
from the environment into chicken houses somehow and human traffic has been identified as an 
important vehicle for this transmission (Kapperut et al. 1993; Berndtson et al., 1996; Evans and 
Sayers, 2000; Cardinale et al., 2004; Hofshagen and Kruse, 2005). Campylobacter strains isolated 
from hands, boots and clothes of farm staff, catchers and farm managers have been associated with 
Campylobacter strains present in broiler flocks (Herman et al., 2003; Ramabu et al., 2004; Johnsen 
et al., 2006; Ridley et al., 2008b, 2011a/b). The number of staff members and the number of human 
visits to the poultry houses have been found to increase the risk of introducing Campylobacter into 
poultry flocks (Refregier-Petton et al., 2001; Huneau-Salaun et al., 2007; Chowdhury et al., 2012). 
Campylobacter can survive well in water (Blaser et al., 1980) and a close association between rainy 
weather and Campylobacter prevalence in puddles or standing water around chicken houses has 
been reported (Hansson et al., 2007). Additionally, Campylobacter strains isolated from soil and 
puddles around broiler houses in many cases can be identical to the strains isolated from the flocks 
supporting the hypothesis of Campylobacter transfer from the external environment into the broiler 
houses (Herman et al., 2003; Bull et al., 2006; Messens et al., 2009). 
 
Campylobacter survives in poultry litter posing a risk for the infection of new flocks when poultry 
waste is stored on farm (Petersen et al., 2001; Rothrock et al., 2008). In fact, the risk of 
Campylobacter infection of flocks may increase significantly when the distance between the poultry 
house and used litter is less than 200 meters (Cardinale et al., 2004; Arsenault et al., 2007). 
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Consequently, adequate removal and treatment of used litter from the farm will potentially decrease 
the risk of Campylobacter infection in poultry. Removal of dead chickens from the house may also 
reduce the risk of a Campylobacter positive flock (Evans and Sayers, 2000).  
 
The presence of other livestock on the same farm has been identified as a risk factor for the 
introduction of Campylobacter in poultry flocks in several studies (van de Giessen et al., 1996; 
Cardinale et al., 2004; Bouwknegt et al. 2004; Lyngstad et al., 2008; Ellis-Iversen et al., 2009). 
Recommendations have been made to minimize the presence of other livestock on poultry farms 
and/or to implement effective biosecurity barriers (Kapperud et al. 1993; Neubauer et al. 2005; 
Hald et al., 2007a/b). Biosecurity barriers should protect poultry by providing an effective physical 
separation between the “contaminated” environment outside the houses and the “protected” 
environment inside poultry houses. For example, an area at the entrance of a poultry house 
containing protective clothes, boots boot dips and hand washing facilities constitute a hygiene 
barrier. Nonetheless, the effectiveness of biosecurity barriers may vary between farms making the 
assessment of hygiene barriers as protective factors quite difficult (Neubauer et al., 2005). On the 
other hand, a significant reduction of the risk of Campylobacter infection of poultry flocks is 
possible to achieve by the effective use of biosecurity barriers specially when there are other 
animals on farm (van de Giessen et al., 1992; Berndtson et al., 1996; van de Giessen et al., 1998; 
Evans and Sayers, 2000; Hald et al., 2000).  
The poultry house becomes contaminated with Campylobacter for a long time when a poultry flock 
becomes positive (Hiett et al., 2002; Herman et al., 2003; Johnsen et al., 2006). As a result, the 
presence of previous Campylobacter positive flocks in a house has been considered a risk factor for 
Campylobacter infection of new flocks (Refregier-Petton et al., 2001; Chowdhury et al., 2012). 
Cleaning and disinfection of poultry houses should be effective inactivating Campylobacter.  
Campylobacter does not seem to be present in clean litter (Jacobs-Reitsma et al., 1995) and feed 
(Mills et al., 2003) unless they become contaminated during transport and storage although these 
materials are very dry making Campylobacter survival difficult. Conversely, wet litter has been 
shown to be a significant risk factor increasing the risk of infection with Campylobacter (Berndtson 
et al., 1996). Poor quality of drinking water has been identified as a risk factor for Campylobacter 
in several epidemiological studies (Sparks, 2009). The use of unchlorinated water or failure of water 
treatments may introduce Campylobacter in poultry houses (Newell and Fearnley, 2003).  
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The application of hygienic measures and general biosecurity barriers such as the use of separate 
boots between houses and footbath disinfection when entering broiler houses between many others 
may reduce the risk of Campylobacter infections in birds considerably (van de Giessen et al., 1996; 
Evans and Sayers, 2000). Indeed, the prevalence of Campylobacter in broiler flocks decreased from 
66% to 22% on a farm and from 100% to 42% in another broiler farm in the Netherlands due to the 
introduction of hygienic measures and biosecurity barriers such as the control of rodents and insects 
(van de Giessen et al., 1998). The use of house-specific clothes (Hald et al., 2000; Bouwknegt et 
al., 2004), boots (van de Giessen et al., 1996; Evans and Sayers, 2000; Bull et al., 2006) and boot 
dips (van de Giessen et al., 1996; Evans and Sayers, 2000; Gibbens et al., 2001; Bouwknegt et al., 
2004; McDowell et al., 2008)  and the application of overshoes (Puterflam et al., 2005) can 
potentially reduce the risk of Campylobacter infection of poultry flocks. 
 
Depopulation practices such as thinning have been identified as a significant risk factor for 
Campylobacter infection of poultry due to poor biosecurity maintained during these practices (Hald 
et al., 2001; Refregier-Petton et al., 2001; Bouwknegt et al., 2004; Puterflam et al., 2005; Barrios et 
al., 2006; EFSA, 2010a). The risk of introducing Campylobacter in poultry flocks during thinning 
was higher when the crews were larger (Puterflam et al., 2005). In a study conducted by Allen et al. 
(2008a) a Campylobacter strain was isolated from a farm following thinning and from the catcher’s 
hand and it was very similar to the strain recovered from a crate used during thinning.  
On the other hand, after adjusting depopulation practices for confounding with season and age, the 
importance of thinning in introducing Campylobacter in poultry flocks has been questioned (Russa 
et al., 2005). Nevertheless, the risk of introducing Campylobacter during depopulation practices 
could be reduced (Berndtson et al., 1996; Barrios et al., 2006). A relationship between the time of 
depopulation and Campylobacter prevalence in poultry has been observed; Campylobacter 
prevalence might be higher when thinning occurs long time before slaughter (Allen et al., 2008a). 
Increased biosecurity controls during depopulation practices could prevent Campylobacter infection 
in poultry. A clear correlation between the level of biosecurity and poultry flock infection with 
Campylobacter has been observed in Norway and Senegal (Cardinale et al., 2004; Johnsen et al., 
2006). Increased biosecurity could be important at times of the year when the risk of introducing 
Campylobacter in broiler flocks is considered high due in part to seasonality effects (Kapperud et 
al. 1993; Jacobs-Reitsma  et al., 1994; Berndtson et al., 1996; Evans and Sawyers, 2000; Refregier-
Petton et al., 2001; Bouwknegt et al., 2004; Hofshagen and Kruse, 2005; Puterflam et al., 2005; 
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Russa et al., 2005; Barrios et al., 2006; Johnsen et al., 2006; McCrea et al., 2006; Hansson et al., 
2007; Huneau-Salaun et al., 2007; McDowell et al., 2008). Seasonality trends have been observed 
in many areas of the world with a seasonal peak usually happening during summer and/or early 
autumn although the extent and exact time of this peak varies between countries (EFSA, 2010a). 
The cause for this seasonality is not known but it could be related to the breeding of flies (Hald et 
al., 2007a/b). The role of insects in Campylobacter contamination of poultry houses is not clear. 
The presence of insects was not found a significant risk factor in some epidemiological studies 
(Berndtson et al., 1996; Refregier-Petton et al., 2001). Besides, in some studies Campylobacter was 
not recovered from insects or it was isolated only after the birds became infected with 
Campylobacter (Jones et al., 1991; Jacobs-Reitsma et al., 1995; Bates et al., 2004; Neubauer et al. 
2005). Nevertheless, a number of researchers believe that flies can transmit Campylobacter to 
chickens and humans partly explaining the seasonality of human cases (Nichols, 2005; Ekdahl et 
al., 2005; Hald et al., 2004, 2007a,2007b, 2008; Nelson et al., 2006; Guerin et al., 2008; Nichols, 
2010). In Denmark, flies have been identified as one of the most important risk factor for the 
introduction of Campylobacter in broiler flocks. In this country, Campylobacter prevalence in 
broiler flocks is highest during the summer. Studies conducted in Denmark showed that 70% of the 
flies captured around poultry houses carried Campylobacter and that the use of fly screens to 
prevent the access of flies to poultry houses reduced Campylobacter incidence in flocks from 51.4% 
to 15.4% during the summer (Hald et al., 2004, 2007a, 2007b). 
Campylobacter might be present in poultry houses’ air but it is believed that air contamination 
happens after flock colonization (Pearson et al., 1993). Though, some types of ventilation systems 
have been identified as risk factors for Campylobacter colonization of poultry such as horizontal 
(Barrios et al., 2006), static (Refregier-Petton et al., 2001) and nebulization systems. For example, a 
refrigeration system based on nebulization has been identified as the most important risk factor for 
the introduction of Campylobacter in broiler flocks in the South of Spain (personal 
communication).  
 
Campylobacter spreads fast within poultry flocks (Jacobs-Reitsma, 1997) and consequently control 
measures that can impede Campylobacter spread, reduce the speed of transmission and/or decrease 
the numbers of Campylobacter in already contaminated chickens, flocks and poultry houses should 
be selected and implemented. 
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Campylobacter appears sensitive to acidic conditions, therefore, control strategies have been 
developed based on the acidification of feed (Line, 2002), water and the environment. The use of 
feed additives may assist on the control of Campylobacter in chickens. However, feed acidification 
seems to have a limited effect on the prevalence of Campylobacter in broiler flocks (Heres et al., 
2004; Line and Bailey, 2006; Solis de los Santos et al., 2008). A reduction of Campylobacter 
colonization in broilers was obtained after the addition of a combination of 2% formic acid with 
0.1% sorbate (Skånseng et al., 2010) and the addition of fatty acids to the feed (van Gerwe et al., 
2010). The use of enzymes as growth promoters alone or in combination with organic acids has 
been proposed (Anjum and Chaudhry, 2010).  
 
Genetic selection of poultry with superior immunological responses to Campylobacter could be 
explored further (Kapperud et al., 1993; Swaggerty et al., 2009). Successful vaccines will probably 
be the most effective control against Campylobacter but the availability of a cost-effective 
commercial vaccine remains a major goal (Djenane and Roncalés, 2011: Garcia et al., 2012). The 
use of antibodies against Campylobacter in poultry has been proposed. In fact, a strong protection 
against C. jejuni in chickens seemed to be induced by the oral administration of immunoglobins 
preparations from milk or eggs (Tsubokura et al., 1997). 
Treatment of infected chickens with effective bacteriocins has been shown to reduce C. jejuni 
concentration levels substantially (Stern et al., 2008; Svetoch and Stern, 2010). The administration 
of purified encapsulated bacteriocins from P. polymyxa NRRL-B-30509 or L. salivarius NRRL B-
30514 was successful in controlling Campylobacter colonization in young birds (seven to ten days 
of age). The use of bacteriocins BCN E 760 and BCN E 50-52 produced a considerable reduction 
on the numbers of C. jejuni in broilers close to slaughter age and naturally infected with 
Campylobacter (Svetoch and Stern, 2010).  
Bacterial competitive exclusion can serve as basis for the control of Campylobacter, in effect, 
bacterial strains that colonise chicken caeca can produce anti-C. jejuni metabolites. The use of 
probiotics offers many potential benefits based on their ability to balance the intestinal microflora 
(Halfhide, 2003). Though, the effectiveness of prebiotics, probiotics and competitive exclusion 
products on protecting animals against Campylobacter depend on culture preparation techniques 
such as temperature and media used for preparation (Stern et al., 2001). Campylobacter 
colonisation of chickens was reduced in a study after using competitive exclusion cultures of E. 
coli, Klebsiella pneumoniae and Citrobacter diversus (Schoeni and Wong, 1994). A probiotic 
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including Enterococcus faecium and Lactobacillus acidophilus decreased colonization with C. 
jejuni and fecal shedding in broilers (Morishita et al., 1997). Many bacteria have been proven to be 
active against Campylobacter in vitro (Chang and Chen, 2000; Svetoch and Stern, 2010). In fact, a 
Lactobacillus strain isolated from a chicken proved to have bactericidal effect (through the 
production of organic acids) against Campylobacter in vitro (Chaveerach et al., 2004a). The 
inhibition of C. jejuni (below detection level) was obtained in vitro after 24h culture of C. jejuni 
with Lactobacillus plantarum or Bifidobacterium bifidum (Fooks and Gibson, 2002). The use of a 
characterized hyper-colonizing C. jejuni strain to displace other strains present in the chicken 
digestive tract has also been tested (Calderon-Gomez et al., 2009).  
 
The use of antibiotics in animal feed for the only purpose of growth promotion of livestock has 
been officially banned in Europe since January 2006 (Compassion in World Farming [CWF], 2011; 
EFSA, 2012). Some antibiotics may be efficient in reducing C. jejuni concentrations in chickens 
(Farnell et al., 2005; Hermans et al., 2010). However, antibiotics may only be used therapeutically 
when prescribed by a veterinarian. It has been suggested that the consumption of antibiotics in the 
veterinary sector has not decreased and there are huge concerns regarding antimicrobial resistance 
problems in humans and animals (CWF, 2011; European Medicines Agency, 2012). The 
development of antibiotic resistance may compromise treatment of human infections with C.jejuni 
(Dibner and Richards, 2005; Zhu et al., 2006). As a result, the development of innovative methods 
for microbial inactivation such as the use of pulsed electric fields and high hydrostatic pressure has 
been investigated (Sagarzazu et al., 2010). The symbiotic effect of prebiotics and probiotics (the 
combination is known as synbiotics) may act as antimicrobial (Klewicki and Klewicka, 2004; Jones 
and Versalovic, 2009; O’Flaherty et al., 2010; Djenane and Roncalés, 2011). The design of novel 
antimicrobials could be based on the identification of Campylobacter critical metabolic pathways 
such as the shikimate pathway. The shikimate pathway is used by plants, fungi and bacteria to 
produce essential amino acids but is absent in mammals. In fact, this pathway has already been used 
to produce vaccine strains against other bacteria (IFR, 2012). 
 
The treatment of drinking water may reduce Campylobacter numbers in infected chickens 
(Hermans et al., 2011). The addition of organic acids or chlorine to drinking water on poultry farms 
may be able to prevent Campylobacter infection and/or transmission (Chaveerach et al., 2002, 
2004b; Ellis-Iversen et al., 2009). The addition of lactic acid (Byrd et al., 2001), caprilic acid (Solis 
Campylobacter Control in Poultry 
 
26 
 
de los Santos et al., 2010) or monocaprin (Thormar et al., 2006) to drinking water before slaughter 
may reduce Campylobacter counts in chickens (Hilmarsson et al., 2006). The addition of lactic acid 
to drinking water during the feed withdrawal before slaughter produced a significant reduction of 
Campylobacter present in crops of broilers at slaughter (from 85% to 62%). In addition, the 
application of lactic acid to the water did not affect animal health and welfare (Byrd et al., 2001). 
Several acids (propionic, acetic, hydrochloric and formic) were tested in vitro as additives to water 
and/or feed and their effect against Campylobacter seemed to be most effective when the pH was 
around 4.0 (Chaveerach et al., 2002). Drinking water treatment with a combination of 0.1% sorbate 
and 1.5% formic acid produced a significant reduction of C. jejuni colonization in chickens 
(Skånseng et al., 2010). 
Cecal colonization with Campylobacter could be reduced by feeding poultry with plant-protein-
based feed instead of animal-protein-based feed (Udayamputhoor et al., 2003). The use of large 
molecules in feed that can impede Campylobacter adhesion to the host cells has been proven to be 
successful in vitro (Wittschier et al., 2007).  On the other hand, additives may suffer metabolic 
breakdown in the chicken gastrointestinal tract and for that reason additives should be protected, 
encapsulated to avoid premature degradation and to succeed in preventing pathogen colonization 
(Van Immerseel et al., 2004). Hence, it seems difficult to conclude that the use of feed additives 
will always aid in the control of Campylobacter in vivo.  
The use of bacteriophages to control Campylobacter colonization in poultry seems promising and 
immediate significant reductions in the numbers of Campylobacter in chickens after the use of 
bacteriophages have been reported (Wagenaar et al., 2005; El-Shibiny et al., 2009). Nevertheless, 
Campylobacter counts seemed to stabilize a few days after treatment with bacteriophages and for 
that reason the use of phage therapy just before slaughter has been recommended (Hermans et al., 
2011). Carvalho et al. (2010) showed that the addition of phages in the feed was more efficient than 
oral administration to control Campylobacter in chickens. On the other hand, an increase in 
Campylobacter phage-resistant strains has been observed after phage therapy (El-Shibiny et al., 
2009; Carvalho et al., 2010). Vaccination strategies and the use of phage therapy are currently being 
tested (Goode et al., 2003; Wagenaar et al., 2005; Loc Carrillo et al., 2005; Wagenaar et al., 2006). 
New technologies such as nanotechnology and reverse vaccinology can be used to improve food 
safety (Malsch, 2005). 
Strict biosecurity might be difficult to achieve and maintain and even when strict hygiene measures 
are successfully applied, Campylobacter-free flocks are almost always contaminated at slaughter 
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(Rivoal et al., 2005). Consequently, controls against Campylobacter should be implemented during 
transport of poultry, at slaughter and during the production of poultry products and by-products.  
 
5.4.2. Controls during transport 
 
The level of cross-contamination during transportation of poultry from farm to the abattoir can be 
very high because birds defecate over other birds and on the crates (Stern, 1992; Wesley et al., 
2009). Transport crates are washed and used again for the transport of poultry from diverse farms. 
Still, crates and transport modules may remain contaminated after washing posing a risk for the 
transmission of Campylobacter and other pathogens to farms (McKenna et al., 2001; Berrang et al., 
2004b; Hansson et al., 2005; Tinker et al., 2005; Bull et al., 2006; Allen et al., 2008a,b; Hastings et 
al., 2011). Hastings et al. (2011) demonstrated that Campylobacter could survive on crates for at 
least three hours after washing; the crates may have been used in many farms during that time 
indicating potential Campylobacter transmission. Moreover, Campylobacter strains isolated from 
transport crates may be the same as those recovered from poultry during holding at the abattoir 
(Hiett et al., 2002; Slader et al., 2002; Rasschaert et al., 2007).  
Different potential treatments of transport materials in order to reduce the risk of Campylobacter 
introduction into poultry flocks have been assessed. Spray washing transport materials can reduce 
Campylobacter numbers (Berrang and Northcutt, 2005). The storage of transport materials during 
48 hours can reduce Campylobacter numbers but this control measure does not seem cost-effective 
(Berrang et al., 2004b). The use of detergent during the washing of the crates might not always 
eliminate Campylobacter attached to crate surfaces (Slader et al., 2002). Research into new 
methods for the effective cleaning and disinfection of transport materials and vehicles should be 
conducted in order to decrease or eliminate the risk of pathogen introduction into poultry farms this 
way. 
 
5.4.3. Controls at slaughter, processing and consumption 
 
Chicken meat and other poultry products can become contaminated with Campylobacter by cross-
contamination during processing at the slaughter line (Allen et al., 2008a). Logistic slaughter has 
been proposed to process Campylobacter free flocks before Campylobacter positive flocks in order 
to avoid contamination of meat and the processing environment. In order to achieve this aim, a 
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rigorous and accurate sampling protocol for Campylobacter should be in place to obtain reliable 
data from all flocks just before slaughter which might be difficult to perform. Studies have 
demonstrated that cross-contamination from positive flocks might contaminate with low 
Campylobacter concentration a number of chicken carcasses from negative flocks (Hermosilla, 
2004; Johannessen et al., 2007). On the other hand, risk assessment models have shown that logistic 
slaughter may have a limited effect on the reduction of the number of human cases (Havelaar et al., 
2007a/b). Thus the costs in terms of sampling and practical efforts for the implementation of 
logistic slaughter seem to surpass the public health benefits.  
Scheduled slaughter consists on identifying Campylobacter positive flocks for subsequent 
decontamination treatment like freezing. Scheduled slaughter is applied in some countries such as 
Denmark, Norway and Iceland. Nonetheless, the efficiency of this system is highly dependent on 
the time of sampling and the use of rapid, simple tests for the detection of Campylobacter just 
before slaughter. For example, a study conducted in Norway showed that the percentage of 
Campylobacter positive flocks increased from 50% to 75% by moving the sampling time from one 
week to four days before slaughter (Hofshagen et al., 2010). Moreover, scheduled slaughter and 
selective treatment of Campylobacter positive flocks requires complex practical methods and 
logistics that may not always be applicable. As a result, treatment of all positive birds might not be 
a realistic aim (EFSA, 2011a). 
Poultry processing areas such as scalding, de-feathering, evisceration, washing and chilling are 
considered critical control points where controls could be most effective in preventing, eliminating 
or reducing food safety hazards (Mulder, 1999; Hafez, 1999; United States Department of 
Agriculture [USDA], 1999; Rosenquist et al., 2006; Barros et al., 2007). Water used in immersion 
scalding becomes heavily contaminated during processing increasing the risk for cross-
contamination. The temperature generally used in scalding tanks is not high enough to ensure 
complete elimination of pathogens (Townsend, 2006). Cloacal contents may be released during 
automated de-feathering (Berrang et al., 2001). In this way, poultry meat may become contaminated 
during the scalding process and also during the de-feathering step due to cross-contamination of the 
machinery and the production of aerosols (Izat et al., 1988; Berrang and Dickens, 2000). Many 
studies have investigated the potential antimicrobial effect of scald additives such as chlorine, 
trisodium phosphate, sodium metabisulfite (Tambyln et al., 1997), sodium hydroxide, propionic 
acid (Humphrey et al., 1981), acetic acid (Okrend et al., 1986; Lillard et al., 1987; Tamblyn et al., 
1997) and a commercial additive known as RP Scald (Townsend, 2006). Evisceration is a critical 
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step because gastrointestinal tracts of chickens can harbor high numbers of Campylobacter that may 
be liberated during evisceration contaminating meat and the processing environment (International 
Commission on Microbiological Specifications for Foods [ICMSF], 1996; Perko-Mäkelä et al., 
2009). Consequently, minimizing intestinal ruptures and preventing Campylobacter spread are very 
important control measures. A significant reduction in the numbers of Campylobacter present on 
chicken meat can be achieved by washing (Cudjoe et al., 1991). But chicken skin protects 
Campylobacter (Atterbury et al., 2003) and Campylobacter may form or attach to biofilms in 
diverse surfaces, in chickens and the environment (Kalmokoff et al., 2006; Nguryen et al., 2011). 
Visceral rupture during meat processing has been significantly associated with increased 
Campylobacter contamination levels (Berrang et al., 2004a; Boysen and Rosenquist, 2009). Hence, 
controls should be implemented to prevent visceral rupture and/or to remove fecal contamination 
during the slaughter process. In addition, changes to the poultry processing line such as altering the 
order of the processing steps have been proposed (e.g. performing evisceration prior to scalding) in 
order to reduce Campylobacter contamination of poultry products and by-products (Berrang et al., 
2011). Performing cloacal plugging before slaughter can be very effective in reducing 
Campylobacter numbers on poultry carcasses but the practical application of this control seems 
difficult and labor intensive (Musgrove et al., 1997; Berrang et al., 2011). 
Post-slaughter control measures such as chilling, freezing and the application of decontamination 
technologies such as the use of chlorinated water or irradiation of foods are currently used or tested 
(James et al., 2007). On the other hand chicken skin might protect Campylobacter from some of 
these methods and environmental stresses (Atterbury et al., 2003). Campylobacter-specific 
bacteriophages have been developed and applied to chicken skin successfully reducing the number 
of recovered Campylobacter by 1 log. Despite the success, a larger reduction of the numbers of 
viable Campylobacter present in chicken skin would be desirable. The combined use of phages and 
freezing rendered a significantly larger reduction in the concentration of Campylobacter in chicken 
skin (Atterbury et al., 2003). Freezing is widely used in some countries to control Campylobacter 
and other pathogens that may be present in chicken products (Sampers et al., 2010), in actual fact, 
Campylobacter numbers on chicken carcasses can be reduced by 1 to 3 logs by freezing 
(Rosenquist et al., 2006; Georgsson et al., 2006). Rapid freezing of chicken carcasses can be 
effective against Campylobacter (Sandberg et al., 2005). Freezing of chicken products has the 
advantage that meat quality and appearance is minimally affected although the use of freezing 
might translate on increase costs for the industry (EFSA, 2011a). Freezing of poultry meat from 
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Campylobacter positive flocks is a Campylobacter control strategy adopted by several EU countries 
(Hofshagen and Kruse, 2005; Tustin et al., 2011). Freezing has been considered the most effective 
method in reducing Campylobacter contamination between several decontamination techniques 
(Sandberg et al., 2005; Georgsson et al., 2006). Other technologies such as crust freezing and 
forced air chilling can reduce Campylobacter numbers in poultry products but to a lesser extend 
(Boysen and Rosenquist, 2009). 
The use of steam-ultrasound technologies to reduce Campylobacter numbers in poultry meat has 
been investigated. In a study conducted by Boysen and Rosenquist (2009) a considerable decrease 
of the numbers of Campylobacter was achieved in some samples (reduction of > 2.5 logs/sample) 
but as a result the meat appeared partially cooked. Thus, significant Campylobacter reductions can 
be difficult to obtain using steam-ultrasound alone without compromising the appearance and 
quality of the meat products (Whyte et al., 2003; James et al., 2007).   
The application of organic acids into the cloaca of chicken carcasses during processing may 
decrease the numbers of Campylobacter in broiler meat (Berrang et al., 2006). The application of 
organic acids onto beef carcasses produced a decrease on the numbers of recovered bacteria (Bell et 
al., 1997; Dorsa et al., 1997; Castillo et al., 1998, 1999; Cutter, 1999). Salmonella numbers present 
on broiler carcasses can be reduced by spraying broiler carcasses with lactic acid (Li et al., 1997; 
Xiong et al., 1998; Yang et al., 1998). Organic acids can also reduce numbers of bacteria present in 
chicken meat when applied to scald water (Izat et al., 1990) as a spray during defeathering (Dickens 
and Whittemore, 1997) and before and after chilling (Izat et al., 1990; Dickens and Whittemore, 
1994). Furthermore, lactic acid used in combination with modified atmosphere parking technology 
can preserve fresh chicken meat and increase the shelf life (Zeitoun and Debevere, 1992; Jimenez et 
al., 1999). The addition of acidifying bacteria particularly lactic acid bacteria (LAB) may preserve 
foods and several studies have demonstrated inhibitory effects against Campylobacter possibly due 
to pH reduction and/or the bactericidal effect of hydrogen peroxide (H2O2) generated by LAB 
when there is oxygen (Chaveerach et al., 2004a; Svetoch et al., 2005; Strus et al., 2006).  
The effect of irradiation to eliminate pathogenic bacteria such as Campylobacter present in poultry 
meat has been investigated (Kampelmacher, 1984; Lacroix and Ouattara, 2000; Chun et al., 2010). 
The application of UV-C irradiation can be effective in reducing the numbers of C. jejuni in poultry 
meat and ready-to-eat meat (Chun et al., 2010). In reality, irradiation of foods is effective in the 
inactivation of pathogens and is permitted in some EU countries (Humphrey et al., 2007). 
Irradiation doses allowed in EU and a list of foodstuffs authorized for irradiation decontamination 
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can be found in the UE directive 1999/3/EC. Though, the use of gamma-irradiation is not accepted 
by EU consumers and therefore its use has been discouraged. The use of electron accelerators is 
more acceptable and currently applied for decontamination of chicken meat in Europe (Carry et al., 
1995). Irradiation of poultry meat (at a maximum dose of 3 kGy) for the control pathogens such as 
Campylobacter is allowed in the United States (Keener et al., 2004). 
Irradiation treatments might have detrimental effects on the organoleptic qualities of foods. Hanies 
et al., (1989) observed that off-flavors were detected in poultry meat irradiated above the 2.5 kGy 
threshold dose. On the other hand, the use of spices may control deterioration of irradiated foods 
due to their natural antioxidants, in fact, the joint effects of irradiation of poultry meat and the use 
of rosemary and thyme have been investigated (Ingram and Farkas, 1977; Monk et al., 1995). 
Innovative technologies that produce safe foods conserving their nutritional and sensory properties 
are very attractive because consumers demand safe, natural, nutritious, high quality foods with 
extended shelf-life and natural flavor. Natural food preservatives may have antimicrobial properties 
against Campylobacter and other pathogens (Djenane et al., 2011a/b/c). In this way, consumer 
demands for natural foods, additives and preservatives have forced regulatory agencies and the food 
industry to investigate the use of natural antimicrobials in order to control the growth of spoilage 
microorganisms and pathogens in foods. Essential oils possess potential antimicrobial effects, 
however, their activity seems to be reduced by the presence of protein and fat that may protect 
bacteria (Tassou et al., 1995; Djenane et al., 2011a/b/c ; Burt, 2004). Essential oils could be used as 
antimicrobials in chicken meat but they seem to be less effective in chicken skin due to the skin’s 
rough surface that may protect bacteria such as Campylobacter (Fisher and Philips, 2006). The 
antimicrobial effects of several essential oils against C. jejuni isolated from chicken meat have been 
demonstrated (Nannapaneni et al., 2009; Abdollah et al., 2010; Rattanachaikunsopon and 
Phumkhachorn, 2010; Djenane et al., 2011c) suggesting that essential oils could be used as safe and 
natural additives with antimicrobial activities against Campylobacter. In a study conducted by 
Aslim and Yucel (2008) the essential oil obtained from the plant Origanum minutiflorum displayed 
antimicrobial activity against ciprofloxacin-resistant Campylobacter strains. However, higher 
concentrations of essential oils might be necessary when applied to foods in comparison with the 
amounts used in vitro studies (Djenane et al., 2011a), especially when essential oils’ vapours are 
used (Fisher and Philips, 2006). 
Wine seems to be a hostile environment for Campylobacter (Gañan et al., 2009) and the use of wine 
together with antimicrobial additives in meat marinades has been proposed for the control 
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Campylobacter in meat products (Isohanni et al., 2010). Moreover, the potential use of the phenolic 
compounds found in wine as an alternative to the use of antimicrobials in chickens has been 
suggested (Djenane and Roncalés, 2011). The use of marinating ingredients can reduce 
Campylobacter numbers (Birk et al., 2010) but this technique can be applied only to a proportion of 
the produced chicken meat since consumers demand fresh chicken meat in most countries. 
Novel methods for food preservation and packaging are under investigation. Active packaging such 
as oxygen scavengers, drip absorbent sheets and antioxidant packaging may extend the shelf life of 
foods especially of fresh “easily perishable” foods such as raw meat and fish (Camo et al., 2011). 
Novel antimicrobial films have been developed using diverse concentrations of essential oils into 
chitosan and hydroxypropylmethylcellulose films (Sánchez-González et al., 2011). In addition, the 
application of natural antimicrobial additives together with novel technologies may improve 
pathogen control and therefore food safety and quality (Gálvez et al., 2010). Novel products and 
technologies are designed and developed in order to control foodborne pathogens in food premises 
and kitchens. Thormar and Hilmarsson (2010) demonstrated the efficiency of glycerol monocaprate 
(monocaprin) in reducing Campylobacter concentration on contaminated plastic and wooden 
cutting boards. 
 
In addition to food safety controls, public health education programs have been developed in many 
areas of the world in order to educate consumers in food safety (Center for Science in the Public 
Interest, 2005). Public awareness campaigns contain clear messages (communicated through the 
media in form of advertisements, brochures, videos, web-sites and other education materials) 
designed to inform and educate consumers in food handling in order to decrease the number of 
food-borne illnesses (Partnership for Food Safety Education, 2010; Canadian Partnership for 
Consumer Food Safety Education, 2013).  The World Health Organisation (WHO) has launched a 
global health message known as “The Five Keys to Safer Food” to communicate the basic food 
safety principles that every person in the world should follow to improve food safety and prevent 
food-borne illnesses (WHO, 2012).  
 
5.4.4. Integration of controls against Campylobacter in poultry 
 
Currently there is no one single decontamination technology alone capable to eliminate 
Campylobacter or reduce it to negligible levels in foods without altering food characteristics. For 
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that reason, an integrative approach must be followed in order to control Campylobacter in foods, 
implementing several effective control measures throughout the food chain. It has been 
demonstrated that the microbiological contamination of beef carcasses can be significantly reduced 
by the application of several sequential decontamination techniques (Bacon et al., 2000). 
An integrated approach to the control of Campylobacter in poultry has been adopted in Denmark 
where increased biosecurity, allocation of meat from positive flocks to the production of frozen 
foods and consumer education campaigns have led to a significant decrease in Campylobacter 
prevalence in broiler flocks (from 43% in 2002 to 27% in 2007), a reduction of Campylobacter-
positive samples of fresh broiler meat and a decrease in registered human cases by 12% from 2002 
to 2007 (Rosenquist et al., 2009). 
The combination of decontamination technologies with appropriate storage conditions (low pH and 
low temperature) for the control of C. jejuni in foods has been investigated (Smigic et al., 2010). In 
fact, the synergistic effect against Campylobacter of the use of rosemary essential oil extract and 
freezing has been demonstrated (Piskernik et al., 2011). Nevertheless, the effect of a 
Campylobacter control measure alone or in combination with other controls also depends on a 
number of factors related to the production conditions such as the type of equipment, type of 
processes, temperature, humidity and many others (Van et al., 1995; Purnell et al., 2004). The step 
of the production where the control is applied will affect the effectiveness of this control measure, 
e.g., the effect of chemical products might be different when used in the scalding tank than when 
applied directly onto the meat at the end of the production process (Havelaar et al., 2007a). 
 
5.4.5. Campylobacter risk assessments and evaluation of the public health impact of 
controls against Campylobacter in poultry production 
 
Campylobacter risk assessments have been conducted nationally in some developed countries and 
internationally by WHO and FAO (Cahill, 2005). Risk assessment models may consider the whole 
of the food chain, from farm to the consumer following an integrated and multidisciplinary 
approach (Slorach et al., 2002). In particular, risk assessments conducted in Denmark (Rosenquist 
et al., 2003), the Netherlands (Nauta et al., 2005), UK (Hartnett et al., 2001, 2002) and New 
Zealand (Lake et al., 2007) provide “farm-to-fork” estimations of the risk of human Campylobacter 
infection via the consumption of poultry meat. Risk assessments aim to assess the public health 
risks associated with the consumption of contaminated poultry meat but also to assess the 
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effectiveness of potential control measures (Rosenquist et al., 2003; Nauta et al., 2005). Despite the 
numerous high quality research outcomes regarding Campylobacter infection of broiler chickens, 
prevention and controls, important data gaps make risk assessment models incomplete (FAO, 
2002).  
The public health impact of the use of decontamination technologies against Campylobacter can be 
assessed using risk assessment models but accurate good quality data is necessary to obtain realistic 
and useful results. The synergistic application of effective control measures against Campylobacter 
such as freezing, irradiation and proper cooking could achieve a human risk reduction of 90-100% 
assuming that no re-contamination occurs (Havelaar et al., 2007a/b; EFSA, 2011a). On the other 
hand, estimations of the effectiveness of controls against Campylobacter are uncertain, frequently 
based on limited data that might not be representative as concluded in a recent EFSA Expert 
Opinion:  “Another general finding is that it is difficult to obtain good representative data that allow 
estimating the effect of specific control options in terms of reduction in Campylobacter 
concentration or prevalence. Quite often the effect estimates are based on one or a few published or 
unpublished laboratory experiments, or expert opinion, and they cannot always be correctly applied 
to conditions other than the specific ones under which they were designed. As a consequence their 
predicted effects on risk reduction are also highly uncertain” (EFSA, 2011a, page 53). 
Data related to the effectiveness of decontamination technologies against Campylobacter obtained 
using naturally contaminated samples at an industrial scale are preferred to data produced in the 
laboratory using artificially inoculated samples (EFSA, 2011a). Many laboratory studies have 
investigated Campylobacter inactivation on artificially contaminated chicken meat but there is lack 
of data regarding the effects of using diverse strains and different inoculation levels. In real life 
situations, it is not uncommon that chickens are infected by several Campylobacter strains and that 
Campylobacter concentration varies between chickens. Accordingly, research data based on 
naturally infected birds and commercial production conditions are desirable. The effectiveness of 
decontamination technologies on reducing Campylobacter numbers might vary with the initial 
Campylobacter concentration present and also with different Campylobacter strains. For that 
reason, results obtained using one or few Campylobacter strains and/or concentrations might not 
produce representative data (Greer et al., 1992; Birk et al., 2010). 
 
Quantitative microbiological risk assessments are used for risk management of food safety issues 
and to establish standards for the international trade of food. On the other hand, assessment of the 
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contribution of the diverse potential sources of disease is crucial for the implementation of effective 
control strategies (Havelaar et al., 2007a). Source attribution models are valuable for the selection 
and prioritization of potential controls but the effects of interventions need to be assessed using 
different models such as risk assessment models. Source attribution models can fall into one of 
these two wide categories: epidemiologic approaches (based on public health data) or microbiologic 
approaches. These two approaches may complement each other; in fact, epidemiological data can 
be integrated in microbiologic models. Microbiologic approaches include risk assessment of 
specific pathogens, the Hald model (Hald et al., 2004; Mullner et al., 2009) and other models based 
on microbial source tracing methods which use molecular subtyping data from pathogens isolated 
from humans and potential sources. The use of epidemiological data alone will not be sufficient for 
a complete risk assessment (Haas et al., 1999). The source of disease in sporadic cases seems 
difficult to define, and particularly the identification of sources associated with endemic diseases 
becomes much more difficult (Riley, 2004). Moreover, the complexity can be overwhelming in 
cases when the epidemiology of the disease is complex involving diverse bacterial strains and many 
potential risk factors as it happens with human campylobacteriosis. Recent advances in molecular 
epidemiology have been incorporated in source attribution models providing a better understanding 
of the impact of particular sources and/or transmission routes on the human disease burden. Some 
source attribution models such as the Hald model (Hald et al., 2004), the Island model (Wilson et 
al., 2008) and STRUCTURE (Pritchard et al., 2000) can attribute risks to sources directly. Other 
type of models such as the “Minimum Spanning Trees” based on clustering tools (Spratt et al., 
2004) cannot provide risk estimations but they may increase our understanding of the epidemiology 
of the pathogen and of the relative importance of diverse sources. Knowledge obtained from diverse 
models and research areas can be integrated to increase our understanding of Campylobacter 
epidemiology, human infection sources and the effectiveness of potential controls. Nevertheless, 
disease models are based on assumptions in order to manage the complexity inherent to the disease 
and so models are limited and the results need to be interpreted carefully. 
5.5. Vaccines against Campylobacter and other zoonotic pathogens 
The development of vaccines to protect animals from zoonotic infections has important public 
health implications since approximately 75% of new emerging infections can be considered 
zoonoses (Lütticken et al., 2007). The benefits obtained from the development of successful 
vaccination strategies against zoonotic diseases can be considerably attractive. Nonetheless, the 
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implementation of successful vaccination strategies requires the collaboration of human doctors, 
veterinarians, epidemiologists, scientists and politicians (Lütticken et al., 2007). In general, when 
conducting vaccination trials, vaccine efficiency will be affected by many factors such as the type 
of vaccine, the microbial strain, the animal model used for testing and many others. Hoffelner et al. 
(2008) demonstrated differences on vaccine efficiency when using different strains of Helicobacter 
pylori and alternative animal models.  
Enteric infections are considered one of the main causes for human disease and human casualties 
across the world. The development of effective vaccines to protect humans from the main 
pathogens associated with enteric infections is highly desirable. Rotaviruses have been considered 
the lead cause of enteric infections worldwide. Diagnosis, surveillance and control of enteric 
diseases can be difficult due to the variety of causative agents and to the lack of resources in 
developing countries. Efforts have been directed to share light into the causation of enteric diseases 
in developing countries and into the development of effective vaccines (Walker, 2005). Practical 
considerations regarding the use of vaccines against enteric pathogens need to be considered taking 
on account the target population. Vaccines intended to protect children in developing countries need 
to be safe for very young infants (Walker, 2005). The production of a combined vaccine to protect 
humans against the main pathogens responsible for intestinal disease has been proposed (Walker, 
2005). 
Vaccines are currently being used successfully to control avian diseases such as coccidiosis, 
Marek’s disease and systemic salmonellosis (FAO, 1997). Vaccination is considered one of the 
main strategies to reduce the incidence of human Salmonellosis. Several vaccination strategies 
developed to control Salmonella in chickens and pigs seem to be effective such as the use of 
inactivated bacterins for the immunization of sows (Roesler et al., 2006).The prevalence of 
Salmonella in laying hens can vary between 0% and 79% in EU countries (EFSA, 2007). In 
addition, vaccination of poultry for the control of Salmonella is compulsory in the EU for flocks of 
laying hens with a S. Enteritidis prevalence higher than 10% since 2008 (European Commission, 
2006).  
The development of a cost-efficient vaccine against Campylobacter has been identified as a priority 
especially for travelers, young children and the military (Girard et al., 2006). Vaccines against 
Campylobacter have been developed for humans (Baqar et al., 1995a; Scott, 1997, Scott and 
Tribble 2000), chickens (Khuory and Meinersmann, 1995; Noor et al., 1995; Widders et al., 1996; 
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Rice et al., 1997; Newell and Wagenaar, 2000) and other animals (Baqar et al., 1995b). However, a 
general cost-efficient vaccine for the control of Campylobacter in chickens and humans has not 
been developed despite years of research (Jagusztyn-Krynicka et al., 2009). A successful 
commercial vaccine should be safe, cost-effective and produced in large quantities. Conventional 
vaccines usually perform poorly when applied to chickens due to the interaction of Campylobacter 
with the intestinal niche in poultry (Ringoir and Korolik, 2003; Walker, 2005). Moreover, immunity 
against Campylobacter seems to be strain-specific. Hence, the development of a vaccine able to 
protect the host against all Campylobacter strains seems challenging. 
A vaccine against C. jejuni infections in humans (ACE393) has been developed. A human trial 
confirmed that the injectable vaccine ACE393 was well tolerated and produced satisfactory immune 
responses in vaccinated individuals. In fact, when administered using a 250µg dose, ACE393 
stimulated a four-fold increase in the production of IgG in all persons (Anon, 2007). Conversely, 
the vaccine ACE393 did not seem to produce a statistically significant reduction in Campylobacter 
concentration when administered intramuscularly in broilers under specific experimental conditions 
(Garcia et al., 2012). 
Animals have been used as models for Campylobacter pathogenesis studies and for testing new 
vaccine candidates (Islam et al., 2006). Chickens are obviously the preferred animal model to assess 
the efficacy of vaccines developed to reduce Campylobacter burden in birds (Davis and DiRita, 
2008). Cell mediated immune response against Campylobacter has been observed in chickens three 
days after hatch (Noor et al., 1995; Smith et al., 2005). A significant level of anti-Campylobacter 
IgG antibodies from the maternal source can be detected in chicks younger than 3 weeks, the 
chickens become susceptible to infection later on in life (Sahin et al., 2002; Shoaf-Sweeney et al., 
2008). Therefore, Campylobacter control strategies based on immunization of poultry might be 
feasible. On the other hand, the immune response against Campylobacter in chickens is generally 
moderate and the absence of a strong immune response has been identified as one of the main 
challenges for vaccine efficacy to control Campylobacter in chickens (de Zoete et al., 2007). What's 
more, the genetic diversity of Campylobacter might hamper controls based on immunization of 
chickens. C. jejuni strains differ on the ability to colonize chicken intestines and on the infective 
dose for chickens (Ziprin et al., 2002; Jagusztyn-Krynicka et al., 2009). Genetic manipulation of 
specific C. jejuni genes (dnaJ, cadF9) can alter the ability of C. jejuni strains to colonize chicken 
caeca. Vaccination of chickens using a vaccine cocktail including viable non-colonising C. jejuni 
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strains was tested by Ziprin et al. (2002). However, their results found no statistically significant 
difference between vaccinated and control groups of chickens.  
Vaccines are usually delivered orally but in-ovo vaccination has been developed (Negash et al., 
2004). Campylobacter vaccines have been tested using other experimental animals such as ferrets, 
mice and monkeys. Researchers have studied animals’ immune responses to Campylobacter 
infections (Baqar et al., 1995a/b; Rice et al., 1997; Islam et al., 2006).  Monkeys are generally used 
for developing human vaccine candidates due to similarities with human infections. In actual fact, 
monkeys seem to acquire immunity against Campylobacter infections (Islam et al., 2006). In a 
study conducted by Islam et al. (2006) Rhesus macaque monkeys were challenged with C. jejuni 
strain 81-176 (doses of 107, 109 and 1011). IgM-antibody secreting cells (ASC) responses in 
challenged monkeys were observed but no C. jejuni-specific IgA or IgG ASC responses. Though, 
some animals that recovered from infection seemed to be protected against re-infection.  Rice et al. 
(1997) observed that increased titers of anti-C.jejuni IgA in bile corresponded to reductions in 
C.jejuni cecal colonization in poultry orally vaccinated with killed C. jejuni cells. In-ovo 
vaccination of chicks using heat-killed C. jejuni produced increased IgA antibodies (Noor et al., 
1995). The intraperitoneal administration of killed C. jejuni cells increased specific IgY in the 
intestine of chickens (Widders et al., 1996). Heat-killed and/ or formalin-killed bacteria have been 
used as oral vaccines inducing immune responses in ferrets, monkeys and mice (Rollwagen et al., 
1993; Baqar et al., 1995a/b; Burr et al., 2005). 
Diverse approaches can be followed for the development of Campylobacter vaccines:  
- live attenuated vaccines, 
- vaccines based on killed bacteria (heat-killed/formalin-killed) with or without adjuvants,  
- subunit vaccines and  
- live attenuated Salmonella strains expressing specific Campylobacter proteins 
Live-attenuated vaccines against Shigella infections in humans have been developed (Venkatesan et 
al., 2006; Levine et al., 2007; Phalipon et al., 2008). But the use of a live-attenuated Campylobacter 
vaccine seems unlikely due to the risk of developing long-term sequelae such as GBS and genetic 
recombination of Campylobacter spp. (Jagusztyn-Krynicka et al., 2009). Besides, the use of live 
vaccines for Campylobacter control can be hindered by the genomic instability of Campylobacter 
(de Zoete et al., 2007; Ridley et al., 2008a). Genetic immunization is a novel strategy that seems 
very promising; genes such as the gene flaA are considered very important for the pathogenicity of 
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C. jejuni. Vaccination of chickens with a protein including part of the C. jejuni FlaA proved 
successful in reducing Campylobacter colonization (Khoury and Meinersmann, 1995). 
Campylobacter whole-cell (CWC) vaccines have been developed and tested (Baqar et al., 1995a/b; 
Rice et al., 1997). Nonetheless, the use of CWC seems difficult due to the genetic diversity of 
Campylobacter and to concerns regarding long-term sequaleae such as GBS syndrome despite the 
fact that volunteers infected with a CWC vaccine did not develop persistent antiganglioside 
antibodies (Prendergast et al., 2004). An inactivated whole cell Campylobacter jejuni vaccine was 
used to protect ferrets against Campylobacter (Burr et al., 2005). These authors observed that the 
use of adjuvant was not improving protection and that animals were protected against homologous 
and heterologous Campylobacter strains used in the study (C. jejuni strain 81–176, (Lior serotype 
5) and strain CGL7 (Lior serotype 4)). 
Campylobacter subunit vaccines using specific antigens are safer than CWC vaccines but less 
efficient. Nevertheless, the selection of the antigen(s) proves to be a crucial factor for vaccine 
success. The use of genomics and proteomics allows the identification of new antigens for vaccine 
development (Jagusztyn-Krynicka et al., 2009). Metagenomic experiments and the production of a 
proteome-wide protein interaction map might provide relevant information regarding infection and 
colonization with Campylobacter (Parrish et al., 2007). 
Campylobacter jejuni is able to produce a polysaccharide capsule (CPS) to protect its surface; in 
actual fact, a number of different CPS structures have been identified (Aspinall et al., 1995; 
Muldoon et al., 2002; Karlyshev et al., 2005; Chen et al., 2008). The role of CPS in the 
colonization and virulence properties of different Campylobacter strains has been suggested but this 
role is poorly understood (Champion et al., 2010; Guerry et al., 2012). Some researchers showed 
that Campylobacter strains with CPS performed better at colonizing chickens (Grant et al., 2005; 
Bachtiar et al., 2007). Vaccination strategies based on CPS have been developed to control diseases 
caused by encapsulated bacteria such as H. influenzae and Streptococcus pneumoniae (Lesinski and 
Westernick, 2001; Knuf et al., 2011). A capsule conjugate vaccine was able to protect non-human 
primates against enteric disease with Campylobacter (Monteiro et al., 2009). Genomics and 
proteomics are used to identify key Campylobacter proteins that may play an essential role in the 
stimulation of immune response in infected animals and could be included in vaccines (Prokhorova 
et al., 2006). The use of the flagella gene plasmid DNA has produced interesting results such as the 
reduction of number of Campylobacter in chickens by 2 logs (Wyszynska et al., 2004). 
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Immunization of chickens with flagella protein has proven to produce increased levels of IgG and 
IgM in serum and IgG in intestinal mucosal as well as reducing C. jejuni by 1-2 logs (Widders et 
al., 1996). Vaccination of mice with flaA subunit vaccines stimulated immune responses (Lee et al., 
1999). On the other hand, flagellin genes are highly variable and thus the efficacy of vaccines based 
on these particular genes might vary between Campylobacter strains. The selection of highly 
conservative areas of the Campylobacter genome for vaccine development may offer promising 
results. A Campylobacter gene (cjaA, common to diverse Campylobacter strains) which encodes a 
highly immunogenic lipoprotein was carried by an avirulent recombinant Salmonella strain and 
orally administered to chickens. As a result, production of mucosal IgA and serum IgY was 
observed and chickens seemed to be protected against cecal colonization with a different C. jejuni 
strain (Wyszynska et al., 2004). The use of heterologous vaccines for the control of Campylobacter 
in poultry has been explored (Buckley et al., 2010; Layton et al., 2011). 
The identification of genes that are essential for Campylobacter colonization of chickens may be 
crucial for the development of an effective vaccine against Campylobacter in poultry. It has been 
suggested that inactivation of the gene cfrA may result in complete prevention of Campylobacter 
colonization in chickens and as a result this gene could be a very promising candidate for vaccine 
development (Zeng et al., 2009). The C. jejuni gene that encodes the dps protein plays an important 
role in cecal colonization of chickens and in biofilm formation. A Salmonella-based vaccine 
encoding the Campylobacter dps protein responsible for adherence to host cells seems promising 
and is under development at the University of Arizona, USA (Joens, 2012; Theoret et al., 2012). A 
vaccine candidate based on a live Salmonella vector expressing a linear peptide epitope from a 
Campylobacter protein (Cj0113 (Omp18/CjaD)) produced consistent immune responses and 
reduced Campylobacter numbers below detection level (Layton et al., 2011). Intranasal delivery of 
Chitosan-pCAGCS-flaA nanoparticles as a vaccine for chickens successfully induced effective 
immune response with reductions of Campylobacter by 2-3 logs in large intestine and 2 logs in 
caecum of chickens. Chickens immunized with this vaccine showed significantly increased levels of 
intestinal mucosal antibody IgA and serum anti-C. jejuni IgG (Huang et al., 2010).  Chitosan, a 
natural bioadhesive product, is considered to be a good adjuvant for vaccines offering a few 
advantages as gene vectors. The efficiency of chitosan as gene vector was estimated to be more than 
90% by using electron microscopy (Huang et al., 2010).   
The success of vaccination trials for the control of Campylobacter infections depends on a number 
of factors such as the vaccine candidate, the animal model, individual host factors, Campylobacter 
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strain, environmental factors and others. In addition, the choice of the study unit and clear 
objectives including the expectation for the successful vaccine candidate are crucial for the trials 
(Garcia et al., 2012). A particular vaccine might work on an specific trial (with an animal model for 
example) using a particular Campylobacter strain and controlled experimental conditions but the 
same vaccine might fail when using other strains, different animal models or diverse environments. 
Moreover, field studies to test vaccine efficiency carry additional complexity due to the lack of 
knowledge regarding some environmental factors. Additional factors to consider are 
microbiological methodologies used for isolation, characterization and quantification of 
Campylobacter and the choice of data analysis techniques. Uncertainty plays a key role in the 
studies and should be accounted for when developing mathematical or epidemiological models. It 
could be long and complex to examine and compare every study regarding vaccine development 
and vaccination strategies. Nevertheless, important epidemiological considerations can be 
discussed. The animal model is a crucial factor and chickens are the preferred animal model in 
Campylobacter vaccination trials (Cawthraw et al., 1996; Davis and DiRita, 2008). Leghorn 
broilers have been used in Campylobacter colonization experiments and vaccine trials (Rice et al., 
1997; Stas et al., 1999; Ziprin et al., 2002; Sahin et al., 2003; Shoaf-Sweeney, 2008). Most 
experimental protocols use three groups of chicken: vaccinated, experimentally colonized and 
control groups (Rice et al., 1997). Time and age of animals can be an important factor when 
evaluating the efficacy of vaccines. The time of immunization, the age of the animals when being 
vaccinated, time at which samples are collected and analyzed will influence the results of the 
experiments. Rice et al. (1997) observed that in 31-day-old birds (21 days post-challenge) there was 
81% reduction on Campylobacter numbers between vaccinated chickens and controls while the 
reduction was only 25% in 50-day-old chickens. 
The challenge method is considered a crucial factor when conducting vaccination trials. The use of 
a challenge method that mimics natural transmission of Campylobacter in broiler flocks is highly 
desirable. More knowledge regarding the ecology of Campylobacter in commercial flocks will be 
advantageous. Campylobacter is rarely detected in commercial flocks with birds younger than two 
weeks of age (Annan-Prah and Janc, 1988; Stern, 1992). It has been suggested that this observation 
could be due to Campylobacter characteristics such as the presence of stressed Campylobacter cells 
that could still be infective (Rollins and Colwell, 1986; Jones et al., 1991; Oliver, 2005) or low 
numbers (below detection limit). Besides, young birds could be immunized against Campylobacter 
because a significant level of anti-Campylobacter IgG antibodies from the maternal source can be 
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detected in chicks younger than three weeks (Sahin et al., 2002; Shoaf-Sweeney et al., 2008). It has 
been suggested that this Campylobacter-free “window” could be strategically used to introduce 
vaccination programs (Rice et al., 1997). 
Sampling protocols and microbiological techniques for the detection and quantification of 
Campylobacter will influence the interpretation of the effect of vaccines in clinical trials. 
Quantitative microbiological data need to be properly analyzed. Sample size calculations and 
forecasted group effects need to be carefully considered during the experimental design phase. 
Additionally, data analysis methodologies should be carefully selected based on the experimental 
design (Garcia et al., 2012). 
 
5.6. Discussion 
During the last few years, risk assessment models have been developed to forecast the reduction of 
the number of human campylobacteriosis cases following successful implementation of 
Campylobacter controls. However, models are based on assumptions and uncertain data and 
consequently the results need to be interpreted carefully. In addition, the effectiveness of 
Campylobacter control strategies (one intervention alone or in combination with other controls) will 
depend on the presence and interaction with many factors as previously indicated in this thesis. 
Nevertheless, it has been demonstrated that a reduction on the number of human campylobacteriosis 
cases is possible as a result of the successful implementation of effective interventions in poultry 
production. In New Zealand, reported human campylobacteriosis cases declined by 52% and 
hospitalizations due to GBS by 13% after successful interventions were implemented to reduce 
Campylobacter contamination of poultry meat indicating that additional public health benefits can 
be achieved by controlling foodborne campylobacteriosis (Baker et al., 2012). 
Existing evidence indicates that efforts should be directed towards the successful implementation of 
the most promising interventions to control foodborne campylobacteriosis and particularly 
Campylobacter infections in poultry. Poultry has been identified as one of the main risk factors for 
human campylobacteriosis and extensive research has been conducted to identify the most effective 
Campylobacter control strategies that could be implemented during poultry production. Actually, 
the production of Campylobacter-free flocks has been achieved experimentally, but under 
commercial conditions it can be challenging although not impossible. 
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A considerable number of epidemiological studies have been conducted to identify significant risk 
factors for Campylobacter infections in poultry and to assess the effect of interventions for the 
control of Campylobacter in poultry from farm to fork. As an example, slaughter age has been 
identified as a significant risk factor for Campylobacter infection in many epidemiological studies 
and for that reason reducing the slaughter age of poultry may be an effective control strategy that 
could be used synergistically with other Campylobacter controls (Newell et al., 2011). 
Campylobacter is widespread on the farm environment and thus the implementation of effective 
biosecurity measures seems crucial to prevent Campylobacter introduction into the poultry houses 
(Ridley et al., 2008b, 2011a, 2011b). On the other hand, it has been suggested that not all viable 
Campylobacters present in the environment can colonize chickens (Ridley et al., 2008b). 
Nevertheless, effective bio-security measures can prevent Campylobacter introduction into broiler 
flocks. On-farm controls based on identified risk factors for Campylobacter infection of poultry 
may be effective. Additionally, synergistic effects obtained from the implementation of several 
biosecurity control measures are expected. Although high levels of hygiene and biosecurity may not 
be sufficient to produce a Campylobacter-free flock, the risk of Campylobacter introduction into 
poultry flocks may decrease considerably (Gibbens et al., 2001). Human traffic, the number of staff 
members and the number of human visits to poultry houses have been identified as important 
vehicles for Campylobacter transmission into poultry flocks (Kapperut et al. 1993; Berndtson et al., 
1996; Evans and Sayers, 2000; Refregier-Petton et al., 2001; Cardinale et al., 2004; Hofshagen and 
Kruse, 2005; Huneau-Salaun et al., 2007; Chowdhury et al., 2012). The poultry industry should 
implement and sustain best hygiene practices through adequate assessment, monitoring and staff 
education and motivation (Berndtson et al., 1996; van de Giessen et al., 1998). 
Seasonality trends suggest an increased Campylobacter infections risk caused by particular risk 
factors at specific times of the year. The seasonal peak of Campylobacter infections in poultry is 
much more evident in areas where Campylobacter prevalence is generally low (EFSA, 2010a). In 
places where Campylobacter prevalence in poultry flocks is high most of the time, non-seasonal 
risk factors predominate and constitute a priority for the control of Campylobacter in poultry. 
There is no clear evidence of the introduction of Campylobacter in poultry houses via drinking 
water although the water source or disinfection regimes of water lines have been found significant 
risk factors in some studies (Evans and Sayers, 2000; Gibbens et al., 2001; Herman et al., 2003; 
Arsenault et al., 2007). In particular, lack of cleaning of water lines could be confounded by poor 
general hygiene (Berndtson et al., 1996). Although the presence of other livestock on poultry farms 
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has been identified as a risk factor, the evidence is limited and the impact on the overall risk for 
Campylobacter introduction may be low (Newell et al., 2011), in actual fact, risk assessment 
models showed that removal of other livestock may only reduce Campylobacter prevalence from 
44% to 41% (Katsma et al., 2007). Despite the suggested limited effect on the prevention of 
Campylobacter infection, effective distance between poultry houses and other livestock, effective 
bio-security barriers or poultry-only farms have been recommended (Kapperud et al., 1993; 
Neubauer et al., 2005; Hald et al., 2007).  Similarly, the role of wildlife in the introduction of 
Campylobacter in broiler flocks is not clear (Newell et al., 2011). In a study conducted by Hiett et 
al. (2002) the same Campylobacter strains recovered from wild bird feces on a farm were recovered 
from broilers. Conversely, other studies have found no significant links between Campylobacter 
strains from wildlife and broilers (Petersen et al., 2001; Colles et al., 2008). Rodents and flies have 
been found a significant risk factor in epidemiological studies (Hald et al., 2008; Hazeleger et al., 
2008). Doubts regarding the importance of rodents as risk factors have been raised as 
Campylobacter has been rarely detected in captured rodents (Jones et al., 1991). Nevertheless, 
efficient rodent control on-farm is considered a protective factor (van de Giessen et al., 1998). On 
the other hand, rodent control was found a risk factor in a study conducted by Arsenault et al. 
(2007). This finding could be explained due to the low efficacy of vermin control (Huneau-Salaun 
et al., 2007) but also due to the risk of Campylobacter introduction being higher due to human 
traffic to control rodents than the risk due to the actual presence of rodents. The relevance of flies as 
vectors might vary between geographical areas and it seems difficult to assess (Newell et al., 2011). 
Further research is needed in this area especially on the relevant fly species, on the distance they 
can travel and Campylobacter carriage properties.  
Epidemiological studies may be compromised by limitations in resources, non-adequate sampling, 
poor study design and data analysis. Uncertainty will always surround results from research studies 
and should be considered when interpreting results and implementing controls based on research 
findings. Some Campylobacter control strategies such as vaccination aim to reduce the numbers of 
Campylobacter in the intestinal tract of chickens to achieve a reduction of Campylobacter in 
chicken meat and in turn decrease the risk of human infections with Campylobacter. Promising 
vaccine candidates against Campylobacter have been developed but a commercial Campylobacter 
vaccine for poultry is not available at present. A lack of understanding of the immune system in 
chickens and the general absence of a strong immune response after vaccination against 
Campylobacter hampered vaccine development in some cases. Moreover, the induction of an 
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immune response in the host by a vaccine does not always correlate with a reduction of 
Campylobacter concentration in infected animals (Sizemore et al., 2006). Even when an immune 
response and a reduction in Campylobacter numbers have been achieved, other factors such as 
safety of the vaccine, efficiency under commercial conditions, costs and other practical 
considerations might make the commercialization of a potential vaccine candidate difficult.  
The use of bacteriophages in broilers to control Campylobacter seems promising but there are 
concerns regarding long-term efficacy and consumer safety (Hagens and Loessner, 2010). The long-
term efficacy of phage therapy seems questionable because Campylobacter phage-resistant strains 
may appear naturally and/or due to the use of bacteriophages. The oral administration of phages in 
humans seems to be harmless (Hermans et al., 2011) but the use of bioengineered modified foods 
can be controversial and not accepted by the consumers. 
Field trials need to be conducted to examine the practical effects of the most promising 
Campylobacter control measures. It is important to consider that the effectiveness of some control 
strategies such as phage therapy, vaccination and competitive exclusion products may be influenced 
by the genomic instability of Campylobacter (Ridley et al., 2008a). The type of production system 
will also influence the results. Campylobacter prevalence in free-range poultry flocks is usually 
higher than in poultry flocks produced in intensive conditions (Lund et al., 2003; Ring et al., 2005; 
McCrea et al., 2006). This observation may be explained by the extensive contact with the external 
environment and the fact that free-range birds are generally slaughtered at an older age than 
intensively produced poultry (Huneau-Salaun et al., 2007; Colles et al., 2008). Hence, the 
effectiveness of biosecurity barriers in preventing Campylobacter infection of free-range poultry is 
not clear indicating that the type of poultry production system is an important factor to consider for 
the control of Campylobacter and other pathogens. 
The poultry industry needs to be highly integrated in order to maintain profit margins which are 
usually very low and to meet consumer demands. Campylobacter control measures that can be 
applied at low cost are generally accepted by the poultry industry although the consistency with 
which the controls are implemented may vary. On the other hand, controls that require efforts 
and/or extra costs are not usually welcome by the poultry industry. For this reason, proposed 
controls should be backed up with strong evidence of effectiveness and a satisfactory viable cost-
benefit balance.  
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6. EXPERIMENTAL INFECTION WITH CAMPYLOBACTER AND A 
VACCINATION TRIAL AGAINST CAMPYLOBACTER IN BROILERS (Manuscripts I and 
II) 
 
6.1. Introduction 
Vaccines against Campylobacter have been developed for humans (Baqar et al., 1995; Scott, 1997; 
Scott and Tribble, 2000), chickens (Noor et al., 1995; Widders et al., 1996; Rice et al., 1997; 
Newell and Wagenaar, 2000) and other animals. Chickens have been considered the preferred 
animal model to assess vaccine efficiency to reduce Campylobacter numbers in birds (Davis and 
DiRita, 2008). Poultry might carry Campylobacter in numbers as high as 10 logs CFU per gram of 
faeces (Stas et al., 1999; Sahin et al. 2002; Lütticken et al., 2007) posing a risk for public health. A 
large variation in the amount of Campylobacter spp. in cecae of broilers going for slaughter has 
been reported (Stern et al., 2007; Hansson et al., 2010). Campylobacter dynamics in poultry flocks 
are not fully understood but poultry genetics and the time of Campylobacter introduction in the 
flocks may affect Campylobacter prevalence and concentration in poultry flocks and individual 
birds (Stern et al., 1988, 1990; Boyd et al., 2005; Li et al., 2008). Risk assessment models have 
predicted that the implementation of effective Campylobacter controls in poultry can translate in a 
decrease of human campylobacteriosis cases (Rosenquist et al., 2003; Nauta et al., 2009; EFSA, 
2011a). Based on these models, an expectation for a successful vaccine against Campylobacter in 
poultry could be based on a 2 logs reduction. A cost-effective vaccine against Campylobacter in 
poultry is not commercially available yet despite numerous attempts and years of research in this 
subject. Conventional vaccines usually perform poorly in chickens due to the interaction of 
Campylobacter with the intestinal niche in poultry and the absence of a strong immune response 
(Ringoir and Korolik, 2003; Walker, 2005; de Zoete et al., 2007). Moreover, immunity against 
Campylobacter seems to be strain-specific and consequently the development of a vaccine able to 
protect the host against all Campylobacter strains seems challenging. Nevertheless, an ideal 
successful commercial vaccine should protect poultry against all Campylobacter strains, should be 
not only cost-effective but also safe and produced in large quantities. Recently, a proteomic 
approach has been applied in order to identify new relevant antigens. The application of 
biochemical fractionation and mass spectrometry analysis has conducted to the identification of 
more than 110 surface polypeptides of Campylobacter jejuni (Prokhorova et al., 2006). Following 
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this research, a vaccine against Campylobacter was developed based on the protein ACE 393. 
Colonization with C. jejuni was substantially reduced in mice vaccinated with ACE 393 protein 
(Prokhorova et al., 2006; Schrotz-King et al., 2007). A human trial confirmed that the injectable 
vaccine ACE393 stimulated a four-fold increase in the production of IgG in all persons when 
administered using a 250µg dose (Anon, 2007). These results prompted us to investigate if poultry 
vaccination with ACE393 protein (the most promising candidate obtained in the study by 
Prokhorova et al., 2006) could also induce a protective response against gastrointestinal 
colonization of C. jejuni in broilers. The assessment of vaccine effectiveness based on quantitative 
reduction of pathogens is a complex task, which comprises: i) the statistical design of experimental 
trials, ii) the use of quantitative microbiological detection methods, iii) application of appropriate 
data analysis and finally the transformation of the vaccine effect in public health terms  (e.g. 
reduced number of human cases). Likewise, the choice of study unit, sample size, sampling protocol 
and forecasted group effects as well as data analysis methodologies should be carefully selected as 
they might affect the results of vaccine trials (Manuscript I: Garcia et al., 2012).  
 
6.2 Materials and methods 
6.2.1. Animals and experiments 
The experimental infections and vaccination trials were carried out at the National Veterinary 
Institute (Aarhus, Denmark) following Danish legislation for animal welfare and use of 
experimental animals. Experiments were conducted based on a nested fixed block design (no 
blinding) to test the vaccine candidate ACE 393 based on a Campylobacter surface polypeptide 
discovered by Prokhorova et al. (2006). The experiment used isolators (Montair Andersen B.V. HM 
1500) with 13 broilers placed in each isolator (Figure 2). Commercial broiler chickens (Ross 308) 
of mixed sex obtained from a Danish hatchery (DanHatch A/S) were used for the experiments. 
Chicks were transferred directly from the hatchery to the experimental unit, tested free of 
Campylobacter at placement and placed in the isolators at random. Broilers sharing the same 
isolator were administered the same treatment (either vaccine or placebo). The required sample size 
was calculated based on the sample size for a simple random sample design (16), multiplied by the 
estimated design effect (7). Accordingly, it was necessary to include about 120 broilers in each 
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group. Eight isolators were available for the clinical trial and thereby four rotations were necessary 
to achieve enough number of chickens in the experiment.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Graph representing the parallel group design used in the study. 
Broilers received treatment (either vaccine or placebo) at day 14 (Figure 3).  The vaccine ACE 393 
(Prokhorova et al., 2006) was administered via intramuscular using a dose of 50 µg of recombinant 
protein in 0.1 ml adjuvant (Alhydrogel 2%, Brenntag Biosector) per broiler (Garcia et al., 2012). 
The same adjuvant (0.1 ml of Alhydrogel 2%, Brenntag Biosector) was given to the placebo 
chickens intramuscularly. Chickens were challenged with (1.7 ± 0.5) × 104 (mean ± SE) CFU/g of 
Campylobacter jejuni in 0.5 ml 0.9% saline solution at day 31 (Figure 3). The broiler chickens were 
inoculated individually by crop instillation, using a 1-ml syringe with an attached flexible tube 
(diameter 3 mm, length 10 cm). The C. jejuni strain used in the present study was a broiler strain 
(DVI-SC181) of the most common serotype (Penner serotype 2) and flaA type (1/1) in Denmark. 
Faecal samples were collected at day 35, 38 and 42 during rotations 2, 3 and 4 of the clinical trial 
(Figure 3). Birds were weighted at slaughter on day 42 and several samples were collected: 
Rotation 1 
Rotation 2 
Rotation 3 
Rotation 4 
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individual fecal and cecal samples for the microbiological studies and blood samples for 
immunological research (Manuscript I: Garcia et al., 2012). 
 
Figure 3 Experimental design time-line  
Quantitative laboratory methods based on serial dilutions and selective culture were used to obtain 
Campylobacter quantitative data in order to assess vaccine effectiveness. Relevant calculations 
were performed and Campylobacter jejuni counts were obtained as CFU per gram of chicken 
caecum content or fecal mass. 
Detailed Materials and Methods are described in Manuscript I (Garcia et al., 2012) and Manuscript 
II. 
6.2.2. Data analyses 
Quantitative microbiological data often needs to be transformed for the statistical analyses; typically 
logarithmic transformation is used as in these experiments. Descriptive statistics and diverse 
statistical methods were performed utilizing data obtained from placebo and vaccinated chickens 
(Manuscript I: Garcia et al., 2012 and Manuscript II). Data obtained from chickens administered 
placebo treatment were used to estimate the variability in C. jejuni numbers obtained from fecal 
samples over time and from cecal samples. Mixed linear models were used to estimate the 
contributions of rotation, isolator and broiler (residual) to the variation in C. jejuni counts obtained 
from faecal and caecal samples. Moreover, the numbers of C. jejuni obtained from pooled samples 
were compared with the mean of individual samples. A potential correlation between faecal 
concentrations of C. jejuni at day 35, 38, and 42 prior to slaughter with caecal load at slaughter was 
also investigated using Pearson correlation analysis (Manuscript II).  
The potential effect of the vaccine was analyzed using diverse methods of increased complexity 
(see Manuscript I: Garcia et al., 2012). Initially, t-tests were performed considering all data together 
and ignoring the experimental design. After that, t-tests were produced per rotation, analyzing the 
potential vaccine effect in every rotation. Finally, data obtained from all rotations were analyzed 
Placement Day 1 Vaccination Placebo 
Day 
14 Inoculation 
Day 
31 
Sampling 
faecal  
Day 
35 
Sampling 
faecal  
Day 
38 
Slaughter 
Sampling 
Day 
42 
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together in a mixed effect model, which considers the hierarchical setup of the experiment 
(rotations, isolators within rotations, chickens within isolators within rotations). Mixed linear 
models were conducted in R using the lme4 package and the function lmer. Models were run 
separately for every set of samples (faecal samples at 35, 38 and 42 days, caecum samples at 
slaughter at 42 days). In the mixed models, the vaccine was the fixed effect while the random effect 
of rotations and isolators within rotations were both assumed to be normal distributed (N (0, σ2)). 
 
6.3 Results  
Detailed results are presented in Manuscript I (Garcia et al., 2012) and Manuscript II. 
 
6.3.1. Results obtained from descriptive statistics 
Results from the descriptive statistics are shown in Figure 4, in Appendix 1, Manuscript I (Garcia et 
al., 2012) and in Manuscript II. The logs CFU of C. jejuni per gram of fecal or cecal mass varied 
substantially between broilers, isolators and rotations. Descriptive statistics indicated that the 
numbers of C. jejuni isolated from fecal material at day 35 ranged from 5.26 to 9.41 logs in the 
placebo (non-vaccinated group) and from 5.69 to 9.30 logs in the vaccinated group; the numbers of 
C. jejuni isolated from feces at day 38 varied from 4.90 to 8.84 logs in the placebo group and from 
5.32 to 9.52 logs in the vaccinated group and at day 42 ranged from 4.04 to 9.38 logs in the placebo, 
non-vaccinated group and from 4.83 to 9.51 logs in the vaccinated group. The CFU counts of C. 
jejuni recovered from cecal contents varied from 4.81 to 9.30 logs in the non-vaccinated (placebo 
group) and 5.48 to 9.81 logs in the vaccinated group (Appendix 1). Therefore, counts in the 
vaccinated chickens seemed to be in general slightly higher than in the placebo group even though 
our initial hypothesis was based on a 2-log reduction of the numbers of Campylobacter in 
vaccinated chickens. 
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         a)Fecal data day 35          b)Fecal data day 38 
 
c)Fecal data day 42 
 
 
d) Cecal data day 42      
 
 
Figure 4 Scatterplots data regarding numbers of Campylobacter (logs) recovered from different 
samples from broilers. 
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6.3.2. Results from data analysis (placebo group only) 
Analysis of quantitative data obtained from the placebo group only (Manuscript II) indicated a 
slight decrease in the numbers of Campylobacter obtained from faecal material over time. In fact, 
ANOVA analysis indicated that there was a significant effect (p = 0.003) of time related to the 
numbers of Campylobacter isolated from poultry feces. Additionally, pairwise t-test showed that 
faecal Campylobacter counts at day 42 were significantly lower than at day 35 (p < 0.05). 
Correlation analyses showed that there was a significant correlation between Campylobacter faecal 
counts at day 35 and 38 (r = 0.3; C.I. = 0.11 - 0.47) and at day 38 and 42 (r = 0.2; C.I. = 0.02 - 
0.40). Likewise, a significant correlation was found between faecal and caecal CFU/g at day 42 (r = 
0.7; C.I. = 0.5 – 0-8). When analyzing placebo data only (Manuscript II), a comparison of 
Campylobacter numbers obtained from pooled and individual samples revealed consistently lower 
counts in the pooled samples compared to the mean of the individual samples in all isolators except 
two of them.  Results obtained from mixed linear models indicated that most variation was 
attributed mainly to individual chickens (residual), and a minor part to the effect of isolators. 
6.3.3. Results from data analysis (vaccinated and placebo groups- Manuscript I) 
Detailed results are shown in Manuscript I (Garcia et al., 2012). Results from the t-tests performed 
based on the numbers of C. jejuni recovered from fecal and caecum samples obtained from birds at 
slaughter are presented in Table 1.  
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Table 1 Mean values and t-test p-values obtained from comparison of vaccinated and placebo 
groups 
Campylobacter Recovered At 
Slaughter (Logs) 
Faecal Samples 42 days Caecum Samples 42 days 
 VACCINATED  PLACEBO  T-test p-
value  
VACCINATED  PLACEBO T-test p-
value 
ALL ROTATIONS  7.26 6.95 0.013 8.12  7.93  0.04  
ROTATION 1  N/A N/A N/A 8.14  8.31  0.28  
ROTATION 2  7.12 6.90 0.31 8.28  7.92  0.02  
ROTATION 3  7.55 7.31 0.19 8.19  8.30  0.55  
ROTATION 4  7.16 6.85 0.11 7.93  7.52  0.03  
 
The numbers of C. jejuni recovered from fecal samples at slaughter in all rotations when considered 
separately were higher for vaccinated broilers than for placebo but the differences were not 
statistically significant. The numbers of C. jejuni recovered from broilers belonging to the 
vaccinated groups were higher than numbers recovered from broilers in placebo groups when 
considering all rotations together. The difference was around 0.20-0.31 logs although statistically 
significant (p-values= 0.04; 0.013 when analyzing fecal samples and caecum samples at slaughter 
respectively) based on a significance level of p-value<0.05. On the other hand, vaccine effect was 
found not statistically significant when using mixed linear models (Table 2). Results obtained from 
the mixed models indicated high variability between birds. Variance distribution based on the 
results obtained from caecum and fecal contents are presented in Table 2.  
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Table 2 Variance distribution and p-values (vaccine effect) obtained from Mixed Linear Models 
using quantitative data from faecal and caecum samples  
 Samples Fecal       Cecal   
  Day:  35 38 42 Day: 42 
Rotation   0 0 0.01   0.02 
Isolator  0.07 0.10 0.14  0.21 
Residual  0.38 0.50 0.62  0.35 
Total variance   0.45 0.60 0.77   0.58 
p-value (vaccine effect)           0.70 0.42 0.14       0.40 
 
The variance estimates obtained indicated a relatively high variability between birds. For both cecal 
content and fecal material, most variation was attributed to the broilers, but also a small part of the 
variation was due to the isolators. The results from the mixed linear models indicated that the 
differences between vaccinated and placebo broilers in terms of the numbers of C. jejuni recovered 
in every set of samples were not statistically significant, based on a significance level of p-
value<0.05. Consequently, there was no statistically significant effect of the vaccine ACE 393 in 
this clinical trial in broilers under the experimental conditions applied. The “clustering effect” was 
estimated by calculating the intra-cluster correlation coefficients (ICC or ρ) and the results 
(Manuscript I: Garcia et al., 2012) indicated that the effect of clustering could not be ignored. The 
lack of independence in the data (called the “design effect (DE)”) associated to clustered data was 
obtained (DE= 4.34) and utilized to estimate the effective sample size (Snijders, 2005) which 
indicated the sample size taking on account the clustered design (Manuscript I: Garcia et al., 2012). 
Interestingly, the effective sample size was reduced to 67 animals in the study due to the 
experimental design and clustering effect. 
6.4. Discussion and conclusions 
There seems to be no consensus regarding the most appropriate sampling protocol to obtain 
accurate Campylobacter quantitative data. The sampling protocol (including methods, sample size, 
sample origin, time of sampling and other aspects) will influence the quantitative microbiological 
data and data analyses results. For example, quantitative data related to the concentration of 
Campylobacter in chickens might differ between individual and pooled samples but samples 
obtained on farm and/or at the slaughterhouse are usually pooled for practical reasons. Moreover, 
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faecal samples collected on farm might not be a good predictor of the caecal load of Campylobacter 
in individual chickens going for slaughter (Hansson et al., 2010). Hence further research seems 
necessary to explore and compare sampling protocols in order to obtain accurate Campylobacter 
quantitative data that can be used for risk assessment models and to assess the effectiveness of 
control strategies against Campylobacter. In our studies, a large variation between chickens related 
to the numbers of C. jejuni recovered from caecal samples and fecal samples at different time-points 
was observed. These results are in agreement with other findings showing that Campylobacter 
colonization levels differ between broiler chickens (Hansson et al., 2010). Even more, in our 
studies, results from mixed linear models indicated that the variation can be attributed mainly to 
individual chickens and to a lesser extent to the isolators suggesting that in commercial situations, 
differences might be observed between flocks but even greater differences might be expected due to 
individual chickens. This observation suggests that individual factors such as chicken genetics may 
affect Campylobacter dynamics in poultry flocks (Stern et al., 1990). What's more, in commercial 
farms chickens might be infected with Campylobacter at different times and diverse initial 
concentrations while in this study broilers were inoculated with the same dose of C. jejuni at the 
same time. In addition, the poultry digestive physiology might influence the intermittent excretion 
of Campylobacter. Previously mentioned aspects support concerns related to limited sampling of 
poultry flocks not being representative of the real Campylobacter situation in large flocks. 
Additionally, results from this study suggest that pooling of samples will probably lead to an 
underestimation of the numbers of Campylobacter in the flock. Data obtained from placebo 
chickens indicated that the mean concentration of C. jejuni recovered from caecum samples was 7.9 
log CFU/g in agreement with other studies (Grant et al., 1980; Stern and Robach, 2003; Hansson et 
al., 2010). Campylobacter jejuni concentrations in fecal samples were slightly lower than in caecum 
samples, with mean concentrations decreasing from 7.4 log CFU/g on day 35 to 6.9 log CFU/g at 
day 42. Interestingly, this observation related to the decreased C. jejuni counts in fecal samples 
from day 35 to day 42 was found statistically significant (p < 0.05). Even more, a significant 
correlation was observed between faecal and caecal C. jejuni concentrations at slaughter (r = 0.7; 
C.I. = 0.5 – 0-8) suggesting that Campylobacter counts from fecal samples at slaughter might be a 
good indicator of Campylobacter concentration in the caecum of slaughter chickens. This 
significant correlation is in agreement with other studies (Fluckey et al., 2003) supporting 
recommendations made related to the sampling of chickens closer to slaughter time (Hansson et al., 
2005). Moreover, if there is a significant positive correlation between the numbers of 
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Campylobacter in chickens at slaughter and the numbers of Campylobacter in carcasses as it has 
been suggested (Rosenquist et al., 2003; Lindblad et al., 2005; Reich et al., 2008), Campylobacter 
testing of fecal samples from chickens just before slaughter will aid producers in the control of 
Campylobacter contamination of chicken products. 
Results from our vaccination experiments indicated that the apparent observed differences between 
vaccinated and placebo groups related to Campylobacter counts could be attributed to the variation 
between birds in the same group and between groups. It is possible that poultry sharing the same 
environment re-infect each other with Campylobacter and that the micro-environmental conditions 
might also affect the numbers of Campylobacter in the groups. It seems important to consider the 
“clustering effect” when analyzing quantitative data and also when designing multilevel clinical 
trials. Although clustered designs can be more costly and require more individuals and more 
complex data analysis, they present some advantages. Ideally, an effective vaccine against 
Campylobacter for poultry will work under commercial farming conditions. Consequently, the 
vaccine should be effective when used with poultry belonging to different flocks and diverse 
farming systems. Nevertheless, the success of vaccine trials for the control of Campylobacter 
infections depends on many factors such as the vaccine candidate, the animal model, individual host 
factors, Campylobacter strain, environmental factors and others. A particular vaccine might work 
on a specific trial (with an animal model for example) using a particular Campylobacter strain and 
controlled experimental conditions but the same vaccine might produce results under expectations 
when using other strains, different animal models or environments. In fact, the vaccine ACE 393 
substantially reduced colonization with C. jejuni in vaccinated mice (Prokhorova et al., 2006; 
Schrotz-King et al., 2007) while the same vaccine did not seem to work in this poultry trial. Field 
studies to test vaccine efficiency carry additional complexity due to the lack of knowledge 
regarding some environmental factors. The vaccine was considered a fixed effect in this study, 
however, in field studies it will be expected that the vaccine effect will vary. Moreover, the results 
from data analysis will depend on the methodologies employed for analysis but also on the raw 
quantitative microbiological data obtained during the experiments. Microbiological data will in turn 
be influenced by the choice of sampling site, sampling methodologies and laboratory protocols. The 
effect of the experimental design should not be ignored when analyzing experimental data (Garcia 
et al., 2012). In this study, the effective sample size was reduced to 67 animals due to the 
experimental design and clustering effect. This information can be useful when calculating the 
sample size required in an experiment with clustered sampling.  
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Important considerations that should be taken into 
account when designing randomized controlled 
veterinary vaccine trials have been reviewed [1]. 
A clear objective stating the expectation for the 
successful vaccine candidate and the choice of 
the study unit are crucial for the experiments. 
The sample size and forecasted group effects, as 
well as data analysis methodologies need to be 
selected carefully as they might affect the results 
of vaccine trials. Risk assessment models indicate 
that a reduction of the numbers of campylobacter 
in chickens intended for human consumption 
by 2 logs will translate on a reduction of the 
prevalence of human campylobacteriosis [2]. 
Therefore, the expectation for a successful 
vaccine against campylobacter could be based 
on a 2 logs reduction.
In contrast to vaccines with animal health 
benefits such as reducing clinical symptoms of 
infected animals, in recent years, an interest for 
veterinary vaccines against zoonotic pathogens 
of public health importance has emerged. The 
development of vaccines to protect animals from 
zoonotic infections will have important public 
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The development of effective vaccines against zoonotic pathogens represents a priority in public 
health protection programs. The design of clinical trials and appropriate data analysis of the 
experiments results are crucial for the assessment of vaccine effectiveness. This manuscript 
reviews important issues related to the assessment of the effectiveness of vaccines designed 
to obtain a quantitative reduction of the pathogen in animals or animal products. An effective 
vaccine will reduce the risk of human infections and therefore the number of human cases. 
Important considerations will be illustrated using a vaccination trial of a new campylobacter vaccine 
candidate developed to reduce the numbers of campylobacter in chickens and consequently the 
numbers of human campylobacteriosis cases. The design of the author’s vaccination trial was 
based on the use of isolators, a parallel group design and several rotations. The effect of clustering 
or design effect was considered in the sample size calculations. Chickens were randomly assigned 
to different isolators (treatments) and challenged with Campylobacter jejuni. Samples were 
obtained at different intervals and processed in the laboratory. C. jejuni counts were determined 
as colony-forming unit-per-gram of chicken cecum or fecal mass in order to assess vaccine 
effectiveness. A desired vaccine effect of 2 logs reduction on the numbers of C. jejuni recovered 
from vaccinated chickens was selected. Sample-size calculations, desired vaccine effect, biological 
and epidemiological aspects, experimental design and appropriate statistical analysis of data 
considering group or clustering effects will be the focus of this manuscript.
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health implications as approximately 75% of new emerging infec-
tions can be considered zoonoses [3,4]. In particular, enteric infec-
tions are considered one of the main causes for human disease and 
human casualties across the world. Therefore, the development 
of effective vaccines to protect humans from the main  pathogens 
associated with zoonotic enteric infections is highly desirable.
Important issues related to the assessment of the effectiveness of 
vaccines aiming to result in a quantitative reduction of the patho-
gen in animals or animal products are examined in this manu-
script. The assessment of vaccine effectiveness based on quantita-
tive reduction of pathogens is a complex task, which comprises: 
the statistical design of experimental trials; the use of quantitative 
microbiological detection methods; application of appropriate data 
analysis; and finally the transformation of the vaccine effect in 
public health terms (e.g., reduced number of human cases).
This review discusses and illustrates the interaction between 
the experimental design and appropriate data analysis, and how 
different choice of approaches might influence the conclusions 
from vaccination studies. If the vaccine aims to reduce the num-
ber of pathogens, the vaccine effect will in turn reduce the risk 
of zoonotic infections and the number of human cases. As a case 
story, different aspects and considerations will be discussed based 
on a vaccination trial of a new campylobacter vaccine candidate 
aiming to reduce the numbers of campylobacter in chickens. The 
rapidly emerging knowledge of the biology of campylobacter in 
combination with advances in the fields of molecular vaccinology 
and immunology provide the setting for the development of effi-
cient vaccines. Vaccines against campylobacter have been devel-
oped for humans [5–7], chickens [8–11] and other animals. However, 
no commercial campylobacter vaccine is currently available.
Poultry has been identified as the main risk factor associated with 
human campylobacteriosis [12,13]; chickens intended for human 
consumption can be heavily and persistently colonized with campy-
lobacter representing an important public health risk. Prevalence 
of campylobacter in broiler flocks in Europe can vary between 3 
and 91% [14]. In chicken infected with campylobacter, colonization 
and shedding patterns depend on a number of factors (such as the 
bacterial strain). The intestinal tract of chickens is a complex envi-
ronment where different physical, physio logical and  biochemical 
factors can influence the colonization with campylobacter [15].
The concentration of campylobacter in the gastrointestinal tract 
of poultry can exceed 7.0 log10 colony-forming unit (CFU) per 
gram [16]. In fact, the colonization level can be as high as 1010 
CFU per gram of feces [3,17,18]. Campylobacter can be found in 
high numbers in the large intestine, ceca and cloaca [19]. Small 
amounts of cecal contents can cause campylobacter contamina-
tion of broiler carcases [20]. Campylobacter can also originate 
from feces of infected chickens, contaminate the food processing 
environment and directly contaminate the meat; a positive correla-
tion between numbers of campylobacter in ceca and numbers on 
chicken carcasses has been shown [2,21,22]. Therefore, a reduction 
of the numbers of campylobacter in poultry meat can be attained 
by reducing the number of campylobacters in poultry ceca [16,23], 
which in turn will reduce the risk of campylobacter infections in 
humans.
Experimental design & sample size considerations
The overall aim of vaccination against some zoonotic infections 
in animals is based on the reduction of quantitative exposure of 
pathogens to humans. Therefore, the outcome from the vaccina-
tion trial should be measured on a continuous scale, for instance 
the number of CFU per gram of feces or per cm2 of the carcass. 
Traditionally, the sample size calculation in experiments with a 
continuous outcome is based on the comparison of two means. 
Data measured on a continuous scale, given a valid measurement, 
are mathematically more informative than a binomial outcome 
such as infected/noninfected and, in general, the size of the trial 
is smaller than a trial focusing on a yes or no outcome, for exam-
ple, presence of disease. In our case study, the experiment was 
designed based on the use of isolators with 13 broilers placed in 
each isolator (Figure 1).
Campylobacter can spread quickly between chickens sharing the 
same environment by environmental contamination and coprophagy 
[24]. Broilers placed in the same isolator in our clinical trial shared 
community; calculations from data obtained in previous experiments 
using isolators indicated a 50% correlation on the numbers of 
campylobacter obtained from chickens within an isolator (results 
not shown). A design effect (DE) of seven was obtained in order to 
adjust the effect of correlation on the standard error (SE) [25]. The 
required sample size was calculated as the sample size for simple 
random sample design (16), multiplied by the DE seven, which 
equaled to approximately 120 chickens in each group. Eight isolators 
were available at the research facility, and thereby the authors had to 
run three to four rotations to achieve enough number of chickens 
in the experiment. The eight isolators were used during each 
rotation. Each incubator either contained only vaccinated or only 
nonvaccinated (placebo) chickens in order to design the experiment 
mimicking the infectious dynamics in intensive farming conditions. 
The infectious dynamics within each incubator were then similar to 
the infectious dynamics in production flocks, where campylobacter 
is spread between chickens by a sustained exposure to contaminated 
feces. The opportunity to mimic the realistic working mechanisms 
of a vaccine in the field conditions increased by using groups of 
animals where all the birds had been vaccinated. A vaccination effect 
was expected on the vaccinated animals by decreased susceptibility 
and also on the whole population as such by reduced population 
infectious pressure. In every rotation, four isolators with vaccinated 
chickens and four isolators with nonvaccinated chickens were 
managed in parallel (Figure 1).
Animals, experimental design timeline & treatments
The genetic makeup of animals included in the study might have 
an effect on the experimental results. Leghorn broilers have been 
used in campylobacter colonization experiments and vaccine tri-
als [10,17,18,26–29]. Furthermore, inclusion and exclusion criteria 
should be defined during the experimental design process. In 
general, the animals used in an experimental study should be 
genetically as close as possible to the breed used in the commercial 
production systems. In this study, campylobacter-free 1-day-old 
broilers acquired from a commercial firm in Denmark were used. 
On arrival to the laboratory, the birds were tested to confirm 
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they were campylobacter free and placed in 
incubators at random [30]. Campylobacter 
is rarely detected in commercial flocks with 
birds younger than 2 weeks of age [30,31]. 
Therefore, this 2-week ‘window’ could be 
used strategically to introduce vaccina-
tion programs [10]. The aforementioned 
stated recommendation was followed in 
this study and broilers received treatment 
at day 14 (either vaccine or placebo). The 
vaccine ACE 393 based on a surface poly-
peptide discovered by Prokhorova et al. [32] 
was administered intramuscularly using a 
dose of 50 µg of recombinant protein in 
0.1 ml adjuvant (Alhydrogel 2%, Brenntag 
Biosector, Frederikssund, Denmark) per 
broiler [30]. A dose of 0.1 ml of adjuvant 
(Alhydrogel 2%, Brenntag Biosector) was 
given to the placebo chickens. All birds 
were challenged with Campylobacter jejuni 
at day 31. The use of a challenge method 
that mimics natural transmission of 
 campylobacter in broiler flocks is highly desirable in  experiments. 
Fecal samples were collected during the trial (Figure 2).
In this particular experimental vaccination trial, the outcome of 
interest was the number of Campylobacter in broilers during the 
experiment, but particularly at slaughtering time, which might 
pose a risk to the consumer. Birds were weighted at slaughter on 
day 42 and several samples were collected: blood samples for the 
immunological studies and individual fecal and cecal samples for 
the microbiological tests [30].
Measurement of outcome
Quantitative laboratory methods based on serial dilutions of 
samples followed by selective campylobacter cultivation were 
used in this trial to assess vaccine effectiveness. Relevant cal-
culations were performed and C. jejuni counts were determined 
as CFU per gram of chicken cecum or fecal mass. However, 
several laboratory methods are currently available for the detec-
tion and quantification of campylobacter [33,34]. The choice of 
the laboratory methodologies should be included in the study 
design; furthermore, research results might be affected by the 
choice of laboratory methods and sampling matrices and pro-
tocols. Molecular methodologies such as quantitative PCR are 
based on DNA extraction, purification and quantification. The 
development of quantitative PCR seems promising for the near 
real-time detection of pathogens [35].
More efficient and reliable nonenrichment methods are under 
development in order to separate pathogen cells from complex 
sample matrices and concentrate the cells for quantification. 
However, complex sample matrices might present a challenge 
for the extraction and purification of campylobacter DNA. The 
concentration of bacterial pathogens from complex matrices 
(food, environmental samples and fecal material) can be diffi-
cult because most bacterial cells are fragile. Furthermore, good 
methodologies should be able to concentrate the pathogens while 
removing inhibitors present in the sample matrix. Inhibitory sub-
stances present in complex biological samples may reduce or even 
impede the amplification process [36]. Bile salts, DNase, com-
plex polysaccharides, urea and proteinase present in fecal sam-
ples can act as inhibitors contributing to reduce the sensitivity of 
the PCR technique [37]. Sample quality has been identified as an 
important factor for PCR reliability [38]. An ideal method would 
also be applicable to  multiple matrices and pathogens, rapid and 
 inexpensive [33,39].
Quantitative microbiological data & data management
Reliable and accurate quantitative microbiological data should 
be obtained in order to assess vaccine effectiveness. Furthermore, 
reliable, rapid methods, high quality microbiological data and 
good food safety data management and traceability systems can 
play a key role in preventing diseases. In our case study, the quan-
tification of campylobacter was crucial to conduct the assessment 
of vaccination strategies against campylobacter.
The choice of sampling site, sampling methodologies and 
laboratory protocols will influence quantitative data results. 
Challenges regarding these aspects need to be faced and deci-
sions need to be made during the study design process. However, 
decision-making has to be usually performed under uncertainty 
and challenging conditions in terms of information access, time 
availability, practical limitations and other constraints. Due to 
the nature of sampling and microbiological processes, data might 
be missing in some instances (e.g., when there are too many 
colonies to be counted on a plate). Dealing with missing micro-
biological data can imply the use of complex mathematical meth-
odologies. Furthermore, information regarding sensitivity and 
specificity of different microbiological methods might not always 
be available. New methods should offer increased sensitivity and 
Rotation 1
• 13 chickens
• Vaccine incubator 1
• Vaccine incubator 3
• Vaccine incubator 5
• Vaccine incubator 7
• Placebo incubator 2
• Placebo incubator 4
• Placebo incubator 6
• Placebo incubator 8
• 13 chickens
• 13 chickens
• 13 chickens
• 13 chickens
• 13 chickens
• 13 chickens
• 13 chickens
Rotation 2
Rotation 3
Rotation 4
Figure 1. The parallel group design used in the study.
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specificity in order to minimize false-positive and false-negative 
results that can have important financial and/or public health 
consequences. Therefore, it seems important to elucidate sensi-
tivity and/or specificity of new methodologies. As an example, 
the diagnostic specificity of a recently developed real-time PCR 
for campylobacter in chicken feces was 0.96 and no statistical 
significant difference with selective enrichment techniques was 
observed [40].
The combination of advances in new technologies (e.g., 
quantitative real-time PCR), new or improved microbiological 
methodologies (e.g., optimal sample processing), new ‘omic’ 
technologies, bio-engineering (e.g., new biosensors), the use of 
mathematical models for epidemiological purposes and decision-
making together with effective management and global valida-
tion systems seems crucial for the management of public health 
data. Decision makers face uncertainty and limitations (e.g., 
inaccurate and/or incomplete information, time constraints and 
lack of data) when making difficult decisions regarding disease 
control and global health. Therefore, accurate, reliable and rapid 
microbiological methods can help to decrease uncertainty around 
risk-based decisions.
Statistical analysis of quantitative data
Descriptive statistics are useful to explore the quantitative data in 
order to achieve preliminary conclusions regarding data distribu-
tions and decisions regarding appropriate data analysis methods. 
Furthermore, the choice of data analysis methodologies is very 
much dependent on the scale of measurement used to assess the 
effect of the vaccine, and how the results are distributed. For 
binomial outcomes, the data are analyzed using binomial mod-
els, whereas for continuous outcomes, typically linear methods 
are used. These methods are usually based on normal distribu-
tions of data; however, many biological continuous variables 
are not following normal distributions. Therefore, it might be 
necessary to carefully transform the data to use statistical meth-
ods correctly [101]. Microbiological data obtained from bacterial 
counts often need to be transformed to obtain useful distribu-
tions; typically logarithmic transformation is used, as was the 
case in our case study.
Different statistical software programs are available to manage, 
analyze quantitative data and design mathematical models. The 
authors used Microsoft Excel, R Statistical Software and Minitab® 
Statistical Software in their case study.
In a nested designed infectious animal experiment, a significant 
correlation was expected between the animals that share com-
mon features, for instance a common close environment such as 
an isolator, and this is usually expected to lead to dependence 
between the observations in a group. Clustering is not neces-
sarily restricted to a single level, for instance, in our case study, 
the chickens are clustered within isolators, and the isolators are 
clustered within rotations. The clustering must be taken into 
account for obtaining valid estimates of the effect of a vaccine. 
This is because the assumption of independence inherent in most 
statistical models will be invalidated by the clustering [41]. The 
general effect of ignoring clustering is that the SE of the estimate 
of the effect of the vaccine will be too small. A reduction of the 
SE will also reduce the significance level, and therefore, there 
is a risk that the effect will be interpreted as significant, even if 
strictly speaking there is not enough power for that significance 
in the analysis [41].
To illustrate the importance of taking the structure of the 
trial into account in the data analysis, the effect of the vac-
cine was analyzed using methods with increased complexity. 
In all analyses, the effect of vaccine was estimated as a fixed 
effect. Initially, a t-test of all data, ignoring the physical setup 
of the trial, was performed. Subsequently, the t-test was strati-
fied, analyzing each rotation separately. Finally, data from all 
rotations were analyzed together in a mixed effect model, tak-
ing into account the physical hierarchical setup of the trial 
(rotations, isolators within rotations, chickens within isolators 
within rotations). In the mixed model, the effect of rotation 
and isolator with rotation were both assumed to be normal 
distributed (N [0, σ2]).
In this clinical trial, birds were clustered into groups in isolators 
and nested in rotations. The clustering effect can be described by 
the intracluster correlation coefficient (ICC or ρ), which compares 
the variance within clusters with the variance between clusters 
and therefore indicates the ‘relatedness’ of clustered data. A clus-
tered design implicates loss of independence and data analysis 
needs to account for this lack of independence in the data (termed 
the DE). Furthermore, clustered sampling is not as statistically 
efficient as simple random sampling and therefore sample size 
calculations need to be adjusted to the clustered design. The effec-
tive sample size indicates the sample size taking on account the 
clustered design (in comparison with the number of  individuals 
actually included in the study).
Results from descriptive statistics applied to the 
quantitative data obtained in our clinical trial
Results from quantitative data analysis revealed that recovered 
campylobacter numbers from fecal and cecal samples collected at 
slaughter varied between 4 and 10 logs (Figures 3 & 4). Quantitative 
data obtained from chickens included in placebo groups are rep-
resented in blue and from chickens included in vaccinated groups 
Placement Inoculation Samplingfecal
Sampling
fecal
Slaughter
sampling
Vaccination
placeboDay 1 Day 14 Day 31 Day 35 Day 38 Day 42
Figure 2. Experimental design time-line. 
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are presented in red. Differences between 
 rotations are also revealed in Figures 3 & 4.
Results obtained from t-tests 
(between vaccinated & placebo 
groups) conducted in our case study
The results of the initial crude and strati-
fied t-tests performed based on the numbers 
of campylobacter (in logs) recovered from 
fecal and cecum samples taken from birds 
after slaughter are shown in Table 1. When 
considering all rotations together in the 
t-test, the numbers of C. jejuni recovered 
from broilers belonging to the vaccinated 
groups were higher than numbers recovered 
from broilers in placebo groups. The dif-
ference was approximately 0.20–0.31 logs 
although statistically significant (p-values 
= 0.04 and 0.013, respectively) based on 
a significance level of p <0.05. However, 
the numbers of C. jejuni recovered from 
ceca from broilers in placebo groups in 
rotations one and three were higher when 
 compared with  vaccinated birds although 
the  differences were not statistically  significant. The  numbers of 
C. jejuni recovered from fecal samples at slaughter in all rota-
tions when considered separately were higher for vaccinated 
broilers than for placebo, but the differences were not  statistically 
significant.
Results from mixed linear models designed in case trial 
& the ‘clustering effect’
The vaccine effect was found to be not 
statistically significant when using mixed 
linear models (Table 2). Results obtained 
from these models indicated high variabil-
ity between birds. Variance distribution 
for the results obtained from cecum and 
fecal contents is presented in Table 2. For 
observations from both cecum and fecal 
contents, most variation was attributed to 
the individual chickens, but a relatively 
large part of the observed variation was also 
attributed to the isolators. The clustering 
effect was estimated by calculating the ICC 
presented in Table 3.
The results indicate that although some 
of the variation is within the groups, the 
effect of clustering should not be ignored. 
The lack of independence in the data (the 
DE) associated to clustered data was calcu-
lated. Furthermore, the effective sample size 
(ESS) can then be estimated [25] and indi-
cates the sample size taking into account 
the clustered design (in comparison with 
the number of individuals actually included in the study). The 
design effect (DE) can be obtained using the  following equation: 
DE 1   m 1 1  4   9 35 1 4 34= + −( ) = + × −( ) =r 0 0. . .
where ρ is the ICC for the statistic in question and m is the average 
size of the cluster (in this case between eight and 13 broilers were 
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placed in the incubators, with an average size of 9.35). The ESS 
can be calculated considering the 290 birds included in the study.
ESS = 290/4.34 = 67
Therefore, the ESS was reduced to 67 animals in the study due 
to the experimental design and clustering effect. This information 
can be used when designing studies for sample size calculations 
considering clustered sampling.
The use of data analysis methods that ignore the clustering 
effect such as the t-test in our case study, translates on a small SE 
of the estimate of the effect of the vaccine [41]. This reduction of 
the SE will translate on the reduction of the significance level, 
and therefore there is a risk that the effect will be interpreted as 
significant, as illustrated in Table 4.
Expert commentary
It has been suggested that new vaccine candidates should be tested 
in randomized controlled trials in order to provide evidence of 
vaccine effectiveness [41,42]. An effort towards innovative designs 
of clinical experiments and the use of advances in systems biology 
could assist on the discovery of novel vaccine candidates and/or 
novel strategies for immunization [43]. Furthermore, a predeter-
mined expectation of the vaccine effect necessary to reduce the 
public health impact of the disease should be considered [44,45]. In 
our clinical trial, the desired effect of the vaccine was defined as 
2 logs reduction on the numbers of recovered C. jejuni from vac-
cinated chickens. Risk assessment models indicate that a reduc-
tion of the numbers of campylobacter in chickens intended for 
human consumption by 2 logs will translate on a reduction of the 
prevalence of human campylobacteriosis [2]. However, no previ-
ous studies had been found that indicated whether this aim was 
biologically possible. Experts within the research group made 
this decision regarding vaccine effectiveness. In general, it seems 
important to have a sound knowledge of the potential vaccine 
effect to avoid conducting an experiment based on impossible 
expectations. In conclusion, in this study, we obtained no evi-
dence of 2 logs reduction on the numbers of C. jejuni isolated from 
infected vaccinated chickens. However, we observed diverging 
results of the effect of the vaccine depending on which approach 
we used in the statistical analysis of the quantitative data obtained 
from the clinical trials. In the crude analysis, when considering all 
rotations together, there were statistically significant results but 
the numbers of campylobacter were higher in vaccinated birds. 
A similar result was obtained in some of the rotations when we 
stratified the crude analysis per rotation.
There are many different studies conducted on vaccination 
research and diverse statistical analysis methods performed to 
assess vaccine effectiveness [46]. However, most assessments of 
vaccine trials have been generally based on data analysis using the 
student t-test [15,47]. The number of experimental studies where 
data are analyzed by adjusting for clustering seems to be limited. 
Mixed effect models can incorporate both fixed and random 
effects being suitable to analyze longitudinal data and clustered 
data [48–51]. Many standard statistical programs today have acces-
sible options to account for clustering when analyzing quantita-
tive data, but efforts should be made to adjust the  analysis for 
 clustering due to a nested setup of an animal experiment.
In our case study, we estimated the effect of vaccine as a fixed 
effect, assuming that the effect should be the same in all rotations 
and incubators. However, in the field you can expect that the effect 
of the vaccine will vary within different flocks and farming condi-
tions. The selection of particular vaccination strategies will also 
vary depending on the factors considered [52]. In fact, the apparent 
observed differences between vaccinated and placebo groups in 
this study can be attributed to the variation between incubators, 
where chickens in the same incubator had more equal numbers 
of C. jejuni compared with chickens in other incubators. It is 
possible that chickens in the same incubator re-infect each other 
with campylobacter and that the microenvironmental conditions 
might also affect the numbers of campylobacter in the incubators. 
It is important to consider the clustering effect when analyzing 
Table 2. Variance distribution and p-values (vaccine 
effect) obtained from mixed linear models using 
quantitative data from fecal and cecum samples.
Fecal (days) Cecal (days)
35 38 42 42
Rotation 0 0 0.01 0.02
Isolator 0.07 0.10 0.14 0.21
Residual 0.38 0.50 0.62 0.35
Total variance 0.45 0.60 0.77 0.58
p-value (vaccine effect) 0.70 0.42 0.14 0.40
Table 1. Mean values and t-test p-values obtained from comparison of vaccinated and placebo groups.
Rotations Campylobacter recovered at slaughter (logs)
Fecal samples 42 days Cecum samples 42 days
Vaccinated Placebo t-test p-value Vaccinated Placebo t-test p-value
All rotations 7.26 6.95 0.013 8.12 7.93 0.04
Rotation 1 NA NA NA 8.14 8.31 0.28
Rotation 2 7.12 6.90 0.31 8.28 7.92 0.02
Rotation 3 7.55 7.31 0.19 8.19 8.30 0.55
Rotation 4 7.16 6.85 0.11 7.93 7.52 0.03
NA: Not applicable.
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quantitative data and also when designing multilevel clinical tri-
als [25]. The initial sample size calculations were based on a DE 
of 7 and a 50% ICC (ρ= 50%). The results obtained from the 
clinical trial indicated different values for ICC (ρ = 40%) and DE 
(4.34). The DE can be considerable, reducing the effective sample 
size (in this case, 63 animals instead of the 290 animals included). 
Although clustered designs can be more costly and require more 
individuals and more complex data analysis, they present some 
advantages. The design used in this trial was trying to emulate 
the clustering effect found in broiler flocks and farms. Ideally, 
an effective vaccine against campylobacter for broiler chickens 
will work under commercial farming conditions. Therefore, the 
vaccine should be effective when used with  chickens belonging 
to different flocks and diverse farming systems.
However, the success of vaccine trials for the control of campy-
lobacter infections depends on many factors such as the vaccine 
candidate, the animal model, individual host factors, campylo-
bacter strain, environmental factors and others. A particular vac-
cine might work on an specific trial (with an animal model for 
example) using a particular campylobacter strain and controlled 
experimental conditions; however, the same vaccine might pro-
duce results under expectations when using other strains, differ-
ent animal models or environments. Furthermore, field studies to 
test vaccine efficiency carry additional complexity due to the lack 
of knowledge regarding some environmental factors. Additional 
complexities to consider are microbiological methodologies used 
for isolation, characterization and quantification of campylobacter 
and the choice of data analysis techniques. The results from data 
analysis will depend on the methodologies used for analysis and 
also on the raw quantitative microbiological data obtained during 
the experiments. Microbiological data will in turn be influenced by 
the choice of sampling site, sampling methodologies and labora-
tory protocols. In our clinical trial, the numbers of campylobac-
ter recovered from cecum samples were consistently higher than 
the numbers obtained from feces. This finding is in agreement 
with other studies [38]. However, the choice of laboratory methods 
(e.g., the choice of selective agar) might also influence the results 
obtained from fecal and cecal samples [53].
Uncertainty plays a key role in biological studies and should be 
accounted for the analysis and interpretation of laboratory data 
and when developing mathematical or epidemiological models 
[54–57]. Furthermore, the distinction between uncertainty and 
variability can influence research results and therefore should 
not be ignored [58,102].
Five-year view
Future advances in biotechnology and new technologies will assist 
public health experts, epidemiologists and workers in the fields of 
quantitative microbiology, vaccinology, immunology and math-
ematical modeling in providing efficient strategies for the control 
of zoonotic infections. Innovation in all areas is highly desirable 
for the control of important zoonoses. Furthermore, innovative 
integration of the different aspects will translate in more efficient 
controls for the protection of public health.
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Table 3. Intracluster correlation coefficients.
Data from fecal 
samples 35 days
Data from fecal 
samples 38 days
Data from fecal 
samples 42 days
Data from cecum 
samples 42 days
Correlation between chickens in the same 
isolator and same rotation
0.16 0.17 0.20 0.40
Correlation between chickens in the same 
rotation but different isolators
0 0 0.013 0.035
Correlation between means of two incubators 
of size 10 chickens per incubator
0 0 0.05 0.07
Table 4. Comparison of the standard errors of estimated vaccine effects using different data analysis 
methods (t-tests and mixed linear models).
Samples
Fecal 35 days Fecal 38 days Fecal 42 days Cecal 42 days
Estimates of the vaccine  
effect (logs, all rotations)
0.08 logs (higher in 
placebo)
0.10 logs (higher in 
vaccinated)
0.31 logs (higher in 
vaccinated)
0.19 logs (higher in 
vaccinated)
Statistical methods t-test MLM t-test MLM t-test MLM t-test MLM
SE 0.10 0.14 0.11 0.17 0.12 0.19 0.09 0.09
p-value 0.39 0.70 0.37 0.42 0.013 0.14 0.04 0.40
MLM: Mixed linear model; SE: Standard error.
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Key issues
• The safe use of effective vaccines against zoonotic pathogens represents a priority in public health protection programs.
• An effective vaccine will potentially reduce the risk of human infections and therefore the number of human cases.
• The assessment of vaccine effectiveness can be a complex task that requires careful consideration of experimental design and data 
analysis methodologies.
• The desired impact or effect of the vaccine needs to be selected during the trial design process.
• The design of the experiments needs to be carefully planned in order to maximize the research investment and to obtain accurate and 
useful results.
• Descriptive statistics can be used to explore the data in order to achieve preliminary conclusions regarding data distributions and to 
choose appropriate data analysis methods.
• Complex data analysis methods need to be selected based on the experimental design.
• The use of a clustered design implicates loss of independence and therefore data analysis needs to account for this effect (called the 
‘design effect’). The design effect can be considerable, reducing the effective sample size of the experiment.
• Vaccines against campylobacter have been developed; however, no commercial vaccine is yet available. A reduction in the numbers of 
campylobacter in chickens intended for human consumption will reduce the risk of campylobacter infections in humans.
• Field trials of vaccine effectiveness need to consider epidemiological factors. Mathematical models can be developed to assist in the 
assessment of vaccine effectiveness under different conditions.
• Uncertainty plays a key role in the studies and should be considered when developing mathematical or epidemiological models.
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Abstract 21 
Consumption of poultry meat is considered as one of the main sources of human 22 
campylobacteriosis. Quantitative data on the Campylobacter spp. colonization dynamics in broiler 23 
chickens is thus crucial to implement effective control measures. We carried out four experimental 24 
infection trials (rotations) looking at the colonization of Campylobacter jejuni over time in 25 
individual broiler chickens. There were large differences between broiler chickens in the number of 26 
C. jejuni in caecal and faecal material. Faecal samples of C. jejuni ranged from 1.1×104 to 2.4×109 27 
CFU/g and from 6.5×104 to 2.0×109 CFU/g in the caecae. There was a significant correlation 28 
between caecal and faecal CFU/g. Individual broiler chicken variation contributed significantly to 29 
the total variance of colonization, followed by isolators. Rotations did not contribute to the total 30 
variance. The results showed that pooled samples within isolators had lower CFU/g compared to the 31 
mean of the individual samples.  32 
 33 
 34 
 35 
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Introduction 42 
Campylobacter spp. is the leading cause of bacterial gastroenteritis in the world, causing 2.4 million 43 
cases yearly in the United States [1]. In 2011 220,209 cases were reported in the European Union 44 
(EU) [2]. The total annual cost of campylobacteriosis in the EU is estimated to be 2.4 billion € [3]. 45 
Campylobacteriosis is largely perceived to be food-borne disease with poultry meat as the primary 46 
infection source. The incidence of campylobacteriosis in humans is correlated with the prevalence 47 
of Campylobacter spp. in chickens [4]. It is an international priority to eliminate Campylobacter 48 
spp. from broiler chickens to ensure better food safety [5,6].  49 
 50 
There are large variations in the numbers of Campylobacter spp. in the cecae of broiler chicken 51 
flocks collected at slaughter plants [7,8]. Chicken lineage and time of infection in chickens seems to 52 
influence variability in colonisation of the chick intestine [9-12]. Despite the contribution of host 53 
genetics and time of introduction into the flock the dynamics of Campylobacter spp. in broiler 54 
chicken houses are not fully understood.  55 
 56 
Efforts to reduce Campylobacter spp. flock prevalence and  level of colonization include increased 57 
biosecurity [13-15], competitive exclusion, antibacterial agents, or phage-therapy [16,17], poultry 58 
vaccines [18-22] and improving the genetic resistance to Campylobacter spp. colonization in broiler 59 
chickens [10].  60 
 61 
Risk assessment models have been developed to determine which strategies are the most efficient in 62 
reducing Campylobacter spp. flock prevalence and the number of cases of campylobacteriosis. 63 
[14,23]. 64 
 65 
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At present there is no consensus regarding the most appropriate way of sampling a flock to provide 66 
data that can be used in risk assessment models. Commonly a large (10-25) number of caecal 67 
samples is taken at the slaughterhouse or faecal samples collected at the farm and pooled for 68 
analysis. This can produce misleading results if CFU differ significantly between individual 69 
numbers and pooled samples. Furthermore, it is unclear if faecal samples at the farm level is a good 70 
predictor of the caecal load at the slaughter plant [7].  71 
 72 
To increase our understanding of the dynamics of Campylobacter spp. in broiler chickens we 73 
studied the numbers of Campylobacter in broiler chickens infected under controlled experimental 74 
conditions and addressed the effect of pooling samples. The aims were to 1) estimate the variation 75 
in number of C. jejuni in faecal and caecal samples over time in a conventional chicken broiler 76 
breed (Ross 308) inoculated with the same dose of C. jejuni, 2) compare C. jejuni CFU/g in pooled 77 
samples with the mean of individual samples, 3) evaluate any correlation between faecal loads of C. 78 
jejuni at day 4, 7, and 12 post infection (PI), and with caecal loads at day 12 PI.  79 
  80 
Material and methods 81 
Experimental birds  82 
The experimental infections were carried out at the National Veterinary Institute (Aarhus, 83 
Denmark) following the Danish legislation for animal welfare and use of experimental animals and 84 
approved by the Supervisory Authority on Animal Testing (2010/561-1803). Conventional broiler 85 
chickens (Ross 308) of mixed sex were obtained from a Danish hatchery (DanHatch A/S). Chicks 86 
were transferred directly from the hatchery to the experimental unit, where they were housed in 87 
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isolators (Montair Andersen B.V. HM 1500). All chicks were tested free of Campylobacter spp. at 88 
placement and before inoculation. 89 
 90 
The chickens were killed by decapitation, and each chicken was sampled and examined individually 91 
at slaughter. 92 
 93 
Experimental design 94 
The placebo group described in the present paper was part of a larger vaccine study [24] and, due to 95 
the design of this study received 0.1 ml Alhydrogel (2% solution) adjuvant intramuscularly 17 days 96 
before C. jejuni challenge. In order for an Alhydrogel adjuvant to increase specific immunity 97 
against an antigen, in this case C. jejuni the antigen must be mixed with the adjuvant and injected as 98 
a mixed suspension and thus it is highly unlikely that the chickens of the placebo group have any 99 
specific immunity against C. jejuni.  100 
 101 
The broiler chickens used were housed in isolators. All handling of chickens was done through the 102 
isolator gloves attached to the isolators. Four identical infection trials (rotations) were carried out in 103 
2011, where only the flock of broiler chickens used differed between rotations. During each 104 
infection trial four identical isolators were used with an average of 9 birds per isolator. A total of 105 
134 broiler chickens were infected.   106 
 107 
6 
 
Broiler chickens were challenged with a C. jejuni suspension at day 31. Faecal samples were 108 
collected on day 4, 7 and 12 PI, and caecal samples collected on day 12 PI. CFU/g of individual 109 
faecal samples was determined in samples from rotation 2, 3 and 4. Faecal and caecal samples were 110 
collected individually from each broiler chicken at each timepoint and kept separately in tubes and 111 
stored on ice until CFU determination was done. All birds were marked which ensured that faecal 112 
and caecal samples were only taken once from each bird. Faecal droppings were sampled by gentle 113 
anal stimulation and directly into a sterile falcon tube avoiding any cross contamination. CFU/g of 114 
pooled and individual samples was subsequently established.  115 
 116 
Challenge with Campylobacter jejuni 117 
On day 31 post hatch, all broiler chickens were challenged with (1.7 ± 0.5) × 104 (mean ± SE) 118 
CFU/g of C. jejuni in 0.5 ml 0.9% saline solution. The broiler chickens were inoculated individually 119 
by crop instillation, using a 1-ml syringe with an attached flexible tube (diameter 3 mm, length 10 120 
cm).  121 
 122 
Preparation of inoculum 123 
The C. jejuni strain used in this study was a broiler strain (DVI-SC181) which belongs to the most 124 
common serotype (Penner serotype 2) and flaA type (1/1) [25]. This strain originated from a 125 
collection of Campylobacter spp. isolates obtained from faecal samples collected at the time of 126 
slaughter in Denmark [25]. Bacterial inoculum was prepared from cultures grown on blood agar 127 
base plates (Oxoid) supplemented with 5% (v/v) calf blood (BA) and incubated at 42 °C for 48 h 128 
under microaerobic conditions. Subsequently the bacteria were prepared by shaking of bacterial 129 
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material in 0.9% saline solutions at 4 °C. Before inoculation the bacterial suspension was adjusted 130 
to an optical density of approximately OD620 = 0.6 and diluted to the desired concentration 131 
(CFU/ml). The actual inoculation dose was determined by direct bacteria counting before and after 132 
inoculation. 133 
 134 
Bacterial culture and counting  135 
Quantification of C. jejuni followed the Nordic standard protocol for enumeration of thermotolerant 136 
Campylobacter [26]. One gram of caecal or faecal material was weighed and diluted 1:10 in 0.9% 137 
saline dilution series. The pooled samples were made out of 1 g from each individual sample within 138 
each isolator. Subsequently dilution series were streaked onto Campylobacter spp. selective 139 
Abeyta-Hunt-Bark agar plates (AHB) with 1% triphenyltetrazoliumchloride. The plates were 140 
incubated microaerobically at 42 °C for 48 h before being enumerated. 141 
 142 
 Statistics 143 
A mixed linear model was used to estimate the contribution of rotation, isolator and broiler 144 
(residual) to the variation seen in the CFU/g found in individual faecal and caecal samples. Based 145 
on the estimated variances for rotation, isolator and broiler in the mixed linear model, the 146 
percentage of total variance that was due to rotation, isolator and broiler was calculated. The data 147 
obtained at the different timepoints were analysed separately. For each day of sampling (day 4, 7 148 
and 12 PI, respectively), the data from all rotations were included in the model. At day 12 PI, 149 
CFU/g in faecal and caecal samples was analysed separately. CFU were log transformed log 150 
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(CFU/g) to normalize data. In the mixed model, the effect of rotation and isolator within rotation 151 
were both assumed to be normal distributed (N(0, σ2).  152 
 153 
Distributions of number of Campylobacter spp. in individual faecal samples at different sampling 154 
timepoints (day 4, 7 and 12 PI, respectively) were diagrammed as box plots. A non-parametric 155 
ANOVA (Kruskal-Wallis test) based on ranks was used to test for the effect of time on CFU/g in 156 
the faecal samples and Dunn multiple comparisons was used to compare timepoints. The p-values 157 
were compared to the Bonferroni corrected significance level.  158 
 159 
CFU of the pooled caecal samples was compared to the individual caecal samples from each 160 
isolator by taking the arithmetic mean of the individual caecal and comparing it with the pooled 161 
caecal samples. We expected that the CFUpool would be equal to the arithmetic mean of the 162 
individual faecal samples, (CFU1 + CFU2 + …….CFUn) / n. 163 
 164 
Individual faecal and caecal CFU/g between timepoints is shown as a scatter plot with the 165 
regression line. Correlation analysis (Pearson) was used to evaluate the relationship between caecal 166 
and faecal counts at different timepoints.  167 
 168 
Results 169 
Concentrations of C. jejuni at different timepoints  170 
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There was a large difference between broiler chickens in gut content of C. jejuni at slaughter (Table 171 
1). In the faecal samples number of C. jejuni ranged from 4.0 to 9.4 log CFU/g and for caecal 172 
samples from 4.8 to 9.3 log CFU/g. The mean number of C. jejuni detected in the caecal content of 173 
the broiler chickens was 7.9 log CFU/g and slightly lower for the faecal samples, with mean 174 
concentration decreasing from 7.4 on day 4 PI to 6.9 log CFU/g on day 12 PI.  175 
 176 
When comparing the faecal CFU/g at day 4, 7 and 12 PI of each individual broiler chicken there 177 
was a slight decrease in CFU/g over time (Fig. 1). ANOVA analysis indicated that there was a 178 
significant effect of time on faecal CFU/g (p = 0.003) and pairwise test showed that faecal CFU/g at 179 
day 12 PI were significantly lower than at day 4 PI (p < 0.001), whereas neither CFU/g at day 4 and 180 
7 (p = 0.180) or day 7 and 12 (p = 0.041) were significantly different when compared to the 181 
Bonferroni corrected significance level (p = 0.0167). 182 
 183 
To further evaluate the change in CFU/g over time, variance contributions to the total variance were 184 
estimated at the different timepoints (Table 2). In the faecal samples, most variation was attributed 185 
to the broiler chicken (residual), and a minor part to the isolator whereas rotation did not affect the 186 
total variance. The total variance increased slightly with time, but the proportion of the different 187 
levels stayed the same at the different timepoints. For the caecal samples at day 12 PI the variance 188 
contributions looked similar to the faecal samples. 189 
 190 
CFU/g of C. jejuni in pooled samples versus individual samples 191 
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When comparing the pooled and individual caecal samples from each isolator group there was a 192 
consistent lower CFU/g in the pooled samples compared to the arithmetic mean of the individual 193 
samples except in two isolators out of a total of 15 isolators during four rotations (Fig. 2). Pooled 194 
and individual faecal samples from each isolator group were only established in rotation 2, 3 and 4 195 
and showed that CFU/g of pooled faecal samples taken at day 12 PI was lower or equal to in 8 out 196 
of a total of 11 isolators during three rotations (results not shown).  197 
 198 
Correlation of CFU/g of faecal and caecal samples  199 
The collection of faecal and caecal samples from each individual at multiple timepoints allowed us 200 
to compare CFU/g of faecal samples at different timepoints and also faecal with caecal samples 201 
(Fig. 3). There was a significant correlation between faecal CFU/g at day 4 and 7 PI (r = 0.3; C.I. = 202 
0.11 - 0.47) and day 7 and 12 PI (r = 0.2; C.I. = 0.02 - 0.40). Likewise a significant correlation was 203 
found between faecal and caecal CFU/g at day 12 PI (r = 0.7; C.I. = 0.5 – 0-8).  204 
  205 
Discussion 206 
The results of the present study showed large variation in the load of C. jejuni in the caecal and 207 
faecal samples. The mean number of C. jejuni detected in the caecal content of the broiler chickens 208 
was 7.9 log CFU/g in the present study. This is slightly higher, but still within the range reported in 209 
other studies [7,27,28]. Faecal content was slightly lower than the caecal content, with mean 210 
concentration decreasing from 7.4 on day 4 to 6.9 log CFU/g at day 12 PI. In contrast to earlier 211 
studies broiler chickens in the present study were infected with the same dose of C. jejuni and at the 212 
same age. The results confirm that colonization differs between broiler chickens and support the 213 
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concern raised by Hansson et al. [7], suggesting that limited sampling for quantification of 214 
Campylobacter spp. in broiler chicken flocks will not be representative of large broiler chicken 215 
flocks.  216 
 217 
The novel design of the present infection trials allowed the variance contributions to be established 218 
and show that most of the variation in colonization of C. jejuni could be attributed to factors such as 219 
broiler chickens and to lesser extent isolators and rotations. Furthermore, the total variation 220 
increased slightly with time in the faecal samples, but with the same factors attributing 221 
proportionally to the total variance. In a Swedish study results showed that slaughter groups that 222 
were tested positive at the farm level had mean number of Campylobacter spp. in carcass rinse 223 
samples 3 log units higher than the mean number in samples from slaughter groups in which 224 
Campylobacter spp. was first isolated at slaughter. In the present study the broiler chickens were 225 
inoculated with the same dose of C. jejuni and at the same time. Therefore the variation observed 226 
between individuals in our study is not due to the time of infection. This suggests that other factors 227 
in addition to the time of infection, such as the broiler chicken genetics [10] are involved in the 228 
Campylobacter spp. dynamics in broiler chicken flocks. The chicken intestinal physiology, most 229 
probably the caecal function may also cause an intermittent and fluctuating excretion of 230 
Campylobacter spp.   231 
 232 
In the present study individual caecal samples were obtained allowing the CFU/g in both pooled 233 
and individual samples in each isolator to be established. To our knowledge no other studies have 234 
compared CFU/g of Campylobacter spp. in paired pooled and individual caecal samples. Based on 235 
the way the CFU of the pooled sampled was made up, we expected that the CFUpool would be equal 236 
to the arithmetic mean of the individual faecal samples. However, in most of the cases, the 237 
12 
 
estimated arithmetic mean from the individual samples was higher than the obtained CFU/g in the 238 
pooled samples although the difference was smaller than 1 log. One explanation for this could be 239 
that the mean of a lognormal distribution is usually underestimated when it is based on sample data: 240 
on average, the fewer samples taken, the lower the estimate. Of course, as we also see in this 241 
experiment, the arithmetic mean can also be lower than the measured CFU/g in the pooled samples. 242 
The results therefore suggest that pooling of samples will generally lead to an underestimate of 243 
CFU/g compared to mean CFU/g of individual samples.  244 
 245 
Human risk of campylobacteriosis from broiler chickens results predominantly from meat products 246 
with high concentrations of Campylobacter spp. This is confirmed by data from Iceland [29] and 247 
risk assessments [5,30-32]. It has therefore been suggested that the human incidence of 248 
campylobacteriosis can be strongly reduced by aiming control strategies at products with relatively 249 
high concentrations of Campylobacter spp. Several studies have therefore suggested that “testing 250 
and scheduling” might be an efficient control strategy for Campylobacter spp. in broiler chicken 251 
meat [33,34]. This strategy entails testing of broiler flocks at the farm shortly before transport to the 252 
processing plant. Flocks with high concentrations of Campylobacter spp. at the farm can then be 253 
diverted from the fresh meat production chain. For this approach to be successful there needs to be a 254 
significant correlation between concentrations of Campylobacter spp. in the feces and on the meat 255 
product. Earlier studies have shown a correlation between the proportion of positive cloacal and 256 
caecal samples or the number in the caecal content and the number of Campylobacter spp. on 257 
carcasses [5,35,36]. Our results showed that there was a significant correlation between CFU/g in 258 
individual faecal and caecal samples before slaughter and that the caecal CFU/g was slightly higher 259 
than the faecal CFU/g values. The significant correlation is in agreement with other studies [37] and 260 
indeed suggest that “testing and scheduling” could be possible with faecal sampling before 261 
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slaughter. However, if faecal samples are taken earlier there is no or only a weak correlation. What 262 
could hamper the usefulness of “testing and scheduling” would be low variance of Campylobacter 263 
spp. concentrations between flocks and high variance of Campylobacter spp. concentrations 264 
between broiler chickens within flocks. Our results show that most of the variation in faecal or 265 
caecal load is indeed due to variation between broilers and not isolators or rotations. This indicates 266 
that most variation is between individuals and not flocks although in the present study the number 267 
of birds per isolator and rotation are far fewer then in natural broiler chicken systems.  268 
 269 
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 396 
Figure legends 397 
Figure 1: CFU/g of individual faecal samples from each broiler chicken at day 4, 7 and 42 post 398 
infection (n = 97). The boundary of the box closest to zero indicates the 25th percentile, the line 399 
within the box marks the median, and the boundary of the box farthest from zero indicates the 75th 400 
percentile. Whiskers (error bars) above and below the box indicate the 90th and 10th percentiles and 401 
black dots the outliers.     402 
 403 
Figure 2: CFU/g of pooled caecal samples (grey bars) from each isolator and the mean CFU/g of 404 
the individual caecal samples (open bars) obtained from each isolator. Samples were taken from 405 
each of four isolators during each of four rotations except in rotation four where samples were only 406 
obtained from three isolators.  407 
 408 
Figure 3: Illustration of CFU/g of individual samples for a) faecal at day 4 and 7 post infection 409 
(PI), b) faecal at day 7 and 12 PI and c) faecal and caecal samples at day 12 PI (n = 97). The plotted 410 
line is the estimated regression line. 411 
 412 
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Fig. 3 b 435 
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Fig. 3 c 444 
 445 
 446 
 447 
 448 
 449 
23 
 
Table 1: Colony forming units of C. jejuni in faecal and caecal material collected from broiler chickens at different timepoints post  450 
infection (PI) with C. jejuni. Table shows geometric mean ± SD CFU for individual samples and CFU of pooled samples (log CFU per 451 
gram faecal or caecal content). All samples used to establish individual and pooled CFU/g are paired. N is based on number of samples 452 
obtained from each isolator.   453 
   
Log CFU/g of faecal content 
    
 
 
Log CFU/g of caecal content  
Rotation Isolator 
Days 
PI 4 
 
7 
 
12 
 
 
 
12 
 
 
   
Individual Pooled Individual Pooled Individual Pooled n 
 
Individual Pooled n 
1 1 
 
 8.0  7.8  8.0 9 8.5±0.4 8.6 9 
 
2 
  
7.3  7.0  7.5 9  8.2±0.7 8.5 9 
 
3 
 
 7.5  7.5  7.9 10  8.4±0.6 8.8 10 
 
4 
  
6.9  7.3  7.9 9  8.1±0.3 8.2 9 
         
 
   
 
2 1 
 
7.7±0.5 7.9 7.4±1.3 7.6 7.2±0.6 7.4 8 7.9±0.8 8.3 8 
 
2 
 
7.1±0.9 6.7 7.6±0.8 8.0 7.2±1.1 8.3 9  8.2±0.7 8.5 9 
 
3 
 
7.1±1.0 7.6 7.1±0.9 7.2 6.6±0.6 7.3 8  7.5±0.6 7.8 8 
 
4 
 
7.4±0.6 7.7 6.5±0.8 7.2 6.6±1.1 7.2 8  8.1±0.4 8.3 7 
         
 
   
 
3 1 
 
6.6±0.4 7.5 7.1±0.7 7.5 7.2±0.5 7.3 8 8.2±0.5 8.4 8 
 
2 
 
7.1±0.8 7.7 6.9±0.4 7.3 7.5±0.5 7.7 6  8.4±0.3 8.5 5 
 
3 
 
8.2±0.9 7.9 7.8±0.6 7.8 7.3±0.2 7.3 4  8.5±0.3 8.5 4 
 
4 
 
*     
 
     
         
 
   
 
4 1 
 
7.5±0.5 7.9 7.6±0.5 7.9 7.3±0.6 7.4 11 7.9±0.3 7.9 11 
 
2 
 
7.3±0.7 7.4 7.2±1.0 7.6 7.4±0.6 7.9 13  8.7±0.3 8.5 13 
 
3 
 
7.9±0.5 8.0 7.5±0.3 7.7 7.0±1.1 7.6 10  7.2±1.0 7.8 12 
 
4 
 
7.4±0.4 7.4 6.7±0.7 7.4 5.7±1.1 6.6 12  6.3±1.1 7.4 12 
* Birds from this isolator were not included due to functional breakdown of the isolator. Grey areas indicate that individual samples were 454 
not taken during this rotation. 455 
24 
 
 456 
 457 
 458 
Table 2: Variance estimates (percentage) of the various levels in the infection trials using quantitative data from faecal and caecal samples.  459 
  Faecal       Caecal   
 Days PI:  4 7 12 Days PI: 12 
Rotation   0 0 0   0.03 
Isolator 
 
0.10 0.05 0.20  0.29 
Residual   
 
0.41 0.61 0.67  0.40 
Total  0.51 0.66 0.87   0.72 
 460 
 461 
 462 
 463 
 464 
 465 
 466 
 467 
 468 
 469 
 470 
 471 
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7.  MICROBIOLOGICAL TECHNOLOGIES FOR THE QUANTITATIVE 
ASSESSMENT OF CAMPYLOBACTER PRESENT IN POULTRY FECAL SAMPLES 
(Manuscripts III and IV) 
 
7.1. Introduction 
Direct, fast and accurate detection and quantification of pathogens such as Campylobacter that 
might be present in clinical samples and suspected sources of disease (e.g. food, water and 
environmental samples) is crucial for the investigation and control of disease cases and outbreaks 
and the protection of public health. Foodborne outbreaks caused by the presence of hazards such as 
chemical substances, toxins and pathogens are very common (WHO, 2007a). In 2005, 1.8 million 
persons died from enteric diseases mainly caused by contaminated food and water (WHO, 2007b). 
Global trading of food may increase the potential for outbreaks and consequently fast and sensitive 
detection of contaminated food is considered a priority in public health agendas all over the world. 
Campylobacter is the most frequent and important cause of foodborne diseases in some areas of the 
world, such as Ireland and New Zealand (Food Safety Authority of Ireland [FSAI], 2006; French, 
2008; Sears et al., 2011). Campylobacter is also one of the most frequently identified pathogens in 
very young children suffering from diarrhoea in developing countries (Coker et al., 2002).  
 
European legislation states that “foodstuffs should not contain microorganisms or their toxins or 
metabolites in quantities that present an unacceptable risk for human health” Regulation (EC) No 
2073/2005” (FSAI, 2012). In order to comply with EU legislation, food safety controls based on 
risk assessment such as good manufacturing practices and hazard analysis and critical control point 
(HACCP) are implemented in the food industry (Mucchetti et al., 2008; Jin et al., 2008). On the 
other hand, prompt and accurate identification and quantification of pathogens that might be 
contaminating food is crucial to assist food safety controls.  Conventional microbiological 
methodologies for the detection, identification and quantification of pathogens are commonly based 
on specific microbiological and biochemical characteristics of pathogens. These methods can be 
inexpensive and sensitive but they can also be time consuming and they usually rely on initial 
enrichment procedures that might introduce bias in the results. Some enrichment broths may select 
against specific Campylobacter spp. (Moore and Madden, 1998; Madden et al., 2000; Nachamkin 
and Blaser, 2000). The use of enrichment broth might also increase the numbers of Campylobacter 
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in the sample depending on time and temperature of incubation (Sails et al., 2003). As a result, it 
seems challenging to accurately quantify the initial numbers of pathogens present when using 
enrichment steps (Postollec et al., 2011). 
Most common microbiological methods used for the detection and quantification of pathogens such 
as Campylobacter are based on selective culture. Nevertheless, the development of quantitative or 
real-time PCR seems promising for the near real-time detection and quantification of pathogens and 
beneficial populations such as probiotics (Stevens and Jaykus, 2004; Masco et al., 2007; Malorny et 
al., 2008; Le Drèan et al., 2010). PCR offers some advantages in comparison with standard 
microbiological methods such as rapidity, specificity, sensitivity, the ability to detect small amounts 
of target DNA in samples and to quantify genes and gene expression (Toze, 1999; Nolan et al., 
2006; Postollec et al., 2011). International standard (ISO) guidelines to detect pathogens by PCR 
are available (ISO 22174:2005, ISO 20838:2006). What's more, quantitative PCR with the use of 
adequate controls offers interesting applications in risk analysis and in gene expression (Bustin, 
2009; Postollec et al., 2011). PCR detects viable and non-viable cells which could lead to an 
overestimation of the number of viable pathogens present in the initial sample. The use of an 
enrichment step can reduce PCR inhibition but can also lead to an overestimation of the numbers of 
pathogens initially present in the sample (Postollec et al., 2011). On the other hand, PCR is a rapid 
and sensitive method for identification and quantification of pathogens that can be however limited 
by inhibitory substances. These inhibitory substances present in complex biological samples may 
reduce or even completely impede the amplification process (Lantz et al., 1997). False negative 
PCR results may occur due to the presence of inhibitors but also due to DNA degradation or 
interference with the lysis needed for DNA extraction. For that reason, adequate treatment of 
samples prior to real-time PCR and the inclusion of appropriate controls in the PCR reactions are 
crucial to obtain reliable results (Rådström et al., 2003, 2004; Murphy et al., 2007). Sample 
treatment methodologies depend on the target organism and also on the sample matrix (Stevens and 
Jaykus, 2004). Poultry fecal samples represent complex matrices for the quantification of 
Campylobacter. Consequently, matrix preparation for the concentration and purification of 
Campylobacter is crucial for detection and quantification. Efficient and reliable non–enrichment 
methods should be developed in order to separate pathogen cells from the sample matrices and 
concentrate pathogen cells for quantification. An ideal method should be able to remove matrix-
associated inhibitors without harming the bacterial cells and to concentrate pathogens. It should also 
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be universal (e.g., applicable to multiple food types and microorganisms), inexpensive, simple, fast 
and efficient.  
Several PCR assays for the detection of Campylobacter in foods, milk, water and environmental 
samples have been developed (Ng et al., 1997; Waage et al., 1999; O’Sullivan et al., 2000; Yang et 
al., 2003; Hong et al., 2007; Ridley et al., 2008b; Rothrock et al., 2009; Josefsen et al., 2010; 
Schnider et al., 2010; Leblanc-Maridor et al., 2011a, Toplak et al., 2012). Researchers have applied 
real-time PCR for the quantification of Campylobacter spp. in food samples using no enrichment or 
a short enrichment procedure (Yang et al., 2003; Botteldoorn et al. 2008). However, PCR detection 
and quantification of Campylobacter present in fecal samples might be hampered by the presence of 
inhibitors in fecal matrices. Several PCR methodologies have been described for the detection and 
quantification of Campylobacter in feces (Inglis and Kalischuk, 2004; Rudi et al., 2004; Lagier et 
al., 2004; Jensen et al., 2005; Leblanc-Maridor et al., 2011a, 2011b). New or improved PCR 
methodologies for accurate, fast and direct detection and quantification of Campylobacter spp. 
should be tested using naturally infected samples and comparing the results with gold standard 
methods.  
In our studies, several DNA extraction methods were tested for the quantification of Campylobacter 
(using real-time PCR) present in spiked poultry fecal samples. Subsequently, two methods were 
selected to extract Campylobacter DNA for real-time PCR quantification of Campylobacter present 
in naturally infected chicken fecal samples and the results were compared to data obtained using 
selective culture methods.  
The main aim of these studies was to identify and improve (if possible) an efficient, accurate real-
time PCR methodology for the quantification of Campylobacter present in poultry fecal samples 
directly without the use of enrichment steps. The following work was undertaken: 
- Preparation of Campylobacter spiked chicken fecal samples. Comparison of real-time PCR 
results obtained from six commercially available DNA extraction methods using fecal 
samples spiked with Campylobacter. Standard curves were produced and methods were 
compared based on the results obtained from real-time PCR assays in terms of detection 
limit, limit of quantification, reproducibility (assessed by comparison of the obtained 
standard deviation between replicates), amplification efficiency (based on the slope of the 
standard curve), detection range (range of concentration levels detected) and precision (data 
fit to the standard curve).  
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- Preparation of Campylobacter naturally infected chicken fecal samples (using stomacher 
bags without filter and with number 6 filter) for the evaluation of two of the methods 
previously assessed using spiked fecal samples.  
- Comparison of Campylobacter quantitative data obtained by selective culture and by real-
time PCR (using two different DNA extraction methods) for the quantification of 
Campylobacter present in the naturally infected samples 
- Quantitative microbiological data analysis 
 
7.2. Materials and methods 
7.2.1. Samples  
  
Fecal samples from broilers confirmed to be Campylobacter negative were spiked with 
Campylobacter jejuni CCUG 11284 and used for the quantification of Campylobacter by real-time 
PCR. Six rapid DNA extraction methods were assessed in their performance and effectiveness for 
the direct quantification of Campylobacter jejuni in spiked chicken fecal samples using real-time 
PCR. Subsequently, naturally infected samples with Campylobacter were obtained and processed 
for the quantification of unknown concentrations of Campylobacter using two of the six DNA 
extraction methods previously assessed.  
Detailed descriptions of the spiking protocols and the preparation of samples (spiked samples, 
naturally infected samples and negative controls) are provided in manuscripts III (Garcia et al., 
2013a) and IV. 
 
7.2.1.1. Spiked samples 
Three different fecal samples obtained from broilers confirmed to be Campylobacter negative (by 
selective culture and PCR) were spiked with C. jejuni CCUG 11284 and used for the quantification 
of Campylobacter by real-time PCR. The spiked fecal samples (23.8 g, 21.3 g and 18.7 g) were 
mixed with saline (214.2 ml, 191.7 ml and 168.3 ml respectively) to produce the first ten-fold 
dilution. The produced biological replicates (Invitrogen, 2013) were placed into stomacher bags and 
homogenized for 30 s at average speed (400 Stomacher®, Seward Limited, London, UK). The 
culture used for spiking was prepared with a particular strain of C.jejuni CCUG 11284, inoculated 
on a modified charcoal cefoperazone deoxycholate agar (mCCDA) plate and incubated at 42ºC 
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overnight. Five colonies of the recovered C. jejuni were enriched in 10 mL Müeller Hinton broth 
and incubated at 42ºC in microaerobic conditions for approximately 18 hours. Serial dilutions (10-1 
-10-8) and culture on mCCDA plates allowed for the counts of the numbers of C.jejuni (CFU/mL) in 
order to determine the numbers of C.jejuni in the initial culture.  
Homogenized fecal samples were spiked with C. jejuni CCUG 11284 (calculations were performed 
based on fecal sample volume and numbers of C. jejuni in the initial culture) to produce five spiking 
levels (101-105) and mixed thoroughly to promote equal distribution of C. jejuni in the samples.  
Validation of the correct dilutions of the samples spiked with Campylobacter was performed in the 
laboratory. Spiked fecal samples were alliquoted in 50 eppendorf tubes per dilution series. The 
remaining fecal sample that had not been spiked was homogenized and distributed in 20 eppendorf 
tubes to be used as negative controls during the experiments. Prepared samples (spiked samples and 
negative controls) were centrifuged at 5000 x g for 5 minutes, supernatants were discarded and the 
pellets kept for DNA extraction and quantification. Samples were stored at -20ºC until their use for 
Campylobacter DNA extraction and quantification with real-time PCR. 
7.2.1.2. Naturally infected samples 
Communication with one of the poultry processing companies in Denmark allowed us to obtain 
faecal samples from chickens known to be Campylobacter positive at a particular time of the year. 
Faecal samples from Campylobacter positive chickens were collected by abattoir personnel on the 
18th of September 2012 and sent to the laboratory the same day. The received samples had been 
collected in four sterile pots; the pots were numbered 1 to 4 in the laboratory and the samples were 
processed within 30 hours. Two grams of fecal samples were taken from every pot: one gram was 
deposited in a stomacher bag without filter (samples A) and the other gram in a stomacher bag with 
number 6 filter corresponding to a pore size of 280 µm (samples B) as illustrated in Figure 5. Every 
gram of sample was diluted in 9 mL of sterile water and homogenized using a stomacher 
(Stomacher® 400 A.J. Seward & Co. Ltd., West Sussex, UK). The homogenized sample was 
transferred to a sterile tube (dilution 10-1). One mL of the first dilution was transferred to another 
sterile tube containing 9 mL of sterile salted water (dilution 10-2). The same protocol was used to 
produce dilutions 10-3 to 10-5 (Figure 5). 
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Figure 5 Sub-sampling and dilutions from naturally infected chicken fecal samples 
  
The dilutions prepared this way (Figure 5) for every fecal sample (numbers 1-4) were subsequently 
processed in the following manner: 
a. Conventional direct culture for Campylobacter quantification was performed within 30 
hours from the collection of poultry fecal samples using Campylobacter selective agar, 
the modified charcoal cefoperazone deoxychocolate agar (product codes: CM0739, 
SR0155, Oxoid, Hampshire, UK). The previously prepared five dilutions from every 
sample (1A, 1B, 2A, 2B, 3A, 3B, 4A, 4B) were mixed thoroughly trying to achieve equal 
distribution of the Campylobacter in the samples and 100 μL were then spread onto 
mCCDA agar. Inoculated plates were incubated microaerobically at 42°C for 48 hours 
(Forma Scientific Incubator from Thermo Fisher Scientific Inc. Waltham, MA, USA). 
After 48 hours, suspected Campylobacter colonies growing in every plate were counted 
and numbers recorded in Excel for further data analysis. 
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b. Tubes containing the dilutions prepared from every sample were stored at +5°C for future 
DNA extraction processing. Just before DNA extraction, every sample was mixed 
thoroughly and 1 mL transferred to a sterile Eppendorf tube. Samples were centrifuged at 
117000 x g for 15 min, the supernatants were discarded and the pellets used for DNA 
extraction.  
 
7.2.2. DNA extraction methodologies for Campylobacter quantification with real-time   
PCR 
Samples spiked with Campylobacter (with Campylobacter concentrations from 10 to 105) had been 
previously prepared and stored at -20ºC. Required samples for every DNA extraction method were 
taken from the freezer and thawed before every DNA extraction method. Sample pellets were re-
suspended and DNA extracted according to instructions found in every DNA extraction protocol 
(Manuscript III: Garcia et al., 2013a). The following six DNA extraction methods were evaluated:   
1. Easy-DNA™ Kit For genomic DNA Isolation (Invitrogen, Leek, The Netherlands.).  
2. MagneSil® KF, Genomic system (KingFisher®) (Promega, Madison, WI, USA).  
3. SureFood® PREP Campylobacter (Congen Biotechnologie GmbH, Berlin, Germany).  
4. QIAamp Qiagen DNA stool mini kit (Qiagen, Hilden, Germany).  
5. NucliSENS® miniMAG® (bioMérieux sa, Lyon France).  
6. NucleoSpin® Tissue (Macherey-Nagel GmbH & Co. KG, Düren, Germany).  
 
The final DNA elution volume was 100 μl for all methods except for QIAamp Qiagen DNA stool 
mini kit. In the Qiagen method, the purified, concentrated DNA was eluted from the spin column in 
200 μl of low-salt elution buffer. 
Two biological replicates were analyzed when using the NucliSENS® miniMAG method (due to 
protocol limitations) and three biological replicates were processed when using the rest of the 
methods.  Furthermore, two real-time PCR replicates from one biological replicate (all dilutions) 
were included to evaluate variation attributable to the real-time PCR run. Therefore, a total of five 
replicates per sample (Campylobacter concentration level) were analyzed for every DNA extraction 
method except for NucliSENS® miniMAG (four replicates/per sample). The methods KingFisher 
Campylobacter Control in Poultry 
 
64 
 
(Promega) and MiniMAG (BioMérieux) were partly automated, the rest of the extraction methods 
were manual. After DNA extraction, measurements (in duplicate or triplicate in case of large 
deviations) of DNA yield and purity were obtained using NanoDrop (Thermo Fisher Scientific Inc) 
spectrophotometer. Values related to DNA yield and purity obtained from DNA extracted using 
every protocol were recorded in Excell. Extracted DNA was stored at -20°C for real-time PCR 
assays.  
  
7.2.3. Real-time PCR 
Real-time PCR detects specific target DNA sequences as they are amplified. The amount of target 
DNA sequences theoretically doubles with every cycle (Figure 6). The copies of the target DNA 
sequence are measured through fluorescent signals in order to quantify the amplified products in 
“real time”. It is possible to distinguish four phases in a real-time PCR cycle: the lag phase or 
baseline, the exponential phase, the linear phase and the plateau phase (Figure 7). The process can 
be followed on a computer screen during the real-time PCR run. 
 
 
 
 
 
Figure 6 Number of copies of the target DNA sequence obtained in every cycle of the real-time PCR 
(Hunt, 2010). 
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Figure 7 Real-time PCR cycle phases (Abbott Molecular, 2012) 
 
Real-time PCR was performed using a real-time PCR thermo cycler Mx3005P™ (Strategene, La 
Jolla, USA). Samples and PCR mix were placed in the thermal cycler using MicroAmp Optical 96-
well reaction plates (Applied Biosystems) covered with MicroAmp Optical caps (Applied 
Biosystems). The 25-µl real-time PCR mixture contained 1 U of Tth DNA polymerase (Roche A/S), 
1 x PCR buffer for Tth DNA polymerase (Roche A/S, Hvidovre, Denmark), 0.6 mM 
deoxynucleoside triphosphate mixture (Amersham Pharmacia Biotech, Buckinghamshire, United 
Kingdom), 2.5 mM MgCl2 (Applied Biosystems), 0.8 ml/l of glycerol (87%; Merck, Darmstadt, 
Germany), 0.5 µM forward primer OT-1559-5’-CTG CTT AAC ACA AGT TGA GTA GG-3', 0.5 
µM reverse primer 18-1-5’- TTC CTT AGG TAC CGT CAG AA-3’(DNA Technology, Århus, 
Denmark; C. jejuni 16S rRNA; GenBank accession no. Y19244), 0.2 g/l bovine serum albumin 
(Roche A/S), 75 nM target locked nucleic acid (LNA) Campylobacter probe 5’ [6FAM] CA[+T] 
CC[+T] CCA CGC GGC G[+T]T GC[BHQ1] 3’ (Sigma-Aldrich), 60 nM internal amplification 
control (IAC) probe (5’-VIC-TTC ATG AGG ACA CCT GAG TTG A-TAMRA 3’; Applied 
Biosystems), 5 x 103 copies  of IAC (124bp) and 10 µl of extracted template DNA. 
The primers used (the forward primer OT-1559 and the reverse primer 18-1) amplify a 287 basepair 
fragment of the 16S rRNA gene of thermotolerant C. jejuni, C. coli and C. lari (Lübeck et al. 2003; 
Josefsen et al. 2004). The amplification products were detected by using the FAM (fluorescein 
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amidite) -labeled probe. Furthermore, an internal control (amplified with the target) was visualized 
using a HEX (hexachloro fluorescein) -labeled probe. The thermal profile included an initial 
denaturation step at 95°C for 3 min followed by 40 cycles consisting of denaturation at 95°C for 15 
s, annealing at 60°C for 60 s and extension at 72°C for 30 s.  
Adequate positive and negative controls need to be used in real-time PCR reactions. In our study, 
the following controls were included: (i) two positive controls, (DNA from C. jejuni, dilutions 
1:100 and 1:1000) (ii) one negative control (DNA from E.coli, dilution 1:1000) and (iii) a non-
template control (NTC) in duplicate. The inclusion of a non-template control (NTC) allowed for the 
identification of potential non-specific fluorescence signals (false positives).  
 
7.2.4. Data analyses 
 
Real-time PCR detects the increase in fluorescent signal throughout the PCR cycling process 
produced by all the samples (Figure 8). During the exponential phase and the linear phase of the 
real-time PCR assay the amount of fluorescence increases with the amount of the target DNA 
sequence amplified. Moreover, the rate at which the target DNA is amplified indicates the amount 
of target DNA in a particular sample (Edwards et al., 2004). 
  
Figure 8 Amplification curves, showing terms commonly used in real-time PCR 
The amplification threshold is usually set above the baseline. The cycle number corresponding to 
the point where the curve (for a positive sample) crosses the threshold line is called Ct value 
(threshold cycle). Ct values are used to evaluate the results of the experiments. The ΔCt method is 
based on obtained Ct values for different samples in a real-time PCR run. Comparison of the 
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obtained Ct values with a standard curve designed from known amounts of the target gene will 
allow for quantification of the samples. Samples with known concentrations of the DNA target can 
be used to construct standard curves. Quantification of the amount of target DNA in unknown 
samples can be done indirectly by measuring corresponding Ct values and using the standard curve 
to determine initial numbers of DNA in the samples. The lower the Ct value for a given sample, the 
greater the amount of DNA initially present in the sample. Ideally, in experiments using dilution 
series, the dilution with the highest amount of target DNA should correspond to the lowest Ct value 
and Ct values should be 3.5 cycles apart for each of the 10-fold dilution series. The results obtained 
from real-time PCR using dilution series might indicate the degree of inhibitors present in the 
sample.  
Most software programmes available with real-time PCR technologies can be used to calculate Ct 
values, prepare standard curves and for the determination of initial DNA concentration in samples. 
Amplification thresholds and Ct values can be obtained in three different ways when using real-time 
PCR Mx3005P (Stratagene, La Jolla, CA, USA): (i) default method set by the software (ii) 
background-based method (based on the background fluoresce of the experiment) and (iii) threshold 
manually set by the user (Stratagene, 2004). The selected threshold will determine the Ct values and 
consequently will influence the quantification results. In our experiments conducted to compare 
several DNA extraction methods (Manuscript III: Garcia et al., 2013a), real-time PCR data obtained 
from the six DNA extraction methods were analyzed all together in a common project using the 
MxPro-Mx3005P software (version 3.00, Stratagene, La Jolla, CA, USA). The amplification 
threshold was set using the software option “background-based threshold” which determines the 
standard deviation of all amplifications (from cycles 5 to 9) and multiplies them by a factor of 10 
(default factor). A common baseline was set for all amplification plots obtained using an adaptive 
baseline and a non-adaptive baseline for comparison of the six DNA extraction methods 
(Stratagene, 2004). A common amplification threshold was generated and the threshold cycle values 
(Ct values) obtained were used to compare the different DNA extraction methodologies. In general, 
the lower the Ct values, the higher the DNA quantity obtained (Stratagene, 2004; Armbruster and 
Pry, 2008; Abdelwhab et al., 2010). Real-time PCR reproducibility was assessed by calculating the 
standard deviation (SD) between replicates, ideally the SD between replicates should be less than 
0.5 (Eurogentec, 2012). The numbers of CFU (logs) obtained were plotted against the Ct values 
obtained in the real-time PCR runs and standard curves were produced by linear regression for all 
DNA extraction methods tested. Standard curves were used to determine the overall performance of 
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real-time PCR in terms of amplification efficiency, detection range (range of C. jejuni levels 
detected), limit of detection, limit of quantification and precision for every DNA extraction method. 
The slope of the standard curve indicates the amplification efficiency of the real-time PCR assay. 
The amplification efficiency (AE) was calculated based on this equation: AE = 10(−1/slope) – 1 (Klein 
et al., 1999). An amplification efficiency of 100% indicates perfect reactions where the amplicon 
doubles each cycle (Stratagene, 2004). An assessment of precision, linearity or data fit to the 
standard curve is produced using the parameter “R squared (R2)” which should be close to 1, in fact 
values ≥0.985 indicate good correlation (Stratagene, 2004).  
Real-time PCR results (related to the direct quantification of Campylobacter in spiked chicken 
faecal samples) obtained from the six DNA extraction methods were carefully analyzed 
(Manuscript III: Garcia et al., 2013a) and two selected DNA extraction methods were tested with 
poultry fecal samples naturally infected with Campylobacter (manuscript IV). Results related to 
real-time PCR assays using the two selected DNA extraction methods and fecal samples naturally 
infected with Campylobacter were compared based on limit of detection, limit of quantification and 
real-time PCR amplification efficiency. Furthermore, estimates of the number of Campylobacter  
(present in naturally infected chicken fecal samples) obtained by real-time PCR when using the two 
different DNA extraction methods were compared with those obtained from selective culture. 
Correlation coefficients were obtained to assess agreement between the methods used in this study. 
Statistical significance of the differences observed between results from culture and from real-time 
PCR when using the two different DNA extraction methods were assessed using the multcomp 
package in the statistical program R (R Development Core Team, 2008). 
7.3. Results  
Detailed results can be found in manuscripts III (Garcia et al., 2013a) and IV. 
 
7.3.1. Results obtained from the different methods used to extract Campylobacter 
DNA from spiked fecal samples 
7.3.1.1. Results related to DNA yields and purity 
Results related to DNA yield obtained for each of the six DNA extraction methods are presented in 
Manuscript III: Garcia et al., 2013a (Figure 1). The Easy-DNA™ Invitrogen method produced the 
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highest DNA yield (ranging from 188 ng/μl to 317 ng/μl) followed by KingFisher® (ranging from 
54 ng/μl to 177 ng/μl).  The method QIAamp (Qiagen) produced the lowest DNA yield (3 ng/μl-6 
ng/μl). 
Results related to DNA purity (absorbance ratio A260/280 values) were obtained for every method 
as follows: Easy-DNA kit (Invitrogen): 1.5-1.6, KingFisher (Promega): 1.1-1.8, miniMAG 
(bioMérieux): 1.0-1.4, SureFood (Congen): 0.9-4.9, NucleoSpin (Macherey-Nagel): 1.6-2.2 and 
QIAamp (Qiagen): 1.3-3.3. Purity ratios around 1.8 or higher are desirable (Thermo Fisher 
Scientific, 2011).  
 
7.3.1.2. Results related to real-time PCR 
Identical results (FAM Ct values) were obtained by selecting an adaptive baseline and a non-
adaptive baseline (from cycles 3 to 12) with a common threshold (740) which was used for 
comparison of the six DNA extraction methods. Results related to the average FAM Ct values 
obtained from the real-time PCR experiments for the quantification of Campylobacter jejuni DNA 
extracted using the different extraction methods are presented in Manuscript III (Garcia et al., 
2013a). All the controls included in real-time PCR assays produced the expected results. Briefly, 
FAM Ct values were obtained from the samples spiked with the lowest concentration (10 CFU/ml) 
only when using the NucleoSpin® Tissue DNA extraction method. No FAM Ct values were 
generated from the samples spiked with 102 CFU/ml when using the following methods: 
MagneSil® KingFisher, Easy-DNA Invitrogen and SureFood. Regarding the FAM Ct values 
generated from amplification signals produced by samples spiked with 102 CFU/ml, the NucleoSpin 
method produced the lowest FAM Ct value followed by miniMAG. Results related to samples 
spiked with 103 CFU/ml indicated that Easy-DNA Invitrogen produced the lowest FAM Ct values 
followed by miniMAG and MagneSil® KingFisher. Real-time PCR results obtained from samples 
spiked with 104 CFU/ml indicated that Easy-DNA Invitrogen generated the lowest FAM Ct values. 
SureFood produced the lowest FAM Ct value when using samples spiked with 105 CFU/ml 
followed by Easy-DNA Invitrogen. Overall, the Easy-DNA Invitrogen method generated the lowest 
FAM Ct values followed by the miniMAG method. SureFood generated a very low Ct value for the 
Campylobacter concentration level 105 CFU/ml; however, the variation between replicates was high 
as illustrated by a standard deviation of 2.5 cycles. The MagneSil® KingFisher method performed 
poorly in this study. DNA extraction methods Easy-DNA Invitrogen, miniMAG and NucleoSpin 
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offered general good real-time PCR reproducibility generating standard deviations from 0.3 to 0.8 
between replicates. 
 
7.3.1.3. Standard curves, amplification efficiency and linearity 
 
Standard curves were generated and used to evaluate the amplification efficiency, detection range 
and precision of the DNA extraction methods tested. Generated amplification plots and standard 
curves are presented in Appendix 2. Results related to real-time PCR performance indicators used 
to evaluate the different DNA extraction methods can be found in manuscript III. The amplification 
efficiency of the real-time PCR assay was calculated based on the slope of the standard curve. 
Amplification efficiencies between 90% and 110% were considered acceptable (Stratagene, 2004). 
The methods Easy-DNA Invitrogen and QIAamp Qiagen generated the best amplification 
efficiencies (93.2% and 91.5% respectively). These two methods also produced R squared (R2) 
values close to 1 indicating good precision. The method NucleoSpin® Tissue was able to detect 
samples spiked with the lowest Campylobacter concentration level (10 CFU/ml), however, this 
extraction method generated higher Ct values for most concentration levels than the other methods 
and the amplification efficiency obtained was significantly above 100% (139.5%) possibly caused 
by inhibitors and/or experimental error (Stratagene, 2004).   
Based on the results obtained (Manuscript III: Garcia et al., 2013a), the methods Easy-DNA and 
MiniMAG were selected to quantify directly (without enrichment) Campylobacter present in 
naturally infected chicken fecal samples (manuscript IV). 
7.3.2. Results related to the quantification of Campylobacter present in naturally 
infected chicken fecal samples 
7.3.2.1. Standard curves generated for absolute quantification 
The standard curves designed from real-time PCR data from spiked chicken fecal samples for the 
extraction methods Easy-DNA and MiniMAG showed the methods to be linear in the range 103 -
105 CFU/mL (manuscript IV). Standard curves should be carefully designed (Whelan et al., 2003; 
Leong et al., 2007; Malorny et al., 2008; Dhanasekaran et al., 2010). In this study, identical results 
were obtained by selecting an adaptive baseline and a non-adaptive baseline (from cycles 3 to 12) 
with a common threshold (740). The limit of detection when extracting DNA using MiniMAG was 
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102 CFU/ml; however, the standard curve did not seem to be linear below the 103 CFU/ml level and 
the limit of quantification was considered to be 103 CFU/ml. The amplification efficiencies obtained 
for the Easy-DNA and MiniMAG methods were 96.6% and 116.9% respectively. Data fit to the 
standard curves were assessed using R2values which were 0.961 and 0.945 for the Easy-DNA and 
MiniMAG methods, respectively (manuscript IV). 
 
7.3.2.2. Comparison of enumeration by culture and real-time-PCR  
Results obtained from selective culture of the chicken fecal samples naturally infected with 
Campylobacter are presented in manuscript IV. Results indicated that samples 1 and 4 contained 
higher numbers of Campylobacter (in the order of 107 CFU/g) while samples 2 and 3 had lower 
numbers (in the order of 105 and 104 CFU/g respectively). The numbers of Campylobacter obtained 
by culture from samples B were consistently lower than those obtained from samples A (processed 
without filter during the sample homogenization step). 
Generated standard curves were used for the real-time PCR direct quantification of Campylobacter 
spp. present in naturally infected chicken fecal samples. Quantification of samples with 
Campylobacter numbers higher than 105CFU/g was performed based on extrapolation of the 
standard curves (see manuscript IV). Obtained real-time PCR data were transformed for every 
dilution level and mean values were calculated as estimates of the numbers of Campylobacter 
present in every biological sample (manuscript IV). Real-time PCR data were obtained from all 
dilution levels when using the DNA extraction method MiniMAG, however, no real-time PCR 
results were obtained for the dilutions 10-4 and 10-5of samples 2, 3 and 4when extracting DNA with 
the Easy-DNA method. The mean estimates for the numbers of Campylobacter in every sample 
obtained by culture and by real-time PCR using the two different DNA extraction methods are 
presented in manuscript IV. Standard deviations were calculated and found to be lower when using 
the DNA extraction method MiniMAG. The numbers of Campylobacter obtained by real-time PCR 
when using MiniMAG for DNA extraction were in most cases higher than the numbers obtained by 
culture (for all samples except for Sample 3). Sample number 3 had the lowest Campylobacter 
concentration (below 5 logs) and the enumeration results obtained by culture were higher than those 
obtained using real-time PCR for this sample. In general, the numbers of Campylobacter obtained 
by real-time PCR when extracting DNA with the Easy-DNA method were lower or very similar to 
the numbers obtained by culture (manuscript IV). Agreement between methods was investigated 
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and the correlation coefficients obtained were 0.98 between culture and real-time PCR (both DNA 
extraction methods) and 0.99 between Easy-DNA and MiniMAG extraction methods.  
The statistical significance of the differences between estimates of the numbers of Campylobacter 
obtained by culture and by real-time PCR using the two different DNA extraction methods was 
investigated. A result with a p-value ≤ 0.05 was considered a statistically significant result. The 
only difference found to be statistically significant was the one related to the estimates of the 
numbers of Campylobacter obtained for sample 1A by real-time PCR when using the two different 
DNA extraction methods (p-value = 0.02). The results from this study indicated that there were no 
statistically significant differences between culture and real-time PCR.  
 
7.4. Discussion 
Reliable quantification of pathogens is crucial to ensure food safety and consequently fast, sensitive 
and accurate methodologies and data analysis techniques need to be properly tested, improved or 
developed. Real-time PCR is widely used to detect and quantify pathogens or beneficial microbes 
(Masco et al., 2007; Malorny et al., 2008; Le Dréan et al., 2010). Real-time PCR also allows for the 
detection and quantification of viable but non-culturable microbial forms that might be of high 
relevance in some cases (Postollec et al., 2011). In these studies, several DNA extraction methods 
were assessed in their effectiveness for the quantification of Campylobacter jejuni present in spiked 
chicken fecal samples using real-time PCR. Moreover, two of the methods were used to quantify 
Campylobacter (by real-time PCR) present in naturally infected chicken fecal samples and the 
results were compared to quantitative data obtained from traditional culture. Conventional 
microbiological methods for the detection, identification and quantification of Campylobacter can 
be time consuming, usually rely on initial enrichment procedures that might introduce bias (in 
relation to the strains identified and the numbers of pathogens) in the results (Velusamy et al., 2010) 
and will not detect viable but non-culturable (VBNC) Campylobacter cells (Postollec et al., 2011). 
On the other hand, real-time PCR might produce false negative results when no enrichment is used 
and the samples contain low numbers of bacteria. Real-time PCR quantifies DNA present in the 
samples; amplified DNA could be derived from live cells, viable but non-culturable microbial forms 
and dead cells (Botteldoorn et al., 2008). Amplified DNA from dead cells may lead to an 
overestimation of the numbers of the target organism or even false-positive results (Wolffs et al., 
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2005). As a result, it will be expected that quantification results from real-time PCR will be higher 
than those obtained by traditional culture. Despite the differences found between methods in these 
studies (manuscript IV), there was good agreement between real-time PCR methods and culture. 
The fact that chicken fecal samples were used for the preparation of spiked samples and 
construction of standard curves could partly explain this agreement because we already accounted 
for the effect of inhibitors that may be present in chicken fecal samples when building the standard 
curves. Several studies have compared quantification results obtained by culture and by real-time 
PCR with contradictory results. Some researchers found that the estimated numbers of target 
organisms were higher when using real-time PCR in comparison with traditional culture-based 
methods (Yang et al., 2003; Lebuhn et al., 2005; Pujol et al., 2006; Lahtinen et al., 2006; Hong et 
al., 2007; Botteldoorn et al., 2008; Reichert-Schwillinsky et al., 2009 Löfström et al., 2010; 
Converse et al., 2012). However, other studies reported good agreement between the methods 
(Martín et al., 2006; Josefsen et al., 2010; Bui et al., 2011) while others found an underestimation 
of the numbers of the target organism when using real-time PCR in comparison with culture 
(Pennacchia et al., 2009; Noble et al., 2010). Even when there is agreement between methods, the 
stability of this agreement might be dependent on other factors such as time, season and 
environmental factors (Shibata et al., 2010; Converse et al., 2012).  
Direct quantification of Campylobacter present in fecal samples has proven to be difficult  
(Leblanc-Maridor et al., 2011) and poultry faeces, in particular, represent complex samples for 
accurate quantification of Campylobacter (Rudi et al., 2004). Inhibitory substances present in 
biological matrices may reduce the efficiency of real-time PCR assays significantly (Perch-Nielsen 
et al., 2003; Guy et al., 2003; Rådström et al., 2004; Sunen et al., 2004; Stratagene, 2004; Jiang et 
al., 2005). In addition, the species of Campylobacter and the initial numbers of Campylobacter 
present in the naturally infected chicken fecal samples in this study were unknown. It seems 
difficult to be completely certain about the numbers of a given bacteria in a particular sample even 
when the methodologies used are very sensitive. The distribution of bacteria in samples might not 
be homogeneous (Griffith et al., 2003) even though chicken fecal samples were homogenised using 
a stomacher in this study. What's more, microbiological methods might select against certain 
species of Campylobacter that may be present in the samples. In fact, CCDA agar is selective for 
Campylobacter spp. but some strains may fail to grow or grow poorly (Neogen, 2010). In general, 
CCDA agar plates (from Oxoid, Hampshire, UK) are selecting for Campylobacter jejuni, 
Campylobacter coli and Campylobacter lari. Chickens usually carry C. jejuni, C. coli and 
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occasionally C. lari (Newell and Fearnley, 2003; European Food Safety Authority and European 
Centre for Disease Control, 2011). Interestingly, C. jejuni and C. coli are the main species 
responsible for most human campylobacteriosis cases (Nachamkin and Blaser, 2000; Friedman et 
al., 2000; Allos, 2001; Gillespie et al., 2002; Tam et al., 2003).  Furthermore, mixed infections with 
diverse Campylobacter spp. are not uncommon in poultry (Jacobs-Reitsma et al., 1995; De Boer et 
al., 2002).When using traditional microbiological methods for quantification it is important to bear 
on mind that culture selects for culturable bacterial cells only, other viable but non-culturable 
bacterial states could be missed in the quantification. Traditional microbiological methods for 
quantification rely on counting bacteria growing on plates; however, the results may differ between 
persons performing the enumeration of bacteria growing on a given plate in some occasions (US 
Food and Drug Administration, 2006). Furthermore, when using selective culture for 
Campylobacter it is generally assumed that colonies growing on plates are Campylobacter colonies. 
On the other hand, distinguishing Campylobacter colonies from other contaminants growing on 
plates may prove difficult (Line, 2001; Stern et al., 2001).   
The quantification results obtained in this study suggested that the use of filters during sample 
processing could translate on lower estimates of the numbers of Campylobacter in the samples 
independently of the quantification method applied (culture or real-time PCR). This finding is in 
agreement with other studies where the use of specific types of filters partly or completely inhibited 
PCR amplification due to target Campylobacter DNA binding to the filter membranes (Oyofo and 
Rollins,1993). 
The presence of inhibitory substances in complex biological samples may reduce or even 
completely impede the amplification process (Nolan et al. 2006). The use of PCR facilitators has 
been recommended (Hedman and Rådström, 2013).  The addition of bovine serum albumin (BSA) 
may help to overcome PCR inhibition in fecal samples and other types of samples such as blood 
and meat samples (Abu Al-Soud and Rådström 2000). The use of nonionic detergents such as 
detergents Tween 20 and Triton X-100 and polymers such as PEG and dextran has been shown to 
facilitate PCR amplification and reduce PCR inhibition in fecal samples (Abu Al-Soud and 
Rådström, 2000). The addition of phytase has been proposed to relieve inhibition caused by the 
presence of phytic acid in feces (Thornton and Passen, 2004). In this study, BSA was added to the 
PCR mix to facilitate PCR amplification. The selection of DNA polymerase might have an 
important effect on overcoming PCR inhibitors (Katcher and Schwartz, 1994; Abu Al-Soud and 
Rådström, 1998; Wolffs et al., 2004; Bessetti, 2007). The Tth DNA polymerase was used in this 
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study. The Tth polymerase can significantly improve PCR amplification efficiency in comparison 
with the Taq DNA polymerase when processing feces or samples containing fecal material (Shames 
et al., 1995; Abu Al-Soud and Rådström, 1998; Dahlenborg et al., 2001). Additionally, the Tth 
buffer contains bovine serum albumin (BSA) and the detergent Tween 20 which facilitate PCR 
amplification (Hedman and Rådström, 2013).  
Diverse combinations of DNA extraction methods may be used for the removal of PCR inhibitors 
and the concentration of target DNA in digesta and fecal samples (Yu and Morrison, 2004; 
Zoetendal et al., 2001). DNA extraction methods can remove a significant amount of PCR 
inhibitors but they can be expensive and laborious (Rådström et al., 2003).  Advances in the 
development and improvement of DNA extraction methods can translate to fast, easier-to-use and 
cheaper methods. In these experiments, the methods Easy-DNA and MiniMAG were relatively fast, 
it was possible to process approximately 30 samples in less than 6 hours. In terms of cost per DNA 
extraction, the cheapest methods were Easy-DNA and KingFisher (17 DKK/DNA extraction) while 
the most expensive was MiniMAG (125 DKK/DNA extraction). 
Real-time PCR data analyses can be complex and the comparison between real-time PCR results 
from different methodologies might be difficult and cumbersome (Karlen et al., 2007). Different 
real-time PCR data analysis methods have been described (Karlen et al., 2007) but no method 
seems to be fully characterized and completely reliable statistically (Karlen et al., 2007). In fact, 
good statistical methods for thorough and rigorous Q-PCR data analyses have lagged behind the 
numerous applications of real-time PCR. 
The amount of DNA will double at each real-time PCR cycle in a perfectly efficient reaction but 
this is difficult to achieve in experimental conditions. PCR efficiency depends primarily on the 
primers used and therefore careful design of primers seems necessary to obtain highly efficient PCR 
reactions (Tichopad et al, 2004; Tichopad et al., 2010). The results from this study indicated that 
the method Easy-DNA Invitrogen produced the most optimal real-time PCR performance indicators 
when used with chicken fecal samples. On the other hand, the limit of detection obtained when 
using Easy-DNA Invitrogen was relatively high (103 CFU/ml). In a study conducted by Lund et al. 
(2004), a detection limit of 250 Campylobacter CFU/g of feces was obtained using the KingFisher 
method. In the study presented here, the KingFisher method did not seem to work very well with 
the spiked chicken fecal samples. 
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The limit of detection and the limit of quantification might differ because the limit of detection may 
be found at a concentration below the linear part of the standard curve (Armbruster and Pry, 2008; 
Leblanc-Maridor et al., 2011). It is generally accepted that real-time PCR may provide accurate 
quantification estimates when using samples with numbers of target organism exceeding 102-103 
CFU/g or ml but not with lower concentrations due to the loss of target DNA during sample 
preparation and to the small volumes analyzed (Malorny et al., 2008; Löfström et al., 2010; 
Josefsen et al., 2010). Besides, the use of increased concentrations of target DNA might help to 
overcome the effect of PCR inhibitors (Rådström et al., 2003; Lund et al., 2004; Roussel et al., 
2005).  
Quantification results depend on the sample matrix, sample preparation, DNA extraction method, 
real-time PCR reagents, real-time PCR experiments and real-time PCR data analysis. On the other 
hand, experimental variability can be very high even when the best methodologies are used and 
experiments are performed under very controlled conditions. Variability between different PCR 
plates or runs can be high; even when considering only one specific PCR plate, intra-plate 
variability can be significant (Karlen et al. 2007).  In fact, biological variability between samples 
and replicates can also be high and partly explain different real-time PCR efficiencies.  
Research results might also be different when using fresh samples for DNA extraction than when 
extracting DNA from frozen samples. Chicken feces present a semi-dry viscous consistency that 
might cause problems during sample processing and DNA extraction (Silkie and Nelson, 2009). It 
has been recommended that fecal samples are processed very soon after collection or alternatively, 
samples should be placed in the freezer (Nechvatal et al., 2008). Sample storage conditions may 
affect detection and quantification of bacterial pathogens in fecal samples (Tang et al., 2008; 
Barnard et al., 2011). In this study, spiked samples and negative controls were immediately placed 
in the freezer (stored at -20ºC) after preparation as recommended (Qiagen, 2013) and used for DNA 
extractions within four months. However, it has been shown that freezing may affect DNA stability 
and produce false-negative results when using PCR for pathogen detection (Jensen et al., 2004; 
Brinkman et al., 2004). Further research should be conducted to assess the degree of 
Campylobacter DNA damage associated with freezing and/or other storage conditions. The 
naturally infected chicken fecal samples used in this study were processed within 30 hours from the 
time of collection and it is possible that Campylobacter cells with intact membranes survived well 
during that time which in turn could explain the statistical agreement between quantification results 
obtained by culture and by real-time PCR. Campylobacter jejuni can survive up to six days in 
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poultry feces (Ahmed et al., 2013). We could hypothesize that most Campylobacter cells present in 
our samples were in viable and culturable state because chicken fecal samples were fresh and 
processed within 30 hours of collection. It is therefore possible that not a great amount of stressed 
Campylobacter cells, VBNC Campylobacter states or free Campylobacter DNA were present in 
these samples. Novel and accurate methods able to discriminate between the different 
Campylobacter viable and non-viable states could share light in this matter. 
In conclusion, there was good agreement between the Campylobacter direct quantification results 
obtained by selective culture and by real-time PCR when using two different DNA extraction 
methods in these studies which could indicate that the main aim to obtain reliable Campylobacter 
direct quantification results using chicken fecal samples was fulfilled. 
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Abstract Direct and accurate quantification of Campylo-
bacter in poultry is crucial for the assessment of public
health risks and the evaluation of the effectiveness of control
measures against Campylobacter in poultry. The aim of this
study was to assess several rapid DNA extraction methods
for their effectiveness for the direct quantification (without
enrichment) of Campylobacter jejuni in chicken fecal sam-
ples using real-time PCR. The presence of inhibitory sub-
stances in chicken fecal samples may reduce or even
completely impede the PCR amplification process making
quantification very difficult. Six rapid DNA extraction
methods were compared based on their limit of detection,
efficiency, reproducibility, and precision. Standard curves
were designed for all the methods tested in order to assess
their performance on the direct quantification of C. jejuni in
chicken fecal samples. As a result of this study, the Easy-
DNA (Invitrogen) method generated lower Ct values, the
best amplification efficiency (AE=93.2 %) and good preci-
sion (R squared=0.996). The method NucleoSpin® Tissue
was able to detect samples spiked with the lowest Campylo-
bacter concentration level (10 CFU/ml) but the amplifica-
tion efficiency was not optimal (AE=139.5 %). DNA extrac-
tion methods Easy-DNA Invitrogen, MiniMAG® and
NucleoSpin® Tissue produced good real-time PCR repro-
ducibility generating standard deviations from 0.3 to 0.8
between replicates.
Keywords Campylobacter . Quantification . Chickens .
Real-time PCR . DNA extraction methods
Introduction
Rapid and accurate detection and quantification of pathogens
such as Campylobacter that might be present in clinical
samples and suspected sources of disease (e.g., food, water,
and environmental samples) are crucial for the investigation
and control of disease cases and outbreaks and the protection
of public health (World Health Organization 2007). Cam-
pylobacter is the most frequent cause of foodborne disease in
many areas of the world (French 2008; Sears et al. 2011).
Accurate methods for Campylobacter quantification may
assist on the assessment of public health risks and the eval-
uation of control measures implemented during poultry pro-
duction such as vaccination strategies (Garcia et al. 2012).
Prompt and accurate identification and quantification of
pathogens that might be contaminating food are crucial to
assist food safety controls (Mucchetti et al. 2008; Jin et al.
2008). Most common microbiological methods for the de-
tection and quantification of Campylobacter are based on
selective culture. Conventional microbiological methodolo-
gies for the detection, identification, and quantification of
pathogens are usually based on specific microbiological and
biochemical characteristics of pathogens (Anonymous 2006;
Velusamy et al. 2010). These methods can be inexpensive
and sensitive but they can also be time consuming and they
usually rely on initial enrichment procedures that might
introduce bias (in relation to the strains identified and the
numbers of pathogens) in the results. Some enrichment
broths may select against specific Campylobacter spp.
(Moore and Madden 1998; Madden et al. 2000; Nachamkin
and Blaser 2000). The use of enrichment broth might also
increase the numbers of Campylobacter in the sample
depending on time and temperature of incubation (Sails
et al. 2003). Therefore, it seems very difficult to accurately
identify and/or quantify the initial numbers of pathogens
present in the samples when using enrichment steps
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(Postollec et al. 2011). Furthermore, viable but non-
culturable (VBNC) Campylobacter cells will not be detected
using conventional microbiological techniques (Postollec
et al. 2011).
The development of real-time PCR seems promising for
the real-time detection and quantification of pathogens
(Stevens and Jaykus 2004; Masco et al. 2007; Malorny
et al. 2008). In general terms, real-time PCR offers some
advantages in comparison with standard microbiological
methods such as rapidity, the potential ability to detect
small amounts of target DNA in samples and to quantify
genes and gene expression (Toze 1999; Nolan et al. 2006;
Postollec et al. 2011). However, direct quantification of
Campylobacter (without the use of enrichment) by real-
time PCR might prove difficult when low numbers of bac-
teria are present in samples. On the other hand, dead
Campylobacter cells will be detected by real-time PCR
which may produce an overestimation of the viable
Campylobacter cells present in the samples. Real-time
PCR can be extremely sensitive when pure target DNA is
analyzed. However, the limit of detection, the limit of quan-
tification and the amplification efficiency can be negatively
affected by the presence of PCR inhibitors (Rådström et al.
2003; Hedman and Rådström 2013). Diverse compounds
such as food degradation products, bilirubin (Kreader
1996), phytic acid (Thornton and Passen 2004), bile salts
(Lantz et al. 1997; Abu Al-Soud et al. 2005), and complex
polysaccharides (Demeke and Adams 1992; Lantz et al.
1997; Monteiro et al. 1997) present in feces have been
identified as PCR inhibitors. Substances such as excess
NaCl, KCl, and other salts, ionic detergents (Weyant et al.
1990), phenol (Katcher and Schwartz 1994), ethanol and
isopropanol (Loffert et al. 1997), and other materials might
also inhibit PCR. PCR inhibitors might originate from the
samples and/or from materials and reagents used during
sampling and sample preparation (Rossen et al. 1992;
Wilson 1997; Bessetti 2007; Hedman and Rådström 2013).
PCR inhibitors can interfere with target DNA and/or with
DNA amplification reagents such as thermostable DNA
polymerases and/or inhibit fluorescence (Bessetti, 2007;
Hedman and Rådström 2013). DNA polymerases might be
affected by compounds present in biological samples reduc-
ing PCR amplification efficiency (Rossen et al. 1992;
Katcher and Schwartz 1994; Abu Al-Soud and Rådström
1998). In general, DNA extraction methods and DNA poly-
merases need to be carefully selected because their compo-
nents might influence PCR reactions by inhibiting or facili-
tating DNA amplification. Furthermore, DNA extraction
methods might work differently when using the same sample
matrix resulting in different DNA extraction efficiencies. On
the other hand, false negative PCR results may occur due to
the presence of inhibitors in the samples but also due to DNA
loss, DNA degradation or interference with the reagents
needed for DNA extraction. Therefore, adequate treatment
of samples prior to real-time PCR and appropriate controls
should be included in the PCR reactions (Rådström et al.
2004; Cankar et al. 2006; Murphy et al. 2007). Sample
treatment methodologies depend on the target organism
and also on the sample matrix (Stevens and Jaykus 2004;
Nolan et al. 2006). Poultry fecal samples represent complex
matrices for the quantification of Campylobacter. Therefore,
matrix preparation for the removal of inhibitory substances
and for the concentration and purification of Campylobacter
DNA is crucial for Campylobacter detection and quantifica-
tion (Perch-Nielsen et al. 2003; Guy et al. 2003; Rådström
et al. 2004; Sunen et al. 2004; Jiang et al. 2005).
The aim of this study was to assess six DNA extraction
methods in their performance and effectiveness for the direct
quantification of Campylobacter jejuni in spiked chicken
fecal samples using real-time PCR. Standard curves were
produced and methods were compared based on the results
obtained from real-time PCR assays in terms of detection
limit, limit of quantification, reproducibility (assessed by
comparison of the obtained standard deviation between rep-
licates), amplification efficiency (based on the slope of the
standard curve), detection range (range of concentration
levels detected), and precision (data fit to the standard
curve).
Materials and Methods
Chicken Fecal Samples, Spiking Protocol, and Negative
Controls
Three different fecal samples obtained from broilers were
confirmed to be Campylobacter negative (by selective cul-
ture and PCR), spiked with C. jejuni CCUG 11284 and used
for the quantification of Campylobacter by real-time PCR.
The spiked fecal samples (23.8, 21.3, and 18.7 g) were
mixed with saline (214.2, 191.7, and 168.3 ml, respectively)
to produce the first tenfold dilution. The biological replicates
produced this way (Invitrogen 2013) were placed into stom-
acher bags and homogenized for 30 s at average speed (400
Stomacher®, Seward Limited, London, UK).
The culture produced for spiking fecal samples was pre-
pared from C. jejuni CCUG 11284, inoculated on a modified
charcoal cefoperazone deoxycholate agar (mCCDA; Oxoid,
Greve, Denmark) plate and incubated at 42 °C inmicroaerobic
conditions overnight. Five colonies of C. jejuni were enriched
in 10 ml Müller Hinton broth (MH; Oxoid, Greve, Denmark)
and incubated at 42 °C in microaerobic conditions for approx-
imately 18 h. Culture of serial dilutions (10−1–10−8) on
mCCDA plates allowed for enumeration of C. jejuni (CFU/
ml) in the spiking culture.
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Homogenized fecal samples were spiked with C. jejuni
CCUG 11284 (calculations were performed based on fecal
sample volume and numbers of C. jejuni in the initial cul-
ture) to produce five spiking levels (101–105) and mixed
thoroughly to promote equal distribution of C. jejuni in the
samples. Validation of the spiking levels was performed in
the laboratory. Aliquots of 1 ml were produced to obtain 50
replicates of each of the following spiking levels 10, 100,
1,000, 10,000, and 100,000. The remaining non-spiked fecal
sample was homogenized and distributed in aliquots of 1 ml to
produce negative controls for the real-time PCR experiments.
DNA Extraction Methods for the Quantification
of Campylobacter Using Real-Time PCR
Prepared samples (spiked samples and negative controls)
were centrifuged at 5,000×g for 5 min and the supernatants
were discarded. Sample pellets were stored at −20 °C until
their use for Campylobacter DNA extraction and quantifi-
cation with real-time PCR.
Sample pellets were taken from the freezer and thawed at
room temperature before DNA extraction. Sample pellets
were re-suspended and DNA extracted according to instruc-
tions found in every DNA extraction protocol. The following
six DNA extraction methods were evaluated:
1. Easy-DNA™Kit for genomic DNA Isolation (Invitrogen,
Leek, The Netherlands).
The published protocol #3 from the Easy- DNA™ Kit
(Invitrogen) for the extraction of DNA from small amounts
of cells, tissues, or plant leaves was followed. Samples
(pellets) were re-suspended in 200 μl of 10 mM Phosphate
Buffered Saline (PBS) buffer. The solutions and reagents
included in the Kit were used together with chloroform and
ethanol for the extraction of Campylobacter DNA. The
approximate cost per DNA extraction (including laboratory
materials) was 17 Danish Kroners (DKK).
2. MagneSil®KF, Genomic system (KingFisher®) (Promega,
Madison, WI, USA).
The MagneSil® KF, Genomic system (KingFisher®) is
based on the use of paramagnetic particles. Initially, sample
pellets were re-suspended in 200 μl of lysis buffer. Samples
were lysed allowing the DNA to bind to the paramagnetic
particles. In the next steps, particles with DNAwere washed
(with salted water and alcohol) and air dried. In the final step,
DNA was eluted and ready for PCR use. The approximate
cost (including laboratory materials) was 17 DKK per DNA
extraction.
3. SureFood® PREP Campylobacter (Congen Biotechnologie
GmbH, Berlin, Germany).
Sample pellets were re-suspended in 400 μl of lysis buffer
solution. The method SureFood® PREP Campylobacter used
the spin column technique for the extraction of Campylobac-
ter DNA. In the initial steps, cells were lysed by boiling
allowing the DNA to bind to the column. Extracted DNA
was washed and finally eluted. The approximate cost (includ-
ing laboratory materials) was 49 DKK per DNA extraction.
4. QIAamp Qiagen DNA stool mini kit (Qiagen, Hilden,
Germany).
Sample pellets were re-suspended in 1.4 ml of commer-
cial buffer (buffer ASL).The protocol for the isolation of
DNA from stool for pathogen detection from the QIAamp
Qiagen DNA stool handbook was followed. This protocol
indicated the use of buffer ASL and heat for cell lysis and the
use of InhibitEX tablets for DNA purification. PCR inhibi-
tors and substances that might damage DNAwere absorbed
using the InhibitEX matrix which was pelleted by centrifu-
gation afterwards. The extracted DNA was further purified
using QIAamp Mini spin columns which allowed for the
digestion of proteins, DNA binding, washing, and finally,
elution of pure DNA from the spin columns. The approxi-
mate cost per DNA extraction (including laboratory mate-
rials) for this method was 43 DKK.
5. NucliSENS®MiniMAG® (BioMérieux SA, Lyon France).
Sample pellets were re-suspended in 2 ml of 10 mM PBS
buffer. The NucliSENS® miniMAG® method used magnetic
silica particles for DNA extraction. Initially, cells were lysed
using a lysis buffer and free DNA could bind the magnetic
silica particles. After several washes with different buffers,
DNAwas eluted using an elution buffer and ready for further
processing. The approximate cost (including laboratory ma-
terials) for this method was 125 DKK per DNA extraction.
6. NucleoSpin® Tissue (Macherey-Nagel GmbH & Co.
KG, Düren, Germany).
Sample pellets were re-suspended in 200 μl of lysis buffer
T1 (part of the kit).The “support protocol for genomic DNA
from stool” was used to extract Campylobacter DNA using
the NucleoSpin® Tissue methodology. TE buffer, buffer T1,
and proteinase K were used to prepare the samples. Samples
were subsequently treated using buffer B3 and heat to lyse
cells. The use of ethanol and NucleoSpin® Tissue Columns
allowed for DNA binding. Extracted DNAwas then washed
with buffers from the kit and eluted using an elution buffer.
The approximate cost per DNA extraction (including labo-
ratory materials) for this method was 26 DKK.
The final DNA elution volume was 100 μl for all methods
except for QIAamp Qiagen DNA stool mini kit. In the
Qiagen method, the purified, concentrated DNA was eluted
from the spin column in 200 μl of low-salt elution buffer.
Food Anal. Methods
Author's personal copy
Two biological replicates were analyzed when using the
NucliSENS® miniMAG method (due to protocol limitations)
and three biological replicates were processed when using the
rest of the methods. Furthermore, two real-time PCR repli-
cates from one biological replicate (all dilutions) were includ-
ed to evaluate variation attributable to the real-time PCR run.
Therefore, a total of five replicates per sample (Campylobac-
ter concentration level) were analyzed for every DNA extrac-
tion method except for NucliSENS® miniMAG (four repli-
cates/per sample).
The methods MagneSil® KingFisher and NucliSENS®
miniMAG were partly automated, the rest of the extraction
methods were manual. After DNA extraction, measurements
(in duplicate or triplicate in case of large deviations) of total
DNA yield and quality were obtained using a NanoDrop
(Thermo Fisher Scientific Inc., Delaware, USA) spectropho-
tometer. An absorbance ratio A260/280 of ∼1.8 is generally
accepted as “pure DNA” (Thermo Fisher Scientific 2011).
Extracted DNA was stored at −20 °C ready for real-time
PCR assays.
Real-Time PCR
Real-time PCR was performed using a real-time PCR thermal
cycler Mx3005P™ (Strategene, La Jolla, USA). Samples and
PCR mix were placed in the thermal cycler using MicroAmp
Optical 96-well reaction plates (Applied Biosystems) covered
with MicroAmp Optical caps (Applied Biosystems).
The 25-μl real-time PCR mixture contained 1 U of Tth
DNA polymerase (Roche A/S), 1×PCR buffer for Tth DNA
polymerase (Roche A/S, Hvidovre, Denmark), 0.6 mM
deoxynucleoside triphosphate mixture (Amersham Pharmacia
Biotech, Buckinghamshire, UK), 2.5 mM MgCl2 (Applied
Biosystems), 0.8 ml/l of glycerol (87 %; Merck, Darmstadt,
Germany), 0.5 μM forward primer OT-1559-5′-CTG CTT
AAC ACA AGT TGA GTA GG-3′, 0.5 μM reverse primer
18-1-5′-TTC CTTAGG TAC CGT CAG AA-3′ (DNATech-
nology, Århus, Denmark; C. jejuni 16S rRNA; GenBank
accession no. Y19244), 0.2 g/l bovine serum albumin (Roche
A/S), 75 nM target locked nucleic acid (LNA)Campylobacter
probe 5′ [6FAM] CA[+T] CC[+T] CCA CGC GGC G[+T]T
GC[BHQ1] 3′ (Sigma-Aldrich), 60 nM internal amplification
control (IAC) probe (5′-VIC-TTC ATG AGG ACA CCT
GAG TTG A-TAMRA 3′; Applied Biosystems), 5×103 cop-
ies of IAC (124 bp), and 10 μl of extracted template DNA.
The primers used (the forward primer OT-1559 and the
reverse primer 18–1) amplify a 287-basepair fragment of the
16S rRNA gene of thermotolerant C. jejuni, Campylobacter
coli, and Campylobacter lari (Lübeck et al. 2003; Josefsen
et al. 2004). The amplification products were detected by
using the FAM (fluorescein amidite)-labeled probe. Further-
more, an internal control (amplified with the target) was
visualized using a HEX (hexachloro fluorescein)-labeled
probe. The thermal profile included an initial denaturation
step at 95 °C for 3 min followed by 40 cycles consisting of
denaturation at 95 °C for 15 s, annealing at 60 °C for 60 s and
extension at 72 °C for 30 s.
The following controls were included: (a) two positive con-
trols (DNA from C. jejuni with concentrations: 100 and
1,000 CFU/ml), (b) a negative control (DNA from Escherichia
coli with a concentration of 1,000 CFU/ml, and (c) a non-
template control (NTC) in duplicate. The inclusion of a non-
template control (NTC) allowed for assessment of master mix
contamination.
Data Analysis Methodologies
Total DNA yields and quality values obtained from DNA
extracted using every protocol were recorded in Excel. Real-
time PCR data obtained from the six DNA extraction methods
were analyzed all together in a common project using the
MxPro-Mx3005P software (version 3.00, Stratagene, La Jolla,
CA, USA). The amplification threshold was set using the
software option “background-based threshold” which deter-
mines the standard deviation of all amplifications (from cycles
5 to 9) and multiplies them by a factor of 10 (default factor). A
common baseline was set for all amplification plots obtained
using an adaptive baseline and a non-adaptive baseline for
comparison of the six DNA extraction methods (Stratagene
2004). A common amplification threshold was generated, and
the threshold cycle values (Ct values) obtained were used to
compare the different DNA extraction methodologies. In gen-
eral, the lower the Ct values, the higher the DNA quantity
obtained (Stratagene 2004; Armbruster and Pry 2008;
Abdelwhab et al. 2010). Real-time PCR reproducibility can
be assessed by calculating the standard deviation (SD) be-
tween replicates, ideally the SD between replicates should be
less than 0.5 (Eurogentec 2012). The numbers of CFU (logs)
obtained were plotted against the Ct values obtained in the
real-time PCR runs, and standard curves were produced by
linear regression for all DNA extraction methods tested. Stan-
dard curves were used to determine the overall performance of
real-time PCR in terms of amplification efficiency, detection
range (range of C. jejuni levels detected), limit of detection,
limit of quantification and precision for every DNA extraction
method. The slope of the standard curve indicates the ampli-
fication efficiency of the real-time PCR assay. The amplifica-
tion efficiency (AE) was calculated based on this equation:
AE=10(−1/slope)−1 (Klein et al. 1999). The amplification effi-
ciency is between 90 % and 110 % when the slope varies
between −3.1 and −3.6. An amplification efficiency of 100 %
indicates perfect reactions where the amplicon doubles each
cycle (Stratagene 2004). An assessment of precision, linearity
or data fit to the standard curve is produced using the
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parameter “R squared (R2)”which should be close to 1, in fact
values ≥0.985 indicate good correlation (Stratagene 2004).
Results
Results Related to DNAYield and Purity
Results related to DNA yield obtained for each of the six
DNA extraction methods are presented in Fig. 1. The Easy-
DNA™ Invitrogen method produced the highest DNA yield
(ranging from 188 to 317 ng/μl) followed by KingFisher®
(ranging from 54 to 177 ng/μl).
Results related to DNA purity (absorbance ratio A260/280
values) were obtained for every method as follows: Easy-
DNA kit (Invitrogen), 1.5–1.6; KingFisher (Promega), 1.1–
1.8; miniMAG (bioMérieux), 1.0–1.4; SureFood (Congen),
0.9–4.9; NucleoSpin (Macherey-Nagel), 1.6–2.2; and
QIAamp (Qiagen), 1.3–3.3. Purity ratios around 1.8 or higher
are desirable (Thermo Fisher Scientific 2011).
Results Related to Real-Time PCR
A common real-time PCR project was produced in order to
analyze data obtained from all DNA extraction methods
based on the same baseline and identical amplification
threshold. Identical results (FAM Ct values) were obtained
by selecting an adaptive baseline and a non-adaptive baseline
(from cycles 3 to 12) with a common threshold (740) which
was used for comparison of the six DNA extraction methods.
Table 1 presents results related to the average FAM Ct values
obtained from the real-time PCR experiments with C. jejuni
DNA extracted using the different extraction methods. All
the controls included in real-time PCR assays produced the
expected results (data not shown).
FAM Ct values were obtained from the samples spiked
with the lowest concentration (10 CFU/ml) only when using
the NucleoSpin® Tissue DNA extraction method. No FAMCt
values were generated from the samples spiked with 102 CFU/
ml when using the following methods: MagneSil® KingFish-
er, Easy-DNA Invitrogen and SureFood. Regarding the FAM
Ct values generated from amplification signals produced by
samples spiked with 102 CFU/ml, the NucleoSpin method
produced the lowest FAM Ct value followed by miniMAG.
Results related to samples spiked with 103 CFU/ml indicated
that Easy-DNA Invitrogen produced the lowest FAM Ct
values followed by miniMAG and MagneSil® KingFisher.
Real-time PCR results obtained from samples spiked with
104 CFU/ml indicated that Easy-DNA Invitrogen generated
the lowest FAM Ct values. SureFood produced the lowest
FAM Ct value when using samples spiked with 105 CFU/ml
followed by Easy-DNA Invitrogen.
The internal amplification control was visualized using a
HEX signal which was detected from all samples except for
theCampylobacter concentration levels 104 and 105 CFU/ml
when using the MagneSil® KingFisher DNA extraction
method.
Overall, the Easy-DNA Invitrogen method generated the
lowest FAM Ct values followed by the miniMAG method.
SureFood generated a very low Ct value for the Campylo-
bacter concentration level 105 CFU/ml; however, the varia-
tion between replicates was high as illustrated by a standard
deviation of 2.5 cycles. Standard deviations higher than
1 cycle were obtained when using the method QIAamp
Qiagen with samples with a Campylobacter concentration
level 102 CFU/ml. The MagneSil® KingFisher method
performed poorly in this study. DNA extraction methods
Fig. 1 DNA extracted from
three different biological
replicates using six different
DNA extraction methods.
Samples numbers 1–3 represent
a spiking level of 10 CFU/ml,
numbers 4–6 represent 102 CFU/
ml, numbers 7–9 represent
103 CFU/ml, numbers 10–12
represent 104 CFU/ml, numbers
13–15 represent 105 CFU/ml,
and numbers 16 and 17 are
negative controls
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Easy-DNA Invitrogen, miniMAG and NucleoSpin offered
general good real-time PCR reproducibility generating stan-
dard deviations from 0.3 to 0.8 between replicates.
Standard Curves, Amplification Efficiency, and Linearity
Standard curves were generated and used to evaluate the
amplification efficiency, detection range, and precision of
the DNA extraction methods tested. Results related to real-
time PCR performance indicators obtained to evaluate the
different DNA extraction methods are presented in Table 2.
The amplification efficiency of the real-time PCR assay was
calculated based on the slope of the standard curve. Ampli-
fication efficiencies between 90 % and 110 % were consid-
ered acceptable (Stratagene 2004).
The methods Easy-DNA Invitrogen and QIAamp Qiagen
generated the best amplification efficiencies (93.2 % and
91.5 % respectively). These two methods also produced R
squared (R2) values close to 1 indicating good precision. The
method NucleoSpin® Tissue was able to detect samples
spiked with the lowest Campylobacter concentration level
(10 CFU/ml), however, this extraction method generated
higher Ct values for most concentration levels than the other
methods and the amplification efficiency obtained was sig-
nificantly above 100 % (139.5 %) possibly caused by inhib-
itors and/or experimental error (Stratagene 2004).
Conclusions and Discussion
The strain C. jejuni CCUG 11284 was used in this study to
spike different chicken fecal samples in order to compare
quantification results obtained when using six DNA extrac-
tion methods and real-time PCR. Overall, the Easy-DNA
Invitrogen method seemed to offer the best amplification
efficiency, low FAM Ct values and good precision and
reproducibility when extracting DNA from chicken fecal
samples spiked with C. jejuni CCUG 11284 for quantifica-
tion using real-time PCR. Direct quantification of Campylo-
bacter present in fecal samples has proven to be difficult
(Leblanc-Maridor et al. 2011) and poultry faeces, in partic-
ular, represent complex samples for the accurate quantifica-
tion of Campylobacter (Rudi et al. 2004).
Conventional microbiological methods for the detection,
identification and quantification of Campylobacter can be
time consuming, usually rely on initial enrichment proce-
dures that might introduce bias (in relation to the strains
identified and the numbers of pathogens) in the results
(Velusamy et al. 2010) and will not detect viable but non-
culturable (VBNC) Campylobacter cells (Postollec et al.
2011). On the other hand, real-time PCR might produce false
negative results when no enrichment is used and the samples
contain low numbers of bacteria. Real-time PCR quantifies
DNA present in the samples; amplified DNA could be de-
rived from live cells, viable but non-culturable microbial
forms and dead cells (Botteldoorn et al. 2008). Amplified
DNA from dead cells may lead to an overestimation of the
numbers of the target organism or even false-positive results
(Wolffs et al. 2005). Therefore, it will be expected that
quantification results from real-time PCR will be higher than
those obtained by traditional culture. In order to quantify
bacterial DNA from viable cells only when using real-time
PCR, the use of ethidium monoazide (EMA) and propidium
monoazide (PMA) has been recommended (Rudi et al. 2005;
Josefsen et al. 2010). However, these methods need to be
evaluated further because the use of EMA resulted in an
underestimation of viable cells of C. jejuni and Stahylococcus
spp. in some studies (Flekna et al. 2007; Kobayashi et al.
Table 1 FAM average Ct values (and standard deviations SD) obtained
from real-time PCR results when using different DNA extraction
methods
DNA
extraction
method
Campylobacter concentrations (CFU/ml)
10 102 103 104 105
Easy-DNA
Invitrogen
NA NA 28.0±0.4 24.3±0.7 21.1±0.6
MagneSil®
King Fisher
NA NA 30.6a 25.3a 26.3±1.0
NucliSENS®
MiniMAG®
NA 35.7±0.3 29.2±0.8 26.0±0.5 23.4±0.6
SureFood®
PREP
NA NA 35.2±1.7 26.8±2.6 18.6±2.5
NucleoSpin®
Tissue
37.8±0.8 34.5±0.4 33.1±0.6 29.2±0.8 27.4±0.5
QIAamp
Qiagen
NA 36.3±1.2 33.1±0.6 29.7±0.6 25.5±0.5
NA no Ct values obtained
a Only one Ct value obtained
Table 2 Results related to real-time PCR performance indicators de-
rived from standard curves generated for all six DNA extraction
methods tested
DNA extraction
method
Amplification
efficiency (AE)
Slope R squared Detection
range
Easy-DNA
Invitrogen
93.2 % −3.496 0.996 103–105
MagneSil®
KingFisher
56.2 % −5.160 0.774 103–105
NucliSENS®
MiniMAG
79.8 % −3.924 0.953 102–105
SureFood®
PREP
31 % −8.512 0.998 103–105
NucleoSpin®
Tissue
139.5 % −2.636 0.985 10–105
QIAamp Qiagen 91.5 % −3.545 0.996 102–105
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2009). Inhibitory substances present in biological matrices
may reduce the efficiency of real-time PCR assays significant-
ly (Perch-Nielsen et al. 2003; Guy et al. 2003; Rådström et al.
2004; Sunen et al. 2004; Jiang et al. 2005; Stratagene 2004).
The selection of DNA polymerase might have an impor-
tant effect on overcoming PCR inhibitors (Katcher and
Schwartz 1994; Abu Al-Soud and Rådström 1998; Wolffs
et al. 2004; Bessetti 2007). The Tth DNA polymerase was
used in this study. The Tth polymerase can significantly
improve PCR amplification efficiency in comparison with
the Taq DNA polymerase when processing feces or samples
containing fecal material (Shames et al. 1995; Abu Al-Soud
and Rådström 1998; Dahlenborg et al. 2001). Furthermore,
the Tth polymerase has been shown to maintain DNA poly-
merase activity when 5 % of phenol is present in the sample
(Katcher and Schwartz 1994).
The use of PCR facilitators has been recommended
(Hedman and Rådström 2013). The addition of bovine serum
albumin (BSA) may help to overcome PCR inhibition in
fecal samples and other types of samples such as blood and
meat samples (Abu Al-Soud and Rådström 2000). The use of
nonionic detergents such as detergents Tween 20 and Triton
X-100 and polymers such as PEG and dextran has been
shown to facilitate PCR amplification and reduce PCR inhi-
bition in fecal samples (Abu Al-Soud and Rådström 2000).
The addition of phytase has been proposed to relieve inhibi-
tion caused by the presence of phytic acid in feces (Thornton
and Passen 2004). In this study, BSAwas added to the PCR
mix to facilitate PCR amplification. Furthermore, the Tth
buffer contains bovine serum albumin (BSA) and the deter-
gent Tween 20 which facilitate PCR amplification (Hedman
and Rådström 2013). The effect of PCR facilitators depends
on their concentration. In fact, using high concentrations of
facilitators (such as BSA, Tween 20, Triton X-100, formam-
ide, and glycerol) might inhibit PCR amplification (Rossen
et al. 1992; Ahokas and Erkkila 1993). Synergistic effects
between facilitators are not clear and in fact, some combina-
tions of facilitators may cause PCR inhibition (Ahokas and
Erkkila 1993; Abu Al-Soud and Rådström 2000).
A thorough investigation into the different DNA extrac-
tion methods tested and a comparison of the results from
diverse research studies when extracting Campylobacter
DNA from different sample matrices are desirable but fall
beyond the scope of this manuscript. Efficient, fast, and
reliable non-enrichment methods should be assessed for their
efficiency to separate pathogen cells from the sample matri-
ces and concentrate the cells for quantification. An ideal
method should be able to remove matrix-associated inhibi-
tors without harming the bacterial cells in order to concen-
trate pathogens. Some commercial methods are specifically
designed for their use with fecal samples, e.g., QIAamp®
DNA stool purification kit (Holland et al. 2000; Gioffré et al.
2004). Diverse combinations of biochemical, physical,
immunological, and commercially available DNA extraction
methods may be used for the removal of PCR inhibitors and
the concentration of target DNA in digesta and fecal samples
(Yu and Morrison 2004; Zoetendal et al. 2001). DNA extrac-
tion methods can remove a significant amount of PCR in-
hibitors but they can be expensive and laborious (Rådström
et al. 2003). Advances in the development and improvement
of DNA extraction methods can translate to fast, easier-to-
use and cheaper methods. In this study, the methods Easy-
DNA and MiniMAG were relatively fast, it was possible to
process approximately 30 samples in less than 6 h. In terms
of cost per DNA extraction, the cheapest methods were
Easy-DNA and KingFisher (17 DKK/DNA extraction),
while the most expensive was MiniMAG (125 DKK/DNA
extraction).
Ideal DNA extraction methods should ensure high DNA
yield and quality and minimize interference with PCR reac-
tions (Cankar et al. 2006). DNA extraction methodologies
will extract DNA from diverse microorganisms present in the
samples. The method Easy-DNA Invitrogen produced the
highest DNA yield in this study; however, extracted DNA
could be originating from other microorganisms (apart from
C. jejuni) present in the chicken fecal samples. DNA purity
ratios around 1.8 or higher are desirable, however, it has been
suggested that “the best indicator of DNA quality is
functionality in the application of interest” (Thermo Fisher
Scientific 2011).
The results from this study indicated that the method
Easy-DNA Invitrogen produced the most optimal real-time
PCR performance indicators when used with chicken fecal
samples. However, the limit of detection obtained when
using Easy-DNA Invitrogen was relatively high (103 CFU/
ml). In a study conducted by Lund et al. (2004), a detection
limit of 250 Campylobacter CFU/g of feces was obtained
using the KingFisher method. However, in the study
presented here, the KingFisher method did not seem to work
very well with the spiked chicken fecal samples. Leblanc-
Maridor et al. (2011) extracted DNA from C. jejuni and C.
coli present in swine feces using the DNA extraction method
NucleoSpin® Tissue and obtained a quantification limit of
250 CFU/g of feces although the method was able to detect
10 genome copies. In this study, the method NucleoSpin®
Tissue was also able to detect samples spiked with the lowest
Campylobacter concentration level (10 CFU/ml) but the
amplification efficiency was not optimal. A negative corre-
lation between the detection limit and amplification efficien-
cy has been previously reported (Rudi et al. 2004).
The limit of detection and the limit of quantification might
differ because the limit of detection may be found at a
concentration below the linear part of the standard curve
(Armbruster and Pry 2008; Leblanc-Maridor et al. 2011).
In fact, it is generally accepted that real-time PCR may
provide accurate quantification estimates when using
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samples with numbers of target organism exceeding 102–
103 CFU/g or ml but not with lower concentrations due to the
loss of target DNA during sample preparation and to the
small volumes analyzed (Malorny et al. 2008; Josefsen
et al. 2010; Löfström et al. 2011). Furthermore, the use of
increased concentrations of target DNA might help to over-
come the effect of PCR inhibitors (Rådström et al. 2003;
Lund et al. 2004; Roussel et al. 2005).
Quantification results depend on the sample matrix, sample
preparation, DNA extraction method, real-time PCR reagents,
real-time PCR experiments, and real-time PCR data analysis.
Research results might also be different when using fresh
samples for DNA extraction than when extracting DNA from
frozen samples. Chicken feces present a semi-dry viscous
consistency that might cause problems during sample process-
ing and DNA extraction (Silkie and Nelson 2009). It has been
recommended that fecal samples are processed very soon after
collection or alternatively, samples should be placed in the
freezer (Nechvatal et al. 2008). Sample storage conditions
may affect detection and quantification of bacterial pathogens
in fecal samples (Tang et al. 2008; Barnard et al. 2011). DNA
is repaired efficiently in living cells, but DNA will degrade
during the death of the organisms (Stivers and Kuchta 2006).
Damaged DNA will hinder DNA amplification representing
an important issue in many research areas. The degree of
DNA damage depends on the environment to which DNA
was exposed and on the DNA source (Lindahl 1993; Lehmann
and Kreipe 2001; Wandeler et al. 2003; Paabo et al. 2004).
In this study, samples (spiked samples and negative con-
trols) were immediately placed in the freezer (stored at −20 °C)
after preparation as recommended (Qiagen 2013) and used for
DNA extractions within 4 months. However, it has been
shown that freezing may affect DNA stability and produce
false-negative results when using PCR for pathogen detection
(Jensen et al. 2004; Brinkman et al. 2004). Further research
should be conducted to assess the degree of Campylobacter
DNA damage associated with freezing and/or other storage
conditions.
When analyzing real-time PCR data, the baseline should be
set accurately in order to obtain reliable Ct values. In this
study, a common baseline range was obtained by using an
adaptive baseline and a non-adaptive baseline (from cycles 3
to 12) for comparison of the six DNA extraction methods.
Amplification thresholds can be obtained in different ways
when analyzing real-time PCR data. The threshold cycle
values (Ct values) and therefore quantification results will
depend partly on the amplification threshold selected in every
case. In this study, a common amplification threshold (740)
was obtained by selecting the software option “background-
based threshold” when data analyses were performed using
the MxPro-Mx3005P software (version 3.00). Standard
curves were generated and used for comparison of all six
DNA extraction methods tested. Standard curves may be used
for quantification of unknown samples and therefore should
be carefully designed (Whelan et al. 2003; Leong et al. 2007;
Malorny et al. 2008; Dhanasekaran et al. 2010). Real-time
PCR reactions producing very similar amplification efficien-
cies should be favoured for threshold-based quantification
methodologies.
The routine use of complex mathematical methods for
thorough and rigorous real-time PCR data analyses can
prove challenging and lag behind the numerous practical
applications of real-time PCR (Liu and Saint 2002). Many
variables may affect real-time PCR efficiency. Inhibitors
present in the samples, contaminants and differences in sam-
ple preparation protocols may also explain variability and
different PCR efficiency estimations (Ståhlberg et al. 2003;
Tichopad et al. 2004; Tichopad et al. 2010). Real-time PCR
data can be used to determine the presence of inhibitors in
samples (Lund et al. 2004; Kontanis and Reed 2006).
Real-time PCR efficiency also depends on the primers used
and therefore careful design of primers is necessary to obtain
highly efficient PCR reactions (Tichopad et al. 2004). A PCR
efficiency of 100 % indicates a perfect reaction with doubling
of amplicon during each cycle. An amplification efficiency of
100 % seems difficult to achieve when using complex biolog-
ical matrices due to the presence of inhibitors (Rådström et al.
2004). Low amplification efficiencies indicate that the reac-
tion is slowed down somehow due to the presence of inhibi-
tors or suboptimal PCR reagents and/or conditions. Amplifi-
cation efficiencies significantly higher than 100 % may indi-
cate experimental error (Stratagene 2004).
Real-time PCR detects and quantifies DNA from viable
and non-viable cells which could lead to an overestimation of
the number of viable pathogens present in the initial sample.
Real-time PCR also allows for the detection and quantification
of viable but non-culturable microbial forms that might be of
high relevance in some cases (Postollec et al. 2011). Real-time
PCR is a rapid and sensitive method for the identification and
quantification of pathogens that can be however limited by
inhibitory substances. These inhibitory substances present in
complex biological samples may reduce or even completely
impede the amplification process (Lantz et al. 2000; Nolan
et al. 2006). Therefore, overestimation of the numbers of
viable pathogens in samples and underestimation of numbers
of viable pathogens due to inhibition of the PCR reactions
might produce results that diverge from the true numbers of
pathogens, in this case, C. jejuni present in chicken fecal
samples. Furthermore, the distribution of pathogens in sam-
ples might not be homogeneous. In fact, diverse non-uniform
distributions of pathogens can be expected in biological sam-
ples and this should be considered when processing samples
in the laboratory (Andrews and Hammack 2003; Van
Schothorst et al. 2009). Samples should be thoroughly mixed
when processed in the laboratory and biological replicates
may be analyzed to assess biological variability in samples.
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A thorough investigation of the inhibitors present on
particular sample matrices is desirable in order to design
the best sample treatment and select the most appropriate
DNA extraction methodology. Rigorous real-time PCR data
analyses and accurate estimations of efficiencies of each
real-time PCR reaction will be ideal. However, this approach
might be demanding in terms of time and other resources.
Furthermore, experimental variability can be very high even
when the best methodologies are used and experiments are
performed under very controlled conditions. Variability be-
tween different PCR plates or runs can be high; even when
considering only one specific PCR plate, intra-plate variabil-
ity can be significant (Karlen et al. 2007). In fact, biological
variability between samples and replicates can also be high
and partly explain different real-time PCR efficiencies. In
future studies, novel and thorough analytical and/or statisti-
cal methods could be applied to accurately quantify viable
pathogens such as Campylobacter present in biological
samples.
Accurate and reliable enumeration of viable pathogens
present in foods and/or environmental samples will assist
exposure assessment and risk assessment models and the
evaluation of the effectiveness of food safety measures and
public health protection programs.
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ABSTRACT 
Poultry has been identified as a significant source for human campylobacteriosis which constitutes 
an important public health problem in many areas of the world. Rapid, direct and accurate 
quantification of Campylobacter in poultry is essential for the assessment of risks and control 
strategies associated with poultry production. The aim of this study was to compare estimates of 
the numbers of Campylobacter spp. in naturally infected chicken faecal samples obtained using 
direct quantification by selective culture and by real-time PCR. Absolute quantification of 
Campylobacter by real-time PCR was performed using standard curves designed for two different 
DNA extraction methods: Easy-DNA™ Kit from Invitrogen (Easy-DNA) and NucliSENS® 
MiniMAG® from bioMérieux (MiniMAG). Results indicated that the estimation of the numbers 
of Campylobacter present in eight chicken faecal samples was partly dependent on the 
methodologies used. In general, the numbers of Campylobacter obtained by real-time PCR when 
extracting DNA using the MiniMAG method were in most cases higher than the numbers of 
Campylobacter obtained by selective culture and by real-time PCR when using the Easy-DNA 
method. Although there were differences between the methods, the results indicated that there 
were no statistically significant differences between the estimates obtained by culture and by real-
time PCR. 
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INTRODUCTION 
Direct, fast and accurate detection and quantification of pathogens such as Campylobacter that 
might be present in suspected sources of disease (water, food and/or environmental sources) is 
essential for the investigation of the burden of disease, for disease control and for the protection of 
public health (Coleman and Marks, 1999; World Health Organization, 2007). The bacteria 
Campylobacter has been recognized as the main etiological agent causing human bacterial 
gastrointestinal disease (Lin, 2009; Hermans et al., 2012). Poultry (including poultry products and 
by-products) has been identified as one of the most significant risk factors for human 
campylobacteriosis (Wingstrand et al., 2006; Wilson et al., 2008; Hermans et al., 2012). Accurate 
methods for the enumeration of Campylobacter in poultry are essential for the assessment of 
public health risks and the evaluation of control strategies that might be implemented during 
poultry production such as vaccination (Garcia et al., 2012). Risk assessment models indicate that 
the control of Campylobacter in poultry may reduce the human burden of disease. In actual fact, a 
reduction of 2 logs in chickens could translate in a significant decrease on the number of human 
cases (Rosenquist et al., 2003). Efficient and rapid direct methods for accurate identification and 
quantification of Campylobacter need to be improved or developed. The use of enrichment 
eliminates the possibility for accurate quantification and may select against specific 
Campylobacter spp. (Madden et al., 2000; Nachamkin and Blaser, 2000; Sails et al., 2003). Thus, 
it seems difficult to accurately identify and/or quantify pathogens when using enrichment steps 
(Postollec et al., 2011).Traditional microbiological methods for the detection and quantification of 
Campylobacter based on selective culture can be time consuming and will not detect viable but 
non-culturable (VBNC) Campylobacter cells that might be infectious (Rollins and Colwell, 1986; 
Josefsen et al., 2010). The use of newer and faster technologies such as real-time PCR seems 
promising for the accurate detection and quantification of microorganisms (Stevens and Jaykus, 
2004; Masco et al., 2007; Malorny et al., 2008). Nevertheless, false negative results might be 
obtained when low numbers of bacteria are present in samples; in this case, direct quantification 
of Campylobacter (with no enrichment steps) by real-time PCR might prove difficult. On the 
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other hand, an overestimation of the numbers of Campylobacter present in samples might be 
produced by real-time PCR because dead Campylobacter cells will be detected. When pure target 
DNA is analysed real-time PCR can be very sensitive. On the other hand, the limit of detection, 
limit of quantification and efficiency of real-time PCR assays can be significantly reduced by the 
presence of inhibitors in biological samples (Perch-Nielsen et al., 2003; Rådström et al., 2004; 
Sunen et al., 2004; Jiang et al., 2005). DNA extraction methods need to be carefully selected to 
remove inhibitors and to minimize interference with PCR in order to improve the efficiency of 
real-time PCR and to obtain accurate and reliable quantification. PCR controls and adequate 
treatment of samples prior to real-time PCR should be included in the assays (Rådström et al., 
2004; Cankar et al., 2006; Murphy et al., 2007). Poultry faecal samples represent complex 
matrices and therefore, sample preparation for the removal of inhibitors and for Campylobacter 
DNA concentration and purification is crucial to obtain accurate quantification results (Perch-
Nielsen et al., 2003; Rådström et al., 2004; Inglis et al., 2010). 
In this manuscript, estimates of the numbers of Campylobacter identified in naturally infected 
chicken faecal samples obtained by selective culture and by real-time PCR (using two different 
DNA extraction methods: Easy-DNA™ Kit from Invitrogen and NucliSENS® miniMAG® from 
bioMérieux) are presented and compared. Diverse aspects related to the direct quantification of 
Campylobacter in chicken faecal samples are discussed in this manuscript such as sample matrix 
characteristics, distribution of pathogens in samples, microbiological methods, real-time PCR 
performance and statistical agreement between methods. 
RESULTS 
Quantification by culture 
The results obtained from selective culture of the faecal samples naturally infected with 
Campylobacter are presented in Table 1. Results indicated that samples 1 and 4 contained higher 
numbers of Campylobacter (in the order of 107 CFU/g) while samples 2 and 3 had lower numbers 
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(in the order of 105 and 104 CFU/g respectively). Variation in the appearance of Campylobacter 
colonies indicated the potential presence of diverse Campylobacter species. The numbers of 
Campylobacter obtained by culture from samples B were consistently lower than those obtained 
from samples A (processed without filter during the sample homogenization step). 
Standard curves generated for absolute quantification 
The standard curves designed from real-time PCR data from spiked chicken faecal samples for 
every DNA extraction method showed the methods to be linear in the range of 103 to 105 CFU/ml 
(Figure 2). Identical results were obtained by selecting an adaptive baseline and a non-adaptive 
baseline (from cycles 3 to 12) with a common threshold (740). The limit of detection when 
extracting DNA using MiniMAG was 102 CFU/ml; however, the standard curve did not seem to 
be linear below the 103 CFU/ml level and the limit of quantification was considered to be 103 
CFU/ml. The amplification efficiencies obtained for the Easy-DNA and MiniMAG methods were 
96.6% and 116.9% respectively. Data fit to the standard curves were assessed using R2values 
which were 0.961 and 0.945 for the Easy-DNA and MiniMAG methods, respectively. 
Comparison of enumeration by culture and real-time-PCR  
Generated standard curves were used for the real-time PCR quantification of Campylobacter spp. 
present in naturally infected chicken faecal samples. Quantification of samples with 
Campylobacter numbers higher than 105CFU/g was performed based on extrapolation of the 
standard curves. 
Obtained real-time PCR data were transformed for every dilution level and mean values were 
calculated as estimates of the numbers of Campylobacter present in every biological sample 
(Table 1). Real-time PCR data were obtained from all dilution levels when using the DNA 
extraction method MiniMAG, however, no real-time PCR results were obtained for the dilutions 
10-4 and 10-5of samples 2, 3 and 4when extracting DNA with the Easy-DNA method. The mean 
estimates for the numbers of Campylobacter in every sample obtained by culture and by real-time 
5 
 
PCR using the two different DNA extraction methods are presented in Table 1 and in Figure 1. 
Standard deviations were calculated and found to be lower when using MiniMAG (results not 
shown). 
Table 1Comparison of results: mean values (CFU/g and in logs) obtained by culture and by real-
time PCR using two DNA extraction methods (Easy-DNA and MiniMAG). 
 
 
 
 
 
 
 
 
*A common real-time PCR threshold of 740 was applied 
SAMPLE ID Culture 
CFU/g (logs) 
Real-time PCR  
(Easy-DNA) * 
CFU/g (logs) 
Real-time PCR  
(MiniMAG) * 
CFU/g (logs) 
1A 2.7×107 (7.43) 8.5×106 (6.93) 7.9×107 (7.90) 
1B 1.1×107 (7.04) 5.6×106 (6.75) 2.5×107 (7.40) 
2A 1.8×105 (5.26) 2.1×105 (5.32) 5.4×105 (5.73) 
2B 1.4×105 (5.15) 1.5×105 (5.18) 2.2×105 (5.34) 
3A 5.4×104 (4.73) 1×104 (4.00) 1.2×104 (4.08) 
3B 2.5×104 (4.40) 8.2×103 (3.91) 9.1×103 (3.96) 
4A 1.6×107 (7.20) 2.1×107 (7.30) 4.5×107 (7.66) 
4B 1.4×107 (7.15) 6.8×106 (6.80) 1.6×107 (7.21) 
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Figure 1 Mean estimates (in logs) of the numbers of Campylobacter present in the naturally 
infected chicken faecal samples obtained by culture and by real-time PCR using two DNA 
extraction methods: Easy-DNA and MiniMAG 
The numbers of Campylobacter obtained by real-time PCR when using MiniMAG for DNA 
extraction were in most cases higher than the numbers obtained by culture (for all samples except 
for Sample 3). Sample number 3 had the lowest Campylobacter concentration (below 5 logs) and 
the enumeration results obtained by culture were higher than those obtained using real-time PCR 
for this sample. In general, the numbers of Campylobacter obtained by real-time PCR when 
extracting DNA with the Easy-DNA method were lower or very similar to the numbers obtained 
by culture (Table 1 and Figure 1). Agreement between methods was investigated and the 
correlation coefficients obtained were 0.98 between culture and real-time PCR (both DNA 
extraction methods) and 0.99 between Easy-DNA and MiniMAG extraction methods. 
The statistical significance of the differences between estimates of the numbers of Campylobacter 
obtained by culture and by real-time PCR using the two different DNA extraction methods was 
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examined. A result with a p-value ≤ 0.05 was considered a statistically significant result. The only 
difference found to be statistically significant was the one related to the estimates of the numbers 
of Campylobacter obtained for sample 1A by real-time PCR when using the two different DNA 
extraction methods (p-value = 0.02).  
Although there were differences between the methods the results indicate that there were no 
statistically significant differences between culture and real-time PCR. The differences between 
the estimates obtained when using MiniMAG and Easy-DNA methods were statistically 
significant only when quantifying Campylobacter present in sample 1A. In general, there was 
good agreement between the estimates obtained by culture and real-time PCR when extracting 
DNA with the two methods Easy-DNA and MiniMAG. 
DISCUSSION  
The species of Campylobacter and the initial numbers of Campylobacter present in the naturally 
infected chicken faecal samples in this study were unknown. It seems difficult to be completely 
certain about the numbers of a given bacteria in a particular sample even when the methodologies 
used are very sensitive. The distribution of bacteria in samples might not be homogeneous (Food 
Standards Agency, 2000; Griffith et al., 2003) even though chicken faecal samples were 
homogenised using a stomacher in this study. Furthermore, microbiological methods might select 
against certain species of Campylobacter that may be present in the samples. In fact, CCDA agar 
is selective for Campylobacter spp. but some strains may fail to grow or grow poorly (Neogen, 
2010). In general, CCDA agar plates (from Oxoid, Hampshire, UK) are selecting 
for Campylobacter jejuni, Campylobacter coli and Campylobacter lari. Chickens usually carry C. 
jejuni, C. coli and occasionally C. lari (Newell and Fearnley, 2003). Interestingly, C. jejuni and C. 
coli are the main species responsible for most human campylobacteriosis cases (Allos, 2001; 
Gillespie et al., 2002; Tam et al., 2003).  Furthermore, mixed infections with diverse 
Campylobacter spp. are not uncommon in poultry (Jacobs-Reitsma et al., 1995; De Boer et al., 
2002). When using traditional microbiological methods for quantification it is important to bear 
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on mind that culture selects for culturable bacterial cells only, other viable but non-culturable 
bacterial states could be missed in the quantification. Furthermore, when using selective culture 
for Campylobacter it is generally assumed that colonies growing on plates are Campylobacter 
colonies. However, sometimes distinguishing Campylobacter colonies from other contaminants 
growing on plates may prove difficult (Line, 2001; Stern et al., 2001). 
The quantification results obtained in this study suggested that the use of filters during sample 
processing could translate on lower estimates of the numbers of Campylobacter in the samples 
independently of the quantification method applied (culture or real-time PCR). This finding is in 
agreement with other studies where the use of specific types of filters partly or completely 
inhibited PCR amplification due to target Campylobacter DNA binding to the filter membranes 
(Oyofo and Rollins,1993). 
In this study, the naturally infected chicken faecal samples were processed within 30 hours from 
the time of collection and it is possible that Campylobacter cells with intact membranes survived 
well during that time which in turn could explain the statistical agreement between quantification 
results obtained by culture and by real-time PCR. Campylobacter jejuni can survive up to six days 
in poultry faeces (Ahmed et al., 2013). Campylobacter DNA (in quantities equivalent to more 
than104 CFU/g of C. jejuni) has also been detected and proved to survive in bovine manure 
compost for more than nine months (Inglis et al., 2010). These authors also concluded that most 
detected Campylobacter DNA originated from viable Campylobacter cells with intact membranes 
which were able to survive in compost (an environment considered inhospitable) for a long time.   
The use of PCR for the real-time quantification of bacteria such as Campylobacter is considered 
promising (Josefsen et al., 2010). Real-time PCR quantifies Campylobacter DNA present in the 
samples which could originate from viable but non-culturable states, live and dead cells (Yang et 
al., 2003; Hong et al., 2007; Botteldoorn et al., 2008). Amplified DNA from dead cells may lead 
to false-positive results or to an overestimation of the numbers of the target organism (Wolffs et 
al., 2005). Thus, it will be expected that quantification results obtained using real-time PCR will 
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be higher than those generated by traditional culture. The use of ethidiummonoazide (EMA) and 
propidiummonoazide (PMA) has been recommended in order to quantify bacterial DNA derived 
only from viable cells when using real-time PCR (Rudi et al., 2005; Delgado-Viscogliosi et al., 
2009; Josefsen et al., 2010). Nonetheless, these methods need to be evaluated further because the 
use of EMA resulted in an underestimation of viable cells of C. jejuni and Stahylococcus spp. in 
some studies (Flekna et al., 2007; Kobayashi et al., 2009). Furthermore, these reagents might not 
be effective when bacteria are embedded in biofilms (Pisz et al., 2007). Campylobacters can be 
present in biofilms, in actual fact, biofilms formed by C. jejuni can be found in the gastrointestinal 
tract of animals (Siringan et al., 2011) and hence Campylobacter may be present in biofilms in 
chicken faecal samples posing a risk for contamination of the food and the food processing 
environment (Hall-Stoodley et al., 2004). Campylobacter cells embedded in biofilms can survive 
much longer under atmospheric conditions than planktonic Campylobacter cells (Garcia and 
Percival, 2011).  
The presence of PCR inhibitors in complex samples has been identified as an important hindrance 
for quantification by real-time PCR (Rådström et al., 2004; Jiang et al., 2005). Thus, the selection 
of an adequate sample treatment and/or DNA extraction method for the quantification of 
Campylobacter in chicken faecal samples is crucial. In a previous study (Garcia et al., 2013), the 
Easy-DNA method produced the highest DNA yield when extracting DNA from chicken faecal 
samples spiked with Campylobacter. However, extracted DNA could also originate from other 
microorganisms present in the faecal samples. The total extracted DNA includes the target 
Campylobacter DNA and the non-target DNA (also called the “burden” DNA) which could 
interfere with the real-time PCR (Ariefdjohan et al., 2010). 
The method Easy-DNA uses chloroform which is a hazardous reagent and therefore health and 
safety precautions must be taken when using this method. In this study, the method Easy-DNA 
produced estimates of the numbers of Campylobacter present in naturally infected chicken faecal 
samples that were lower than the numbers recovered when using the DNA extraction method 
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MiniMAG and similar or lower than the numbers obtained by selective culture. Furthermore, no 
results were obtained from higher dilutions (10-4 and 10-5) for most samples when extracting DNA 
with Easy-DNA. In contrast, the results from quantification by real-time PCR when using 
MiniMAG indicated that more quantitative microbiological data were obtained from all dilutions 
and that the standard deviations were lower suggesting that the method MiniMAG performed 
more robustly than Easy-DNA in this study. Both methods Easy-DNA and MiniMAG were 
relatively fast, it was possible to process approximately 30 samples in less than 6 hours. In terms 
of cost per DNA extraction, Easy-DNA was much cheaper (17 DKK/DNA extraction) than 
MiniMAG (125 DKK/DNA extraction). 
The amplification efficiencies obtained when extracting DNA with the method Easy-DNA and 
when using MiniMAG were 96.6%and 116.9% respectively. Efficiencies between 90% and 110% 
are considered acceptable meaning that the amplicon doubles at each cycle (Stratagene, 2004). 
Several factors will influence PCR efficiency such as the master mix performance, the selected 
primers, type of DNA polymerase, sample quality, DNA extraction method, presence of inhibitors 
in the samples and the assay itself. Sample quality or consistency might hinder DNA extraction 
procedures (Bélanger et al., 2003; Forney et al., 2004). The sensitivity/specificity of primers is 
crucial to obtain good amplification efficiencies (Inglis et al., 2010).  The combination of primers 
used in this study has been found to be selective for the detection of foodborne thermotolerant 
Campylobacter in a previous study (Lübeck et al., 2003). Even when using these primers (the 
forward primer OT-1559 and the reverse primer 18-1), the detection level for Campylobacter 
obtained in this study was 102 CFU/mL which could be due to DNA loss during the DNA 
extraction process and/or the presence of inhibitors although the internal amplification control 
(IAC) indicated that no important inhibition was observed in this case. The choice of DNA 
polymerase might have an important effect on overcoming PCR inhibitors and might influence 
PCR amplification efficiencies (Wolffs et al., 2004; Hedman et al., 2009). The differences in 
amplification efficiencies when using different DNA polymerases could be partly due to the 
presence of PCR facilitators in their buffer systems (Wolffs et al., 2004). The Tth DNA 
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polymerase was used in this study. The Tth polymerase can improve PCR amplification efficiency 
in comparison with the Taq DNA polymerase when processing samples containing faecal material 
(Dahlenborg et al., 2001). 
The use of PCR facilitators has been recommended such as the addition of bovine serum albumin 
(BSA) that may help to overcome PCR inhibition in faecal samples, blood and meat samples (Abu 
Al-Soud and Rådström, 2000; Hedman and Rådström, 2013).In this study, BSA was included in 
the PCR mix to facilitate PCR amplification. Furthermore, the Tth buffer contained bovine serum 
albumin (BSA) and the detergent Tween 20 which facilitate PCR amplification (Hedman and 
Rådström, 2013).  
Despite differences between methods, results obtained in this study indicated good agreement 
between real-time PCR methods and culture. Several studies have compared quantification results 
obtained by culture and by real-time PCR with contradictory results. Some researchers found that 
the estimated numbers of target organisms were higher when using real-time PCR in comparison 
with traditional culture-based methods (Lahtinen et al., 2006; Botteldoorn et al., 2008; Löfström 
et al., 2010; Converse et al., 2012). On the contrary, other studies reported good agreement 
between the methods (Martín et al., 2006; Josefsen et al., 2010; Bui et al., 2011) while others 
found an underestimation of the numbers of the target organism when using real-time PCR in 
comparison with culture (Pennacchia et al., 2009; Noble et al., 2010). Even when agreement 
between methods is observed, the stability of this agreement might be dependent on other factors 
such as time, season and environmental factors (Shibata et al., 2010; Converse et al., 2012). 
Converse et al. (2012) demonstrated that the relationships between methods may vary temporally 
and spatially. 
The chicken faecal samples naturally infected with Campylobacter used in this study seemed to 
contain high numbers of Campylobacter (in some cases higher than 105 CFU/g). The standard 
curves were constructed based on Campylobacter levels up to 105 CFU/g. Therefore, 
quantification of samples with levels higher than 105 CFU/g was obtained based on extrapolation 
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of the linear part of the standard curves. In this study, the enumeration results obtained by culture 
were higher than those obtained using real-time PCR when processing sample number 3 which 
contained a lower Campylobacter concentration. It is likely that real-time PCR methods work 
better with samples containing higher Campylobacter numbers because part of the target DNA 
might get lost during DNA extraction procedures. In this study, the limit of detection when 
extracting DNA using MiniMAG was 102 CFU/mL; however, the limit of quantification was 
considered to be 103 CFU/mL in agreement with other studies (Wolffs et al., 2005). It will be 
interesting to test the methods with samples with lower numbers of Campylobacter (lower than 
103CFU/g which was the limit of quantification for the methods). However, it has been 
recognized that real-time PCR can be used to obtain accurate quantification estimates for samples 
with levels of target organism exceeding 102-103CFU/g but not for lower concentrations mainly 
due to the small volumes analysed and the loss of target DNA during sample preparation 
(Malorny et al., 2008; Löfström et al., 2010; Josefsen et al., 2010). 
In conclusion, there was good agreement between the quantification results obtained by selective 
culture and by real-time PCR when using two different DNA extraction methods in this study. 
The fact that chicken faecal samples were used for the preparation of spiked samples and 
construction of standard curves could partly explain this agreement because we already accounted 
for the effect of inhibitors that may be present in chicken faecal samples when building the 
standard curves. We could also hypothesize that most Campylobacter cells present in our samples 
were in viable and culturable state because chicken faecal samples were fresh and processed 
within 30 hours of collection. It is therefore possible that not a great amount of stressed 
Campylobacter cells, VBNC Campylobacter states or free Campylobacter DNA were present in 
these samples. Novel and accurate methods able to discriminate between the different 
Campylobacter viable and non-viable states could share light in this matter. 
 
EXPERIMENTAL PROCEDURES 
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Preparation of spiked chicken faecal samples and negative controls 
Three different faecal samples from broilers confirmed to be Campylobacter negative (by 
selective culture and PCR) were spiked with known concentrations of C. jejuni CCUG 11284 for 
the generation of standard curves subsequently used for the quantification of Campylobacter 
present in naturally infected chicken faecal samples. Spiking of samples and production of 
negative controls were performed as described previously (Garcia et al., 2013). Fifty replicates of 
each of the following spiking levels 10, 100, 1000, 10000, 100000 were produced and the 
remaining non-spiked faecal samples were homogenized and distributed in aliquots of 1 ml to 
produce negative controls for the real-time PCR experiments. Samples were centrifuged at 5000 x 
g for 5 minutes, supernatants discarded and the pellets stored at -20 ºC for DNA extraction and 
quantification using real-time PCR. 
Preparation of naturally infected chicken faecal samples 
Chicken faecal samples confirmed to be Campylobacter positive were collected by abattoir 
personnel on the 18th of September 2012 and sent the same day at room temperature to the 
National Food Institute at the Technical University of Denmark, where they were processed 
within 30 hours from collection. The received samples had been collected in four sterile pots; the 
pots were numbered (1 to 4) in the laboratory. As illustrated in Figure 2, two grams of faecal 
samples were taken from every pot: one gram was deposited in a stomacher bag without filter 
(samples A) and the other gram in a stomacher bag with filter number 6 corresponding to a pore 
size of 280 µm (samples B). Every gram of sample was diluted in 9 mL of sterile water (dilution 
10-1) and homogenized using a stomacher (Stomacher® 400, Seward Limited, Worthing, UK). 
Dilution rows ranging to 10-5 were produced as shown in Figure 1. 
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Figure 2 Sub-sampling and dilutions from naturally infected chicken faecal samples 
The prepared dilutions for every faecal sample (Samples in pots 1-4) were processed in the 
following manner: 
a. Direct culture for Campylobacter quantification was performed within 30 hours 
from the collection of poultry faecal samples. Direct culture was carried out using 
Campylobacter selective agar, the modified charcoal cefoperazonedeoxychocolate agar 
(mCCDA, product codes: CM0739, SR0155, Oxoid, Hampshire, UK). The previously 
prepared five dilutions from every sample (1A, 1B, 2A, 2B, 3A, 3B, 4A, 4B) were mixed 
thoroughly to achieve equal distribution of Campylobacter in the samples and 100 μl were 
then spread onto mCCDA. Inoculated plates were incubated microaerobically at 42°C for 
48 hours (Forma Scientific Incubator from Thermo Fisher Scientific Inc. Waltham, MA, 
USA). After 48 hours, Campylobacter colonies were counted and numbers recorded in 
Excel for further data analysis.  
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b. The sample dilutions were stored at 5°C. Prior to DNA extraction, every sample was 
thoroughly mixed, 1 ml of diluted sample was centrifuged at 117000 x g for 15 min, and 
the pellet used for DNA extraction.  
DNA extraction  
Pellets from spiked and naturally infected samples were thawed on the laboratory bench.  The 
pellets were re-suspended and DNA extracted according to the kit manufacturers’ instructions: 
1. Easy-DNA™ Kit For genomic DNA Isolation (Invitrogen, Leek, The Netherlands).  
The published protocol #3 from the Easy- DNA™ Kit (Invitrogen) for the extraction of 
DNA from small amounts of cells, tissues, or plant leaves was followed. Samples (pellets) 
were re-suspended in 200 μl of 10mM Phosphate Buffered Saline (PBS) buffer. This 
method is manual, the solutions and reagents included in the Kit were used together with 
chloroform and ethanol for the extraction of Campylobacter DNA. The final DNA elution 
volume was 100 μl and the approximate cost (including laboratory materials) was 17 
Danish Kroners (DKK) per DNA extraction. 
 
2. NucliSENS® MiniMAG® (bioMérieux SA, Lyon France).  
Sample pellets were re-suspended in 2 ml of 10mM PBS buffer. The NucliSENS® 
MiniMAG® method required a machine and magnetic silica particles for DNA extraction. 
Initially, cells were lysed using a lysis buffer and the extracted DNA bound the magnetic 
silica particles. After several washes with different buffers, DNA was eluted using an 
elution buffer (final DNA elution volume was 100 μl) and ready for further processing. 
The approximate cost (including laboratory materials) for this method was 125 DKK per 
DNA extraction. 
Biological and real-time PCR replicates from spiked samples were produced as described 
previously (Garcia et al., 2013). When processing spiked samples, three biological replicates were 
analysed when using the Easy-DNA™ Kit and two biological replicates (two sub-samples from 
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each Campylobacter level) were processed when using the NucliSENS® miniMAG method (due 
to protocol limitations).  In addition, two real-time PCR replicates from one biological replicate 
(all dilutions) were included to evaluate variation attributable to the real-time PCR experiment. 
Consequently, a total of five replicates per spiked sample (Campylobacter level) were analysed 
when DNA was extracted with the Easy-DNA™ method and four replicates per spiked sample 
when using the NucliSENS® miniMAG®. 
Replicates from naturally infected chicken faecal samples were produced in the following manner: 
four different chicken faecal samples were sub-divided to obtain a total of eight biological 
replicates and three real-time PCR replicates from every biological replicate were included in real-
time experiments for every dilution level.   
 
Real-time PCR 
A real-time PCR thermo cycler Mx3005P™ (Strategene, La Jolla,USA) was used, MicroAmp 
Optical 96-well reaction plates (Applied Biosystems) were available to place the samples with 
PCR master mix in the thermal cycler and covered with MicroAmp Optical caps (Applied 
Biosystems). The 25-µl real-time PCR mixture was prepared as previously described (Garcia et 
al., 2013). 
The primers included in this study (the forward primer OT-1559 and the reverse primer 18-1) 
amplify 287-basepair fragment of the 16S rRNA gene of thermotolerant C. jejuni, C. coli and C. 
lari (Lübeck et al., 2003; Josefsen et al., 2004). The amplification products were detected using a 
FAM (fluorescein amidite) -labeled probe. An internal control (amplified with the target) was 
visualized using a HEX (hexachloro fluorescein) -labeled probe. The thermal profile consisted of 
an initial denaturation step at 95°C for 3 min followed by 40 cycles consisting of denaturation at 
95°C for 15 sec, annealing at 60°C for 60 sec and extension at 72°C for 30 sec.  
The following controls were included: (i) two positive controls (DNA from C. jejuni with 
concentrations: 100 and 1000CFU/mL), (ii) a negative control (DNA from E. coli with a 
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concentration of 1000 CFU/mL) and (iii) a non-template control (NTC) in duplicate for 
assessment of master mix contamination. 
Data analyses  
Data analyses were performed using the MxPro-Mx3005P software (version 3.00). Standard 
curves were generated for the two DNA extraction methods and used to quantify Campylobacter 
present in the naturally infected chicken faecal samples. The amplification threshold was set using 
the software option “background-based threshold” which determines the standard deviation of all 
amplifications (from cycles 5 to 9) and multiplies them by a factor of 10 (default factor). A 
common baseline was set for all amplification plots obtained using an adaptive baseline and a 
non-adaptive baseline (Stratagen, 2004) and a common amplification threshold was generated in 
this way. The slope of the standard curve indicated PCR amplification efficiency (AE) which can 
be calculated using the equation: AE = 10(-1/slope) –1.Amplification efficiency should be obtained 
for every PCR run and it is calculated from the slope of the linear regression between log10 of 
initial microbial concentration (CFU/ml) in known samples and the Ct values; an amplification 
efficiency of 100% indicates that the amplicon doubles each cycle in perfect reactions (Stratagene, 
2004).Data fit to the standard curve is measured using the coefficient of determination R2 which 
should be close to 1.00 (Stratagene, 2004). 
Results related to real-time PCR assays using the two different DNA extraction methods were 
compared based on limit of detection, limit of quantification and real-time PCR amplification 
efficiency. Additionally, estimates of the number of Campylobacter  (present in naturally infected 
chicken faecal samples) obtained by real-time PCR when using the two different DNA extraction 
methods were compared with those obtained from selective culture. Correlation coefficients were 
obtained to assess agreement between the methods used in this study. Statistical significance of 
the differences observed between results from culture and from real-time PCR when using the two 
different DNA extraction methods were assessed using the multcomp package in the statistical 
program R (R Development Core Team, 2008). 
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8.  THE USE OF PROBABILISTIC GRAPHICAL MODELS AND EXPERT 
SYSTEMS FOR THE CONTROL OF CAMPYLOBACTER IN POULTRY (Manuscripts V 
and VI). 
 
8.1. Introduction  
Probabilistic graphical models (PGMs) are increasingly and widely used to support knowledge 
management and decision making under conditions of uncertainty (Kjærulff & Madsen, 2008; 
Darwiche, 2009; Koller & Friedman, 2009; Madsen et al., 2012). PGMs are extensively used in a 
variety of disciplines including medicine and epidemiology (Lucas et al., 2000). The application of 
probability theory to complex problems involving many variables such as the development of 
Probabilistic Graphical Models (PGMs) is quite recent and increasingly popular. Probability theory 
sets the basis for modeling the diverse possible states of the parts of the world that we want to 
consider and to update the models with new evidence or knowledge. Decisions on vaccination and 
other public health controls have to be generally made under conditions of uncertainty. PGMs use 
Bayesian networks and other methods to include probability distributions in models that can involve 
hundreds or even thousands of variables. The aim of PGMs is the efficient representation and 
integration of knowledge obtained from sources such as epidemiological data, scientific knowledge, 
research data and expert opinions in order to support decision processes made under conditions of 
uncertainty. Knowledge is the product of complex and multifaceted processes. Furthermore, the 
creation and integration of knowledge seem crucial for Knowledge management (Wickramasinghe 
et al., 2007). Stemke (2001:3) defines Knowledge Management (KM) as “the set of processes, 
technology and behaviors that deliver the right content to the right people at the right time and in 
the right context” so that they can make the best decisions and solve problems. In fact, the main 
objective of Knowledge Management is to produce better solutions (Firestone & McElroy, 2005; 
Garcia, 2012). The interaction between information, knowledge and technology seems crucial for 
innovation (Brelade & Harman, 2003). The use of Information and Communication Technologies 
(ICTs) and probabilistic graphical models has become an important and innovative tool for 
sustainable animal production and disease control strategies. Selective representation of important 
data and information is necessary for the efficient use of ICTs. The use of ICTs and selective 
objectification might be necessary in cases when the complexity of the reality we try to represent is 
very high. PGMs represent knowledge and relationships in structured models designed to represent 
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real situations where uncertainty plays an important role. The relationships of dependence or 
independence between the entities included in the models can be represented and the strength of the 
relationships can be defined using conditional probability distributions (Madsen et al., 2012). The 
HUGIN tool is a commercial-off the-shelf software package designed for the construction, and 
deployment of probabilistic graphical models (PGMs). Engagement of different stakeholders in the 
PGMs development process is highly desirable. The use of sophisticated and complex computing 
interfaces and mathematical expressions and probabilities distributions needs to be reconciled with 
a simple and efficient tool that can be used by different stakeholders (Madsen et al., 2012). On the 
other hand, newer technologies seem to be more flexible in relation to supporting individuals’ 
creativity and innovation.  
Several PGMs designed using the HUGIN software in order to aid the poultry industry to make 
complex decisions regarding vaccination against Campylobacter are presented in this thesis.  
 
Human campylobacteriosis is considered an important public health problem all over the world. 
Poultry has been identified as one of the main risk factors associated with human 
campylobacteriosis cases (Christenson et al., 1983; Neimann et al., 2003). In fact, seasonality 
effects have been detected regarding Campylobacter numbers in chickens and cases of human 
campylobacteriosis (Reich et al., 2008). Campylobacter does not seem to induce health or welfare 
problems in chickens. Campylobacter colonizes the chicken intestine and quickly multiplies in the 
intestinal mucosa (Van Deun et al., 2008). Furthermore, Campylobacter spreads fast within broiler 
flocks, once a bird has been colonized by Campylobacter it has been suggested that the rest of the 
birds in the same house will be infected within one week (Jacobs-Reitsma, 1997). Broilers might 
carry high numbers of Campylobacter in some cases exceeding 107 CFU/g of caecal content 
(Rosenquist et al., 2006) and sometimes up to 1010 CFU/g of faeces (Stas et al. 1999, Sahin et al., 
2002; Lütticken et al., 2007). Campylobacter present in feces of chickens going for slaughter might 
contaminate the food processing environment and the food products. Reducing the numbers of 
Campylobacter in chickens at farm level seems crucial to prevent Campylobacter contamination of 
chicken products. Furthermore, humans can be infected from poultry by other pathways than 
poultry products and therefore there are increased public health benefits associated with the 
implementation of effective controls of Campylobacter in primary production. The CamVac project 
aims to develop a cost effective vaccination strategy against Campylobacter in poultry in order to 
reduce the numbers of Campylobacter in poultry farms. Risk assessment studies have demonstrated 
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that a reduction of 2 logs on the numbers of Campylobacter in chickens can translate in a reduction 
of human Campylobacter cases by 30 times (Rosenquist et al., 2003). Campylobacter control 
strategies should be implemented at all levels of the food chain. This part of the thesis focuses on 
the development of an expert system to support decision making on Campylobacter vaccination of 
poultry and particularly commercial broilers.  
The type of PGM that we used for our models is an influence diagram (Howard & Matheson, 1981). 
An influence diagram formed by a set of variables has two components: a qualitative and a 
quantitative part. The qualitative part is represented by a directed acyclic graph (DAG) which 
includes diverse “nodes” such as variables, decision nodes and utility functions as well as arcs 
representing relationships between them. A decision node (drawn as a rectangle) defines decision 
alternative at a specific point in time, a chance node (drawn as an oval) represent a random variable 
and a utility node (drawn as a diamond) represents a reward or cost function, see Figure 1 for an 
example. Arcs directed into a decision node (e.g vaccination at two weeks in Figure 1) define the 
information that is known by the decision maker at the time that the decision needs to be made. 
The quantitative part of the models encodes mathematical expressions and probability distributions 
associated with chance nodes and utility functions associated with the utility nodes as defined by 
the structure of the DAG. The solution of an influence diagram is a strategy consisting of a policy 
for each decision, i.e., a mapping from what the decision maker knows to the decision alternative. 
The strategy is determined using the principle of maximizing expected utility. The influence 
diagram is a powerful representation for supporting decision making under uncertainty. It represents 
the probabilistic structure of the complex problem such as vaccination decisions compactly and it 
facilitates communication between analysts and decision makers, i.e., farmers. 
 
8.2. The design of probabilistic graphical models: epidemiological, microbiological and 
quantitative considerations  
A very simple example of a PGM with just one input variable (that could be nonetheless the result 
of the interaction of many variables) is presented in Figure 9. The probabilistic dependence 
relationships between the variables are illustrated in Figure 9 using an influence diagram. An 
influence diagram formed by a set of variables has two components: a qualitative and a quantitative 
part. The qualitative part is represented by a directed acyclic graph (DAG) which includes diverse 
“nodes” such as variables, decision nodes and utility functions as well as arcs representing 
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relationships between them. A decision node (a rectangle in Figure 9) defines decision alternatives 
at a specific point in time, a chance node (an oval) represents a random variable and a utility node (a 
diamond in Figure 9) represents a reward or cost function. Arcs directed into a decision node define 
the information that is known by the decision maker at the time that the decision needs to be done. 
Each node includes a set of states or alternatives and the arcs represent the relationships between 
variables. Variables, decision nodes and utility functions need to be carefully selected in order to 
obtain reliable outcomes from the PGM.   
 
Figure 9 A simple PGM to assist on a decision related to vaccination of poultry against 
Campylobacter  
The relationships of dependence or independence between the entities included in the models can be 
represented and the strength of the relationships can be defined using conditional probability 
distributions (Heckerman et al., 1995). The quantitative part of the models encodes the 
mathematical expressions and probability distributions associated with the different states of the 
chance nodes and utility functions associated with the utility nodes as defined by the structure of the 
DAG. There are probability tables for each variable which include probabilities for every state of 
the variables. These tables will contain the prior probability distributions for variables without 
parents in the DAG and the conditional probabilities for each combination of states for variables 
with parents. The prior probability distributions should integrate knowledge obtained from sources 
such as empirical observations, epidemiological data and expert knowledge in order to obtain 
reliable outcomes from the decision support models. Bayesian inference and probability theory set 
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the basis for the quantitative outputs of the models. Decision support models offer flexibility and 
can be updated with new evidence, knowledge or information.  
After careful design of the qualitative and the quantitative part of the models, the outcome of the 
models will include potential decisions related to Campylobacter control strategies that can be 
considered and selected for implementation. The solution of an influence diagram is a strategy 
consisting of a policy for each decision, for example, the use of vaccination strategy A (Figure 9). 
The strategy is determined using the principle of maximizing expected utility based on selecting a 
decision that will offer the decision maker the greatest expected reward. In this example, 
vaccination strategy A is able to reduce the expected numbers of Campylobacter in infected 
chickens. The results from the model will include posterior probability distributions (under the 
identified strategy) related to expected Campylobacter numbers in the flock (in logs) before and 
after the implementation of the decision/s and the expected cost-reward balance associated with 
each decision/s (Table 1).  
Table 3 Hypothetical results from a Probabilistic Graphical Model (PGM) with one decision 
related to the use of Vaccination strategy A against Campylobacter in broilers. 
No vaccination 
Posterior probabilities related to expected 
Campylobacter levels: 
Vaccination strategy A 
Posterior probabilities related to expected 
Campylobacter levels: 
0-2 logs (7.00%) 
2-4 logs (20%) 
4-6 logs (23%) 
6-8 logs (24%) 
8-10 logs (26%) 
0-2 logs (52%) 
2-4 logs (18%) 
4-6 logs (12%) 
6-8 logs (10%) 
8-10 logs (8%) 
Expected cost-reward balance:  
+0.36 euros/chicken  
Expected cost-reward balance (gross profit) 
for an average flock with 20000 chickens:  
7200 euros 
Expected cost-reward balance: 
+ 0.44 euros/chicken  
Expected cost-reward balance (gross profit) 
for an average flock with 20000 chickens:     
8800 euros 
 
The model presented in Figure 9 is an influence diagram (Howard and Matheson, 1981) constructed 
around the decision on vaccination against Campylobacter; still, other control strategies could be 
considered in the models. The selection of factors, control strategies and quantitative data to be 
included in the models will obviously influence the final results. To be able to obtain financial 
results on the use of vaccines and/or other control strategies against Campylobacter in poultry the 
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models estimate the expected (average) utility on each decision. The flexibility of this methodology 
allows the user to consider different costs depending on the diverse strategies followed to control 
Campylobacter. Similarly, several reward strategies can be accounted for in the models. In the 
presented model, the reward system is based on the level of Campylobacter (logs) measured around 
slaughter time. 
Diverse conceptual models (or qualitative parts of PGMs) have been designed to integrate existing 
knowledge in order to help poultry managers to decide whether to vaccinate poultry. The most 
general model (SimpleVac Model) is presented in Figure 10. Figure 11 shows the model referred to 
as ComBVac (vaccination of commercial broilers) which is an instantiation of the more general 
PGM SimpleVac Model. A more complex model defined as CampyCVac Model is presented in 
Figure 12. These influence diagrams have been constructed around the decision on vaccination but 
other control strategies could be included in the models. The outputs of the complete PGMs (after 
the quantitative parts have been developed) will be obtained as distributions of the expected 
numbers of Campylobacter in the flock and expected financial balances (that will be influenced by 
the cost-reward function and the rest of factors in the model). Consequently, the selection of factors 
and quantitative data included in the models will obviously influence the final results of the PGMs. 
The models presented in Figures 10-12 share the following similarities: 
1- Cost-reward functions 
A cost-reward function is included in all the models in order to obtain financial results on the use of 
vaccines and/or other control strategies against Campylobacter in poultry. The flexibility of this 
methodology allows the users to consider different costs depending on the diverse strategies 
followed to control Campylobacter. Similarly, several reward strategies can be accounted for in the 
models.  
2- The decision node is based on performing vaccination against Campylobacter in broilers at 2 
weeks of age.  
Campylobacter is not usually detected in birds younger than two weeks of age (Annan-Prah and 
Janc, 1988; Stern, 1992). It has been suggested that this “two weeks window” could be strategically 
used to introduce vaccination programs (Rice et al., 1997). Therefore, vaccination is usually 
performed in chickens around the 2 weeks of age (except in-ovo vaccination). On the other hand, 
the immune response against Campylobacter in poultry is generally low or moderate. The absence 
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of a strong immune response has been identified as one of the main challenges for the development 
of an efficient vaccine to control Campylobacter in poultry (de Zoete et al., 2007).  
The decision about vaccination in poultry needs to be made usually before Campylobacter is 
introduced in the flock. Even more, there is uncertainty regarding the introduction of 
Campylobacter into the flock that needs to be taken into account in the decision making process. 
Historical farm data regarding Campylobacter status could be accounted for in the models and in 
fact, it has been included in the PGMs presented in Figures 10-12. 
 
3- Measured and/or observed Campylobacter at 2 weeks of age and at slaughter time. Vaccination 
impact (based on logs reduction of Campylobacter) 
Microbiological methods for the detection and quantification of Campylobacter can be used to 
assess the Campylobacter status of birds. However, it seems important to distinguish between the 
true numbers of Campylobacter in birds and the detected or measured numbers. There are several 
microbiological techniques available for the detection and enumeration of Campylobacter spp. from 
different sample matrices. Some techniques are still under development and the detection limit of 
most methodologies seems to be 100 CFU/g (depending on sample preparation). Hence, a negative 
result might actually indicate very low numbers of Campylobacter (1 to 100 CFU). In addition, it 
may not be possible to assess Campylobacter status at 2 weeks of age or even before slaughter time 
due to husbandry or farm management practices.  Nevertheless, it will be useful to quantify 
Campylobacter before slaughter and at slaughter time in order to assess Campylobacter status and 
any potential vaccine (and/or other control strategies) effect.  
 
PGMs can be extended and/or modified to adapt to different real circumstances. For example, the 
time of slaughter might vary depending on the final product. Nevertheless, Campylobacter 
quantification at slaughter time should be performed in order to assess the effectiveness of vaccines 
and/or other control strategies. In the models presented in Figures 10-12, the vaccination impact (in 
terms of reduction of Campylobacter numbers) has been included as a node between the 
quantification of Campylobacter at 2 weeks of age and at slaughter time.  
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Figure 10 The Simple Vaccination (SimpleVac) Model 
 
The SimpleVac Model includes very general biological, epidemiological and husbandry factors 
(known and unknown) that might affect the numbers of Campylobacter (in logs) in poultry primary 
production at 2 weeks of age and at slaughter time. This general model also includes groups of 
factors that might influence vaccine effectiveness (known and unknown factors). The general 
SimpleVac Model offers a reliable representation of the Campylobacter control in poultry. On the 
other hand, due to the intangible nature of the unknown factors, the quantitative part of the model 
seems difficult to perform. Consequently, a more specific model was developed, the Commercial 
Broilers Vaccination (ComBVac) model (Figure 11) which includes epidemiological factors 
selected from published epidemiological data (EFSA, 2011a) that significantly influence the 
numbers of Campylobacter in broilers produced for human consumption. 
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Figure 11 Commercial Broilers Vaccination (ComBVac) model  
 
The epidemiological factors bio-security, risk of pests and thinning/depopulation practices have 
been included in the ComBVac model. Several definitions of bio-security have been proposed but 
in practice it should include effective measures taken by food producers to protect food producing 
animals from disease and zoonotic pathogens (Permin and Detmer, 2007). Bio-security has been 
identified as a crucial factor for the introduction or control of Campylobacter in poultry farms 
(Berndtson et al., 1996; Gibbens et al., 2001; Rivoal et al., 2005; Johnsen et al., 2006). An effective 
and comprehensive biosecurity plan is recommended to protect food producing animals from 
disease and infection with zoonotic pathogens (Segal, 2011). The importance of a good biosecurity 
program has been highlighted in a Swedish study where the contamination level in the environment 
surrounding farms was found similar for Campylobacter negative and positive flocks (Hansson et 
al., 2007). Strict on-farm biosecurity can prevent Campylobacter colonization in poultry, in 
particular, restricting the access of pests (e.g., rodents and flies) into chicken houses will protect 
against Campylobacter colonization (Hald et al., 2008; McDowell et al., 2008). Ventilation has also 
been identified as an important factor (Newell and Fearnley, 2003; Guerin et al., 2007; Rushton et 
al., 2009). Thinning (a depopulation practice consisting on removing a number of birds from the 
flock) has been identified in many studies as a significant risk factor for the introduction of 
Campylobacter into chicken houses (Wedderkopp et al., 2000; Hald et al., 2001; Refregier-Petton 
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et al., 2001; Bouwknegt et al., 2004; Adkin et al., 2006 Allen et al., 2008a; Hansson et al., 2010). A 
study conducted by Puterflam et al. (2005) indicated that this risk was higher when the thinning was 
performed by large crews.  
There are many factors that might affect vaccine effectiveness, but their assessment can be complex 
in many cases (it will depend on vaccine design, delivery method, dose, particular Campylobacter 
strains, animal genetics and other factors). In the models presented in Figures 11 and 12, only the 
storage conditions have been considered to affect vaccine effectiveness. Nonetheless, diverse 
vaccine candidates could be tested under different conditions and the information related to its 
general effectiveness should be included in the models as “vaccination impact”. What’s more, the 
flexibility of these methodologies allows the users to expand and/or modify the information contain 
in the node named “vaccination impact” and/or include several options (with different probabilities 
or probability distributions).  
 
PGMs can be modified and adapted to diverse farming conditions and/or new knowledge. Many 
different risk or protective factors could be potentially included in the models.  A humble, 
preliminary review of the literature on epidemiological data related to risk/protective factors that 
might significantly influence Campylobacter in chickens was performed (Table 4). 
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Table 4 Risk Factors (From Selected Publications) Significantly Associated With The Presence Of 
Campylobacter In Poultry  
 
Geographical 
area/reference 
Production 
system 
Selected Risk factors 
Reunion Island,  Indian 
Ocean (Henry et al., 
2011)  
50 broiler flocks Several houses on-farm 
Cleaning with no detergent 
Shiraz, Iran 
(Ansari-Lari et al., 2011) 
100 broiler 
flocks 
Age at slaughter >45 days 
Use of antibiotics 
Level of owner’s education 
Sweden 
(Hansson et al., 2010) 
37 producers, 90 
broiler houses  
Presence of other livestock on farm, presence of 
other livestock within 1 km., poor hygiene, thinning, 
farm workers changing footwear once only  
Germany 
(Näther et al., 2009) 
146 broiler 
flocks 
Free-range and organic farms 
Flocks with less than 15000 birds and more than 
25000 
Use of nipple drinkers with trays 
Great Britain 
(Ellis-Iversen et al., 
2009) 
603 broiler 
flocks from 137 
farms 
Time of the year  
(July, August, Sept) 
Cattle present or near 
Non-chlorinated water  
Flocks closed to each other 
Norway 
(Lyngstad et al., 2008) 
131 broiler 
farms 
Private water supply 
Pigs closer than 2 km 
Transport personnel 
Less than 9 days between depopulation and 
restocking 
Multiple houses on farm 
Denmark 
(Hald et al., 2008) 
5 broiler farms Large numbers of flies  
Iceland 
(Guerin et al., 2008) 
 
792 broiler 
flocks  
Temperature-related risk factors. Higher risk when 
the cumulative-degree days (CDD) WAS >139 and 
temperature >8.9 degrees 2-4 weeks before slaughter 
Northern Ireland 
(McDowell et al., 2008)  
88 broiler 
farms,388 flocks 
Rodents on farm 
Age of birds at sampling 
Season (summer) 
3 or more broiler houses 
Frequency of footbath disinfectant changes 
General hygiene 
 
Campylobacter Control in Poultry 
 
89 
 
Table 4 (cont.) Risk Factors (From Selected Publications) Significantly Associated With The 
Presence Of Campylobacter In Poultry 
Geographical 
area/reference 
Production 
system 
Selected Risk factors 
Iceland 
(Guerin et al.., 
2007) 
1425 broiler 
flocks (analyses 
included 792 
flocks) 
Vertical ventilation in-house 
Vertical and horizontal ventilation 
Cleaning and disinfection of boots 
Cleaning with geothermal water 
Increasing flock size 
Using manure on-farm 
Increased number of broiler houses on-farm 
Canada 
(Arsenault et al., 
2007) 
81 broiler flocks 
and 59 turkey 
flocks  
Farms with rodent control 
Manure 200 m from chickens 
Number of birds on farm 
Age at slaughter 
Great Britain 
(Adkin et al., 
2006) 
Data extracted 
from 159 
research papers 
Depopulation events 
Another house on-farm 
On-farm staff 
Other animals on-farm 
Senegal 
(Cardinale et al., 
2004) 
70 broiler farms  Other animals on-farm 
Staff not wearing protective clothing 
Uncemented house floors 
Use of cartons to transport chicks as feed plates 
Protective factors: cleaning and disinfection, manure 
outside the farm 
Netherlands 
(Bouwknegt et al., 
2004)  
495 broiler flocks Age 
=5 broiler houses on farm 
Other animals on farm 
Animals on farms within 1 km 
Summer 
Fall 
Children entering broiler house 
Netherlands 
(Van de Giessen 
et al.,1996) 
20 broiler farms, 
112 flocks  
Other farm animals  
Protective factors: hygiene measures 
Red- numbers of animals/houses on farm, age related factors 
Orange- type of farm 
Blue- biosecurity related factors (including thinning and depopulation events, rodents and people) 
Green- Other animals on farm  
Purple- time of the year, temperature-related factors 
 
Many variables have to be considered when designing epidemiological studies and mathematical 
models. Furthermore, material, human, knowledge and time limitations will influence the 
Campylobacter Control in Poultry 
 
90 
 
epidemiological studies and in turn the results from the models. Campylobacter prevalence, 
quantification and strains of Campylobacter might vary with the geographical area and animal, 
husbandry and microbiological factors. Similarly, the significance of the considered risk/protective 
factors in every study will be influenced by many variables. As human beings, we are restricted by 
a limited capacity to understand the complex subjects. Classifications and representations can help 
us to understand the complex world we face. Therefore, the factors identified in Table 4 have been 
classified in five different groups to be included in the models. A Campylobacter Complex 
Vaccination (CampyCVac) Model has been produced including these five groups of risk/protective 
factors (Figure12).  
Figure 12 Campylobacter Complex Vaccination (CampyCVac) model  
 
The CampyCVac Model is based on the general SimpleVac model but it considers only known and 
quantifiable factors (risk, protective and effectiveness factors). These groups of factors include 
different quantifiable factors so the user can select the ones that are more relevant or applicable to a 
particular real life situation for the control of Campylobacter in poultry. 
PGMs take on account uncertainty and use probability functions to fulfill its purpose. Quantitative 
models offer flexibility by allowing the user to change probability functions to adapt the models to 
the different conditions that might be present in real life situations. The general SimpleVac Model 
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presented in Figure 10 offers a good representation of the Campylobacter control in poultry but due 
to the intangible nature of the unknown factors, the quantitative part of the model does not seem 
feasible. A number of risk factors were selected to design the ComBVac Model (Figure 11). 
Important considerations related to the selection of risk factors to be included in models have been 
previously mentioned. On the other hand, it has been recognized that while the construction of 
conceptual models is feasible, the quantitative part represents a hard task (Renooij, 2001). Crucial 
challenges regarding the quantitative part of our models after selection of factors are related to: 
 
- A “selected risk factor” such as biosecurity could be influenced by many other factors or 
variables and as a result it may be very difficult to select “one number or defined 
distribution” to represent the group of factors. Additionally, some of these factors may well 
be protective instead of risk factors based on particular epidemiological studies. In fact, 
results related to the same factor can be contradictory in different studies (e.g. pest control 
has been found to be a risk factor instead of a protective factor in some papers). The 
presence of potential cofounders could explain some findings making the analysis and the 
models more complex. 
- Epidemiological studies are conducted in different areas of the world, diverse conditions, 
farming systems, sample sizes, sampling protocols to name a few. Accordingly, it seems 
challenging to design a general PGM that could be applied in all circumstances to support 
decision making. In fact, the quantitative part of the model should be based on one 
“standardized measure of risk”; however, epidemiological studies use different 
measurements or parameters to represent the concept of “increased or decreased risk” due to 
the factor considered. Even when the parameter used is the same (e.g. Odds Ratio) the 
quantitative values associated with a particular risk factor can be very different between 
studies. Although many epidemiological studies use the Odds Ratio as a measurement of 
risk attributable to the factor considered, this mathematical value cannot be used in the 
models as such. It is necessary to transform the Odds Ratio value to a fixed probability value 
or a specific distribution of potential values to be included in the quantitative part of the 
PGMs.  
In summary, different PGMs can be constructed to assist poultry farmers in decision making 
regarding Campylobacter vaccination of poultry. However, it seems challenging to design a general 
model (qualitative and quantitative) that could be applied to all situations, poultry farming 
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conditions and geographical areas. For that reason, our suggestion is that several specific PGMs 
may be constructed or adapted to address particular decision making processes under specific 
circumstances. Moreover, the conditions, selection of factors, different parts of the models, 
quantitative data should be clearly specified to add value and perspective to the decision support 
system designed in every case.  
We have designed several PGMs to assist poultry farmers in making decisions related to 
Campylobacter controls based on published data from United Kingdom (Manuscript V: Garcia et 
al., 2013b), Denmark (manuscript VI) and Spain (not shown). 
 
8.3. The development of a decision support model for the control of Campylobacter in 
poultry farms in the United Kingdom (Manuscript V: Garcia et al., 2013b) 
8.3.1. Introduction 
The estimated prevalence values of Campylobacter in UK broilers (caecal samples) and UK broiler 
carcasses (samples taken from skin) were 75% and 86% respectively in the EU baseline survey 
carried out in 2008 (European Food Safety Authority, 2010a). These values exceeded the mean EU 
prevalence percentages of 71% and 77% respectively. Quantitative data indicated that 
Campylobacter numbers on broiler carcasses varied widely; the numbers of Campylobacter in UK 
broiler carcasses were reported as less than 100 Campylobacter per gram (cfu/g) in 42% of the 
samples and more than 1,000 Campylobacter per gram (cfu/g) in 27% of the samples. Even when 
contaminating with low numbers of Campylobacter, infected chickens going for human 
consumption pose a public health risk. Consequently, efforts should be directed to control 
Campylobacter in chickens and to improve food safety. A Campylobacter Risk Management 
Program has been developed in the UK in order to reduce foodborne illnesses due to 
campylobacteriosis (Food Safety Authority, 2010a/b). An important reduction in human 
campylobacteriosis cases in the UK by 2015 is desirable and therefore reducing the level of 
Campylobacter in UK chickens is considered a priority. Working in partnership with the poultry 
and food industries and engaging stakeholders (including the consumers) is considered crucial to 
achieve these aims. Furthermore, a coordinated program based on Campylobacter research has been 
developed because a greater understanding of the microbiology and epidemiology of 
Campylobacter infections is necessary to control campylobacteriosis. Effective controls and 
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interventions should be implemented and realistic targets defined. The UK target aims to reduce the 
percentage of UK produced chickens with highest levels of Campylobacter (more than 1000 cfu per 
gram) from 27% in 2008 to 10% by 2015 (after chilling). A reduction of the Campylobacter 
numbers and/or prevalence in the least contaminated chickens is also expected as a result of the 
implementation of effective control programs.  
 
8.3.2. Materials and Methods 
Two PGMs have been designed to aid on decision making regarding Campylobacter vaccination of 
UK broiler flocks (Figures 13 and 14). The risk factors and epidemiological quantitative data 
included in the models were selected based on published data from the UK (Lawes et al., 2012). 
These authors conducted epidemiological studies based on twenty-nine risk factors that could be 
potentially associated with Campylobacter status in broilers. The following risk factors were found 
significantly associated with Campylobacter positive flocks in the study: previous depopulation 
practices, higher recent flock mortality, increasing age at slaughter and slaughter in the summer 
months. We have included these risk factors for the presence of Campylobacter in UK broilers at 
slaughter in the PGMs (Figures 13 and 14). The quantitative part (probabilities of events or states of 
the variables) of the PGM (Manuscript V: Garcia et al., 2013b) was obtained by a mathematical 
transformation of odds ratio values presented in the study from the UK (Lawes et al., 2012). 
Furthermore, probabilities related to Campylobacter introduction in the flock due to the presence of 
risk factors are conditional to a “baseline level” of Campylobacter (lowest level of Campylobacter 
in broilers close to slaughter time found in the literature). In these models, the “baseline 
Campylobacter flock prevalence” in the UK considered was 28.8% based on data from a study 
conducted by the Food Standards Agency (2009). 
The formula applied to calculate probabilities of the diverse states of risk factors (P(s)) based on the 
baseline Campylobacter flock prevalence (bp) and odds ratios (ORs) was: 
exp(ln(b / (1 b )) ln(OR ))
( )
1 exp(ln(b / (1 )) ln(OR ))
p p s
p p s
P s
b
− +
=
+ − +
 
A cost-reward function was included in the models in order to assess the financial consequences of 
every decision that the farmer might consider to control Campylobacter in chickens. Financial data 
related to the UK poultry industry was obtained from a farm business survey from 2009/2010 
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(Crane et al., 2011). There is no commercial Campylobacter vaccine at present and thus a 
commercial Campylobacter vaccine price is not available. The cost of a hypothetical vaccine 
against Campylobacter in broilers could be considered to be between 2 and 6 Euro cents based on 
prices of other vaccines used in poultry production (DIANOVA, 2013). The vaccine effectiveness 
or vaccine impact was also hypothetical in these models. We decided to consider a hypothetical 
vaccine B against Campylobacter in broilers able to decrease Campylobacter numbers from 2 to 6 
logs in 20% of the broilers and less than 2 logs in 80% of the chickens with a cost of 0.025 
£/chicken (UK). The reward system has been designed based on the reported average gross profit of 
0.36 £/per chicken for UK farmers in 2010 (Crane et al., 2011). Based on this hypothetical reward 
system (Manuscript V: Garcia et al., 2013b), farmers producing chickens with numbers of 
Campylobacter lower than 4 logs will get higher gross profits (+20% extra with respect to other 
Campylobacter levels) while farmers delivering chickens carrying high numbers of Campylobacter 
(higher than 6 logs) will get lower gross profits (-20% between Campylobacter levels). It was 
assumed that an average broiler chicken from a positive flock in the UK will carry Campylobacter 
in a concentration of 4-6 log CFU/g or ml of sample (from the digestive tract). 
The two models designed to aid on decision making regarding Campylobacter vaccination of UK 
broiler flocks share similarities in the conceptual design but the quantitative components of the 
models differ mainly due to the lack of data regarding how the risk factors may affect the numbers 
of Campylobacter in broilers over time during the rearing period. Epidemiological studies usually 
provide insight regarding the risk of Campylobacter introduction attributable to particular risk 
factors in specified conditions. Conversely, there seems to be lack of data regarding the numbers of 
Campylobacter carried by broilers throughout the farming period in relation to particular risk 
factors. Besides, in the models, the vaccination impact and the cost-reward functions are based on a 
log-scale because the objective is to develop a vaccination strategy able to reduce the numbers of 
Campylobacter in commercial broilers by 2 logs (CamVac, 2012). As a result, a mathematical 
transformation needs to be performed, data related to the effect of risk factors on Campylobacter 
status of the broilers are based on positive/negative results (significant or non-significant effects) 
and they need to be translated to a log scale. The main challenge resides on where this mathematical 
transformation should take place in the models. There are at least two possible alternatives as 
illustrated by the two models presented in Figures 13 and 14. 
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The model named Commercial Broilers Vaccination UK in Logs (ComBVacUK_ Logs) utilizes a 
log-scale (from 0 to 10 logs) from the risk factors part of the model and it is referred to as the logs-
model (Figures 13 and 15). However, the Commercial Broilers Vaccination UK Positive Negative 
(ComBVacUK_PN) uses a positive/negative-scale at the risk factors part of the model assuming 
detection above 2 logs for a positive result and it is referred to at the pn-model (Figure 14). A 
posterior mathematical transformation is performed to transform the positive/negative part of the 
model to the log scale part of the model (Figure 16). 
 
 
 
 
Figure 13 Commercial Broilers Vaccination UK in Logs (ComBVacUK _Logs) Model 
Mathematical transformation 
from positive/negative to 
Campylobacter status in logs 
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Figure 14 Commercial Broilers Vaccination UK Positive Negative (ComBVacUK _PN) Model 
The assumptions consider when building the models are as follows: 
- The assumed detection limit for Campylobacter is 2 logs and the maximum level that can be 
found in chickens is considered 10 logs. Consequently, a negative result means 0-2 logs and 
a positive result indicates 2 to 10 logs.  
- The contributions from different risk factors to the level of Campylobacter are independent. 
- Figure 15 illustrates the mathematical transformation from the positive/negative part of the 
ComBVacUK _Logs model to the log scale part of the model at the risk factors level (risk 
factor “age at slaughter” as an example). The distribution over the positive results for each 
risk factor is uniform as illustrated in Figure 15. 
 
Figure 15 A positive/negative scale for the risk factor “age at slaughter” is presented on the left 
side and a log-scale based on a flat or uniform distribution is shown on the right side 
Mathematical transformation 
from positive/negative to 
Campylobacter status in logs 
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- The effectiveness levels of the vaccines are the same for the two models. The impacts of the 
vaccinations are specified in the conditional probability distribution of node Vaccination 
Impact (logs reduction). 
- The accuracy of the measurement of Campylobacter is specified in the conditional 
probability distribution of node “Measured Campylobacter at slaughter in logs”. The 
measurement is provided on a log-scale and it is used to define the reward system, i.e., the 
reward system is based on the level of Campylobacter (in logs). 
- A mathematical transformation from positive/negative to the logs-scale is performed in the 
model ComBVacUK _PN by introducing the node “Campylobacter status before 
vaccination (logs)”. The posterior distribution of a positive result is transformed to a 
uniform distribution over the different Campylobacter levels (in logs) as illustrated in Figure 
16. 
 
Figure 16 Illustration of the part of the model showing the Campylobacter status before vaccination 
in positive/negative format (0-2 logs is considered negative and 2-10 logs translates on a positive 
result) and in logs format (distribution of the different levels of Campylobacter in logs). 
Sensitivity analyses were conducted using the ComBVacUK _PN model (Manuscript V: Garcia et 
al., 2013b) to determine the sensitivity of the vaccination decision under different evidence 
scenarios with respect to single parameters of the models. In this particular case, two very different 
reward systems and a hypothetical vaccine C were included in the models. Reward system 2 was 
based on an extra payment for chickens testing Campylobacter negative of 2.5 times the normal 
price while reward system 3 was based on the existing reward systems in Denmark which is based 
on an extra payment of about 2% for flocks testing negative for Campylobacter and in Norway and 
Sweden where the payment is reduced by about 4% for flocks that are tested positive for 
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Campylobacter (personal communication). A hypothetical vaccine C able to reduce 2-6 logs the 
level of Campylobacter in 90% of the chickens was considered with a cost of 0.03 £/chicken 
(Manuscript V: Garcia et al., 2013b). 
8.3.3. Results and discussion  
The results from the models can be visualized by selecting diverse combinations of “nodes states” 
and obtaining the output in terms of the expected distribution of probabilities related to 
Campylobacter levels and expected cost-reward balance in every case. A high number of potential 
combinations or scenarios may be considered and so, it is up to the user to select the relevant 
combination of factors. We used three combinations in order to illustrate the potential outputs of the 
model (Manuscript V): most likely combination (based on UK epidemiological data from Lawes et 
al., (2012)), the worst scenario (based on states of risk factors found to increase significantly the 
risk of Campylobacter infection in chickens) and the best scenario (opposite risk factors’ states 
from the worst scenario). 
Detailed results obtained from the ComBVacUK _PN model are presented in Manuscript V: 
(Garcia et al., 2013b). Results obtained from both models ComBVacUK _PN model and 
ComBVacUK _Logs model were very similar (data not shown).  
Results generated from the model ComBVacUK _PN indicated that in the best-case scenario the 
farmer will not gain financially when using vaccine B although the posterior probabilities related to 
the introduction of Campylobacter in the flock will be slightly reduced (approximately from 75% to 
65%). However, in the worst-case scenario the best option will be to use vaccine B because it 
produces the maximum cost-reward balance (0.34 £/chicken) and a reduction on the probabilities 
related to expected high numbers of Campylobacter in the flock. Similarly, results obtained when 
considering the “most-likely” scenario based on study data (Lawes et al., 2012) indicated that the 
best option will be to use vaccine B. However, the results showed that the financial differences 
between diverse strategies were very small mainly due to the narrow differences between the levels 
of the reward system. The results from the model ComBVacUK _PN indicated that the posterior 
probability of introduction of Campylobacter into the UK poultry flock in the most likely scenario 
before vaccination was approximately 93% based on the assumptions and data previously specified. 
The posterior probability of Campylobacter introduction into the flock decreased significantly by 
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the use of a hypothetical vaccine B (to approximately 81%) and even more when using a much 
more effective hypothetical vaccine C (to approximately 46%). 
Sensitivity analyses performed indicated that the factors that influenced the results to a greater 
extent were the financial variables (cost/reward functions) and the effectiveness of the control 
strategy, e.g. vaccination impact. The results indicated that when applying the reward system 2 (a 
system with higher differences between gross benefits obtained by farmers delivering chickens 
Campylobacter negative or with low Campylobacter numbers) the best solution in terms of 
maximum expected benefit will be using the vaccine C (very effective and not expensive) in all 
case-scenarios. However, when implementing reward system 3 (closer to real reward systems 
currently employed in several countries) the best solution in financial terms will be “not 
vaccinating” even though the use of vaccine C could potentially reduce the expected posterior 
probabilities related to high numbers of Campylobacter in the flock significantly (Manuscript V: 
Garcia et al., 2013b). 
The results indicated that the public health impact of the control strategies will depend on the 
effectiveness of the controls. The assessment of the effectiveness of diverse control strategies might 
prove challenging e.g. the assessment of vaccine effectiveness (Garcia et al., 2012). Campylobacter 
control strategies that can significantly reduce the probability of Campylobacter introduction into a 
flock and/or the numbers of Campylobacter in already infected chickens should be implemented 
from a public health perspective. However, the producers will usually base their strategic decisions 
on financial gains and consequently a reward system that can translate on an attractive cost-reward 
balance will be a good incentive for poultry producers to implement Campylobacter control 
strategies. The cost-reward functions are crucial drivers for the selection of the optimal decision 
which is determined based on the principle of maximum benefit (cost-reward balance). The cost 
function included in the models relates only to the cost of the control measure and does not include 
any other additional costs such as those related to microbiological testing. The reward system might 
not be in place in most parts of the world, as a result it should be hypothesized and tailor-made 
based on the gross profit/per chicken for farmers in specific areas and/or production systems (e.g. 
organic farmers might obtain a higher gross profit/chicken than farmers producing commercial 
broilers). Financial gain will also depend on the effectiveness of the vaccine (and/or other control 
strategies) and the costs associated with the controls. A cost-efficient vaccine against 
Campylobacter in chickens is not commercially available at present. We considered that the market 
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price of a cost-effective vaccine against Campylobacter in chickens should be less than 10% of the 
gross profit per chicken to be competitive. However, the market price could be higher depending on 
the effectiveness of the vaccine and the reward system. The flexibility of PGMs allows for the 
inclusion of more than one vaccine and other control measures and more than one reward system.  
8.4. The development of a decision support model for the control of Campylobacter in 
poultry farms in Denmark (Manuscript VI) 
8.4.1. Introduction 
Human campylobacteriosis has been notifiable in Denmark since 1980. Fresh chicken meat has 
been identified as one of the most important risk factors for human campylobacteriosis in Denmark 
(Wingstrand et al., 2006). The first initiatives to control Campylobacter in Danish poultry were 
adopted in the 1990s based on research conducted in Sweden (Berndtson, 1996). A risk profile for 
pathogenic Campylobacter was conducted in 1998 (Anon, 1998). Broiler flocks have been tested 
for Campylobacter at slaughter in Denmark since 1998. The publication of a quantitative 
microbiological risk assessment of Campylobacter in broilers and chicken meat in 2001 lead to the 
first Danish Action plan against Campylobacter in broilers in 2003 (Christensen et al., 2001). In 
Denmark, an integrated approach for the control of Campylobacter in poultry has been adopted 
where increased biosecurity, allocation of meat from positive flocks to the production of frozen 
foods and consumer education campaigns have led to a significant decrease in Campylobacter 
prevalence in broiler flocks (from 43% in 2002 to 27% in 2007), a reduction of Campylobacter-
positive samples of fresh broiler meat (from 18% in 2004 to 8% in 2007) and a decrease in 
registered human cases by 12% from 2002 to 2007 (Rosenquist et al., 2009). These authors 
suggested that the coincidental decrease in the number of reported human campylobacteriosis cases 
was partly due to the implemented Campylobacter control strategies in broiler flocks. One of the 
main intervention strategies implemented was to use Campylobacter-positive broilers for frozen 
products because freezing is known to reduce Campylobacter numbers by around 2 logs (Sandberg 
et al., 2005; Georgsson et al., 2006; Havelaar et al., 2007a). A new four-year action plan was 
adopted in Denmark in 2008 in order to further reduce the prevalence and concentration of 
Campylobacter in chickens and their products. The new plan intensified already implemented 
control strategies and introduced new interventions such as the use of fly screens in broiler houses. 
A Campylobacter prevalence level of 10% in broilers could potentially result in a reduction of 
human cases by nearly 50% (Nauta et al., 2009; EFSA, 2011b). A recent EFSA report reported a 
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prevalence of 19.2% for Campylobacter in Danish broiler flocks (EFSA, 2011a). Chowdhury et al. 
(2012) observed that 14% of Danish broiler flocks included in the study were positive to 
Campylobacter during the study period December 2009 to November 2010. Even more, 
Campylobacter prevalence in Danish fresh chicken meat is affected by the prevalence of 
Campylobacter in Danish broiler flocks and seasonality effects (Boysen et al., 2011). In conclusion, 
Campylobacter prevalence in broiler flocks and chicken meat in Denmark seems to be decreasing, 
but the prevalence can be higher than 14% especially during summer due to seasonality effects. For 
this reason, the most promising control strategy seems to be the use of fly screens in broiler houses 
to reduce the prevalence of Campylobacter in chickens especially during the summer (Hald et al., 
2007b; Boysen et al., 2011).  
8.4.2. Materials and methods 
A PGM (Figure 17) has been developed to assist poultry producers in decision making related to the 
implementation of two different Campylobacter controls: hypothetical Campylobacter vaccines 
and/or the use of fly screens for the control of Campylobacter in broiler flocks based on 
epidemiological and financial data from Denmark. The solution of the developed PGM provides 
posterior probabilities related to expected Campylobacter numbers in chickens and expected cost-
benefit analyses for each decision considered in the model. Poultry producers can then select the 
most optimal decision/s in every case. 
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Figure 17 The commercial broilers DK (ComBDK) model designed to control Campylobacter in 
Danish broiler flocks using hypothetical Campylobacter vaccines and/or the use of fly screens 
The risk factors and epidemiological quantitative data included for the ComBDK model were 
selected based on results from a study conducted by Chowdhury et al. (2012). These authors 
analysed data from the Quality Assurance System in Danish Broiler Production (Kvalitetsikring i 
kyllingeproduktionen: abbreviated as KIK system) in order to identify farm related risk factors for 
Campylobacter infection in broiler flocks in Denmark. In their study, data related to the time period 
December 2009 to November 2010 from 187 farms and 2835 flocks were considered. These authors 
observed that out of the 36 variables initially considered, primary factors like season and increasing 
age of the birds and other risk factors such as the age of the poultry houses, previous 
Campylobacter positive flocks in the same houses and the number of persons entering the poultry 
houses were significantly associated with Campylobacter infection of broilers. These risk factors 
and related epidemiological quantitative data were considered for the development of the ComBDK 
model (manuscript VI). 
The quantitative data (probabilities of events or states of the variables) of the PGM (manuscript VI) 
were obtained by a mathematical transformation of odds ratio values presented in the study 
conducted by Chowdhury et al. (2012). In addition, probabilities related to Campylobacter 
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introduction in the flock due to the presence of selected risk factors were conditional to a “baseline 
level” of Campylobacter (lowest level of Campylobacter in broilers close to slaughter time found in 
the literature). In the ComBDK model, the “baseline Campylobacter broiler flock prevalence” in 
Denmark considered was 14% based on data from the same study by Chowdhury et al. (2012). In 
this study, Campylobacter status of the flocks was assessed by PCR tests using sock samples 
collected on farm 7 to 10 days prior to slaughter. 
The same formula previously shown in this Chapter for the models based on UK data was applied 
to calculate probabilities of the diverse states of risk factors (P(s)) based on the baseline 
Campylobacter flock prevalence (bp) and odds ratios (ORs).  
A cost-reward function was included in the ComBDK model in order to obtain cost-benefit analyses 
related to every decision that the farmer might consider to control Campylobacter in Danish broiler 
flocks. The decisions included in the ComBDK model were related to the use of hypothetical 
vaccines against Campylobacter and the use of fly screens. No commercial vaccine against 
Campylobacter in poultry is currently available and for that reason a real price related to a 
commercial Campylobacter vaccine does not exist at present. A hypothetical vaccine price can be 
considered to be around 0.15-0.50 Danish Kroners (DKK) based on prices of other vaccines used to 
control diseases in poultry (DIANOVA, 2013). Two hypothetical Campylobacter vaccines were 
included in the model with different vaccine effectiveness and costs (manuscript VI). Flies are 
considered important vectors for the introduction of Campylobacter in poultry flocks (Rosef et al., 
1983; Shane et al., 1985; Berndtson et al., 1996). As a consequence, the use of fly screens in 
poultry houses in order to control Campylobacter has been recommended (Hald et al., 2004, 2007b; 
Barhndorff et al., 2013b). Fly screens should be placed in all openings of a poultry house such as 
doors, windows and chimneys to prevent the introduction of Campylobacter into the flocks by flies. 
The average cost (including capital investments and variable expenses) of implementing fly screens 
on broiler farms has been considered to be 0.13 DKK/chicken (Lawson et al., 2009) and included in 
the model (manuscript VI). 
The reward system was designed around an “average” gross profit (for farmers producing chickens 
carrying an “average” number of Campylobacter) reported to be 2.92 (DKK/chicken) based on 
financial data from 2013 (Farmtal Online, 2013). The reward system was designed in relation to a 
real system implemented in Denmark where poultry producers get an extra payment when the flock 
is identified as Campylobacter negative before slaughter (personal communication).  In the model, 
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an extra payment (around 2%) is given to farmers producing chickens carrying Campylobacter in 
numbers less than 4 logs and a reduced payment (around 4% less) is given to farmers producing 
broilers that carry Campylobacter in numbers higher than 6 logs before slaughter (manuscript VI). 
In the ComBDK model, the control measures and the cost-reward functions are based on a log-scale 
but the risk factors affect the probabilities related to Campylobacter status (positive/negative) of the 
flock in the first part of the model. As a result, a mathematical transformation needs to be 
performed, data related to the effect of risk factors on Campylobacter status of the broilers are 
based on positive/negative results (significant or non-significant effects) and they need to be 
translated to a log scale (manuscript VI).  
The Commercial Broilers in Denmark (ComBDK) model (Figure 17) was designed based on the 
following assumptions: 
- A microbiological detection limit of Campylobacter was considered to be 2 logs CFU/g or 
ml of sample while the maximum colonization level was considered to be 10 logs CFU/g or 
ml of sample. Thus, in this model, a Campylobacter level of 0-2 logs will give a negative 
result while a positive result suggests Campylobacter numbers in the samples from 2 to 10 
logs. Intervals for bacterial concentration with two log widths (e.g.0-2 logs, 2-4 logs, 4-6 
logs, 6-8 logs and 8-10 logs) were included in the model. 
- The contributions from different risk factors to the level of Campylobacter are independent.  
- The “measured Campylobacter at slaughter (logs)” will depend on the microbiological 
quantitative methods used and the “true numbers” of Campylobacter in chickens. In the 
model, a hypothetical nearly-perfect quantitative method was considered. 
- The Campylobacter controls included in the model are: the use of fly screens and 
hypothetical Campylobacter vaccines A and B. Fly screens are only used during the summer 
and therefore their effect will be null during the rest of the year although the costs associated 
with the use of fly screens are always considered.  
Sensitivity analyses were performed in order to determine the sensitivity of the decisions considered 
in the model under diverse evidence scenarios with respect to single parameters of the models. In 
this model, the following were included: a different reward system 2 (based on an extra payment of 
2.5 times the normal price for chickens testing Campylobacter negative) and a cost-effective 
hypothetical vaccine C (with an effectiveness level of 90% and a cost of 0.26 DKK/ chicken). 
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8.4.3. Results and discussion 
Results from the ComBDK model including the distribution of expected probabilities related to 
Campylobacter levels and expected cost-reward balance in every case were obtained by selecting 
diverse combinations of “nodes states” or scenarios. Detailed results from the ComBDK model are 
presented in Manuscript VI. 
Results obtained from the model based on the previously described assumptions suggested that the 
best solution in financial terms will be to use the fly screens alone in the worst case scenario and not 
to implement the controls under the assumed conditions in the “most likely” and best case 
scenarios. Nevertheless, the best solution from a public health point of view will be the use of fly 
screens and vaccine B synergistically. Based on the results from the model, this strategy can 
decrease significantly the posterior probability related to expected Campylobacter positive results in 
all scenarios (from 72% to 29% in the most likely scenario; from 55% to 30% in the best scenario 
and from 87% to 9% in the worst case-scenario) although the implementation of this strategy will 
translate on a decrease of expected gross profit (around 0.50 DKK/chicken). During the summer, 
the use of fly screens alone and/or synergistically with vaccines A or B may be able to reduce the 
posterior probability related to expected Campylobacter positive results below the considered 
“baseline level of 14%”. In fact, using fly screens alone during the summer will reduce the posterior 
probability related to expected Campylobacter positive results from 87% to 13% resulting also in a 
small increase of the expected gross profit (based on the cost-reward balance). 
Sensitivity analyses performed showed that the financial variables (cost/reward functions) and to a 
lesser extend the effectiveness of the control measures (e.g. vaccination impact) drive the model’s 
results (manuscript VI). As a result of implementing reward system 2 (based on an extra payment of 
2.5 times the normal price for chickens testing Campylobacter negative) the farmers will potentially 
obtain higher payments and the differences between implementing diverse controls will be much 
more pronounced. The effectiveness of vaccines B and C are very similar but vaccine C is more 
cost-effective and desirable for this reason. From a public health perspective, the best 
Campylobacter control strategy in all case-scenarios will be the use fly screens together with 
vaccine B or C. However, from an economic point of view, the best solution will depend on the 
scenario considered, for example, in the most likely scenario, the best solution is using fly screens 
and vaccine C while during the summer the use of fly screens alone is most rewarding financially. 
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The use of vaccine C alone in the best case scenario seems to be the most cost-efficient strategy 
based on the results from the model. 
The effectiveness of the use of fly screens against Campylobacter in poultry has been reported in 
terms of decreased Campylobacter prevalence in broiler flocks in Denmark. In a study conducted 
by Hald et al. (2007b), the use of fly screens during the 2006 summer (June–October) produced a 
statistically significant decrease from 51.4% to 15.4% of Campylobacter positive flocks in 
comparison with control houses. A recently published paper (Bahrndorff et al., 2013) reports data 
related to the long-term effect of the use of fly screens on the prevalence of Campylobacter in 
broiler flocks in Denmark collected over the years 2006-2009. These authors reported a statistically 
significant decrease in Campylobacter prevalence from 41.4% in 2003–2005 (before the use of fly 
screens) to 10.3% in 2006–2009 in agreement with the results obtained by Hald et al., (2007b). The 
use of fly screens was tested on poultry farms in Iceland during the summer of 2008.  Reductions on 
Campylobacter prevalence were observed: from 48.3% to 25.6% among flocks in 19 houses from 
one company and from 31.3% to 17.2% in 16 houses from another poultry firm (Lowman et al., 
2008). Comparison of the results related to the use of fly screens on broiler farms previously 
reported (Hald et al., 2007; Lowman et al., 2008; Barndorff et al., 2013) with the results from the 
ComBDK model presented here are not straight forward. Results from the experimental studies 
previously mentioned relate to average Campylobacter prevalence values obtained from diverse 
farms and flocks and therefore different farming conditions. Results from the ComBDK model are 
based on one flock level and the expected posterior probability related to a Campylobacter positive 
result for that flock under specific conditions. Even more, a “nearly perfect” quantitative 
microbiological test has been considered in the model and consequently results related to the 
expected probability of a Campylobacter positive result might be higher than the actual result if a 
quantitative Campylobacter test was performed in that particular flock (the detection limit of most 
microbiological test are around 2 logs). Nonetheless, the flexibility of the model allows the user to 
test diverse controls, different farming conditions, microbiological protocols and reward systems. 
Sensitivity analyses performed indicated that the factors that influenced the results to a greater 
extent were the financial variables (cost/reward functions) and the effectiveness of the 
Campylobacter control strategies (manuscript VI). Obviously, cost-effective control measures will 
be preferred by poultry producers and a reward system that can translate on an attractive cost-
reward balance will be a good incentive for poultry producers to implement Campylobacter control 
strategies. 
Manuscript V 
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Abstract: The control of human Campylobacteriosis is a priority in public health agendas 
all over the world. Poultry is considered a significant risk factor for human infections with 
Campylobacter and risk assessment models indicate that the successful implementation of 
Campylobacter control strategies in poultry will translate on a reduction of human 
Campylobacteriosis cases. Efficient control strategies implemented during primary 
production will reduce the risk of Campylobacter introduction in chicken houses and/or 
decrease Campylobacter concentration in infected chickens and their products. 
Consequently, poultry producers need to make difficult decisions under conditions of 
uncertainty regarding the implementation of Campylobacter control strategies. This 
manuscript presents the development of probabilistic graphical models to support decision 
making in order to control Campylobacter in poultry. The decision support systems are 
constructed as probabilistic graphical models (PGMs) which integrate knowledge and use 
Bayesian methods to deal with uncertainty. This paper presents a specific model designed 
to integrate epidemiological knowledge from the United Kingdom (UK model) in order to 
assist poultry managers in specific decisions related to vaccination of commercial broilers 
for the control of Campylobacter. Epidemiological considerations and other crucial aspects 
including challenges associated with the quantitative part of the models are discussed in 
this manuscript. The outcome of the PGMs will depend on the qualitative and quantitative 
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data included in the models. Results from the UK model and sensitivity analyses indicated 
that the financial variables (cost/reward functions) and the effectiveness of the control 
strategies considered in the UK model were driving the results. In fact, there were no or 
only small financial gains when using a hypothetical vaccine B (able to decrease 
Campylobacter numbers from two to six logs in 20% of the chickens with a cost of  
0.025 £/chicken) and reward system 1 (based on similar gross profits in relation to 
Campylobacter levels) under the specific assumptions considered in the UK model. In 
contrast, significant reductions in expected Campylobacter numbers and substantial 
associated expected financial gains were obtained from this model when considering the 
reward system 2 (based on quite different gross profits in relation to Campylobacter levels) 
and the use of a hypothetical cost-effective vaccine C (able to reduce the level of 
Campylobacter from two to six logs in 90% of the chickens with a cost of 0.03 £/chicken). 
The flexibility of probabilistic graphical models allows for the inclusion of more than one 
Campylobacter vaccination strategy and more than one reward system and consequently, 
diverse potential solutions for the control of Campylobacter may be considered.  
Cost-effective Campylobacter control strategies that can significantly reduce the 
probability of Campylobacter introduction into a flock and/or the numbers of 
Campylobacter in already infected chickens, and translate to an attractive cost-reward 
balance will be preferred by poultry producers. 
Keywords: Campylobacter control; epidemiology; poultry; public health; probabilistic 
graphical models; decision support systems 
 
1. Introduction 
Human infections with Campylobacter are considered an important public health problem all over 
the world and poultry has been identified as one of the most significant sources for human 
Campylobacteriosis [1–10]. Campylobacter can break through biosecurity barriers and enter poultry 
houses, colonizing the chicken intestine and quickly multiplying in the intestinal mucosa. However,
 
Campylobacter does not induce health or welfare problems in chickens [11]. After introduction, 
Campylobacter spreads fast within broiler flocks and almost all birds in the same house will be 
infected within one week [12]. Broilers might carry high numbers of Campylobacter in some cases 
exceeding 10
7
 colony forming units per gram (CFU/g) of caecal content [13] and sometimes up to  
10
10
 CFU/g of faeces
 
[14–16]. Campylobacter present in the intestinal tract of chickens going for 
slaughter might contaminate the slaughtering and food processing environment and the food products 
representing a public health risk for the consumers. Campylobacter seems to be highly infectious  
and humans may develop clinical disease with the ingestion of a Campylobacter dose as low as  
500 CFU [17,18]. Furthermore, humans can be infected from poultry by pathways other than poultry 
products and therefore increased public health benefits can be associated with the implementation of 
effective controls against Campylobacter in primary poultry production.
 
Vaccination of chickens 
against Campylobacter has been proposed as a promising Campylobacter control measure [19].  
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A previous risk assessment study has shown that a reduction of two logs on the numbers of 
Campylobacter in chickens can translate in a reduction of human cases by 30 times [20]. 
Consequently, decreasing the numbers of Campylobacter in chickens at the farm level seems crucial to 
prevent Campylobacter contamination of chicken products, which in turn will reduce the risk of human 
infections with Campylobacter. In the last few years, research studies have focused on the reduction of 
the probability of Campylobacter introduction in broiler flocks [3,21–24] but recently some studies 
have focused on the development of vaccination and other control strategies with the aim to reduce the 
concentration of Campylobacter in the intestines of already infected chickens [25–29]. 
Poultry producers need to make important decisions and sometimes expensive investments to 
control Campylobacter.
 
Incentives to differentiate the payment to poultry producers are implemented 
in some countries in order to improve the safety of poultry products regarding Campylobacter. For 
instance, in Denmark, when the microbiological test identifies a flock as Campylobacter negative a 
few days before slaughter, the producer gets an extra payment (around 2%) while in Norway and 
Sweden the payment is reduced by about 4% for flocks that test positive for Campylobacter [30].  
In this way, poultry producers need to make decisions under conditions of uncertainty mainly related  
to the possibility of the flock being infected with Campylobacter. Furthermore, there is always 
uncertainty around existing knowledge and the generalization of results from specific studies further 
increase the uncertainty surrounding the knowledge decisions are based on. Mathematical models can 
be used to simulate the effectiveness and economic impact of diverse control measures. The decision 
support systems presented in this manuscript are constructed as probabilistic graphical models (PGMs) 
which integrate knowledge in one representation and use a Bayesian approach to handle uncertainty. 
Due to the inclusion of uncertain variables in the models (with diverse “states” or alternatives) and the 
use of probability distributions, using a Bayesian inference seems logic when making decisions under 
conditions of uncertainty and in situations that require statistical inference [31]. The integration of 
prior evidence (prior probabilities) can be used to infer the probabilities of other variables (or states) 
that are not known (posterior probabilities) using a Bayesian approach. 
This manuscript describes the development of decision support models for poultry producers, 
focusing on the integration of qualitative and quantitative epidemiological data related to the effect of 
different management factors, in order to select optimal decisions regarding the cost-efficient controls 
that could be implemented to reduce Campylobacter concentration in chickens at farm level.
 
The 
development is exemplified by a model designed using data from the United Kingdom (UK) to assist 
decision-making related to the control of Campylobacter in chicken farms using vaccination strategies. 
Human Campylobacteriosis represents an important problem in the UK causing significant morbidity 
and socio-economic costs [32,33]. The number of reported human Campylobacteriosis cases in 2009 
was 57,772 in England and Wales, however, it has been estimated that the burden of human infection 
in 2009 could be closer to 400,000 [34]. An overall Campylobacter spp. prevalence of 79.2% in UK 
broilers going for slaughter was obtained in a stratified randomized survey conducted during  
2007–2009, including data from the EU baseline survey of 2008 [35]. 
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2. Materials and Methods 
2.1. Probabilistic Graphical Models (PGMs) 
Poultry producers need to make important decisions related to the implementation of interventions 
against Campylobacter in poultry flocks before they know for sure if the flock will be challenged or 
infected with Campylobacter. Probabilistic graphical models (PGMs) may assist poultry producers in 
these crucial decisions made under conditions of uncertainty. The probabilistic graphical models 
presented in this manuscript have been designed using the HUGIN tool which is a commercial  
off-the-shelf software package created for the construction and deployment of probabilistic graphical 
models. A very simple example of a PGM with just one input variable (that could be however the 
result of the interaction of many variables) is presented in Figure 1. 
In Figure 1, the probabilistic dependence relationships between a set of variables are illustrated 
using a probabilistic graphical model (formed by a set of variables) which has two components; a 
qualitative and a quantitative part. The qualitative part is represented by a directed acyclic graph 
(DAG) which includes diverse “nodes” such as variables, decision nodes and utility functions as well 
as arcs representing relationships between them. A decision node (a rectangle in Figure 1) defines 
decision alternatives at a specific point in time, a chance node (an oval) represents a random variable 
and a utility node (a diamond in Figure 1) represents a reward or cost function. Arcs directed into a 
decision node define the information that is known by the decision maker at the time that the decision 
needs to be done. Each node includes a set of states or alternatives and the arcs represent the 
relationships between variables. The strength of the relationships between the entities included in the 
models can be defined using conditional probability distributions [36]. Variables, decision nodes and 
utility functions need to be carefully selected in order to obtain reliable outcomes. 
Figure 1. A simple probabilistic graphical model (PGM) to assist in a decision related to 
vaccination of poultry against Campylobacter. 
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Crucial challenges that might be encountered when developing the quantitative part of the models 
may be related to the following: 
(1) A selected random variable such as “biosecurity” could be influenced by many other factors or 
variables and for that reason it may be difficult to select one defined probability distribution to 
represent the group of factors. Furthermore, some of these factors may well be protective instead of 
risk factors based on particular epidemiological studies. In fact, results related to the same factor can 
be contradictory in different studies (e.g., pest control has been found to be a risk factor instead of a 
protective factor [5]). The presence of potential confounders could explain some epidemiological 
findings making the analysis and the models more complex. 
(2) Epidemiological studies are conducted in different areas of the world, diverse conditions, 
farming systems, sample sizes, sampling protocols, etc. Consequently, it seems challenging to design a 
general PGM that could be applied in all circumstances to support decision-making for Campylobacter 
vaccination of poultry. In fact, the quantitative part of the model should be based on one “standardized 
measure of risk”; however, epidemiological studies use different measurements or parameters to 
represent the concept of “increased or decreased risk” due to the factor/s considered in every case. 
Even when the parameter used is the same (e.g., Odds Ratio) the quantitative values can be very 
different between epidemiological studies. The statistical combination of results from two or more 
studies can be referred to as meta-analysis and needs to be produced with care [37]. 
(3) Although many epidemiological studies use the Odds Ratio as a measurement of risk 
attributable to the factor considered, this mathematical expression cannot be used in the PGMs as such. 
It is necessary to transform the Odds Ratio value to a fixed probability value or a specific distribution 
of potential values to be included in the quantitative part of the Bayesian models. The selection and in 
some cases the combination of different odds ratios or probabilities for their use in PGMs need to be 
carefully performed. Moreover, the use of sensitivity analysis has been recommended [38]. 
After careful design of the qualitative and the quantitative part of the models, the outcome of the 
models will include potential decisions related to Campylobacter control strategies that can be 
considered and selected for implementation. The solution of an influence diagram is a strategy 
consisting of a policy for each decision, for example, the use of vaccination strategy A (Figure 1). The 
strategy is determined using the principle of maximizing expected utility based on selecting a decision 
that will offer the decision maker the greatest expected reward. In this example, vaccination strategy A 
is able to reduce the expected numbers of Campylobacter in infected chickens. The results from the 
model will include posterior probability distributions (under the identified strategy) related to expected 
Campylobacter numbers in the flock (in logs) before and after the implementation of the decision/s and 
the expected cost-reward balance associated with each decision/s (Table 1). 
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Table 1. Hypothetical results from a PGM with one decision related to the use of 
Vaccination strategy A against Campylobacter in broilers. 
No vaccination  
Posterior probabilities related to  
expected Campylobacter levels: 
Vaccination strategy A  
Posterior probabilities related to  
expected Campylobacter levels: 
0–2 logs (7%) 0–2 logs (52%) 
2–4 logs (20%) 2–4 logs (18%) 
4–6 logs (23%) 4–6 logs (12%) 
6–8 logs (24%) 6–8 logs (10%) 
8–10 logs (26%) 8–10 logs (8%) 
Expected cost-reward balance:  Expected cost-reward balance:  
+0.36 euros/chicken  +0.44 euros/chicken  
Expected cost-reward balance  
(gross profit) for an average flock with  
20,000 chickens: 7200 euros 
Expected cost-reward balance  
(gross profit) for an average flock with  
20,000 chickens: 8800 euros 
The model presented in Figure 1 is an influence diagram [39] constructed around the decision on 
vaccination against Campylobacter but other control strategies could be considered in the models. The 
flexibility of this methodology allows the user to consider different costs depending on the diverse 
strategies used to control Campylobacter. Similarly, several reward strategies can be accounted for in 
the models. In the presented model, the reward is based on the level of Campylobacter (logs) around 
slaughter time. 
In the model presented in Figure 1, the decision node is based on performing vaccination against 
Campylobacter in broilers at two weeks of age. Campylobacter is not usually detected in birds younger 
than two weeks [40,41]. It has been suggested that this “two weeks window” could be strategically 
used to introduce vaccination programs [42]. Therefore, the decision about vaccination in poultry 
needs to be made usually before Campylobacter is introduced into the flock, and there is uncertainty 
regarding the introduction of Campylobacter into the flock that needs to be taken into account in the 
decision-making process. For this reason, historical farm data related to previous Campylobacter status 
could be accounted for in the models. 
2.2. Case Study Model 
2.2.1. Current Knowledge Related to Poultry Management Factors 
Here, we present a decision model we have developed based on the results from an observational 
study on risk factors that could be associated with Campylobacter in broilers in the UK [35]. These 
authors conducted epidemiological studies based on 29 risk factors that could be potentially associated 
with Campylobacter status in broilers. The following risk factors were found significantly associated 
with Campylobacter positive flocks in the study: previous depopulation practices, higher recent flock 
mortality, increasing age at slaughter and slaughter in the summer months. We have included these risk 
factors for the presence of Campylobacter in UK broilers at slaughter in a probabilistic graphical 
model. The quantitative part (probabilities of events or states of the variables) of the PGM (Table 2) 
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was obtained by a mathematical transformation of odds ratio values presented in the study from the 
UK [35]. Additionally, probabilities related to Campylobacter introduction in the flock due to the 
presence of risk factors are conditional to a “baseline level” of Campylobacter (lowest level of 
Campylobacter in broilers close to slaughter time found in the literature). In these models, the 
“baseline Campylobacter flock prevalence” in the UK considered was 28.8% based on data from a 
study conducted by the Food Standards Agency [43]. 
The formula applied to calculate probabilities of the diverse states of risk factors (P(s)) based on the 
baseline Campylobacter flock prevalence (bp) and odds ratios (ORs) was: 
 exp(ln(b / (1 b )) ln(OR ))
( )
1 exp(ln(b / (1 )) ln(OR ))
p p s
p p s
P s
b
 

  
 
(1) 
Table 2. Significant risk factors, frequency of occurrence [35] and associated probability 
of Campylobacter introduction in UK broiler flocks. 
Risk factor and frequency 
of occurrence 
Odds Ratio (95% CI) 
Probability of a Campylobacter 
positive flock * due to the 
presence of specific risk factors 
Season   
Summer (26.32%) 14.27 (7.83–26.02) 0.85 
Autumn (25.38%) 1.70 (1.21–2.37) 0.41 
Spring or winter 
a
 (48.3%) 1  
Age of broilers   
≥46 days (19.59%) 13.43 (7.40–24.35) 0.85 
42–45 days (15.67%) 3.56 (2.39–5.29) 0.59 
40–41 days (18.57%) 3.18 (1.42–7.12) 0.57 
36–39 days (21.98%) 1.25 (0.86–1.81) 0.34 
<36 days 
a
 (24.19%) 1  
Flock recent mortality   
>1.49% (32.22%) 2.74 (1.18–6.40) 0.53 
1.00%–1.49% (29.35%) 1.57 (1.12–2.21) 0.39 
<1.00% 
a
 (38.43%) 1  
Previous partial depopulation   
Yes (64.94%) 5.21 (2.89–9.38) 0.68 
No 
a
 (35.06%) 1  
a
 Reference category (mathematical models); * Based on a baseline level of Campylobacter  
of 28.8% [44]. 
2.2.2. Cost-Reward Function 
Accurate cost-benefit analyses of potential control measures against a particular disease play a 
crucial role in the implementation of successful disease control programs. A cost-reward function was 
included in this model in order to assess the financial consequences of every decision that the farmer 
might consider to control Campylobacter in chickens. Financial data related to the UK poultry industry 
was obtained from a farm business survey from 2009/2010 [44]. There is no commercial 
Campylobacter vaccine at present and thus a commercial Campylobacter vaccine price is not 
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available. The cost of a hypothetical vaccine against Campylobacter in broilers could be considered to 
be between 2 and 6 Euro cents based on prices of other vaccines used in poultry production [45]. The 
vaccine effectiveness or vaccine impact was also hypothetical in these models. We decided to consider 
a hypothetical vaccine B against Campylobacter in broilers able to decrease Campylobacter numbers 
from two to six logs in 20% of the broilers and less than two logs in 80% of the chickens with a cost of  
0.025 £/chicken (UK). The reward system has been designed based on the reported average gross 
profit of 0.36 £/per chicken for UK farmers in 2010 [44]. Based on this hypothetical reward system 
(Table 3), farmers producing chickens with numbers of Campylobacter lower than four logs will get 
higher gross profits (+20% extra with respect to other Campylobacter levels) while farmers delivering 
chickens carrying high numbers of Campylobacter (more than six logs) will get lower gross profits  
(−20% between Campylobacter levels). It was assumed that an average broiler chicken from a positive 
flock in the UK will carry Campylobacter in a concentration of 4–6 log CFU/g or mL of sample (from 
the digestive tract). 
Table 3. Reward system 1 considered in the model. 
Campylobacter numbers (logs) 0–2 2–4 4–6 6–8 8–10 
Gross profit (£/chicken) 0.52 0.43 0.36 0.29 0.23 
2.2.3. Designing the PGM 
The model we present in this case study (Figure 2) was designed based on the following 
assumptions: 
(1) The contributions from different risk factors to the level of Campylobacter are independent. 
(2) It is considered that the detection level of Campylobacter is 2 logs CFU/g or mL of sample and 
the maximum colonization level is 10 logs CFU/g or mL of sample. This means that a Campylobacter 
level of 0–2 logs will give a negative result while a positive result includes Campylobacter numbers 
from 2 to 10 logs. In this model, we use intervals for bacterial concentration with two log widths  
(e.g., 0–2 logs, 2–4 logs, 4–6 logs, 6–8 logs and 8–10 logs). 
(3) Vaccination impact is based on log-reduction of the numbers of Campylobacter in chickens and 
therefore the numbers of Campylobacter in broilers going for slaughter will be lower after vaccination. 
(4) The “measured Campylobacter numbers at slaughter” will depend on the “true numbers” and the 
microbiological quantitative methods used. In these models, we assume a nearly-perfect quantitative 
method so the obtained Campylobacter numbers in the lab are closer to the numbers in reality. 
Epidemiological studies provide insight regarding the risk of Campylobacter introduction 
attributable to particular risk factors in specified conditions. However, there seems to be lack of data 
regarding the numbers of Campylobacter carried by broilers throughout the farming period in relation 
to particular risk factors. In the models presented here, the vaccination impact and the cost-reward 
functions are based on a log-scale because the objective is to develop a control strategy  
(e.g. vaccination strategy) able to reduce the numbers of Campylobacter in commercial broilers.  
In order to obtain reliable results from the model, data must be on the same scale. Data related to  
the effect of risk factors on the Campylobacter status of the flock are based on positive  
(2–10 logs)/negative (0–2 logs) results and they need to be translated to the expected distribution of 
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probabilities related to Campylobacter levels in the flock (Figure 3). The nodes “Campylobacter status 
before vaccination” and “Campylobacter status before vaccination (logs)” in this model specify the 
transformation from positive/negative to the diverse Campylobacter levels (in logs) scale (Figure 3). A 
flat distribution is used in this case to transform a general Campylobacter probability (e.g., 92.36%) 
into a distribution of equal probabilities for different levels of Campylobacter as illustrated in Figure 3. 
Figure 2. The model Commercial Broilers Vaccination (ComBVacUK) based on 
epidemiological and financial data from the UK. 
 
Figure 3. Illustration of the part of the model showing the Campylobacter status before 
vaccination in positive/negative format (0–2 logs is considered negative and 2–10 logs 
translates on a positive result) and in logs format (distribution of the different levels of 
Campylobacter in logs). 
 
The quantitative part of the models encodes the mathematical expressions and probability 
distributions associated with the different states of the chance variables and utility functions associated 
with the utility nodes as defined by the structure of the influence diagram. For example, the following 
mathematical expression: “max (prob_season, prob_previousdepop, prob_flock_recentmortality, 
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prob_age_at_slaughter)” is introduced in the variable “Campylobacter status before vaccination” to 
calculate the posterior conditional probabilities based on probability distributions from the parent 
variables (Figure 4). There are probability tables for each variable which include probabilities for 
every state of the variables. These tables will contain the prior probability distributions for variables 
without parents in the model and the conditional probability distributions for variables with parents. 
Figure 4 illustrates probability tables for the variables: prob_season, prob_previousdepop, 
prob_flock_recentmortality and prob_age_at_slaughter in the Commercial Broilers Vaccination 
(ComBVacUK) model. 
Figure 4. Probability tables for the variables: prob_season, prob_previousdepop, 
prob_flock_recentmortality and prob_age_at_slaughter. 
 
The prior probability distributions should integrate knowledge obtained from sources such as 
empirical observations, epidemiological data and experts in order to obtain reliable outcomes  
from the decision support models. Bayesian inference and probability theory set the basis for the 
quantitative outputs of the models. Decision support models can be updated with new evidence, 
knowledge or information. 
2.2.4. Sensitivity Analyses 
The aim of performing sensitivity analyses is to determine the sensitivity of the vaccination 
decision under different evidence scenarios with respect to single parameters of the models. In this 
particular case, two very different reward systems and a hypothetical vaccine C were included in the 
models. Reward system 2 was based on an extra payment for chickens testing Campylobacter negative 
of 2.5 times the normal price while reward system 3 was based on the existing reward systems in 
Denmark which is based on an extra payment of about 2% for flocks testing negative for 
Campylobacter and in Norway and Sweden where the payment is reduced by about 4% for flocks that 
are tested positive for Campylobacter (personal communication). A cost-efficient hypothetical vaccine 
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C able to reduce 2–6 logs the level of Campylobacter in 90% of the chickens was considered with a 
cost of 0.03 £/chicken. 
3. Results 
3.1. Results from the Model Commercial Broilers Vaccination UK Model (ComBVacUK) 
The results from the model can be visualized by selecting diverse combinations of “nodes states” 
and obtaining the output in terms of the expected distribution of probabilities related to Campylobacter 
levels and expected cost-reward balance in every case. A high number of potential combinations or 
scenarios can be considered and therefore it is up to the user to select the relevant combination of 
present factors. In Table 4, we have described three combinations in order to illustrate the potential 
outputs of the model. 
Table 4. Scenarios considered in the model; risk factors and their frequency of occurrence 
in every scenario. 
Best-case scenario  Worst-case scenario 
“Most likely” scenario (based 
on study data [35]) 
Spring or winter (100%) Summer (100%) Season 
  Summer (26.32%) 
  Autumn (25.38%) 
  Spring or winter 
a
 (48.3%) 
Age of broilers Age of broilers Age of broilers 
≤36 days (100%) ≥46 days (100%) ≥46 days (19.59%) 
  42–45 days (15.67%) 
  40–41 days (18.57%) 
  36–39 days (21.98%) 
  <36 days 
a
 (24.19%) 
Flock recent mortality
 
Flock recent mortality Flock recent mortality 
<1.00%
 
(100%) >1.49% (100%) >1.49% (32.22%) 
  1.00%–1.49% (29.35%) 
  <1.00% 
a
 (38.43%) 
Previous partial depopulation Previous partial depopulation Previous partial depopulation 
No (100%) Yes (100%) Yes (64.94%) 
  No 
a
 (35.06%) 
a
 Reference category (mathematical models). 
Results from the models (based on prior probabilities shown in Table 4) are included in Table 5 
where expected posterior probabilities and expected cost-reward financial balances are presented. 
Results from the model indicate that the financial results are relatively insensit ive to choices in this 
case. There are no or only small financial gains when using vaccine B and reward system 1 under the 
specific assumptions considered in the model. Actually, in the best-case scenario the farmer will not 
gain financially when using vaccine B although the posterior probabilities related to expected high 
numbers of Campylobacter in the flock will be reduced. On the contrary, in the worst-case scenario the 
best option will be to use vaccine B because it produces the maximum cost-reward balance  
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(0.34 £/chicken) and a reduction on the probabilities related to expected high numbers of 
Campylobacter in the flock. Similarly, results obtained when considering the “most-likely” scenario 
based on study data [35] indicate that the best option will be to use vaccine B. 
Table 5. Results based on the model Commercial Broilers Vaccination (ComBVacUK) 
using reward system1 (Table 3) and a hypothetical Campylobacter vaccine B. 
 Scenarios 
 Best-case scenario  Worst-case scenario 
“Most likely” scenario 
(based on study data 
from the UK [35]) 
Posterior 
probabilities related 
to expected 
Campylobacter levels 
when implementing 
no additional 
protective measure  
0–2 logs (25.70%) 0–2 logs (0.35%) 0–2 logs (7.27%) 
2–4 logs (18.58%) 2–4 logs (24.91%) 2–4 logs (23.18%) 
4–6 logs (18.58%) 4–6 logs (24.91%) 4–6 logs (23.18%) 
6–8 logs (18.58%) 6–8 logs (24.91%) 6–8 logs (23.18%) 
8–10 logs (18.58%) 8–10 logs (24.91%) 8–10 logs (23.18%) 
Cost-reward balance: 
0.38 £/chicken 
Cost-reward balance: 
0.33 £/chicken 
Cost-reward balance: 
0.34 £/chicken 
Flock with 50,000 
chickens = 19,000 £ 
Flock with 50,000 
chickens = 16,500 £ 
Flock with 50,000 
chickens = 17,000 £ 
Posterior 
probabilities related 
to expected 
Campylobacter levels 
after the 
implementation of a 
decision (Vaccine B) 
Vaccine B Vaccine B Vaccine B 
0–2 logs (35%) 0–2 logs (12.82%) 0–2 logs (18.87%) 
2–4 logs (18.59%) 2–4 logs (24.94%) 2–4 logs (23.21%) 
4–6 logs (17.67%) 4–6 logs (23.70%) 4–6 logs (22.05%) 
6–8 logs (15.81%) 6–8 logs (21.21%) 6–8 logs (19.74%) 
8–10 logs (12.93%) 8–10 logs (17.34%) 8–10 logs (16.14%) 
Expected cost-reward 
balance: 0.38 £/chicken 
Expected cost-reward 
balance: 0.34 £/chicken 
Expected cost-reward 
balance: 0.35 £/chicken 
Flock with 50,000 
chickens = 19,000 £ 
Flock with 50,000 
chickens = 17,000 £ 
Flock with 50,000 
chickens = 17,500 £ 
3.2. Results from the Sensitivity Analyses 
Sensitivity analyses performed indicated that the factors that influenced the results to a greater 
extent were the financial variables (cost/reward functions) and the effectiveness of the control strategy, 
e.g. vaccination impact. On the other hand, the results showed that the financial differences between 
diverse strategies were very small mainly due to the narrow differences between the levels of the 
reward system. The results indicated that when applying the reward system 2 (a system with higher 
differences between gross benefits obtained by farmers delivering chickens Campylobacter negative or 
with low Campylobacter numbers), the best solution in terms of maximum expected benefit would be 
using the vaccine C in all case-scenarios. Significant reductions in expected Campylobacter levels and 
substantial associated expected financial gains were obtained from this model when considering the 
reward system 2 and the use of vaccine C; for example, in the most-likely scenario, the expected 
benefit increased from 0.34 £/chicken to 0.69 £/chicken (translated to a flock with 50,000 chickens, 
from 17,000 £ to 34,500 £). However, when implementing reward system 3 (closer to real reward 
Agriculture 2013, 3 528 
 
 
systems currently employed in several countries) the best solution in financial terms will be “not 
vaccinating” even though the use of vaccine C could potentially reduce the expected posterior 
probabilities related to high numbers of Campylobacter in the flock significantly. In fact, the use of a 
hypothetical vaccine C in the most-likely scenario could reduce the probability of Campylobacter 
introduction into the flock from around 93% to approximately 46%. 
4. Discussion 
Poultry producers need to make important, complex decisions and related investments for the 
sustainability of their businesses. Increased consumer concerns related to food safety put pressure on 
food producers to implement food safety assurance systems. In particular, poultry producers should 
implement effective controls against Campylobacter in poultry to increase food safety and to reduce 
the burden of human Campylobacteriosis. 
Different PGMs can be developed to assist in decision-making regarding Campylobacter 
vaccination of poultry and/or other Campylobacter control strategies. The graphical nature and 
decomposition into variables and relationships of PGMs make it possible to create a common generic 
model to assess diverse strategies for the control of Campylobacter in poultry. Nevertheless, it seems 
challenging to design a general model (qualitative and quantitative) that could be applied to all 
situations, poultry farming conditions and geographical areas. Furthermore, the conditions, selection of 
factors or variables, different parts of the models, and quantitative data need to be clearly specified to 
add value and perspective to the decision support system designed in every case. Tailor-made properly 
developed PGMs will help poultry managers make important decisions in order to solve complex 
problems such as the control of Campylobacter. PGMs can be extended and/or modified to adapt to 
different real circumstances. For example, the time of slaughter might vary depending on the final 
product. In addition, the assumption about independence between factors gives flexibility to include 
supplementary factors or new knowledge in the model. 
Microbiological methods for the detection and quantification of Campylobacter can be used to 
assess the Campylobacter status of birds. However, it seems important to distinguish between the true 
numbers of Campylobacter in birds and the detected or measured numbers. There are several 
microbiological techniques available for the detection and enumeration of Campylobacter spp. from 
different sample matrices. However, some techniques are still under development and the detection 
limit of most methodologies seems to be 100 CFU/g or mL (depending on sample type and sample 
preparation). Therefore, a negative result might actually indicate very low numbers of Campylobacter 
(1–100 CFU/g or mL). Moreover, microbiological sampling and processing methods will not be 
perfect and in reality, the sampling procedures and microbiological techniques will affect the estimates 
of the true numbers of Campylobacter in chickens and in poultry flocks. In this model, we assumed a 
nearly-perfect quantitative method but other tests and/or other uncertainties related to microbiological 
sampling could be considered in the models. Similarly, diverse sources of contamination of broiler 
flocks could be included. Sources of Campylobacter contamination might be implicit in some risk 
factors (e.g., biosecurity). In this model, the presence of flies (a potential source of Campylobacter 
contamination) could be a confounder with the risk factor “season: summer”. Nevertheless, other 
potential Campylobacter sources could be considered, increasing the complexity of the models. 
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In the UK, human Campylobacteriosis represents an important public health problem [32,33]. 
Estimates of Campylobacter prevalence in UK poultry flocks can be found in the literature, e.g., 75% 
in the EU baseline survey carried out in 2008 [46] and 79.2% in the considered study from the UK [35] 
which are average prevalence values obtained from sampling a number of poultry flocks for human 
consumption. The introduction of Campylobacter in the food processing environment poses a risk for 
the contamination of food products; in fact, in the EU baseline survey carried out in 2008, 86% of the 
UK poultry carcasses tested were found positive for Campylobacter. It seems crucial to reduce the 
number of Campylobacter positive flocks and the numbers of Campylobacter in chickens and their 
products. The control of Campylobacter in poultry could translate to a decrease in the incidence of 
human Campylobacteriosis cases in the UK. 
The results from the model presented here indicated that the posterior probability of introduction of 
Campylobacter into the UK poultry flock in the most likely scenario before vaccination was 92.36% 
based on the assumptions and data specified in this manuscript. The posterior probability of 
Campylobacter introduction into the flock decreased significantly by the use of a hypothetical vaccine B 
(to approximately 81%) and even more when using a much more effective hypothetical vaccine C (to 
approximately 46%). The results indicated that the public health impact of the control strategies will 
depend on the effectiveness of the controls. However, the assessment of the effectiveness of diverse 
control strategies might prove challenging in some cases, e.g., the assessment of vaccine effectiveness [29]. 
In any case, decreasing the probability of Campylobacter introduction into poultry flocks is highly 
desirable. The EU baseline survey carried out in 2008 identified a trend in countries with higher 
prevalence of Campylobacter positive poultry flocks to produce poultry carcasses with high numbers 
of Campylobacter due to Campylobacter in the intestines of infected chickens contaminating the food 
processing environment and the poultry products [46]. In fact, high numbers of Campylobacter in the 
cecum of chickens for slaughter can correlate with high numbers of Campylobacter on chicken 
carcasses [47]. Campylobacter control strategies that can significantly reduce the probability of 
Campylobacter introduction into a flock and/or the numbers of Campylobacter in already infected 
chickens should be implemented from a public health perspective. On the other hand, poultry 
producers will usually make strategic decisions based on financial gains and therefore a reward system 
that can translate to an attractive cost-reward balance will be a good incentive for poultry producers to 
implement Campylobacter control strategies. In actual fact, the financial results obtained from the 
model when using the reward system 1 and a hypothetical Campylobacter vaccine B indicated that the 
expected financial gains might be too small to justify the use of vaccine B in this case. Nevertheless, 
this type of information might prove very valuable and it is likely that producers will find this 
decision-making tool more beneficial at times when the consequences from implementing alternative 
decisions for the control of Campylobacter are not very clear. In contrast, when considering the reward 
system 2 and the use of vaccine C, significant reductions in expected Campylobacter levels and 
substantial expected financial gains were obtained. Sensitivity analyses can be used to test diverse 
hypothetical vaccines and reward systems in order to compare them and their combinations. 
The aim of the sensitivity analyses was to determine the sensitivity of the vaccination decision 
under different evidence scenarios with respect to single parameters of the models but we did not 
perform sensitivity analyses on the probabilistic quantification of the model. The cost-reward functions 
are crucial drivers for the selection of the optimal decision which is determined based on the principle 
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of maximum benefit (cost-reward balance). It is important to bear in mind that in the model the cost 
function relates only to the cost of the control measure and does not include any other additional costs 
such as those related to microbiological testing. 
Financial data considered in the models should be as accurate as possible (e.g., cost of a specific 
Campylobacter control). The reward system might not be in place in most parts of the world, therefore 
it should be hypothesized and tailor-made based on the gross profit/per chicken for farmers in specific 
areas and/or production systems (e.g., organic farmers might obtain a higher gross profit/chicken than 
farmers producing commercial broilers). The reward system currently used in Denmark is based on an 
extra payment of about 2% for flocks testing negative for Campylobacter while in Norway and 
Sweden the payment is reduced by about 4% for flocks that test positive for Campylobacter (personal 
communication). The results from the model presented here indicate that it might be useful for the 
reward system to be based on an increased extra payment for flocks testing negative for 
Campylobacter in order to justify financially the use of a commercial vaccine against Campylobacter. 
However, financial gain will depend on the effectiveness of the vaccine (and/or other control 
strategies) and the costs associated with the controls. A cost-efficient vaccine against Campylobacter 
in chickens is not commercially available at present. We considered that the market price of a  
cost-effective vaccine against Campylobacter in chickens should be less than 10% of the gross profit 
per chicken to be competitive. Nonetheless, the market price could be higher depending on the 
effectiveness of the vaccine and the reward system. 
There are many potential strategies for the control of Campylobacter in poultry that could be 
included in the models but the complexity of the models will increase significantly. Campylobacter 
vaccination strategies have been considered in the models presented in this paper but the authors are 
working on different models where three Campylobacter control strategies (and their combinations) 
are included. Consequently, the selection of Campylobacter control strategies in poultry will become 
more and more complex due to the increased number of possibilities, and poultry producers may 
benefit from the use of decision support models. The flexibility of PGMs allows for the inclusion of 
more than one hypothetical Campylobacter vaccine and other control measures and more than one 
reward system. The users might then obtain a range of potential solutions for the control of 
Campylobacter in poultry. The most profitable solutions will be more attractive for poultry farmers, 
although they might not be feasible in the real world. On the other hand, some producers may be 
inclined to implement food safety controls (even when there is little financial reward involved)  
if the controls improve the image of their brands and/or the producers feel pressure from consumers 
and/or governments. 
From a public health perspective, results from the model in terms of expected reductions in the 
numbers of Campylobacter in chickens after the implementation of controls could be translated into 
the expected decrease in human Campylobacteriosis cases and expected reductions in associated health 
care costs using mathematical models. However, at present, a risk assessment model to estimate the 
number of human cases based on the occurrence of Campylobacter in chickens sent for slaughter does 
not seem to be available. Information related to public health benefits that could be obtained from the 
implementation of cost-effective Campylobacter controls in poultry will prove very useful, for 
example, when considering future reward systems. 
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PGMs represent knowledge and probabilistic conditional relationships in structured models 
designed to represent real situations where uncertainty plays an important role. The integration of 
information, knowledge and technology is crucial to discover new/better solutions to complex 
problems [48,49] and may aid poultry farmers to make optimal decisions on the implementation of 
controls against Campylobacter. In addition, engagement of different stakeholders in the PGMs’ 
development process is highly desirable. The use of sophisticated and complex computing interfaces, 
mathematical expressions and probability distributions needs to be reconciled with a simple and 
efficient tool that can be used by different stakeholders [50,51]. Considerations regarding the 
epidemiological and microbiological factors to be included in the models together with important 
challenges for the development of the quantitative part of the models have been presented in  
this manuscript. 
5. Conclusions 
Poultry producers should implement cost-effective Campylobacter control strategies in order to 
protect public health and to reduce the burden of human Campylobacteriosis. Decision support tools 
such as probabilistic graphical models (PGMs) will aid poultry producers to select cost-effective 
Campylobacter control strategies. The cost-reward functions and the effectiveness of the control 
strategies integrated in the models are crucial drivers for the selection of optimal decision/s. The public 
health impact of the control strategies depends on the effectiveness of the controls. The model’s 
optimal decision in every case is determined based on the principle of maximum benefit (cost-reward 
balance). Poultry producers will be able to choose from a range of potential solutions for the control of 
Campylobacter in poultry. Some decisions might be ideal from a public health perspective but may be 
costly for producers. The flexibility of PGMs allows for the consideration of diverse real-life 
circumstances, the integration of new knowledge, the inclusion of more than one Campylobacter 
control measures and more than one reward system. Nonetheless, the selection of epidemiological 
evidence, qualitative and quantitative data needs to be clearly specified to add value and perspective to 
the decision support system designed in every case. 
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Abstract 
The control of Campylobacter in poultry is considered a public health priority and some 
intervention strategies have been implemented in Denmark. Nonetheless, Campylobacter infection 
in poultry can still be considerable particularly during the summer when the most promising 
Campylobacter control strategy seems to be the use of fly screens. The use of cost-effective 
vaccines against Campylobacter is also desirable. Poultry producers need to make crucial decisions 
related to the control of Campylobacter under conditions of uncertainty. This manuscript describes 
a decision support model (for Campylobacter control in poultry flocks) which integrates knowledge 
and use a Bayesian approach to handle uncertainty. The model integrates epidemiological data, 
microbiological considerations, financial information and potential control strategies (the use of fly 
screens and hypothetical vaccines). The results from the model and sensitivity analyses indicate that 
the financial variables (cost/reward functions) and the effectiveness of the control measures drive 
the model’s results.  
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Introduction 
Human campylobacteriosis represents an important public health issue and it has been notifiable in 
Denmark since 1980. Fresh chicken meat is considered one of the most important risk factors for 
human infections with Campylobacter in Denmark (1). A risk profile for pathogenic Campylobacter 
was conducted in 1998 (2) and ever since broiler flocks have been tested for Campylobacter at 
slaughter. The first Danish Action plan against Campylobacter in broilers was established in 2003 
(3). A more recent action plan to control Campylobacter in broilers and broiler meat was 
implemented in Denmark in 2008. Between 2001 and 2009, Campylobacter prevalence in Danish 
broiler flocks before slaughter decreased from around 40% to about 30% (4). A recent report from 
the European Food Safety Authority stated an average prevalence of 19.2% for Campylobacter in 
Danish broiler flocks (5). Nevertheless, Campylobacter prevalence in broiler flocks during the 
summer months in Denmark can be as high as 51.4% (6). Researchers have reported several risk 
factors significantly associated with Campylobacter infection of broilers in Denmark such as late 
introduction of whole wheat in the chickens’ diet, improper storage of whole wheat, age of birds at 
slaughter, old broiler houses, number of chimneys on the broiler house, improper rodent control, 
number of broiler houses on farm and the location of the poultry farm in relation to cattle farms (7-
9). A recent Danish study (10) reports that season, increasing age of the birds and several factors 
related to biosecurity (age of the poultry houses, previous Campylobacter positive flocks in the 
same houses and the number of persons entering the houses) were significantly associated with 
Campylobacter infection of broilers. Field trials conducted in Denmark showed that the use of fly 
screens in broiler houses during the summer can reduce the prevalence of Campylobacter in Danish 
broilers (6, 11). A recommendation of using fly-nets in all the houses on a farm has been made 
because transmission of Campylobacter from the non-netted houses to the netted houses has been 
considered probable (5, 12). In fact, the use of fly screens on farm may decrease Campylobacter 
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prevalence in broilers by 10-30% (6) which in turn may translate in a significant reduction of 
human campylobacteriosis cases. 
Alternative Campylobacter control measures that can reduce the numbers in already infected 
chickens such as vaccination strategies might also be considered. Effective vaccination is highly 
desirable; however, a cost-efficient vaccination strategy against Campylobacter in poultry is not 
commercially available at present. In the last couple of years, we have conducted studies aiming to 
reduce the numbers of Campylobacter in chickens and their products by developing a vaccination 
strategy against Campylobacter in poultry (13). In addition, a decision support tool has been 
developed to assist poultry producers to make complex decisions (sometimes expensive 
investments) under conditions of uncertainty for the control of Campylobacter in poultry flocks (14, 
15).  
The decision support system presented in this manuscript is constructed as a probabilistic graphical 
model (PGM) which integrates prior knowledge related to the farm as well as the expected cost-
effect of two different Campylobacter controls on-farm: hypothetical Campylobacter vaccines 
and/or the use of fly screens. The integration of prior knowledge (prior probabilities) can be used to 
infer the probabilities of other variables that are not known (posterior probabilities) using a 
Bayesian approach. The prior probability distributions should integrate knowledge obtained from 
diverse reliable sources such as epidemiological data, empirical observations and expert knowledge 
in order to obtain reliable outcomes from the models. Epidemiological data, microbiological 
considerations, financial information and diverse control strategies have been integrated in the 
model. The solution of the developed PGM offers posterior probabilities related to expected 
Campylobacter levels in chickens before and after implementation of controls and a cost-benefit 
balance for each control strategy considered. Poultry producers can adapt the model to real-life 
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conditions and decide if/when to use fly screens and/or vaccines selecting the most beneficial 
decision/s in every real-life situation. 
MATERIALS AND METHODS 
Probabilistic Graphical Models (PGMs) 
Poultry producers need to make decisions related to the implementation of control strategies 
against Campylobacter in poultry flocks before they even know if the birds will be challenged or 
infected with Campylobacter. The probabilistic graphical model presented in this manuscript has 
been designed using the HUGIN tool which is a commercial software package (16). Briefly, PGMs 
include prior knowledge and uncertainties using a number of variables and probabilistic dependence 
relationships between the variables (14, 15). PGMs formed by a set of variables have two 
components: a qualitative and a quantitative part. The qualitative part includes diverse “nodes” such 
as variables, decision nodes and utility functions and arcs representing relationships between them 
(as exemplified in Figure 1). A chance node (an oval in Figure 1) represents a random variable, a 
decision node (a rectangle in Figure 1) defines decision alternatives at a specific point in time and a 
utility node (a diamond in Figure 1) represents a reward or cost function. The relationships of 
dependence or independence between the variables included in the models can be represented and 
the strength of the relationships can be defined using conditional probability distributions (17). The 
quantitative part of the models includes the mathematical expressions and probability distributions. 
The results from the models comprise posterior probability distributions (for every strategy) related 
to expected Campylobacter numbers in the flock (in logs) before and after the implementation of 
the decision/s and the expected cost-reward balance associated with each decision/s. 
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Prior knowledge related to poultry production management factors 
A decision model has been developed (Figure 1) based on the results from an epidemiological study 
on risk factors potentially associated with Campylobacter infection in Danish broiler flocks (10). 
These authors analysed data from 2835 flocks originating from 187 farms from December 2009 to 
November 2010 (database: Quality Assurance System in Danish Broiler Production). The database 
included more than 1700 variables and the following risk factors were found significantly 
associated with Campylobacter positive flocks: season, increasing age of the birds, the age of the 
poultry houses, previous Campylobacter positive flocks in the same houses and the number of 
persons entering the poultry houses (10). Odds Ratio (OR) values were used to represent the 
concept of “increased risk” due to the factor/s considered in their research. To integrate this 
information into the PGM, the significant risk factors were included in the model (Figure 1) and the 
OR values were transformed to a probability infection with Campylobacter at varying states of the 
risk factor (P(s)) using formula 1 (Table 1). In addition, Campylobacter introduction in the flock 
due to the presence of risk factors was assumed to be conditional to a baseline Campylobacter flock 
prevalence (bp: lowest level of Campylobacter in broilers close to slaughter time found in the 
literature) of 14 % (10).   
 Formula 1 Formula applied to calculate probabilities of the diverse states of risk factors (P(s)) 
based on the baseline Campylobacter flock prevalence (bp) and odds ratios (ORs)  
exp(ln(b / (1 b )) ln(OR ))
( )
1 exp(ln(b / (1 )) ln(OR ))
p p s
p p s
P s
b
− +
=
+ − +
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Table 1 Significant risk factors, frequency of occurrence and associated probability of 
Campylobacter introduction in broiler flocks in Denmark (Chowdhury et al., 2012) 
 
The “Commercial Broilers in Denmark“ model design and assumptions 
This model (Figure 1) was developed to assist poultry producers in Denmark to make decisions 
regarding Campylobacter controls in commercial broilers based on the following assumptions: 
- A microbiological detection level of Campylobacter was considered to be 2 logs CFU/g or ml of 
sample while the maximum colonization level was assumed to be 10 logs CFU/g or ml of 
sample. Thus, in this model, a Campylobacter level of 0-2 logs will produce a negative result 
while a positive result suggests Campylobacter numbers present in the samples from 2 to 10 
Risk factor and frequency of 
occurrence (ref.) 
p-value Odds Ratio (95% CI) Probability 
Campylobacter 
positive* 
Season 
       Summer (28.05%) 
       Fall (22.15%) 
       Spring (25%) 
      Winter (24.8%)a 
<0.001  
12.59 (6.79-23.36) 
  5.27 (2.77-10.02) 
  1.33 (0.66-2.67) 
 
0.6721 
0.4618 
0.178 
Number of persons entering the house 
      >1 person (85.97%) 
        1 person (14.03%) a 
0.009  
2.03 (1.19-3.84) 
 
 
0.2482 
Campylobacter infection status (previous 
flock)    Positive  (21.61%) 
            Negative (78.39%)a 
0.002  
1.80 (1.22-2.63) 
 
0.2266 
Establishment year of the house  
       Before or during 1990 (46.03%) 
       After 1990 (53.97%)a 
0.002  
1.60 (1.17-2.18) 
 
0.2066 
Age of birds at slaughter 
        >35.5 days (45.68%) 
       <=35.5 days (54.32%)a 
 
0.04  
1.33 (1.02-1.76) 
 
0.178 
a Reference category. 
*Based on a basic level of Campylobacter of 14% (Chowdhury et al., 2012) 
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logs. Intervals for bacterial concentration with two log widths (e.g.0-2 logs, 2-4 logs, 4-6 logs, 6-
8 logs and 8-10 logs) were considered. 
- The contributions from different risk factors to the level of Campylobacter are independent.  
- The “measured Campylobacter numbers at slaughter” will depend on the microbiological 
quantitative methods used and the “true numbers” of Campylobacter in chickens. In the model, a 
hypothetical nearly-perfect quantitative method has been considered. 
- The Campylobacter controls included in the model are: the use of fly screens and hypothetical 
Campylobacter vaccines A and B. Fly screens are used during the summer but the costs 
associated with the use of fly screens are always considered (18). 
 
Figure 1 The Commercial Broilers in Denmark (ComBDK) model designed based on 
epidemiological and financial data from Denmark 
Data related to the influence of the risk factors on the expected Campylobacter status of the flock 
are based on a positive (2-10 logs)/negative (0-2 logs) result while data related to the effect of 
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interventions are based on a log-scale because the objective is to develop a control strategy (e.g. 
vaccination strategy) able to reduce the numbers of Campylobacter in commercial broilers. Data 
must be on the same scale to obtain reliable results from the model. For this reason, a mathematical 
transformation from positive/negative to the diverse Campylobacter levels (in logs)-scale has been 
performed. Figure 2 illustrates the mathematical transformation used to translate results from a 
positive/negative format (“Campylobacter slaughter time w/o vaccine”) to a log scale format 
(“Campylobacter slaughter time logs w/o vaccine”). A flat distribution has been selected to 
transform a general expected posterior probability of a Campylobacter flock (e.g. 71.60 %) into a 
distribution of equal probabilities (17.90 %) for the different levels of Campylobacter considered in 
the model (Figure 2).  
 
Figure 2 Illustration showing the part of the model where a mathematical transformation is 
performed to translate results from a positive/negative format (“Campylobacter slaughter time w/o 
vaccine”) to a log scale format (“Campylobacter slaughter time logs w/o vaccine”). 
The effectiveness of Campylobacter controls and cost-reward functions included in the model 
The use of a cost-effective vaccine against Campylobacter in chickens is desirable but no 
commercial vaccine (and price) is currently available. Based on prices of other vaccines used to 
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control diseases in poultry (19), a hypothetical price can be considered to be around 0.15-0.50 
Danish Kroners (DKK). Two hypothetical vaccines (A and B) were incorporated in the model with 
different vaccine effectiveness and costs (Table 2).  
The use of fly screens in poultry houses in order to control Campylobacter has been recommended 
(6, 12, 20). The average cost (including capital costs that cover long term investments and variable 
expenses) of implementing fly screens on broiler farms has been calculated to be 0.13 DKK/chicken 
(18) and it has been included in the model (Table 2). The impact of interventions and the cost-
reward functions are based on a log-scale because the objective is to develop a control strategy that 
can reduce the numbers of Campylobacter in already infected chickens. The use of fly screens can 
reduce the prevalence of Campylobacter in broiler flocks significantly and therefore, in the model it 
was assumed that the effectiveness of fly screens was 90% (expected reduction of Campylobacter 
numbers in more than 2 logs). 
Table 2 Costs and effectiveness related to control measures included in the model 
Control measure Cost (DKK/chicken) Effectiveness (expected reductions of 
Campylobacter numbers in more than 2 logs) 
Vaccine A -0.19  40% 
Vac B -0.45 80% 
Fly screens  -0.13 90% 
Vac A + fly screens  -0.32 95% 
Vac B + fly screens  -0.58 100% 
 
The reward system (Table 3) has been designed based on an “average” gross profit (for Danish 
farmers producing chickens carrying an “average” number of Campylobacter) considered to be 2.92 
(DKK/chicken) based on financial data from 2013 (21). It was assumed that an average broiler 
chicken from a positive flock in Denmark will carry Campylobacter in a concentration of 4 to 6 
logs CFU/g or ml of sample (from the digestive tract). The reward (reward system 1) is based on a 
system implemented in Denmark where poultry producers get an extra payment when the flock is 
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identified as Campylobacter negative before slaughter (personal communication).  In the model, an 
extra payment (around 2%) is given to farmers producing chickens carrying Campylobacter in 
numbers less than 4 logs and a reduced payment (about 4% less) is established for farmers 
producing poultry flocks that carry Campylobacter in numbers greater than 6 logs before slaughter 
(Table 3). 
Table 3 Reward system 1 
Campy level (logs) 0-2  2-4 4-6 6-8 8-10 
Gross profit (DKK/chicken) 3.04 2.98 2.92 2.80 2.69 
Sensitivity analyses 
Sensitivity analyses were performed in order to determine the sensitivity of the decisions considered 
in the model under diverse evidence scenarios with respect to single parameters of the models. In 
the Commercial Broilers in Denmark (ComBDK) model, the following were included: a different 
reward system 2 (based on an extra payment of 2.5 times the normal price for chickens testing 
Campylobacter negative before slaughter) and a cost-effective hypothetical vaccine C (with an 
effectiveness level of 90% and a cost of 0.26 DKK/ chicken). 
RESULTS 
Interpretation of results obtained from the ComBDK model 
A high number of the diverse risk factors’ states and combinations or scenarios could be considered 
in the model and therefore it is up to the user to select the most adequate combination for the real 
life problem under investigation. Three combinations are described in Table 4 in order to illustrate 
the potential outputs of the models in terms of expected posterior probabilities related to 
Campylobacter numbers in chickens and associated expected cost-benefit analyses (Table 5). 
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Table 4 Risk factors and frequency of occurrence in every scenario 
 
Table 5 Results from “Commercial Broilers in Denmark” model  
Scenarios Best Worst ”most likely” 
Decisions Posterior 
probabilities 
related to 
expected 
Campylobacter 
positive results 
(2-10 logs) 
Expected  
cost-
reward 
financial 
balance 
Gross  
profit  
(DKK/ 
chicken) 
Posterior 
probabilities 
related to 
expected 
Campylobacter 
positive results 
(2-10 logs) 
Expected 
cost-
reward 
financial 
balance  
Gross  
profit  
(DKK/ 
chicken) 
Posterior 
probabilities 
related to 
expected 
Campylobacter 
positive results 
(2-10 logs) 
Expected 
cost-
reward 
financial 
balance 
Gross 
profit 
(DKK/ 
chicken) 
None 55% +2.94 87% +2.87 72% +2.90 
Vac A 42% +2.78 65% +2.74 55% +2.76 
Vac B 30% +2.55 46% +2.53 39% +2.54 
Fly 
screens 
55% +2.81 13% +2.89 52% +2.81 
Vac A + 
fly 
screens 
42% +2.65 11% +2.71 40% +2.66 
Vac B + 
fly 
screens 
30% +2.42 9% +2.45 29% +2.43 
 
Best scenario  Worst scenario Real-life scenario (based on study 
data) 
 Winter (100%)  Summer (100%) Summer (28) 
Fall     (22%) 
Spring (25%) 
Winter (25%) 
Age of broilers 
≤35.5 days (100%) 
Age of broilers 
>35.5 days  (100%) 
Age of broilers 
      >35.5 days  (46%) 
      ≤35.5 days  (54%) 
Number of persons 
1 person  (100%) 
Number persons more than 
one person (100%) 
Number of persons 
       1 person (14%) 
       >1 person (86%) 
Campylobacter status 
of previous flock  
Negative    (100%) 
Campylobacter status of 
previous flock  
Positive (100%) 
 
Campylobacter status of previous 
flock  
Positive (22%) 
Negative  (78%) 
Age of poultry houses 
After 1990 (100%) 
Age of poultry houses 
Before 1990 (100%) 
Age of poultry houses 
After 1990 (54%) 
Before 1990 (46%) 
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Results obtained from the model based on the previously described assumptions suggested that the 
best solution in financial terms will be to use the fly screens alone in the worst case scenario and not 
to implement the controls under the assumed conditions in the “most likely” and best case 
scenarios. Nevertheless, the best solution from a public health point of view will be the use of fly 
screens and vaccine B synergistically. Based on the results from the model, this strategy (fly screens 
and vaccine B) can decrease significantly the posterior probability related to expected 
Campylobacter positive results in all scenarios (from 72% to 29% in the most likely scenario; from 
55% to 30% in the best scenario and from 87% to 9% in the worst case-scenario) although the 
implementation of this strategy will translate on a decrease of expected gross profit (around 0.50 
DKK/chicken). During the summer, the use of fly screens alone and/or synergistically with vaccines 
A or B may be able to reduce the posterior probability related to expected Campylobacter positive 
results below the considered “baseline level of 14%”. In fact, using fly screens alone during the 
summer will reduce the posterior probability related to expected Campylobacter positive results 
from 87% to 13% resulting also in a small increase of the expected gross profit (based on the cost-
reward balance). 
 
3.2. Results from the sensitivity analyses 
Results from the model when using the reward system 2 (based on an extra payment of 2.5 times 
the normal price for chickens testing Campylobacter negative before slaughter) and the diverse 
control options (including vaccine C) are presented in Table 6. 
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Table 6 Results from the model when considering reward system 2 and an additional vaccine C 
Scenarios Best Worst ”most likely” 
Decisions Posterior 
probabilities 
related to 
expected 
Campylobacter 
positive results 
(2-10 logs) 
Expected  
cost-
reward 
financial 
balance 
Gross  
profit  
(DKK/ 
chicken) 
Posterior 
probabilities 
related to 
expected 
Campylobacter 
positive results 
(2-10 logs) 
Expected 
cost-
reward 
financial 
balance  
Gross  
profit  
(DKK/ 
chicken) 
Posterior 
probabilities 
related to 
expected 
Campylobacter 
positive results 
(2-10 logs) 
Expected 
cost-
reward 
financial 
balance 
Gross 
profit 
(DKK/ 
chicken) 
None 55% +4.89 87% +3.37 72% +4.07 
Vac A 42% +5.47 65% +4.46 55% +4.92 
Vac B 30% +5.87 46% +5.29 39% +5.56 
Fly 
screens 
55% +4.76 13% +6.76 52% +4.90 
Vac A + 
fly 
screens 
42% +5.34 11% +6.68 40% +5.44 
Vac B + 
fly 
screens 
30% +5.74 9% +6.51 29% +5.80 
Vac C 29% +6.18 44%  +5.69 37% +5.91 
Vac C + 
fly 
screens 
29% +6.05 9% +6.72 28% +6.10 
 
Sensitivity analyses performed showed that the financial variables (cost/reward functions) and to a 
lesser extend the effectiveness of the control measures (e.g. vaccination impact) drive the model’s 
results. The results presented in Table 5 (Reward system 1) and Table 6 (Reward system 2) indicate 
that the posterior probabilities related to expected Campylobacter positive results are the same but 
the financial results (cost-benefit balances) are very different. As a result of implementing reward 
system 2 the farmers will potentially obtain higher payments and the differences between 
implementing diverse controls are more pronounced.  
The effectiveness of vaccines B and C are very similar but vaccine C is more cost-effective and 
desirable for this reason. From a public health perspective, the best Campylobacter control strategy 
will be the use fly screens together with vaccine B or C. However, from an economic point of view, 
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the best solution will depend on the scenario considered, for example, in the most likely scenario, 
the best solution will be using fly screens and vaccine C while in the worst case scenario (during the 
summer) the use of fly screens alone is most rewarding financially. The use of vaccine C alone in 
the best case scenario seems to be the most cost-effective strategy based on the results from the 
model. 
Discussion  
Poultry producers need to make decisions and sometimes expensive investments to control 
Campylobacter before they even know for sure if the flock will become infected or challenged with 
Campylobacter. The integration of increasing amounts of knowledge from diverse sources makes 
the decision process complex but if done properly, the accuracy of the results will increase and 
there will be less uncertainty surrounding the decision making process. Bayesian inference is used 
when decisions have to be made under conditions of uncertainty and statistical inference is required 
(22). Many potential risk factors for the introduction of Campylobacter in poultry flocks may be 
considered in predictive models increasing their complexity (15). The development of a generic 
global model would be almost utopic because risk factors may vary between geographical regions 
as well as between production systems (23-25). For this reason, it seems useful to include risk 
factors found to be statistically significant for the introduction of Campylobacter in poultry flocks 
under specified conditions. Results related to the control of Campylobacter in broiler flocks in 
Denmark obtained from the developed model depend on the qualitative and quantitative data 
considered. The risk factors incorporated in this model were those found significant for the presence 
of Campylobacter in Danish broilers in a recent study (10). Other studies have also found a clear 
correlation between biosecurity-related risk factors and flock infection with Campylobacter (26, 
27). 
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More Campylobacter controls could have been incorporated in the model but the complexity will 
increase accordingly. For example, hygiene barriers have been suggested as the most important 
biosecurity measures to produce Campylobacter-free chickens (28-31). The use of fly screens has 
been recommended for the control of Campylobacter in Danish broiler systems (5, 6, 12, 20). The 
effectiveness of the use of fly screens against Campylobacter in poultry has been reported in terms 
of decreased Campylobacter prevalence in broiler flocks in Denmark. The experimental use of fly 
screens during the 2006 summer (June–October) produced a statistically significant decrease from 
51.4% to 15.4% of Campylobacter positive flocks in comparison with control houses (6). A 
recently published study (20) reports data related to the long-term effect of the use of fly screens on 
the prevalence of Campylobacter in broiler flocks in Denmark collected over the years 2006-2009. 
These authors reported a statistically significant decrease in Campylobacter prevalence from 41.4% 
in 2003–2005 (before the use of fly screens) to 10.3% in 2006–2009. The use of fly screens was 
tested on poultry farms in Iceland during the summer of 2008 and significant reductions on 
Campylobacter prevalence were observed (32). Results from the experimental studies previously 
mentioned relate to average Campylobacter prevalence values obtained from diverse farms and 
flocks and therefore different farming conditions.Comparison of the results related to the use of fly 
screens on broiler farms previously reported (6, 20, 32) with the results from the ComBDK model 
presented here are not straight forward. Results from the ComBDK model are based on one flock 
level and the expected posterior probability related to a Campylobacter positive result for that flock 
under specific conditions. Even more, a “nearly perfect” quantitative microbiological test has been 
incorporated in the model and consequently results related to the expected probability of a 
Campylobacter positive result might be higher than the real result if a quantitative Campylobacter 
test was performed in that particular flock (the detection limit of most microbiological test are 
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around 2 logs). Nonetheless, the flexibility of the model allows the user to test diverse controls, 
different farming conditions, microbiological protocols and cost-reward systems.  
Sensitivity analyses performed indicated that the factors that influenced the results to a greater 
extent were the financial variables (cost/reward functions) and the effectiveness of the 
Campylobacter control strategies. The assessment of the effectiveness of control strategies might 
prove challenging in some cases e.g. the assessment of vaccine effectiveness (13). The effectiveness 
of fly screens was assumed to be 90% but only used during the summer. The financial impact of the 
implementation of disease control strategies needs to be considered in disease control programs. 
The financial results obtained from the model seemed to be highly dependent on the reward systems 
and the scenarios considered. From a public health perspective, the best Campylobacter control 
strategy will be the use fly screens alone or synergistically with vaccine B or C. In some occasions, 
the financial results obtained from the model indicated that the expected financial gains might be 
too small to justify the implementation of controls. Nevertheless, this type of information might 
prove very valuable and it is likely that producers will find this decision making tool more 
beneficial at times when the consequences from implementing alternative decisions for the control 
of Campylobacter are not so obvious.  In contrast, when considering the most cost-efficient choices 
(e.g. reward system 2 and the use of vaccine C) significant reductions in expected Campylobacter 
levels and substantial expected financial gains were obtained. Sensitivity analyses can be used to 
test diverse hypothetical vaccines and reward systems in order to compare them and their 
combinations. Clearly, cost-effective control measures will be preferred by poultry producers and a 
reward system that can translate on an attractive cost-reward balance will be a good incentive for 
producers to implement Campylobacter control strategies in poultry production. The 
implementation of cost-effective control strategies during primary poultry production will 
potentially translate into a decrease of Campylobacter prevalence in chickens, a reduction of 
18 
 
Campylobacter numbers in poultry products and in turn, a decrease of human campylobacteriosis 
cases. From a public health perspective, a Campylobacter prevalence level of 10% in broilers could 
potentially result in a reduction of human cases by nearly 50% (5, 33).  
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9.  GENERAL DISCUSSION AND CONCLUSIONS 
A reduction of the incidence of human campylobacteriosis cases has been documented following 
temporary limitation on the consumption of chicken meat in the Netherlands and Belgium, after 
successful implementation of Campylobacter controls in poultry in Iceland, Denmark and New 
Zealand (Vellinga et al., 2002; Stern et al., 2003; Rosenquist et al., 2009; EFSA, 2010b; Sears et 
al., 2011) and it has been forecasted by risk assessment models (Rosenquist et al., 2003; Nauta et 
al., 2009; EFSA, 2011b). Risk assessments conducted in Denmark (Rosenquist et al., 2003), the 
Netherlands (Nauta et al., 2005), United Kingdom (Hartnett et al., 2001, 2002) and New Zealand 
(Lake et al., 2007) provide “farm-to-fork” estimations of the risk of human Campylobacter 
infection via the consumption of poultry meat. Risk assessments aim to assess the public health 
risks associated with the consumption of contaminated poultry meat but also to assess the 
effectiveness of potential control measures (Rosenquist et al., 2003; Nauta et al., 2005). The 
evidence demonstrates that efforts directed towards the control of foodborne campylobacteriosis 
and in particular, successful implementation of effective control strategies against Campylobacter in 
poultry can produce additional public health benefits (Baker et al., 2012) because humans might 
become infected via other pathways apart from poultry meat. The production of Campylobacter-
free flocks has been achieved experimentally although under commercial conditions can be 
challenging but not impossible. Currently there is no one single decontamination technology alone 
capable to eliminate Campylobacter or reduce it to negligible levels in foods without altering food 
characteristics. Consequently, an integrative approach must be followed in order to control food-
borne Campylobacter, implementing several effective control measures throughout the food chain. 
An integrated approach to the control of Campylobacter in poultry has been adopted in Denmark 
where increased biosecurity, allocation of meat from positive flocks to the production of frozen 
foods and consumer education campaigns have led to a significant decrease in Campylobacter 
prevalence in broiler flocks (from 43% in 2002 to 27% in 2007), a reduction of Campylobacter-
positive samples of fresh broiler meat and a decrease in registered human cases by 12% from 2002 
to 2007 (Rosenquist et al., 2009). The synergistic application of effective control measures against 
Campylobacter such as freezing, irradiation and proper cooking could achieve a human risk 
reduction of 90-100% assuming that no re-contamination occurs (Havelaar et al., 2007a/b; EFSA, 
2011a). On the other hand, estimations of the effectiveness of controls against Campylobacter are 
uncertain, frequently based on limited data that might not be representative. 
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Extensive research has been conducted to identify the most effective Campylobacter control 
strategies that could be implemented during poultry production. For example, a considerable 
number of epidemiological studies have been conducted to identify significant risk factors for 
Campylobacter infections in poultry and to assess the effect of interventions for the control of 
Campylobacter in poultry from farm to fork. On-farm controls based on identified risk factors for 
Campylobacter infection of poultry may be effective. An extensive review of the potential control 
measures and interventions against Campylobacter in poultry production from “farm-to-fork” has 
been provided in Chapter 5 of this thesis.  
Estimated Campylobacter prevalence in the environment around broiler houses from different farms 
seems to be quite similar independently of the biosecurity level (Hald et al., 2000; Hansson et al., 
2007; Ridley et al., 2011a). Consequently, Campylobacter must be carried from the environment 
into chicken houses. First of all, controls should be implemented to avoid Campylobacter 
introduction from the environment into poultry flocks, once a bird is colonized with Campylobacter 
the rest of the birds will be infected in a short time (Jacobs-Reitsma, 1997). Once Campylobacter is 
present in poultry flocks, control strategies should be implemented in order to reduce the numbers 
of Campylobacter in chickens and their environment. Some Campylobacter control strategies aim 
to reduce the numbers of Campylobacter in the digestive tract of chickens to achieve a reduction of 
Campylobacter in chicken meat. Additionally, controls should be implemented during transport, 
slaughter, further processing and retail in order to reduce the numbers of Campylobacter in already 
infected chickens, to avoid contamination of the food processing environment and to protect 
Campylobacter-free chickens and their products from being contaminated. Moreover, cleaning and 
disinfection of poultry houses, transport materials, food processing areas should be effective 
inactivating Campylobacter. The poultry house becomes contaminated with Campylobacter for a 
long time when a poultry flock becomes positive (Hiett et al., 2002; Herman et al., 2003; Johnsen et 
al., 2006). The presence of previous Campylobacter positive flocks in a house has been found as a 
significant risk factor for Campylobacter infection of new flocks (Refregier-Petton et al., 2001; 
Chowdhury et al., 2012).  
The implementation of effective biosecurity measures seems crucial to prevent Campylobacter 
introduction into the poultry houses (Ridley et al., 2008, 2011a, 2011b). A clear correlation between 
the level of biosecurity and poultry flock infection with Campylobacter has been observed in 
Norway and Senegal (Cardinale et al., 2004; Johnsen et al., 2006). Additionally, synergistic effects 
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are expected from the implementation of several biosecurity control measures. The implementation 
of hygienic measures and biosecurity barriers such as the control of rodents and insects produced 
significant reductions in Campylobacter prevalence of broiler flocks in the Netherlands (van de 
Giessen et al., 1998). Although high levels of hygiene and biosecurity may not be sufficient to 
produce a Campylobacter-free flock, the risk of Campylobacter introduction into poultry flocks 
may decrease considerably (Gibbens et al., 2001). Increased biosecurity could be particularly 
important at times of the year when the risk of introducing Campylobacter in broiler flocks is 
considered high due in part to seasonality effects (Kapperud et al., 1993.; Jacobs-Reitsma et al., 
1994; Berndtson et al., 1996; Evans and Sawyers, 2000; Refregier-Petton et al., 2001; Bouwknegt 
et al., 2004; Hofshagen and Kruse, 2005; Puterflam et al., 2005; Russa et al., 2005; Barrios et al., 
2006; Johnsen et al., 2006; McCrea et al., 2006; Hansson et al., 2007; Huneau-Salaun et al., 2007; 
McDowell et al., 2008). In Denmark, the use of fly screens during the summer to prevent the access 
of flies to poultry houses has been recommended (Hald et al., 2004, 2007a/b; Bahrndorff et al., 
2013).  
Field trials need to be conducted to examine the practical effects of the most promising 
Campylobacter control measures. The effectiveness of some control strategies such as phage 
therapy, vaccination and competitive exclusion products may be influenced by the genomic 
instability of Campylobacter (Ridley et al., 2008a). Campylobacter strains and the type of 
production system will influence the results of field trials. Campylobacter prevalence in free-range 
poultry flocks is usually higher than in poultry flocks produced in intensive conditions (Lund et al., 
2003; Ring et al., 2005; McCrea et al., 2006). Even more, controls that aim to avoid Campylobacter 
introduction in flocks produced in extensive conditions might not work because Campylobacter is 
highly prevalent in the environment and can resist environmental stresses (Garcia and Percival, 
2011).  
The poultry industry needs to be highly integrated in order to maintain profit margins which are 
usually very low and to meet consumer demands. Campylobacter control measures that can be 
applied at low cost are generally accepted by the poultry industry although the consistency with 
which the controls are implemented may vary. On the other hand, controls that require efforts 
and/or extra costs are not usually welcome by poultry producers. For this reason, proposed controls 
should be backed up with strong evidence of effectiveness and a satisfactory viable cost-benefit 
balance. Nevertheless, food producers need to comply with relevant legislation related to the 
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protection of public health. The poultry industry should implement and sustain best hygiene 
practices through adequate assessment, monitoring and staff education and motivation (Berndtson et 
al., 1996; van de Giessen et al., 1998). 
Some controls against Campylobacter in poultry production can be relatively easy to implement at a 
low cost while other strategies might be more difficult to introduce, to maintain and/or might be 
expensive. Some controls could be easy to implement but the consumers’ preferences and/or food 
market characteristics might impede the implementation of such controls. For example, reducing the 
slaughter age of poultry may be an effective control strategy that could be used synergistically with 
other Campylobacter controls (Newell et al., 2011). However, some consumers demand chickens of 
a particular weight when sold at retail and the production of smaller chickens might not be accepted 
by consumers. Consumers should also be properly informed about the safety of some food controls 
(Jordan and Stockley, 2010). For example, consumers seem to appreciate the benefits and safety of 
irradiation as a food safety control; as a result, several countries are implementing irradiation of 
chicken products for the control of pathogens such as Campylobacter (International Consultative 
Group on Food Irradiation [ICGFI], 1999). 
Accurate and reliable Campylobacter quantitative data are crucial for Campylobacter risk 
assessments and for the assessment of Campylobacter control strategies. However, there seems to 
be no consensus regarding the most appropriate sampling protocol to obtain accurate 
Campylobacter quantitative data. Quantitative microbiological data and data analyses results will be 
influenced by the sampling protocol (including methods, sample size, sample origin, time of 
sampling and other aspects). For example, samples obtained on farm and/or at the slaughterhouse 
are usually pooled for practical reasons but quantitative data related to the concentration of 
Campylobacter in chickens might differ between individual and pooled samples. In this thesis, we 
present research conducted to share light in some of these aspects related to the production of 
accurate Campylobacter quantitative data. In our studies, high variability between chickens was 
observed related to the numbers of C. jejuni recovered from caecal samples and fecal samples at 
different time-points in agreement with other findings that showed that Campylobacter colonization 
levels differ between broiler chickens (Hansson et al., 2010). Even more, in our studies, results 
from mixed linear models indicated that the most of the variation can be attributed to individual 
chickens and to a lesser extent to the isolators suggesting that in commercial situations, differences 
might be observed between flocks but even greater differences might be expected due to individual 
chickens. This research finding suggests that individual factors such as chicken genetics may affect 
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Campylobacter dynamics in poultry flocks (Stern et al., 1990). What's more, in commercial farms 
chickens might be infected with Campylobacter at different times and diverse initial concentrations 
while in this study broilers were inoculated with the same dose of C. jejuni at the same time. In 
addition, poultry digestive physiology might influence the intermittent excretion of Campylobacter. 
As a result, concerns are raised in relation to limited sampling of poultry flocks not being 
representative of the real Campylobacter situation in large flocks. Moreover, faecal samples 
collected on farm might not be a good predictor of the caecal load of Campylobacter in individual 
chickens going for slaughter (Hansson et al., 2010). Additionally, results from this study suggest 
that pooling of samples will probably lead to an underestimation of the numbers of Campylobacter 
in the flock.  
In our studies, Campylobacter jejuni concentrations in fecal samples were slightly lower than in 
caecum samples, nevertheless, a significant correlation was observed between faecal and caecal C. 
jejuni concentrations at slaughter (r = 0.7; C.I. = 0.5 – 0-8) suggesting that Campylobacter counts 
from fecal samples at slaughter might be a good indicator of Campylobacter concentration in the 
caecum at slaughter. This significant correlation is in agreement with other studies (Fluckey et al., 
2003) supporting recommendations made related to the sampling of chickens closer to slaughter 
time (Hansson et al., 2005). Moreover, if there is a significant positive correlation between the 
numbers of Campylobacter in chickens at slaughter and the numbers of Campylobacter in carcasses 
as it has been suggested (Rosenquist et al., 2003; Lindblad et al., 2005; Reich et al., 2008), 
Campylobacter testing of fecal samples from chickens just before slaughter will aim on the 
implementation of Campylobacter control strategies such as logistic, schedule slaughter and others. 
Vaccines against Campylobacter have been developed for humans (Baqar et al., 1995; Scott, 1997, 
Scott and Tribble 2000), chickens (Khuory and Meinersmann, 1995; Newell and Wagenaar, 2000; 
Noor et al., 1995; Rice et al., 1997; Widders et al., 1996) and other animals. However, a general 
cost-efficient vaccine for the control of Campylobacter in chickens and humans has not been 
developed despite years of research (Jagusztyn-Krynicka et al., 2009). A successful commercial 
vaccine should be safe, cost-effective and produced in large quantities. Conventional vaccines 
usually perform poorly when applied to chickens due to the interaction of Campylobacter with the 
intestinal niche in poultry (Ringoir and Korolik, 2003; Walker, 2005). Moreover, immunity against 
Campylobacter seems to be strain-specific. Hence, the development of a vaccine able to protect the 
host against all Campylobacter strains seems challenging. The use of genomics and proteomics for 
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the identification of genes that are essential for Campylobacter colonization of chickens and new 
antigens may be crucial for the development of an effective vaccine against all Campylobacter 
strains in poultry (Jagusztyn-Krynicka et al., 2009). 
In this thesis, we have presented clinical trials conducted for the assessment of the Campylobacter 
vaccine ACE393 in broilers under experimental conditions. Ideally, a statistically significant 
reduction of the numbers of Campylobacter in vaccinated chickens (by at least 2 logs) was 
expected. The potential effect of the vaccine was analyzed using diverse data analyses methods of 
increased complexity. Results from our vaccination experiments indicated that the apparent 
observed differences between vaccinated and placebo groups related to Campylobacter counts 
could be attributed to the variation between birds in the same group and between groups. Data 
analyses using methods that did not consider the experimental design indicated that some 
differences between vaccinated and placebo groups related to Campylobacter counts were 
statistically significant (based on a significance level of p-value<0.05) although the desired vaccine 
effect (reducing Campylobacter counts in vaccinated chickens by 2 logs) was never achieved. 
However, when taking on account the hierarchical design, the results from the mixed linear models 
indicated that the differences between vaccinated and placebo broilers in terms of the numbers of C. 
jejuni recovered were not statistically significant, based on a significance level of p-value<0.05. It 
was concluded that there was no statistically significant effect of the vaccine ACE 393 in this 
clinical trial in broilers under the experimental conditions applied. We demonstrated how crucial is 
to consider the “clustering effect” when analyzing quantitative data and also when designing 
multilevel clinical trials. Clustered designs are desirable in some cases although they can be more 
costly and require more individuals and more complex data analysis. 
In conclusion, sampling protocols and microbiological techniques used for the detection and 
quantification of Campylobacter will influence the results of Campylobacter testing in poultry 
and/or research studies e.g. the effect of vaccines in clinical trials. Moreover, quantitative 
microbiological data need to be properly analyzed. Sample size calculations and forecasted group 
effects need to be carefully considered during the experimental design phase. Additionally, data 
analysis methodologies should be carefully selected based on the experimental design (Garcia et al., 
2012). 
 
Campylobacter Control in Poultry 
 
113 
 
Reliable Campylobacter quantification is crucial to assess public health risks and to ensure food 
safety. Consequently, fast, sensitive and accurate methodologies and data analysis techniques need 
to be properly tested, improved or developed. Real-time PCR is considered a promising technique 
for the accurate quantification of Campylobacter on chicken carcasses (Josefsen et al., 2010). Real-
time PCR allows for the detection and quantification of viable but non-culturable (VBNC) 
microbial forms that might be of public health relevance in some cases (Postollec et al., 2011). On 
the other hand, accurate direct (without the use of enrichment) quantification of viable 
Campylobacter in complex biological samples such as chicken feces can be challenging (Rudi et 
al., 2004; Leblanc-Maridor et al., 2011). In the studies presented in this thesis, several DNA 
extraction methods were assessed in their effectiveness for the direct quantification of 
Campylobacter jejuni present in spiked chicken fecal samples using real-time PCR. Moreover, two 
of the methods (Easy-DNA and MiniMAG extraction methods) were used to quantify 
Campylobacter (by real-time PCR) present in different naturally infected chicken fecal samples and 
the results were compared to Campylobacter quantitative data obtained from traditional culture. 
When using real-time PCR, amplified DNA from dead cells may lead to an overestimation of the 
numbers of the target organism or even false-positive results (Wolffs et al., 2005). For that reason, 
it was expected that quantification results from real-time PCR were higher than those obtained by 
traditional culture. The results indicated that there were differences between Campylobacter 
quantification data obtained by culture and by real-time PCR when using two different extraction 
methods (Easy-DNA and MiniMAG extraction methods). However, there were no statistically 
significant differences between culture and real-time PCR in these studies. Several reasons can be 
hypothesised to try to explain the results obtained. The presence of inhibitors in chicken fecal 
samples can reduce the efficiency of real-time PCR assays significantly (Perch-Nielsen et al., 2003; 
Guy et al., 2003; Rådström et al., 2004; Sunen et al., 2004; Jiang et al., 2005; Stratagene, 2004). In 
theory, overestimation of the numbers of the target organism are expected when using real-time 
PCR but due to the presence of inhibitors, this effect might be suppressed which could explain the 
similar results obtained by real-time PCR and culture in this study. The fact that chicken fecal 
samples were used for the preparation of spiked samples and construction of standard curves could 
partly explain this agreement because we already accounted for the effect of inhibitors that may be 
present in chicken fecal samples when building the standard curves. It could also be possible that 
not a great amount of stressed Campylobacter cells, VBNC Campylobacter states or free 
Campylobacter DNA were present in the naturally infected samples because samples were fresh 
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and processed within 30 hours of collection. This observation could also explain the statistical 
agreement between Campylobacter quantification results obtained by culture and by real-time PCR. 
Novel and accurate methods able to discriminate between the different Campylobacter viable and 
non-viable states could share light in this matter. 
 
The culture used for spiking in our studies was prepared with a particular strain of C.jejuni CCUG 
11284 but the use of several Campylobacter strains has been recommended (Greer et al., 1992; Birk 
et al., 2010; Boyse, 2012). Moreover, research data based on naturally infected birds and 
commercial production conditions are desirable. For these reasons, the selected two DNA extraction 
methods were tested using chicken fecal samples naturally infected with Campylobacter and more 
than one Campylobacter strain were likely to be present in these samples.  
The assessment of Campylobacter controls in poultry will partly depend on the quantitative 
microbiological techniques used and hence the use of reliable and accurate techniques for 
Campylobacter quantification in diverse samples is crucial. A thorough investigation of the 
inhibitors present on particular sample matrices is desirable in order to design the best sample 
treatment and select the most appropriate DNA extraction methodology. Rigorous real-time PCR 
data analyses and accurate estimations of efficiencies of each real-time PCR reaction will be ideal. 
Though, this approach might be demanding in terms of time and other resources. On the other hand, 
experimental variability can be very high even when the best methodologies are used and 
experiments are performed under controlled conditions. Variability between different PCR plates or 
runs can be high; even when considering only one specific PCR plate, intra-plate variability can be 
significant (Karlen et al., 2007).  In fact, biological variability between samples and replicates can 
also be high and partly explain different real-time PCR efficiencies and therefore should be 
accounted for when analysing real-time PCR data. Novel mathematical methods to calculate PCR 
efficiencies and quantification of samples have been developed (Lalam et al., 2004). The use of 
nonlinear regression analysis has been proposed instead of relying on the cycle threshold method 
for absolute sample quantification (Goll et al., 2006). Stochastic models such as Bayesian models 
have also been designed to analyze real-time PCR experimental and simulated data (Lalam, 2007).  
 Accurate and reliable enumeration of viable pathogens present in foods and/or environmental 
samples will assist exposure assessment, risk assessment models and the evaluation of the 
effectiveness of food safety measures and public health protection programs. In particular, accurate 
and reliable quantification of Campylobacter in poultry will provide good quality data for the 
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probabilistic models presented in this thesis that have been designed to assist the poultry industry in 
making decisions related to the control of Campylobacter in poultry. Increased consumer concerns 
related to food safety are applying pressure on food producers to implement food safety assurance 
systems. Poultry producers need to make important and complex decisions and related investments 
(sometimes expensive) for the sustainability of their businesses. In particular, poultry producers 
should implement effective controls against Campylobacter in poultry to increase food safety and to 
reduce the burden of human campylobacteriosis. The use of decision support systems can aid 
poultry producers to make difficult decisions under conditions of uncertainty. Decisions on 
vaccination and other public health controls have to be generally made under conditions of 
uncertainty. Probabilistic graphical models (PGMs) are widely used to support knowledge 
management and decision making under conditions of uncertainty (Kjærulff and Madsen, 2008; 
Darwiche, 2009; Koller and Friedman, 2009; Madsen et al., 2012). PGMs represent knowledge and 
probabilistic conditional relationships in structured models designed to represent real situations 
where uncertainty plays an important role. PGMs use Bayesian networks and other methods to deal 
with uncertainty and efficiently represent and integrate knowledge obtained from sources such as 
epidemiological data, scientific knowledge, research data and expert opinions in order to support 
decision processes made under conditions of uncertainty. 
 
Several probabilistic graphical models have been designed and presented in this thesis to assist in 
decision making regarding Campylobacter vaccination of poultry and/or other Campylobacter 
control strategies. Considerations regarding the epidemiological and microbiological factors to be 
included in the models together with important challenges for the development of the quantitative 
part of the models were included in this thesis. Generic conceptual models for the control of 
Campylobacter in poultry that could be applied to many different real-life situations, poultry 
farming conditions and geographical areas were presented in this thesis. However, the quantitative 
part of generic models presents important challenges. For that reason, our recommendation is that 
specific PGMs may be constructed or adapted to address particular decision making processes 
under specific circumstances. Moreover, the conditions, model assumptions, selection of factors, 
different parts of the models, quantitative data should be clearly specified to add value and 
perspective to the decision support system designed in every case.  
The selection of factors to include in the models and the use of reliable, good quality data will 
significantly influence the results of the models. In our models, we distinguished between the true 
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numbers of Campylobacter in birds and the detected or measured numbers. The latter depends on a 
number of factors such as sampling protocols and quantitative microbiological methods. Some 
quantitative microbiological techniques are being tested, improved or under development and the 
detection limit of most methodologies seems to be 100 CFU/g or ml (depending on sample type and 
sample preparation). Even more, as explained previously in this thesis, the quantification limit can 
be higher than the detection limit when using some microbiological methods. Consequently, we 
considered in our models that a negative result might actually indicate low numbers of 
Campylobacter in samples (1 to 100 CFU/ g or ml). It was also considered that a positive result will 
translate on a distribution of the numbers of Campylobacter in chickens in a flock between 2 and 10 
logs because it seems difficult to obtain continuous accurate data on the numbers of Campylobacter 
in chickens in a flock during the rearing period. Even more, chickens might carry Campylobacter at 
different concentrations; as previously shown in this thesis, variability between chickens in a flock 
can be considerable.  
Sensitivity analyses performed using specific models indicated that the factors that influenced the 
results to a greater extent were the financial variables (cost/reward functions) and the effectiveness 
of the control strategies considered, e.g. vaccination impact. The results from specific models 
indicated that the public health impact of the control strategies considered in the models will greatly 
depend on the effectiveness of the controls, costs of the controls and the reward systems. The 
assessment of the effectiveness of diverse control strategies might prove challenging especially 
when the control measure is innovative or not even commercially available e.g. the assessment of 
Campylobacter vaccines. 
Campylobacter control strategies that can significantly reduce the probability of Campylobacter 
introduction into a flock and/or the numbers of Campylobacter in already infected chickens should 
be implemented from a public health perspective. On the other hand, poultry producers will usually 
base their strategic decisions on financial gains and consequently a reward system that can translate 
on an attractive cost-reward balance will be a good incentive for poultry producers to implement 
Campylobacter control strategies. The reward system might not be in place in most parts of the 
world, as a result it could be hypothesized for inclusion in the models. Reward systems could be 
designed based on the gross profit/per chicken for farmers in specific areas and/or production 
systems (e.g. organic farmers might obtain a higher gross profit/chicken than farmers producing 
commercial broilers). Financial gain will also depend on the effectiveness of the vaccine (and/or 
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other control strategies) and the costs associated with the controls. A cost-efficient vaccine against 
Campylobacter in chickens is not commercially available at present. We considered that the market 
price of a cost-effective vaccine against Campylobacter in chickens should be less than 10% of the 
gross profit per chicken to be competitive. However, the market price could be higher depending on 
the effectiveness of the vaccine and the reward system. The flexibility of PGMs allows for the 
inclusion and comparison of more than one Campylobacter vaccine and other control measures and 
more than one reward system. Tailor-made properly developed PGMs will assist poultry producers 
to make important decisions in order to solve complex problems such as the control of 
Campylobacter. Even more, engagement of different stakeholders in the PGMs development 
process is highly desirable. The use of sophisticated and complex computing interfaces and 
mathematical expressions and probabilities distributions needs to be reconciled with a simple and 
efficient tool that can be used by different stakeholders (Madsen et al., 2012). On the other hand, 
newer technologies seem to be more flexible in relation to supporting individuals’ creativity and 
innovation.  
In conclusion, Campylobacter controls in poultry should be cost-effective, reliable, easy to 
implement, easy to maintain and accepted by consumers. Consumers’ acceptance is highly relevant; 
for example, in the case that a cost-effective vaccine against Campylobacter in poultry was finally 
commercialized but not accepted by the consumers, significant efforts and investments made could 
be lost.  
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10.  PERSPECTIVE AND FUTURE TRENDS 
 
Ideal Campylobacter control strategies should be safe, cost-effective, cheap, easy to implement and 
maintain and accepted by the industry and consumers. Innovative controls and/or integration of 
effective controls should be investigated further and potential short-term and long-term 
consequences should be considered.  For example, some antibiotics may reduce C. jejuni 
concentrations in chickens (Farnell et al., 2005; Hermans et al., 2010). However, there are huge 
concerns regarding antimicrobial resistance problems in humans and animals (CWF, 2011) and 
antibiotics may only be used therapeutically when prescribed by a veterinarian. Effective vaccines 
offer a good alternative to the use of antibiotics. Successful vaccines will probably be the most 
effective control against Campylobacter but the availability of a cost-effective commercial vaccine 
remains a major goal (Djenane and Roncalés, 2011: Garcia et al., 2012) mainly due to the absence 
of a strong immune response against Campylobacter in chickens (de Zoete et al., 2007). Genetic 
selection of poultry with superior immunological responses to Campylobacter could be explored 
further (Kapperud et al., 1993; Swaggerty et al., 2009). What’s more, the genetic diversity of 
Campylobacter might hamper controls based on immunization of chickens. The design of a cost-
efficient vaccine that can decrease the numbers of all pathogenic strains of Campylobacter in 
poultry is desirable. In addition, the vaccine administration method might influence the results of 
clinical trials and/or the commercialization of the vaccine for use in poultry production systems. In 
the clinical trials presented in this thesis, the vaccine ACE 393 was administered intramuscularly 
following instructions from the manufacturer. Nevertheless, oral administration of vaccines against 
Campylobacter in poultry might be the preferred option. 
Theoret et al., (2012) performed oral vaccination of chickens (via oral gavage) with a recombinant 
attenuated Salmonella enterica strain synthesizing the C. jejuni Dps protein with promising results. 
The attenuated Salmonella vector achieved a reduction of 2.5 logs of C. jejuni numbers in 
vaccinated chickens. Experimental trials conducted at the University of Arizona as part of the 
CamVac project demonstrated that water vaccination in poultry is feasible. The vaccine utilized in 
these trials was a Salmonella vector expressing CjLAJ1 administered in the chickens' drinking 
water which resulted in a reduction of Campylobacter counts in vaccinated chickens by 2.5 logs 
CFU (personal communication). Greater variability related to the numbers of Campylobacter was 
observed in vaccinated groups possibly as a reflection of differences in protection levels related to 
the different vaccine doses ingested by chickens (via drinking water).  
Campylobacter Control in Poultry 
 
119 
 
The use of antibodies against Campylobacter in poultry has been proposed. In fact, a strong 
protection against C. jejuni in chickens seemed to be induced by the oral administration of 
immunoglobulin preparations from milk or eggs (Tsubokura et al., 1997). In a recent preliminary 
study conducted by Heegaard et al. (2012) avian immunoglobulins (200 mg) were administered to 
chickens orally together with the challenge (at day 21 of age). Results showed that caecal and faecal 
counts of Campylobacter were between 0.5 and 1.0 log lower in birds treated with avian 
immunoglobulins. Immunoglobulins can be produced in great quantities from renewable sources 
but the price of the immunoglobulin products needs to be low to become a real alternative to 
antibiotics. 
The implementation of Campylobacter controls “from farm-to-fork” may require great efforts and 
investments. For this reason, the development and application of mathematical models to estimate 
and compare potential effects of interventions “from farm-to-fork” can be very useful (Nauta et al., 
2009; EFSA, 2011). The results from the models will partly depend on high quality quantitative 
microbiological data. In future studies, novel and thorough analytical and/or statistical methods 
could be applied to accurately quantify viable pathogens such as Campylobacter present in 
biological samples. Even more, innovative Campylobacter control strategies could be tested 
experimentally and/or included in mathematical models for the assessment of potential 
effectiveness. New technologies such as nanotechnology and reverse vaccinology can provide novel 
food safety controls (Malsch, 2005). Innovations in control strategies, quantitative microbiological 
and mathematical methods and the integration of advances related to high quality data collection 
and data management will assist producers in making important decisions related to Campylobacter 
controls in poultry production. From a public health perspective, results from mathematical models 
in terms of reduced risk and/or decreased numbers of Campylobacter in chickens after the 
implementation of controls could be translated into the expected reduction in human 
campylobacteriosis cases using mathematical models such as risk assessment models.  
 
Socio-economic aspects related to the implementation of Campylobacter control strategies in 
poultry production should not be ignored. The poultry industry generally works within narrow 
profit margins and for that reason, poultry producers will usually make strategic decisions based on 
financial gains. On the other hand, food producers might be inclined to offer products that may 
increase their popularity, image, social recognition by consumers and/or the power of the brand.  In 
agreement with the previous statement, food producers will feel reluctant to implement food safety 
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controls that might not be accepted by consumers. In general, food safety controls that change the 
smell, appearance and taste of chickens will not be accepted by consumers. For example, chickens 
that have been slightly cooked during food processing and/or the use of decontamination 
technologies such as steam ultrasound will not be purchased by consumers, even though they might 
be safer to eat than other chickens. Consumers drive the market and consumers’ preferences will 
influence the type of products available. Consumers demand safe, natural, nutritious, high quality 
foods with extended shelf-life and natural flavor. Consumers prefer natural food preservatives such 
as plant extracts to the use of artificial compounds. Consumers might not accept foods that have 
been modified or altered in particular ways. For this reason, some potential Campylobacter controls 
in poultry might not be feasible. The use of bioengineered modified foods may not be accepted by 
the consumers. Interestingly, a study conducted by Jordan and Stockley (2010) related to 
consumers’ decisions when buying chickens indicated that consumers trusted that there was 
adequate legislation to ensure food safety and in particular to protect them against Campylobacter. 
These authors recommended addressing consumers ‘concerns related to the safety of new 
interventions and/or the effect of new interventions on the organoleptic characteristics and /or the 
price of chickens. Consumer education on kitchen hygiene practices and food safety is crucial to 
prevent human campylobacteriosis (Rosenquist et al., 2003; Uyttendaele et al., 2006) and it has 
been promoted by governments. Interestingly, consumers seem to trust the governments to ensure 
food safety and in this way elude their own responsibility. Nonetheless, food safety is everyone’s 
responsibility.  
 
 
 
 
 
 
 
 
 
 
 
 
Campylobacter Control in Poultry 
 
121 
 
11.  REFERENCES 
 
1. Abbott Molecular (2012). MaxRatio. Retrieved September14, 2012, from 
http://www.abbottmolecular.com/technologies/real-time-pcr/maxratio-data-analysis.html  
2. Abdelwhab, el S.M., Erfan, A.M., Grund, C., Ziller, M., Arafa, A.S., Beer, M., Aly, M.M., 
Hafez, H.M. & Harder, T.C. (2010). Simultaneous detection and differentiation by multiplex 
real time RT-PCR of highly pathogenic avian influenza subtype H5N1 classic (clade 2.2.1 
proper) and escape mutant (clade 2.2.1 variant) lineages in Egypt. Virology Journal, 7, 260. 
3. Abdollah, G.P., Sayed, H.M., Hasan, M., Ebrahim, M. & Behzad, H. (2010). Antibacterial 
activities of the essential oils of some Iranian herbs: against Campylobacter jejuni and 
Campylobacter coli. Advances in Food Science, 32, 30-34. 
4. Abu Al-Soud, W. & Rådström, P. (1998). Capacity of nine thermostable DNA polymerases 
to mediate DNA amplification in the presence of PCR-inhibiting samples. Applied and 
Environmental Microbiology, 64, 3748–3753. 
5. Abu Al-Soud, W. & Rådström, P. (2000). Effects of amplification facilitators on diagnostic 
PCR in the presence of blood, feces, and meat. Journal of Clinical Microbiology, 38, 4463–
4470.  
6. Adak, G.K., Long, S.M & O’Brien, S.J. (2002). Trends in indigenous foodborne disease and 
deaths, England and Wales: 1992 to 2000. Gut, 51, 832-841. 
7.   Adkin, A., Harnett, E., Jordan, L., Newell, D. & Davison, H. (2006). Use of a systematic 
review to assist the development of Campylobacter control strategies in broilers. Journal of 
Applied Microbiology, 100, 306-315. 
8. Ahmed, M.F., Schulz, J. & Hartung, J. (2013). Survival of Campylobacter jejuni in naturally 
and artificially contaminated laying hen feces. Poultry Science, 92(2), 364-369.  
9. Ailes, E., Demma, L., Hurd, S., Hatch, J., Jones, T.F., Vugia, D., Cronquist, A., Tobin-
D'Angelo, M., Larson, K., Laine, E., Edge, K., Zansky, S., Scallan, E. (2008). Continued 
decline in the incidence of Campylobacter infections, FoodNet 1996–2006. Foodborne 
Pathog Diseases 5, 329–337. 
10. Allen, V. M., Weaver, H., Ridley, A.M., Harris, J.A., Sharma, M., Emery, J., Sparks, N., 
Lewis, M. & Edge, S. (2008a). Sources and spread of thermophilic Campylobacter spp. 
during partial depopulation of broiler chicken flocks. Journal of Food Protection 71, 264–
270. 
11. Allen, V. M., Burton, C.H., Wilkinson, D.J., Whyte, R.T., Harris, J.A., Howell, M. &Tinker, 
D.B. (2008b).Evaluation of the performance of different cleaning treatments in reducing 
microbial contamination of poultry transport crates. British Poultry Science, 49, 233–240. 
12. Allos, B.M. (2001). Campylobacter jejuni Infections: update on emerging issues and trends. 
Clinical Infectious Diseases 32, 1201-1206. 
13. Altekruse, S. F., Stern, N. J., Fields, P. I. & Swerdlow, D. L. (1999). Campylobacter 
jejuni—an emerging foodborne pathogen. Emerging Infectious Diseases 5: 28-35. 
14. Anjum, M.S. & Chaudhry, A.S. (2010). Using Enzymes and Organic Acids in Broiler Diets. 
The Journal of Poultry Science, 47 (2), 97-105. 
15. Annan-Prah, A. & Janc, M. (1988). The mode of spread of Campylobacter jejuni/coli to 
broiler flocks. Journal of Veterinary Medicine 35, 11-18. 
16. Anonymous. (2007). Ace Biosciences, Ace393, the World's First Commercial Vaccine for Travellers' 
Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials . Retrieved 
September 21, 2011, from http://www.drugs.com/clinical_trials/ace-biosciences-ace393-
world-s-first-commercial-vaccine-travellers-diarrhoea-caused-campylobacter-440.html  
Campylobacter Control in Poultry 
 
122 
 
17. Anonymous. (1998). Risk profile for pathogenic species of Campylobacter in Denmark. The 
Danish Veterinary and Food Administration, Division of Microbiological Safety. Retrieved 
from http://www.vfd.dk/publikationer/publikationer/publikationer/campuk/cameng_ref.doc. 
18. Ansari-Lari, M., Hosseinzadeh, S., Shekarforoush, S.S., Abdollahi, M. & Berizi, E. (2011). 
Prevalence and risk factors associated with campylobacter infections in broiler flocks in 
Shiraz, southern Iran. International Journal of Food Microbiology 144(3), 475-479.  
19. Armbruster, D.A. & Pry, T. (2008). Limit of blank, limit of detection and limit of 
quantitation. Clinical Biochemical Reviews 29, S49–S52. 
20. Arsenault, J., Letellier, A., Quessy, S., Normand, V. & Boulianne, M. (2007). Prevalence 
and risk factors for Salmonella spp. and Campylobacter spp. caecal colonization in broiler 
chicken and turkey flocks slaughtered in Quebec, Canada. Preventive Veterinary Medicine, 
81, 250–264. 
21. Artis, D. (2008). Epithelial-cell recognition of commensal bacteria and maintenance of 
immune homeostasis in the gut. Nature Reviews Immunology. 8(6), 411-20. doi: 
10.1038/nri2316. 
22. Aslim, B. & Yucel, N. (2008). In vitro antimicrobial activity of essential oil from endemic 
Origanum minutiflorum on ciprofloxacin-resistant Campylobacter spp. Food Chemistry, 
107, 602-606. 
23. Aspinall, G. O., Lynch, C. M., Pang, H., Shaver, R. T. & Moran, A. P. (1995). Chemical 
structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an 
associated polysaccharide. European Journal of Biochemistry, 231, 570–578. doi: 
10.1111/j.1432-1033.1995.tb20734.x. 
24. Atterbury, R.J., Connerton, P.L., Dodd, C.E., Rees, C.E. & Connerton, I.F. (2003). 
Application of host-specific bacteriophages to the surface of chicken skin leads to a 
reduction in recovery of Campylobacter jejuni. Applied and Environmental Microbiology, 
69, 6302–6306. 
25. Bachtiar, B.M., Coloe, P.J. & Fry, B.N. (2007). Knockout mutagenesis of the kpsE gene of 
Campylobacter jejuni 81116 and its involvement in bacterium-host interactions. FEMS 
Immunology and Medical Microbiology, 49, 149–154. 
26. Bacon, R.T., Belk, K.E., Sofos, J.N., Clayton, R.P., Reagan, J.O. & Smith, G.C. (2000). 
Microbial populations on animal hides and beef carcasses at different stages of slaughter in 
plants employing multiple-sequential interventions for decontamination. Journal of Food 
Protection, 63, 1080-1086. 
27. Bahrndorff, S., Rangstrup-Christensen, L., Nordentoft, S. & Hald, B. (2013). Foodborne 
disease prevention and broiler chickens with reduced Campylobacter infection. Emerging 
Infectious Diseases, 19(3), 425-430.  
28. Baker, M., Wilson, N. & Edwards, R. (2007a). Campylobacter infection and chicken: an 
update on New Zealand's largest “common source outbreak.” New Zealand Medical 
Journal, 120, U2717.  
29. Baker, M. & Wilson, N. (2007b). The compelling case for urgent action to control New 
Zealand's foodborne campylobacteriosis epidemic. Proceedings of the Food Safety, Animal 
Welfare and Biosecurity Branch of the New Zealand Veterinary Association, 265, 67–76. 
30. Baker, M.G., Kvalsvig, A., Zhang, J., Lake, R., Sears, A. & Wilson, N. (2012). Declining 
Guillain-Barré syndrome after campylobacteriosis control, New Zealand, 1988-2010. 
Emerging Infectious Diseases, 18(2), 226-33.  
31. Baker, M.G., Sneyd, E., Wilson, N.A. (2007). Is the major increase in notified 
campylobacteriosis in New Zealand real? Epidemiology and Infection, 135, 163–70. 
Campylobacter Control in Poultry 
 
123 
 
32. Baqar, S., Bourgeois, A.L., Schultheiss, P.J., Walker, R.I., Rollins, D.M., Haberberger, R.L., 
& Pavlovskis, O.R. (1995a). Safety and immunogenicity of a prototype oral whole-cell 
killed Campylobacter vaccine administered with a mucosal adjuvant in non-human 
primates. Vaccine, 13, 22–28. 
33. Baqar, S., Applebee, L.A. & Bourgeois, A.L. (1995b). Immunogenicity and protective 
efficacy of a prototype Campylobacter killed whole-cell vaccine in mice. Infection and 
Immunology, 63, 3731–3735. 
34. Barnard, T.G., Robertson, C.A., Jagals, P. & Potgieter, N. (2011) A rapid and low-cost 
DNA extraction method for isolating Escherichia coli DNA from animal stools. African 
Journal of Biotechnology, 10, 1485-1490.  
35. Barrios, P.R., Reiersen, J., Lowman, R., Bisaillon, J.R., Michel, P., Fridriksdóttir, V., 
Gunnarsson, E,, Stern, N., Berke, O., McEwen, S. & Martin, W. (2006). Risk factors for 
Campylobacter spp. colonization in broiler flocks in Iceland. Preventive Veterinary 
Medicine, 74, 264–278. 
36. Barros, L.S., Amaral, L.A., Lorenzon, C.S., Junior, J.L. & Neto, J.G. (2007).  Potential 
microbiological contamination of effluents in poultry and swine abattoirs. Epidemiology and 
Infection, 135, 505-518. 
37. Bates, C., Hiett, K.L. & Stern, N.J. (2004). Relationship of Campylobacter isolated from 
poultry and from darkling beetles in New Zealand. Avian Diseases, 48, 138–147. 
38. Bell, K.Y., Cutter C.N. & Sumner S.S. (1997). Reduction of foodborne micro-organisms on 
beef carcass tissue using acetic acid, sodium bicarbonate, and hydrogen peroxide spray 
washes. Food Microbiology, 14, 439–448. 
39. Berndtson, E., Emanuelson, U., Engvall, A. & Dainelsson-Tham, M. L. (1996). A 1-year 
epidemiological study of campylobacters in 18 Swedish chicken farms. Preventive 
Veterinary Medicine, 26, 167–185. 
40. Berrang, M.E., Smith, D.P. & Hinton, A Jr. (2006). Organic acids placed into cloaca to 
reduce Campylobacter contamination of broiler skin during defeathering. Journal of Applied 
Poultry Research, 15, 287-291.   
41. Berrang, M.E. & Dickens, J.A. (2000). Presence and level of Campylobacter on broiler 
carcasses throughout the processing plant. Journal of Applied Poultry Research, 9, 43–47. 
42. Berrang, M.E. & Northcutt, J.K. (2005). Water spray and immersion in chemical sanitizer to 
lower bacterial numbers on broiler transport coop flooring. Journal of Applied Poultry 
Research, 14, 315–321. 
43. Berrang, M.E., Smith, D.P. & Meinersmann, R.J. (2011). Variations on standard broiler 
processing in an effort to reduce Campylobacter numbers on postpick carcasses. Journal of 
Applied Poultry Research, 20, 197-202. 
44. Berrang, M.E., Smith, D.P., Windham, W.R. & Feldner, P.W. (2004a). Effect of intestinal 
content contamination on broiler carcass Campylobacter counts. Journal of Food 
Protection, 67, 235-238. 
45. Berrang, M.E., Northcutt, J.K. & Cason, J.A. (2004b). Recovery of Campylobacter from 
broiler feces during extended storage of transport cages. Poultry Science, 83, 1213–1217. 
46. Berrang, M.E., Buhr, R.J., Cason J.A. & Dickens J.A. (2001). Broiler carcass contamination 
with Campylobacter from feces during defeathering. Journal of Food Protection, 64, 2063–
2066. 
47. Bessetti, J. (2007). An Introduction to PCR Inhibitors. Retrieved May 17, 2013 from 
http://www.promega.com/~/media/files/resources/profiles%20in%20dna/1001/an%20introd
uction%20to%20pcr%20inhibitors.pdf?la=en   
Campylobacter Control in Poultry 
 
124 
 
48. Bhaduri, S. & Cottrell, B. (2004). Survival of cold-stressed Campylobacter jejuni on ground 
chicken and chicken skin during frozen storage. Applied and Environmental Microbiology, 
70, 7103-7109. 
49. Bi, P., Cameron, A.S., Zhang, Y., Parton, K.A. (2008). Weather and notified Campylobacter 
infections in temperate and sub-tropical regions of Australia: an ecological study. Journal of 
Infection 57, 317e23.36.  
50. Birk, T., Gronlund, A.C., Christensen, B.B., Knochel, S., Lohse, K. & Rosenquist, H. 
(2010). Effect of Organic Acids and Marination Ingredients on the Survival of 
Campylobacter jejuni on Meat. Journal of Food Protection, 73, 258-265. 
51. Black, A.P., Kirk, M.D. & Millard, G. (2006). Campylobacter outbreak due to chicken 
consumption at an Australian Capital Territory restaurant. Communicable Diseases 
Intelligence, 30, 373–377. 
52. Black, R.E., Levine, M.M., Clements, M.L., Hughes, T.P. & Blaser M.J. (1988). 
Experimental Campylobacter jejuni infection in humans. Journal of Infectious Diseases, 
157, 472–479. 
53. Blaser, M.J., LaForce, F.M., Wilson, N.A., Wang, W.L. (1980). Reservoirs for human 
campylobacteriosis. Journal of Infectious Diseases, 141(5), 665-669. 
54. Blaser, M.J., Hardesty, H.L., Powers, B. & Wang W.L. (1980). Survival of Campylobacter 
fetus subsp. jejuni in biological milieus. Journal of Clinical Microbiology, 11, 309–313. 
55. Blaser, M.J. & Engberg, J. (2008). Clinical aspects of Campylobacter jejuni and 
Campylobacter coli infections. In I. Nachamkin, C. M. Szymanski, M. J. Blaser (eds.), 
Campylobacter. ASM Press, Washington DC. 
56. Botteldoorn, N., Van Coillie, E., Piessens, V., Rasschaert, G., Debruyne, L., Heyndrickx, 
M., Herman, L. & Messens, W. (2008). Quantification of Campylobacter spp. in chicken 
carcass rinse by real-time PCR. Journal of Applied Microbiology, 105, 1909–1918. 
57. Bouwknegt, M., van de Giessen, A.W., Dam-Deisz, W.D., Havelaar, A.H., Nagelkerke, 
N.J., Henken, A.M. (2004). Risk factors for the presence of Campylobacter spp. in Dutch 
broiler flocks. Preventive Veterinary Medicine, 62, 35–49. 
58. Boyd, Y., Herbert, E.G., Marston, K.L., Jones, M.A. & Barrow, P.A. (2005). Host genes 
affect intestinal colonisation of newly hatched chickens by Campylobacter jejuni. 
Immunogenetics, 57, 248-253. 
59. Boysen, L. & Rosenquist, H. (2009). Reduction of thermotolerant Campylobacter species on 
broiler carcasses following physical decontamination at slaughter. Journal of Food 
Protection, 72(3), 497-502. 
60. Boysen, L., Vigre, H. & Rosenquist H. (2011). Seasonal influence on the prevalence of 
thermotolerant Campylobacter in retail broiler meat in Denmark. Food Microbiology, 28, 
1028 -1032. 
61. Brelade, S. & Harman, C. Practical Guide to Knowledge Management. London, GBR: 
Thorogood, 2003. 
62. Brinkman, J.A., Rahmani, M.Z., Jones, W.E., Chaturvendi, A.K., Hagensee, M.E. (2004) 
Optimization of PCR based detection of human papillomavirus DNA from urine specimens. 
Journal of Clinical Virology, 29, 230-240. 
63. Buckley, A.M., Wang, J.H., Hudson, D.L., Grant, A.J., Jones, M.A., Maskell, D.J., Stevens, 
M.P. (2010). Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter 
antigens for control of C. jejuni in poultry. Vaccine, 28, 1094-1105. 
64. Bui, X.T., Wolff, A., Madsen, M. & Bang, D.D. (2011.) Fate and Survival of 
Campylobacter coli in Swine Manure at Various Temperatures. Frontiers in Microbiology, 
2, 262.  
Campylobacter Control in Poultry 
 
125 
 
65. Bull, S.A., Allen, V.M., Domingue, G., Jørgensen, F., Frost, J.A., Ure, R., Whyte, R., 
Tinker, D., Corry, J.E., Gillard-King, J., Humphrey, T.J. (2006). Sources of Campylobacter 
spp. colonizing housed broiler flocks during rearing. Applied and Environmental 
Microbiology, 72, 645–652. 
66. Bull, S.A., Thomas, A.O., Humphrey, T.J., Ellis-Iversen, J., Cook, A.J., Lovell, R.D.L. & 
Jørgensen, F. (2008). Flock health indicators and Campylobacter spp. in commercial housed 
broilers reared in Great Britain. Applied and Environmental Microbiology, 74, 5408–5413. 
67. Burr, D.H., Rollins, D., Lee, L.H., Pattarini, D.L., Walz, S.S., Tian, J.H., Pace, J.L., 
Bourgeois, A.L. & Walker, R.I. (2005). Prevention of disease in ferrets fed an inactivated 
whole cell Campylobacter jejuni vaccine. Vaccine, 23, 4315–4321. 
68. Burt, S. (2004). Essential oils: their antibacterial properties and potential applications in 
foods--a review. International Journal of Food Microbiology, 94, 223-253. 
69. Bustin, S.A. (2009). Why the need for qPCR publication guidelines? The case for MIQE. 
Methods, 50, 217-226. 
70. Byrd, J.A., Hargis, B.M., Caldwell, D.J., Bailey, R.H., Herron, K.L., McReynolds, J.L., 
Brewer, R.L., Anderson, R.C., Bischoff, K.M., Callaway, T.R. & Kubena, L.F. (2001). 
Effect of lactic acid administration in the drinking water during preslaughter feed 
withdrawal on Salmonella and Campylobacter contamination of broilers. Poultry Science, 
80, 278-283. 
71. Cahill, S.M. (2005). `Risk assessment and campylobacteriosis.' In: Risk Management 
Strategies: Monitoring and Surveillance. F. J. M. Smulders and J. D. Collins, Wageningen 
Academic Publishers. 
72. Calderon-Gomez, L.I., Hartley, L.E., McCormack, A., Ringoir, D.D., & Korolik, V. (2009).  
Potential use of characterised hyper-colonising strain(s) of Campylobacter jejuni to reduce 
circulation of environmental strains in commercial poultry. Veterinary Microbiology, 134, 
353-361 
73. Camo, J., Lorés, A., Djenane, D., Beltrán, J.A. & Roncalés, P. (2011). Display life of beef 
packaged with an antioxidant active film as a function of the concentration of oregano 
extract. Meat Science, 88(1), 174-8.  
74. Canadian Partnership for Consumer Food Safety Education. (2013). Retrieved January 9, 
2013, from http://www.befoodsafe.ca/en-home.asp 
75. Cardinale, E., Tall, F., Gueye, E.F., Cisse, M. & Salvat, G. (2004). Risk factors for 
Campylobacter spp. infection in Senegalese broiler-chicken flocks. Preventive Veterinary 
Medicine, 64, 15–25. 
76. Carrique-Mas, J., Andersson, Y., Hjertqvist, M., Svensson, A., Torner, A. & Giesecke, J. 
(2005). Risk factors for domestic sporadic campylobacteriosis among young children in 
Sweden. Scandinavian Journal of Infectious Diseases, 37, 101–110.  
77. Carry, J.E.L., James, S.J., James, C. & Hinton, M. (1995). Salmonella, Campylobacter and 
Escherichia coli 0157:H7 decontamination techniques for the future. International Journal 
of Food Microbiology, 28, 187-196. 
78. Carter, J.D. & Hudson, A.P. (2009). Reactive arthritis: clinical aspects and medical 
management. Rheumatic Disease Clinics of North America, 35, 21-44. 
79. Carvalho, C.M., Gannon, B.W., Halfhide, D.E., Santos, S.B., Hayes, C.M., Roe, J.M. & 
Azeredo, J. (2010). The in vivo efficacy of two administration routes of a phage cocktail to 
reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens. BMC 
Microbiology, 10, 232. 
Campylobacter Control in Poultry 
 
126 
 
80. Castillo, A., Lucia, L.M., Goodson, K.J., Savell, J.W. & Acuff, G.R. (1998). Comparison of 
water wash, trimming, and combined hot water and lactic acid treatments for reducing 
bacteria of fecal origin on beef carcasses. Journal of Food Protection, 61, 823–828. 
81. Castillo, A., Lucia, L.M., Goodson, K.J., Savell, J.W. & Acuff, G. R. (1999). 
Decontamination of beef carcass surface tissue by steam vacuuming alone and combined 
with hot water and lactic acid sprays. Journal of Food Protection, 62, 146–151. 
82. Cawthraw, S.A., Park, S., Wren, B.W., Ketley, J.M., Ayling, R. & Newell, D.G. (1996). The 
usefulness of the chick colonisation model to investigate potential colonisation factors of 
campylobacters. In D. G. Newell, J. M. Ketley, and R. A. Feldman (ed.), Campylobacter, 
Helicobacter and related organisms. p. 649-652. Plenum Press, New York, NY. 
83. Cawthraw, S.A., Wassenaar, T. M., Ayling, R. & Newell, D.G. (1996). Increased 
colonization potential of Campylobacter jejuni strain 81116 after passage through chickens 
and its implication on the rate of transmission within flocks. Epidemiology and Infection, 
117, 213–215. 
84. Center for Science in the Public Interest (2005). Food Safety around the World. Retrieved 
March 22, 2013, from http://safefoodinternational.org/local_global.pdf  
85. Champion, O.L., Karlyshev, A.V., Senior, N.J., Woodward, M., La Ragione, R., Howard, 
S.L., Wren, B.W. & Titball, R.W. (2010). Insect infection model for Campylobacter jejuni 
reveals that O-methyl phosphoramidate has insecticidal activity. Journal of Infectious 
Diseases, 201, 776–782. 
86. Chaveerach, P., Keuzenkamp, D.A., Urlings, H.A., Lipman, L.J., van Knapen, F. (2002). In 
vitro study on the effect of organic acids on Campylobacter jejuni/coli population in 
mixtures of water and feed. Poultry Science, 81, 621-628. 
87. Chaveerach, P., Lipman, L.J.A. & van Knapen F. (2004a). Antagonistic activities of several 
bacteria on in vitro growth of 10 strains of Campylobacter jejuni/coli. International Journal 
of Food Microbiology, 90, 43-50. 
88. Chaveerach, P., Keuzenkamp, D.A., Lipman, L.J. & Van Knapen, F. (2004b). Effect of 
organic acids in drinking water for young broilers on Campylobacter infection, volatile fatty 
acid production, gut microflora and histological cell changes. Poultry Science, 83, 330-334. 
89. Chaveerach, P., ter Huurne, A.A., Lipman, L.J. & van Knapen F. (2003). Survival and 
resuscitation of ten strains of Campylobacter jejuni and Campylobacter coli under acid 
conditions. Applied and Environmental Microbiology, 69, 711-714. 
90. Chen, Y.H., Poly, F., Pakulski, Z., Guerry, P. & Monteiro, M.A. (2008). The chemical 
structure and genetic locus of the Campylobacter jejuni CG8486 (HS4) capsular 
polysaccharide: the identification of 6-deoxy-D-ido-heptopyranose. Carbohydrate Research, 
343, 1034–1040. 
91. Chowdhury, S., Sandberg, M., Themudo, G.E. & Ersbøll, A.K. (2012).Risk factors for 
Campylobacter infection in Danish broiler chickens. Poult Science, 91, 2701-2709. 
92. Christensen, B.B., Sommer, H.M., Nielsen, N.L. & Rosenquist H. (2001). Risk Assessment 
of Campylobacter jejuni in chicken products. The Danish Veterinary and Food 
Administration. Copenhagen. 
93. Christenson, B., Ringer, A., Blucher, C., Billaudelle, H., Gundtoft, K.N., Ericksson, G. & 
Bottiger, M. (1983). An outbreak of campylobacter enteritis among the staff of a poultry 
abattoir in Sweden. Scandinavian Journal of Infectious Diseases, 15, 167-172. 
94. Christopher, F.M., Smith, G.C. & Vanderzant, C. (1982). Effect of Temperature and pH on 
the Survival of Campylobacter fetus. Journal of Food Protection, 45, 253-259. 
Campylobacter Control in Poultry 
 
127 
 
95. Chun, H.H., Kim, J.Y., Lee, B.D., Yu, D.J. & Song, K.B. (2010). Effect of UV-C irradiation 
on the inactivation of inoculated pathogens and quality of chicken breasts during storage. 
Food Control, 21, 276-280. 
96. Coker, A., Isokpehi, R., Thomas, B., Amisu, K., & Obi, C. (2002). Human 
campylobacteriosis in developing countries. Emerging Infectious Diseases, 8, 237–244. 
97. Colles, F.M., Jones, T.A., McCarthy, N.D., Sheppard, S.K., Cody, A.J., Dingle, K.E., 
Dawkins, M.S. & Maiden, M.C. (2008). Campylobacter infection of broiler chickens in a 
free-range environment. Environmental Microbiology, 10, 2042–2050. 
98. Compassion in World Farming. (2011). Antibiotics in animal farming. Public health and 
animal welfare. Retrieved February14, 2012, from 
http://www.ciwf.org.uk/includes/documents/cm_docs/2011/a/antibiotics_in_animal_farming
.pdf  
99. Conlan, A.J.K., Coward, C., Grant, A.J., Maskell, D.J. & Gog, J.R. (2007). Campylobacter 
jejuni colonization and transmission in broiler chickens: a modelling perspective. Journal of 
Royal Society Interface, 4, 819–829.  
100. Converse, R.R., Griffith, J.F., Noble, R.T., Haughland, R.A., Schiff, K.C. & 
Weisberg, S.B. (2012). Correlation between quantitative polymerase chain reaction and 
culture-based methods for measuring Enterococcus of various temporal scales and three 
California marine beaches. Applied and Environmental Microbiology, 78, 1237–1242. 
101. Crane, R., Davenport, R. & Vaughan, R. (2011). Farm business survey 2009/2010. 
Poultry Production in England. Retrieved February 25, 2013, from 
http://www.fbspartnership.co.uk/documents/2010_11/Horticulture_Production_2010-11.pdf  
102. Cudjoe, K.S., Vik, L., Kapperud, G. & Olsvik, O. (1991). Thermotolerant 
Campylobacters in Norwegian poultry, the influence of processing treatments on numbers 
and their detection using an enzymelinked oligonucleotide DNA probe. In: R.W.A.W. 
Mulder (editor). Prevention and control of potentially pathogenic microorganisms in poultry 
and poultry meat processing. Hygienic aspects of processed poultry meat. 
103. Cutter, C.N. (1999). Combination spray washes of saponina with water or acetic acid 
to reduce aerobic and pathogenic bacteria on lean beef surfaces. Journal of Food Protection, 
62, 280–283. 
104. Dahlenborg, M., Borch, E. & Rådström, P. (2001). Development of a combined 
selection and enrichment PCR procedure for Clostridium botulinum types B, E and F and its 
use to determine prevalence in fecal samples from slaughter pigs. Applied and 
Environmental Microbiology, 67, 4781–4789. 
105. Darwiche, A. (2009). Modeling and Reasoning with Bayesian Networks. Cambridge 
University Press. 
106. Davis, L. & DiRita, V. (2008). Experimental Chick Colonization by Campylobacter 
jejuni. Current Protocols in Microbiology. 11, 8A.3.1–8A.3.7. 
107. De Boer, P., Wagenaar, J.A., Achterberg, R.P., van Putten, J.P.M., Schouls, L.M. & 
Duim, B. (2002). Generation of Campylobacter jejuni genetic diversity in vivo. Molecular 
Microbiology, 44 (2), 351-359. 
108. De Haan, C.P., Kivisto, R., Hakkinen, M., Rautelin, H. & Hänninen, M.L. (2010). 
Decreasing trend of overlapping multilocus sequence types between human and chicken 
Campylobacter jejuni isolates over a decade in Finland. Applied and Environmental 
Microbiology, 76(15), 5228–5236.  
109. De Haan, C.P., Kivisto, R.I., Hakkinen, M., Corander, J., Hanninen, M.L. (2010).  
Multilocus sequence types of Finish bovine Campylobacter jejuni isolates and their 
attribution to human infections. BMC Microbiology, 10, 200. 
Campylobacter Control in Poultry 
 
128 
 
110. De Zoete, M.R., van Putten, J.P. & Wagenaar, J.A. (2007).Vaccination of chickens 
against Campylobacter. Vaccine, 25, 5548–5557. 
111. Dhanasekaran, S., Doherty, T.M. & Kenneth, J. (2010) Comparison of different 
standards for real-time PCR-based absolute quantification. Journal of Immunological 
Methods 354, 34–39. 
112. DIANOVA (2013). Retrieved June 17, 2013, fromhttp://www.dianova.dk/  
113. Dibner, J.J. & Richards, J.D. (2005). Antibiotic growth promoters in agriculture: 
history and mode of action. Poultry Science, 84, 634-643. 
114. Dickens, J.A. & Whittemore, A.D. (1994). The effect of acetic acid and air injection 
on appearance moisture pickup, microbiological quality, and Salmonella incidence on 
processed poultry carcasses. Poultry Science, 73, 582–586. 
115. Dickens, J.A. & Whittemore, A.D. (1997). Effects of acetic acid and hydrogen 
peroxide application during defeathering on the microbiological quality of broiler carcasses 
prior to evisceration. Poultry Science, 76, 657–660. 
116. Djenane, D. & Roncalés, P. (2011). Risk assessment and new developing strategies to 
reduce prevalence of campylobacter spp. in broiler chicken meat. Science against microbial 
pathogens: communicating current research and technological advances. Retrieved March 
26, 2013, from http://www.formatex.info/microbiology3/book/394-406.pdf  
117. Djenane, D., Yangüela, J., Amrouche, T., Boubrit, S., Bousaâd, N. & Roncalés, P. 
(2011a). Chemical composition and antimicrobial effects of essential Oils of Eucalyptus 
globulus, Myrtus communis and Satureja hortensis against Escherichia coli O157:H7 and 
Staphylococcus aureus in minced beef. Food Science and Technology International, 17(6), 
505-515. 
118. Djenane, D., Yangüela, J., Montañés, L., Djerbal, M. & Roncalés, P. (2011b). 
Antimicrobial activity of Pistacia lentiscus and Satureja Montana essential oils against 
Listeria monocytogenes CECT 935 using laboratory media; efficacy and synergistic 
potential in minced beef. Food Control, 22, 1046-1053. 
119. Djenane, D., Yangüela, Y., Gómez, D., Roncalés, P. (2011c). Perspectives on the use 
of essential oils as antimicrobials against Campylobacter jejuni CECT 7572 in retail chicken 
meats packaged in microaerobic atmosphere. Journal of Food Safety, 32(1), 37-47. 
120. Doorduyn, Y., van den Brandhof, W.E., van Duynhoven, Y.T., Breukink, B.J., 
Wagenaar, J.A. & Van Pelt, W. (2010). Risk factors for indigenous Campylobacter jejuni 
and Campylobacter coli infections in The Netherlands: a case-control study. Epidemiology 
and Infection, 138, 1391–1404.  
121. Dorsa, W.J., Cutter C. N. & Siragusa G.R. (1997). Effects of acetic acid, lactic acid 
and trisodium phosphate on the microflora of refrigerated beef carcass surface tissue 
inoculated with Escherichia coli 0157:H7, Listeria innocua, and Clostridium sporogenes. 
Journal of Food Protection, 60, 619–624. 
122. Doyle, M.P. & Roman, D.J. (1982). Sensitivity of Campylobacter jejuni to drying. 
Journal of Food Protection, 45, 507-510. 
123. Dykes, G.A. & Moorhead, S.M. (2001). Survival of Campylobacter jejuni on vacuum 
or carbon dioxide packaged primal beef cuts stored at -1.5C. Food Control 12, 553–557. 
124. Eberhart-Phillips, J., Walker, N., Garrett, N., Bell, D., Sinclair, D., Rainger, W., 
Bates, M. (1997). Campylobacteriosis in New Zealand: results of a case-control study. 
Journal of Epidemiology and Community Health, 51, 686–691. 
125. Edwards, K., Logan, J. & Saunders, N. (2004). Real-time PCR: An essential guide, p. 
51–52. Wymondham, Norfolk, U.K.: Horizon Bioscience. 
Campylobacter Control in Poultry 
 
129 
 
126. Ekdahl, K., Normann, B. & Andersson, Y. (2005). Could flies explain the elusive 
epidemiology of campylobacteriosis? BMC Infectious Diseases, 5, 11. 
127. Ellis-Iversen, J., Jorgensen, F., Bull, S., Powell, L., Cook, A.J. & Humphrey, T.J. 
(2009). Risk factors for Campylobacter colonisation during rearing of broiler flocks in Great 
Britain. Preventive Veterinary Medicine, 89, 178–184. 
128. El-Shibiny, A., Connerton, P.L. & Connerton, I.F. (2005). Enumeration and diversity 
of campylobacters and bacteriophages isolated during the rearing cycles of free-range and 
organic chickens. Applied and environmental Microbiology, 71 (3), 1259-1266. 
129. Eurogentec (2012). QPCR guide. Retrieved May 22, 2011, from 
http://www.eurogentec.com/uploads/qPCR-guide.pdf  
130. European Commission (2006). Salmonella: Commission sets EU targets for laying 
hens and adopts new control rules. Retrieved April 7, 2012, from 
http://ec.europa.eu/dgs/health_consumer/dyna/consumervoice/create_cv.cfm?cv_id=242 
131. European Food Safety Authority [EFSA] and European Center for Disease Control 
[ECDC] (2011). The European Union summary report on trends and sources of zoonoses, 
zoonotic agents and foodborne outbreaks in 2009. The EFSA Journal, 9, 2090, 378 pages. 
132. European Food Safety Authority (2007). Preliminary report: Analysis of the baseline 
study on the prevalence of salmonella in laying hen flocks of Gallus gallus. The EFSA 
Journal, 97. 
133. European Food Safety Authority (2010a). Analysis of the baseline survey on the 
prevalence of Campylobacter in broiler batches and of Campylobacter and Salmonella on 
broiler carcasses in the EU, 2008. The EFSA Journal, 8. 
134. European Food Safety Authority (2010b). Panel on Biological Hazards (BIOHAZ) 
scientific opinion on quantification of the risk posed by broiler meat to human 
campylobacteriosis in the EU. The EFSA Journal, 8, 1437.  
135. European Food Safety Authority Journal (2011a). Panel on Biological Hazards 
(BIOHAZ); Scientific Opinion on Campylobacter in broiler meat production: control 
options and performance objectives and/or targets at different stages of the food chain. The 
EFSA Journal, 9(4), 2105.  
136. European Food Safety Authority (2011b). The European Union summary report in 
trends and sources of zoonoses, zoonotic agents and food-borne utbreaks in 2009. EFSA 
Journal, 9, 2090. 
137. European Food Safety Authority (2012). Antimicrobial resistance. Retrieved May 12, 
2012, from http://www.efsa.europa.eu/en/topics/topic/amr.htm 
138. European Medicines Agency (2012). Antimicrobial resistance. Retrieved May 25, 
2012, from 
http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_conten
t_000439.jsp&mid=WC0b01ac058002d4e9 
139. Evans, S.J., & Sayers, A.R. (2000). A longitudinal study of Campylobacter infection 
of broiler flocks in Great Britain. Preventive Veterinary Medicine, 46, 209–223. 
140. FAO/WHO (2002). Expert Consultation on Risk assessment of Campylobacter 
spp.in broiler chickens and Vibrio spp. in seafood. Report of a Joint FAO/WHO 
Expert Consultation, Bangkok, Thailand 5-9 August 2002. 
141. Farmtald Online 2013. Retrieved July 17, 2013, from 
https://farmtalonline.dlbr.dk/Kalkuler/VisKalkule.aspx?Prodgren=K_8100&Forudsaetninger
=31-12-2013;K_8100;1;3;2;1;2;1;1;1;3;1;n;n;0;n    
Campylobacter Control in Poultry 
 
130 
 
142. Farnell, M.B., Donoghue, A.M., Cole, K., Reyes-Herrera, I., Blore, P.J. & Donoghue, 
D.J. (2005). Campylobacter susceptibility to ciprofloxacin and corresponding 
fluoroquinolon concentrations within the gastrointestinal tracts of chickens. Journal of 
Applied Microbiology, 99, 1043-1050. 
143. Firestone, J. & McElroy, M. (2005). Has Knowledge Management Been Done? 
Bradford, UK: Emerald Group Publishing Limited. 
144. Fisher, K. & Phillips, C.A. (2006). The effect of lemon, orange and bergamot essential 
oils and their components on the survival of Campylobacter jejuni, Escherichia coli O157, 
Listeria monocytogenes, Bacillus cereus and Staphylococcus aureus in vitro and in food 
systems. Journal of Applied Microbiology, 101, 1232-1240. 
145. Fluckey, W.M., Sanchez, M.X., McKee, S.R., Smith, D., Pendleton, E & Brashears, 
M.M. (2003). Establishment of a microbiological profile for an air-chilling poultry operation 
in the United States. Journal of Food Protection, 66, 272-279. 
146. Food and Agriculture Organisation of the United Nations, FAO (1997). Vaccine 
Manual: the production and quality control of veterinary vaccines for use in developing 
countries. Retrieved January 9, 2013, from  
http://www.fao.org/docrep/015/an381e/an381e00.htm  
147. Food Standards Agency, FSA (2009.). A UK survey of Campylobacter and Salmonella 
contamination of fresh chicken at retail sale. Retrieved December 3, 2012, from  
http://www.food.gov.uk/multimedia/pdfs/fsis0409.pdf   
148. Fooks, L.J. & Gibson, G.R. (2002). In vitro investigations of the effect of probiotics 
and prebiotics on selected human intestinal pathogens. FEMSMicrobiology Ecology, 39, 67-
75. 
149. French, N. (2008). Molecular Epidemiology and Veterinary Public Health Group. 
Enhancing surveillance of potentially foodborne enteric diseases in New Zealand: Human 
campylobacteriosis in the Manawatu. Palmerston North (NZ). Retrieved September 13, 
2012, from  http://www.foodsafety.govt.nz/elibrary/industry/enhancing-surveillance-
potentially-research-projects-2/Campy_Attribution_Manawatu.pdf  
150. Friedman, C.R., Neimann, J., Wegener, H.C. & Tauxe, R.V. (2000). Epidemiology of 
Campylobacter jejuni infections in the United States and other industrialized nations. In 
Campylobacter (I. Nachamkin & M.J. Blaser, eds), 2nd Ed. ASM Press, Washington, DC, 
121-139. 
151. Friis, C., Wassenaar, T.M., Javed, M.A., Snipen, L., Lagesen, K., Hallin, P.F., Newell, 
D.G., Toszeghy, M., Ridley, A., Manning, G. & Ussery, D.W. (2010). Genomic 
characterization of Campylobacter jejuni strain M1. PLoS ONE. 5, e12253. 
152. Frost, J.A., Gillespie, I.A. & O'Brien, S.J. (2002). Public health implications of 
campylobacter outbreaks in England and Wales, 1995–9: epidemiological and 
microbiological investigations. Epidemiology and Infection, 128, 111–118. 
153. Food Safety Authority of Ireland, FSAI (2006). Annual report, 2006. Dublin: Food 
Safety Authority of Ireland; 2006. 
154. Food Safety Authority of Ireland, FSAI (2012). Microbiological criteria. Retrieved 
November 26, 2012, from http://www.fsai.ie/food_businesses/haccp/micro_criteria.html  
155. Fussing, V., Moller, N.E., Neimann, J. & Engberg, J. (2007). Systematic serotyping 
and riboprinting of Campylobacter spp. improves surveillance: experiences from two Danish 
counties. Clinical Microbiology and Infection, 13, 635–642. 
156. Gálvez, A., Hikmate, A.H., Benomar, N. & Rosario Lucas, R. (2010). Microbial 
antagonists to food-borne pathogens and biocontrol. Current Opinion in Biotechnology, 21, 
142-148. 
Campylobacter Control in Poultry 
 
131 
 
157. Gañan, M., Martínez-Rodríguez, A.J. & Carrascosa, A.V. (2009). Antimicrobial 
activity of phenolic compounds of wine against Campylobacter jejuni. Food Control, 20, 
739-742. 
158. Garcia, A.B., Steele, W.B. & Taylor, D.J. (2010a). Prevalence and carcass 
contamination with Campylobacter in sheep sent for slaughter in Scotland. Journal of Food 
Safety, 30, 237–250. 
159. Garcia, A.B., Steele, W.B., Reid, S.J. & Taylor, D.J. (2010b). Risk of carcase 
contamination with Campylobacter in sheep sent for slaughter into an abattoir in Scotland. 
Preventive Veterinary Medicine, 95, 99-107.  
160. Garcia, A.B. & Percival, S.L. (2011). Zoonotic infections: the role of biofilms, p. 69-
110. In Biofilms and Veterinary Medicine, Springer, London, New York. 
161. Garcia, A.B. (2012).The use of data mining techniques to discover knowledge from 
animal and food data: Examples related to the cattle industry. Trends in Food Science & 
Technology 29(2), 151-157. 
162. Garcia, A.B., Bahrndorff, S., Hald, B., Hoorfar, J., Madsen, M. & Vigre, H. (2012). 
Design and data analysis of experimental trials to test vaccine candidates against zoonotic 
pathogens in animals: the case of a clinical trial against Campylobacter in broilers. Expert 
Reviews Vaccines 11(10), 1179-1188. 
163. Garcia, A.B., Kamara, J.N., Vigre, H., Hoorfar, J. & Josefsen, M.H. (2013a). Direct 
quantification of Campylobacter jejuni in chicken fecal samples using real-time PCR: 
evaluation of six rapid DNA extraction methods. Food Analytical Methods, in press. 
164. Garcia, A.B., Madsen, A.L. & Vigre, H. (2013b). Integration of Epidemiological 
Evidence in a Decision Support Model for the Control of Campylobacter in Poultry 
Production, Agriculture, 3(3), 516-535. 
165. Georgsson, F., Thorkelsson, A.E., Geirsdóttir, M., Reiersen, J., Stern, N.J. (2006).The 
influence of freezing and duration of storage on Campylobacter and indicator bacteria in 
broiler carcasses. Food Microbiology, 23(7), 677-683. 
166. Gibbens, J.C., Pascoe, S.J., Evans, S.J., Davies, R.H. & Sayers, A.R. (2001). A trial of 
biosecurity as a means to control Campylobacter infection of broiler chickens. Preventive 
Veterinary Medicine, 48, 85–99. 
167. Gillespie, I.A., O’Brien, S.J., Frost, J.A., Adak, G.K., Horby, P., Swan, A.V., Painter, 
M.J. & Neal, K.R. (2002). A case-case comparison of Campylobacter coli and 
Campylobacter jejuni infection: a tool for generating hypotheses. Emerging Infectious 
Diseases, 8, 937-942. 
168. Gillespie, I.A., O'Brien, S.J., Adak, G.K., Tam, C.C., Frost, J.A., Bolton, F.J., 
Tompkins, D.S. & Campylobacter Sentinel Surveillance Scheme Collaborators (2003). 
Point source outbreaks of Campylobacter jejuni infection–are they more common than we 
think and what might cause them? Epidemiology and Infection, 130, 367–375.  
169. Goll, R., Olsen, T., Cui, G. & Florholmen, J. (2006). Evaluation of absolute 
quantitation by nonlinear regression in probe-based real-time PCR. BMC 
Bioinformatics, 7, 107. 
170. Gradel, K.O., Schonheyder, H.C., Dethlefsen, C., Kristensen, B., Ejlertsen, T. & 
Nielsen, H. (2008). Morbidity and mortality of elderly patients with zoonotic Salmonella 
and Campylobacter: a population-based study. Journal of Infection, 57, 214-222. 
171. Grant, A.J., Coward, C., Jones, M.A., Woodall, C.A., Barrow, P.A. & Maskell, D.J. 
(2005). Signature-tagged transposon mutagenesis studies demonstrate the dynamic nature of 
cecal colonization of 2-week old chickens by Campylobacter jejuni. Applied and 
Environmental Microbiology, 71, 8031–8041.  
Campylobacter Control in Poultry 
 
132 
 
172. Grant, I.H., Richardson, N.J. & Bokkenheuser, V.D. (1980). Broiler chickens as 
potential source of Campylobacter infections in humans. Journal of Clinical Microbiology, 
11, 508-510. 
173. Greer, G.G. & Dilts, B.D. (1992). Factors affecting the susceptibility of meatborne 
pathogens and spoilage bacteria to organic acids. Food Research International, 25, 355-364. 
174. Gregory, E., Barnhart, H., Dreesen, D.W., Stern, N.J. & Corn J.L. (1997). 
Epidemiological study of Campylobacter spp. in broilers: source, time of colonization, and 
prevalence. Avian Diseases, 41, 890–898. 
175. Griffith, J.F., Weisberg, S.B. & McGee, C.D. (2003) Evaluation of microbial source 
tracking methods using mixed fecal sources in aqueous test samples. Journal of Water 
Health, 1(4), 141-151. 
176. Guerin, M.T., Martin, S.W., Reiersen, J., Berke, O., McEwen, S.A., Fridriksdóttir, V., 
Bisaillon, J.R., Lowman, R., Campy-on-Ice Consortium. (2008). Temperature-related risk 
factors associated with the colonization of broiler-chicken flocks with Campylobacter spp. 
in Iceland, 2001–2004. Preventive Veterinary Medicine 86, 14–29. 
177. Guerin, M.T., Martin, W., Reiersen, J., Berke, O., McEwen, S.A., Bisaillon, J.R., 
Lowman, R. (2007). House-level risk factors associated with the colonization of broiler 
flocks with Campylobacter spp. in Iceland, 2001-2004. BMC Veterinary Research, 12, 3-30. 
178. Guerry, P., Poly, F., Riddle, M., Maue, A.C., Chen, Y.H. & Monteiro, M.A. 
Campylobacter polysaccharide capsules: virulence and vaccines. Frontiers in Cellular and 
Infection Microbiology, 2, 7.  
179. Gundogdu, O., Bentley, S.D., Holden, M.T., Parkhill, J., Dorrell, N. & Wren, B.W. 
(2007). Reannotation and re-analysis of the Campylobacter jejuni NCTC11168 genome 
sequence. BMC Genomics, 8: 162. 
180. Gunther, N.W. & Chen, C.Y. (2009). The biofilm forming potential of bacterial 
species in the genus Campylobacter. Food Microbiology, 26, 44-51. 
181. Guy, R.A., Payment, P., Krull, U.J. & Horgen, P.A. (2003) Real-time PCR for 
quantification of Giardia and Cryptosporidium in environmental water samples and sewage. 
Applied and Environmental Microbiology, 69, 5178– 5185. 
182. Haas, C.N., Rose J.B. & Gerba C.P. (1999). Risk Assessment Paradigms. Quantitative 
Microbial Risk Assessment. N. C. Haas, John Wiley & Sons, Inc. 
183. Habib, I., Miller, W.G., Uyttendaele, M., Houf, K. & De Zutter, L. (2009). Clonal 
population structure and antimicrobial resistance of Campylobacter jejuni in chicken meat 
from Belgium. Applied and Environmental Microbiology, 75, 4264-4272. 
184. Hafez, H.M. (1999). Poultry meat and food safety: pre- and post-harvest approaches to 
reduce food borne pathogens. World Poultry Science Journal, 55, 269-280. 
185. Hagens, S. & Loessner, M.J. (2010). Bacteriophage for biocontrol of foodborne 
pathogens: calculations and considerations. Current Pharmaceutical Biotechnology, 11, 58-
68. 
186. Hald, B., Skovgard, H., Pedersen, K. & Bunkenborg, H. (2008). Influxed insects as 
vectors for Campylobacter jejuni and Campylobacter coli in Danish broiler houses. Poultry 
Science, 87, 1428-1434. 
187. Hald, B., Wedderkopp, A. & Madsen, M. (2000). Thermophilic Campylobacter spp. 
in Danish broiler production: a cross-sectional survey and a retrospective analysis of risk 
factors for occurrence in broiler flocks. Avian Pathology, 29,123–131. 
188. Hald, B., Rattenborg, E. & Madsen, M. (2001). Role of batch depletion of broiler 
houses on the occurrence of Campylobacter spp. in chicken flocks. Letters in Applied 
Microbiology, 32, 253–256. 
Campylobacter Control in Poultry 
 
133 
 
189. Hald, B., Skovgard, H. & Sommer, H.M. (2007a). Screen out insect vectors to 
significantly reduce Campylobacter prevalence in broilers. Zoonoses Public Health, 54, 
154–155. 
190. Hald, B., Sommer, H.M. & Skovgard, H. (2007b). Use of fly screens to reduce 
Campylobacter spp. introduction in broiler houses. Emerging Infectious Diseases, 13, 1951–
1953. 
191. Hald, B., Skovgard, H., Bang, D.D., Pedersen, K., Dybdahl, J., Jespersen, J.B. & 
Madsen, M. (2004). Flies and Campylobacter infection of broiler flocks. Emerging 
Infectious Diseases, 10, 1490-1492. 
192. Hald, T., Vose, D., Wegener, H.C. & Koupeev, T. (2004). A Bayesian approach to 
quantify the contribution of animal-food sources to human salmonellosis. Risk Analysis 
24(1), 255-269. 
193. Halfhide, B. (2003). Role of the European Probiotic Association. Proceedings: Role of 
probiotics in animal nutrition and their link to the demands of European consumers, 
Lelystad, The Netherlands; 2003. p. 3-4. 
194. Hanis, T., Jelen, P., Klir, P., Mnukova, J., Perez, B. & Pesek, M. (1989). Poultry meat 
irradiation. Effect of temperature on chemical changes and inactivation of microorganisms. 
Journal of Food Protection, 52, 26-29. 
195. Hanninen, M.L., Niskanen, M. & Korhonen, L. (1998). Water as a reservoir for 
Campylobacter jejuni infection in cows studied by serotyping and pulsed-field gel 
electrophoresis (PFGE). Zentralbl Veterinarmed B, 45, 37–42. 
196. Hansson, I., Pudas, N., Harbom, B. & Engvall, E.O. (2010). Within-flock variations of 
Campylobacter loads in caeca and on carcasses from broilers. International Journal of Food 
Microbiology, 141, 51-55. 
197. Hansson, I., Vagsholm, I., Svensson, L. & Olsson Engvall, E.. (2007). Correlations 
between Campylobacter spp. prevalence in the environment and broiler flocks. Journal of 
Applied Microbiology, 103, 640–649. 
198. Hansson, I., Ederoth, M., Andersson, L., Vagsholm, I. & Olsson Engvall, E. (2005). 
Transmission of Campylobacter spp. to chickens during transport to slaughter. Journal of 
Applied Microbiology, 99, 1149–1157. 
199. Hartnett, E., Kelly, L.A., Gettinby, G. & Wooldridge, M. (2002). A quantitative risk 
assessment for campylobacters in broilers: work in progress. International Biodeterioration 
& Biodegradation 50(3-4), 161-165. 
200. Hartnett, E., Kelly, L., Newell, D., Wooldridge, M. & Gettinby, G. (2001). A 
quantitative risk assessment for the occurrence of Campylobacter in chickens at the point of 
slaughter. Epidemiology and Infection 127(2), 195-206. 
201. Hastings, R., Colles, F.M., McCarthy, N.D., Maiden, M.C.J. & Sheppard, S.K. (2011). 
Campylobacter genotypes from poultry transportation crates indicate a source of 
contamination and transmission. Journal of Applied Microbiology, 110, 266–276. 
202. Havelaar, A.H., Mangen, M.J., de Koeijer, A.A., Bogaardt, M.J., Evers, E.G., Jacobs-
Reitsma, W.F., van Pelt, W., Wagenaar, J.A., de Wit, G.A., van der Zee, H. & Nauta, M.J. 
(2007a). Effectiveness and efficiency of controlling Campylobacter on broiler chicken meat. 
Risk Analysis, 27, 831-44. 
203. Havelaar, A., Braeunig, J., Christiansen, K., Cornu, M., Hald, T., Mangen, M.-J. J., 
Molbak, K., Pielaat, A., Snary, E., Van Pelt, W., Velthuis, A. & Wahlstroem, H. (2007b). 
Towards an Integrated Approach on Supporting Microbiological Food Safety Decisions.' 
Zoonosis and Public Health (54), 103 -117. 
Campylobacter Control in Poultry 
 
134 
 
204. Hazeleger, W.C., Bolder, N.M., Beumer, R.R., Jacobs-Reitsma, W.F. (2008). 
Darkling beetles (Alphitobius diaperinus) and their larvae as potential vectors for the 
transfer of Campylobacter jejuni and Salmonella enterica Serovar Paratyphi B variant Java 
between successive broiler flocks. Applied and Environmental Microbiology, 74, 6887-
6891. 
205. Heckerman, D., Mamdani, A. & Wellman, M.P. (1995). Real-World Applications of 
Bayesian Networks. Communications of the ACM 38(3), 24-68. 
206. Hedman, J. & Rådström, P. (2013) Overcoming Inhibition in Real-Time Diagnostic 
PCR. Methods in molecular biology, 943, 17-48. 
207. Heegaard, P.M.H., Hald, B., Madsen, M., Hoorfar, J., Larsen, L.E., Breum, S.Ø., 
Bisgaard-Frantzen, K., Bendix Hansen, M., & Lihme, A. (2012). Enabling Passive 
Immunization as an Alternative to Antibiotics for Controlling Enteric Infections in Production 
Animals. Poster session presented at International Symposium: Alternatives to antibiotics 
(ATA), Paris, France. 
208. Helms, M., Simonsen, J. & Molbak, K. (2006). Foodborne bacterial infection and 
hospitalization: a registry-based study. Clinical Infectious Diseases, 42, 498-506. 
209. Helms, M., Vastrup, P., Gerner-Smidt, P. & Molbak K. (2003). Short and long term 
mortality associated with foodborne bacterial gastrointestinal infections: registry based 
study. BMJ, 326, 357. 
210. Henry, I., Reichardt, J., Denis, M. & Cardinale, E. (2011). Prevalence and risk factors 
for Campylobacter spp. in chicken broiler flocks in Reunion Island (Indian Ocean). 
Preventive Veterinary Medicine, 100, 64-70.  
211. Heres, L., Engel, B., Urlings, H.A., Wagenaar, J.A. & van Knapen, F. (2004). Effect 
of acidified feed on susceptibility of broiler chickens to intestinal infection by 
Campylobacter and Salmonella. Veterinary Microbiology, 99, 259-267. 
212. Herman, L., Heyndrickx, M., Grijspeerdt, K., Vandekerchove, D., Rollier, I. & De 
Zutter, L. (2003). Routes for Campylobacter contamination of poultry meat: 
epidemiological study from hatchery to slaughterhouse. Epidemiology and Infection, 131, 
1169–1180. 
213. Hermans, D., Martel, A., Van Deun, K., Verlinden, M., Van Immerseel, F., Garmyn, 
A., Messens, W., Heyndrickx, M., Haesebrouck, F. & Pasmans, F. (2010). Intestinal mucus 
protects Campylobacter jejuni in the ceca of colonized broiler chickens against the 
bactericidal effects of medium-chain fatty acids. Poultry Science, 89, 1144-1155. 
214. Hermans, D., Pasmans, F., Messens, W., Martel, A., Van Immerseel, F., Rasschaert, 
G., Heyndrickx, M., Van Deun, K. & Haesebrouck, F. (2012). Poultry as a Host for the 
Zoonotic Pathogen Campylobacter jejuni. Vector-Borne and Zoonotic Diseases, 12(2), 89-
98. 
215. Hermans, D., Van Deun, K., Messens, W., Martel, A., Van Immerseel, F., 
Haesebrouck, F., Rasschaert, G., Heyndrickx, M. & Pasmans, F. (2011). Campylobacter 
control in poultry by current intervention measures ineffective: urgent need for intensified 
fundamental research. Veterinary Microbiology, 52, 219–228. 
216. Hermosilla, A.M. (2004). Transfer of contamination of Campylobacter spp. From 
positive broiler flocks to negative flocks during processing. MSc Thesis, University of 
Bristol, Bristol. 
217. Hiett, K.L., Stern, N.J., Fedorka-Cray, P., Cox, N.A., Musgrove, M.T. & Ladely, S. 
(2002). Molecular subtype analyses of Campylobacter spp. from Arkansas and California 
poultry operations. Applied and Environmental Microbiology, 68, 6220–6236. 
Campylobacter Control in Poultry 
 
135 
 
218. Hilmarsson, H., Thormar, H., Thrainsson, J.H., Gunnarsson, E. & Dadadottir, S. 
(2006). Effect of glycerol monocaprate (monocaprin) on broiler chickens: an attempt at 
reducing intestinal Campylobacter infection. Poultry Science, 85, 588-592. 
219. Hoffelner, H., Rieder, G. & Haas, R. (2008). Helicobacter pylori vaccine 
development: Optimisation of strategies and importance of challenging strain and animal 
model. International Journal of Medical Microbiology, 298, 151–159. 
220. Hofshagen, M., Jonsson, M. & Opheim, M. (2010). The surveillance and control 
programme for Campylobacter spp. in broiler flocks in Norway. National Veterinary 
Institute Annual report 2009. Surveillance and control programmes for terrestrial and 
aquatic animals in Norway. Oslo, Norway. 
221. Hofshagen, M. & Kruse, H. (2005). Reduction in flock prevalence of Campylobacter 
spp. In broilers in Norway after implementation of an action plan. Journal of Food 
Protection, 68, 2220-2223. 
222. Hong, J., Jung, W.K., Kim, J.M., Kim, S.H., Koo, H.C., Ser, J. & Park, Y. (2007) 
Quantification and differentiation of Campylobacter jejuni and Campylobacter coli in raw 
chicken meats using a real-time PCR method. Journal of Food Protection, 70, 2015–2022. 
223. Hook, H., Fattah, M., Ericsson, H., Vagsholm, I. & Danielsson-Tham, M. (2005) 
Genotype dynamics of Campylobacter jejuni in a broiler flock. Veterinary Microbiology, 
106, 109–117.  
224. Howard, R.A. & Matheson, J.E. (1984). Influence diagrams. In Readings on the 
Principles and Applications of Decision Analysis, eds. R.A. Howard and J.E. Matheson, 
Vol. II Menlo Park CA: Strategic Decisions Group. 
225. Huang, J.L., Yin, Y.X., Pan, Z.M., Zhang, G., Zhu, A.P., Liu, X.F., Jiao, X.A. 
Intranasal immunization with chitosan/pCAGGS-flaA nanoparticles inhibits Campylobacter 
jejuni in a White Leghorn model. Journal of Biomedical Biotechnology, 2010, pii: 589476.  
226. Humphrey, T., O'Brien, S. & Madsen, M. (2007). Review article: Campylobacters as 
zoonotic pathogens: A food production perspective. International Journal of Food 
Microbiology, 117, 237-257. 
227. Humphrey, T.J., Lanning, D.G. & Beresford, D. (1981). The effect of pH adjustment 
on the microbiology of chicken scald tank water with particular reference to the death rate of 
salmonellas. Journal of Applied Bacteriology, 51, 517-527. 
228. Huneau-Salaun, A., Denis, M., Balaine, L. & Salvat, G. (2007). Risk factors for 
Campylobacter spp. colonization in French free-range broiler-chicken flocks at the end of 
the indoor rearing period. Preventive Veterinary Medicine, 80, 34–48. 
229. Hunt, M. (2010). Real-time PCR. Retrieved September 15, 2012, from 
http://pathmicro.med.sc.edu/pcr/realtime-home.htm  
230. Inglis, G.D. & Kalischuk, L.D. (2004). Direct quantification of Campylobacter jejuni 
and Campylobacter lanienae in feces of cattle by real-time quantitative PCR. Applied and 
Environmental Microbiology, 70(4), 2296-2306. 
231. Ingram, M. & Farkas, J. (1977). Microbiology of food pasteurised by ionising 
radiation. Acta Alimentaria, 6, 123-185. 
232. Institute of Food Research (2012). Finding Campylobacter’s weakness. Retrieved 
October 9, 2012, from http://news.ifr.ac.uk/2012/01/finding-campylobacters-weakness/  
233. International Commission on Microbiological Specifications for Foods, ICMSF 
(1996). Micro-organisms in foods V. Microbiological specifications of food pathogens. 
London: Blackie Academic and Professional, 1996. London, UK. pp. 45-65. 
Campylobacter Control in Poultry 
 
136 
 
234. International Consultative Group on Food Irradiation, ICGFI (1999). Safety of poultry 
meat: from farm to table. Retrieved November 15, 2011, from http://www-
naweb.iaea.org/nafa/fep/public/poultrymeat.pdf 
235. Invitrogen (2013). Life technologies. Retrieved March 19, 2011, from 
http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/PCR/real-
time-pcr/qpcr-education/qpcr-vs-digital-pcr-vs-traditional-pcr.html  
236. Islam, D., Lewis, M.D., Srijan, A., Bodhidatta, L., Aksomboon, A., Gettayacamin, M., 
Baqar, S., Scott, D. & Mason, C.J. (2006). Establishment of a non-human primate 
Campylobacter disease model for the pre-clinical evaluation of Campylobacter vaccine 
formulations. Vaccine, 24, 3762-3771. 
237. Isohanni, P., Alter, T., Saris, P. & Lyhs, U. (2010). Wines as possible meat marinade 
ingredients possess antimicrobial potential against Campylobacter. Poultry Science, 89, 
2704-2710. 
238. Isohanni, P.M. & Lyhs, U. (2009). Use of ultraviolet irradiation to reduce 
Campylobacter jejuni on broiler meat. Poultry Science, 88, 661-668. 
239. Izat, A.L., Gardner, F.A., Denton, J.H. & Golan, F.A. (1988). Incidence and level of 
Campylobacter jejuni in broiler processing. Poultry Science, 67, 1568–1572. 
240. Izat, A.L., Colberg, M., Thomas, R.A., Adams, M.H. & Driggers, C.D. (1990). Effects 
of lactic acid in processing waters on the incidence of salmonellae on broilers. Journal of 
Food Quality, 13, 295–306. 
241. Jacobs, B.C., van Belkum, A. & Endtz, H.P. (2008). Guillain-Barré syndrome and 
Campylobacter infection. In: Nachamkin I, Szymanski CM, Blaser MJ, editors. 
Campylobacter, 3rd ed. Washington: ASM Press; 2008. p. 245–62. 
242. Jacobs-Reitsma, W.F., van de Giessen, A.W., Bolder, N.M. & Mulder, R.W. (1995). 
Epidemiology of Campylobacter spp. at two Dutch broiler farms. Epidemiology and 
Infection, 114 (3), 413-421. 
243. Jacobs-Reitsma, W.F., Bolder, N.M. & Mulder, R.W. (1994). Caecal carriage of 
Campylobacter and salmonella in Dutch broiler flocks at slaughter. A one-year Study. 
Poultry Science, 73, 1260–1266. 
244. Jacobs-Reitsma, W. (1997). Aspects of epidemiology of Campylobacter in poultry. 
Veterinary Quarterly, 19, 113-117. 
245. Jagusztyn-Krynicka, E.K., Dadlez, M., Grabowska, A. & Roszczenko, P. (2009). 
Proteomic technology in the design of new effective antibacterial vaccines. Expert Reviews 
Proteomics, 6(3), 315-330.  
246. James, C., James, S.J., Hannay, N., Purnell, G., Barbedo-Pinto, C., Yaman, H., 
Araujo, M., Gonzalez, M. L., Calvo, J., Howell, M. & Corry, J.E. (2007).  Decontamination 
of poultry carcasses using steam or hot water in combination with rapid cooling, chilling or 
freezing of carcass surfaces. International Journal of Food Microbiology, 114, 195-203. 
247. Janssen, R., Krogfelt, K.A., Cawthraw, S.A., van Pelt, W., Wagenaar, J.A. & Owen, 
R.J. (2008). Host-pathogen interactions in Campylobacter infections: the host perspective. 
Clinical Microbiology Reviews, 21, 505–518.  
248. Jensen, A.N., Andersen, M.T., Dalsgaard, A., Baggesen, D.L. & Nielsen, E.M. (2005). 
Development of real-time PCR and hybridization methods for detection and identification of 
thermophilic Campylobacter spp. in pig faecal samples. Journal of Applied Microbiology, 
99(2), 292-300. 
249. Jensen, J.S., Bjornelius, E., Dohn, B. & Lidbrink, P. (2004) Comparison of first void 
urine and urogenital swab specimens for detection of Mycoplasma genitalium and 
Campylobacter Control in Poultry 
 
137 
 
Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually 
transmitted disease clinic. Sexually Transmitted Diseases, 31, 499-507. 
250. Jerome, J.P., Bell, J.A., Plovanich-Jones, A.E., Barrick, J.E., Brown, C.T. & 
Mansfield, L.S. (2011). Standing genetic variation in contingency loci drives the rapid 
adaptation of Campylobacter jejuni to a novel host. PLoS ONE, 6:e16399. 
251. Jiang, J., Alderisio, K.A., Singh, A. & Xiao, L. (2005) Development of procedures for 
direct extraction of Cryptosporidium DNA from water concentrates and for relief of PCR 
inhibitors. Applied and Environmental Microbiology, 71, 1135–1141. 
252. Jimenez, S.M., Salsi M.S., Tiburzi M.C., Rafaghelli R.C. & Pirovani M.E. (1999). 
Combined use of acetic acid treatment and modified atmosphere packaging for extending 
the shelf-life of chilled chicken breast portions. Journal of Applied Microbiology, 87, 339–
344. 
253. Jin, S., Zhou, J. & Ye, J. (2008) Adoption of HACCP system in the Chinese food 
industry: A comparative analysis. Food Control 19, 823–828. 
254. Joens, L. (2012). The Development of an Efficacious Vaccine to Reduce 
Campylobacter in Chickens. Retrieved May 1, 2013, from 
http://www.cals.arizona.edu/fsc/node/21 
255. Johannessen, G.S., Johnsen, G., Okland, M., Cudjoe, K.S. & Hofshagen, M. (2007). 
Enumeration of thermotolerant Campylobacter spp. from poultry carcasses at the end of the 
slaughter-line. Letters in Applied Microbiology, 44, 92-7. 
256. Johnsen, G., Kruse, H. & Hofshagen, M. (2006). Genetic diversity and description of 
transmission routes for Campylobacter on broiler farms by amplified-fragment length 
polymorphism. Journal of Appled Microbiology, 101, 1130–1139. 
257. Jokinen, C., Edge, T.A., Ho, S., Koning, W., Laing, C., Mauro, W., Medeiros, D., 
Miller, J., Robertson, W., Taboada, E., Thomas, J.E., Topp, E., Ziebell, K., Gannon, V.P. 
(2011). Molecular subtypes of Campylobacter spp., Salmonella enterica, and Escherichia 
coli O157:H7 isolated from faecal and surface water samples in the Oldman River 
watershed, Alberta, Canada. Water Research, 45, 1247–1257. 
258. Jones, S.E. & Versalovic, J. Probiotic Lactobacillus reuteri biofilms produce 
antimicrobial and anti-inflammatory factors. BMC Microbiology, 9, 35. 
259. Jones, D.M., Sutcliffe, E.M. & Curry A. (1991). Recovery of viable but non-
culturable Campylobacter jejuni. Journal of Genetics and Microbiology, 137, 2477-2482. 
260. Jones, F.T., Axtell, R.C., Rives, D.V., Scheideler, S.R., Tarver, F.R.Jr., Walker, R.L., 
& Wineland, M.J. (1991). A survey of Campylobacter jejuni contamination in modern 
broiler production and processing systems. Journal of Food Protection, 54, 259-262. 
261. Jordan, E. & Stockley, R. (2010). Citizens’ Forums- Campylobacter TNS-BMRB 
Report JN 209445. Date 23 September 2010.  Retrieved May 26, 2013, from 
http://www.food.gov.uk/multimedia/pdfs/citforumcampy.pdf   
262. Jore, S., Viljugrein, H., Brun, E., Heier, B.T., Borck, B., Ethelberg, S., Hakkinen, M., 
Kuusi, M., Reiersen, J., Hansson, I., Engvall, E.O., Løfdahl, M., Wagenaar, J.A., van Pelt, 
W. & Hofshagen, M. (2010). Trends in Campylobacter incidence in broilers and humans in 
six European countries, 1997-2007. Preventive Veterinary Medicine, 93, 33-41. 
263. Jorgensen, F., Ellis-Iversen, J., Rushton, S., Bull, S., Harris, S.A., Bryan, S.J., 
Gonzalez, A. & Humphrey, T.J. (2011). Influence of season and geography on 
Campylobacter jejuni and C. coli subtypes in housed broiler flocks reared in Great Britain. 
Applied and Environmental Microbiology, 77, 3741e8. 
264. Josefsen, M.H., Jacobsen, N.R. & Hoorfar, J. (2004) Enrichment followed by 
quantitative PCR both for rapid detection and as a tool for quantitative risk assessment of 
Campylobacter Control in Poultry 
 
138 
 
food-borne thermotolerant campylobacters. Applied and Environmental Microbiology, 70, 
3588–3592. 
265. Josefsen, M.H., Löfström, C., Hansen, T.B., Christensen, L.S., Olsen, J.E. & Hoorfar, 
J. (2010) Rapid quantification of viable Campylobacter bacteria on chicken carcasses, using 
real-time PCR and propidium monoazide treatment, as a tool for quantitative risk 
assessment. Applied and Environmental Microbiology, 76, 5097–104. 
266. Kalmokoff, M., Lanthier, P., Tremblay, T.L., Foss, M., Lau, P.C., Sanders, G., Austin, 
J., Kelly, J. & Szymanski, C.M. (2006). Proteomic analysis of Campylobacter jejuni 11168 
biofilms reveals a role for the motility complex in biofilm formation. Journal of 
Bacteriology, 188(12), 4312–4320.  
267. Kampelmacher, E.H. (1984). Irradiation of food: a new technology for preserving and 
ensuring the hygiene of foods. Fleisch-wirtschaft, 64, 322-327. 
268. Kapperud, G., Espeland, G., Wahl, E., Walde, A., Herikstad, H., Gustavsen, S., Tveit, 
I., Natås, O., Bevanger, L. & Digranes, A. (2003) Factors associated with increased and 
decreased risk of Campylobacter infection: a prospective case-control study in Norway. 
American Journal of Epidemiology, 158, 234–242. 
269. Kapperud, G., Skjerve, E., Bean, N.H., Ostroff, S.M. & Lassen, J. (1992). Risk factors 
for sporadic Campylobacter infections: results of a case-control study in southeastern 
Norway. Journal of Clinical Microbiology, 12, 1317–1321. 
270. Kapperud, G., Skjerve, E, Vik, L, Hauge, K, Lysaker, A, Aalmen, I, Ostroff, SM, 
Potter, M. (1993). Epidemiological investigation of risk factors for Campylobacter 
colonization in Norwegian broiler flocks. Epidemiology and Infection, 111, 245–255. 
271. Karlen, Y., McNair, A., Perseguers, S., Mazza, C. & Mermod, N. (2007). Statistical 
significance of quantitative PCR. BMC Bioinformatics 8, 131. 
272. Karlyshev, A.V., Champion, O.L., Churcher, C., Brisson, J.-R., Jarrell, H.C., Gilbert, 
M., Brochu, D., St. Michael, F., Li, J., Wakarchuk,W.W., Goodhead, I., Sanders, M., 
Stevens, K., White, B., Parkhill, J., Wren, B. W., Szymanski, C. M. (2005). Analysis of 
Campylobacter jejuni capsular loci reveals multiple mechanisms for the generation of 
structural diversity and the ability to form heptoses. Molecular Microbiology, 55, 90–103.  
273. Katcher, H.L. & Schwartz, I. (1994). A distinctive property of Tth DNA polymerase: 
Enzymatic amplification in the presence of phenol. BioTechniques 16, 84–92. 
274. Katsma, W.E., De Koeijer, A.A., Jacobs-Reitsma, W.F., Mangen, M.J. & Wagenaar, 
J.A. (2007). Assessing interventions to reduce the risk of Campylobacter prevalence in 
broilers. Risk Analysis, 27, 863–876. 
275. Keener, K.M., Bashor, M.P., Curtis, P.A., Sheldon, B.W. & Kathariou, S. (2004). 
Comprehensive Review of Campylobacter and Poultry Processing. Comprehensive Reviews 
in Food Science and Food Safety, 3, 105–116.  
276. Kemmeren, J.M., Mangen, M.-J. J., van Duynhoven, Y. T. & Havelaar, A. (2006). 
Priority setting of foodborne pathogens - Disease burden and costs of selected enteric 
pathogens. RIVM. RIVM report 330080001. 
277. Khoury, C.A. & Meinersmann, R.J. (1995). A genetic hybrid of the Campylobacter 
jejuni flaA gene with LT-B of Escherichia coli and assessment of the efficacy of the hybrid 
protein as an oral chicken vaccine. Avian Diseases, 39, 812-820. 
278. Kinana, A.D., Cardinale, E., Tall, F., Bahsoun, I., Sire, J.M., Garin, B., Breurec, S., 
Boye, C.S., & Perrier-Gros-Claude, J.D. (2006). Genetic diversity and quinolone resistance 
in Campylobacter jejuni isolates from poultry in Senegal. Applied and Environmental 
Microbiology, 72, 3309-3313. 
Campylobacter Control in Poultry 
 
139 
 
279. Kjærulff, U.B. & Madsen, A.L. (2008). Bayesian Networks and Influence Diagrams: 
A Guide to Construction and Analysis. Springer, 2008. 
280. Klein, D., Janda, P., Steinborn, R., Müller,  M., Salmons, B. & Günzburg, W.H. 
(1999). Proviral load determination of different feline immunodeficiency virus isolates using 
real-time polymerase chain reaction: influence of mismatches on quantification. 
Electrophoresis 20, 291–299.  
281. Klewicki, R. & Klewicka, E. (2004). Antagonistic activity of lactic acid bacteria as 
probiotics against selected bacteria of the Enterobaceriacae family in the presence of polyols 
and their galactosyl derivatives. Biotechnolgy Letters, 26, 317-320. 
282. Knuf, M., Kowalzik, F. & Kieninger, D. (2011). Comparative effects of carrier 
proteins on vaccine-induced immune response. Vaccine 29, 4881–4890. 
283. Koller, D. & Friedman, N. (2009). Probabilistic Graphical Models | Principles and 
Techniques. MITPress, 2009. 
284. Kovats, R.S., Edwards, S.J., Charron, D., Cowden, J., D'Souza, R.M., Ebi, K.L., 
Gauci, C., Gerner-Smidt, P., Hajat, S., Hales, S., Hernández Pezzi, G., Kriz, B., Kutsar, K., 
McKeown, P., Mellou, K., Menne, B., O'Brien, S., van Pelt, W. & Schmid, H. (2005). 
Climate variability and campylobacter infection: an international study. International 
Journal of Biometeorology, 49, 207-214. 
285. Lacroix, M. & Ouattara, B. (2000). Combined industrial processes with irradiation to 
assure innocuity and preservation of food products-a review. Food Research International, 
33, 719-724. 
286. Lagier, M.J., Joseph, L.A., Passaretti, T.V., Musser, K.A. & Cirino, N.M. (2004). A 
real-time multiplexed PCR assay for rapid detection and differentiation of Campylobacter 
jejuni and Campylobacter coli.  Molecular and Cellular Probes, 18(4), 275-282. 
287. Lahtinen, S.J., Gueimonde, M., Ouwehand, A.C., Reinikainen, J.P. & Salminen, S.J. 
(2006). Comparison of four methods to enumerate probiotic bifidobacteria in a fermented 
food product. Food Microbiology, 23 (6), 571–577. 
288. Lake, R., Hudson, A., Cressey, P. & Bayne, G. (2007). Quantitative Risk Model: 
Campylobacter spp. in the poultry food chain. Institute of Environmental Science & 
Research Limited (ESR).  
289. Lalam, N., Jacob, C. & Jagers, P. (2004). Modelling the PCR amplification process by 
a size-dependent branching process and estimation of the efficiency. Advances in Applied 
Probabity, 36, 602-615. 
290. Lalam, N. (2007). Statistical Inference for Quantitative Polymerase Chain 
Reaction Using a Hidden Markov Model:A Bayesian Approach Statistical 
Applications in Genetics and Molecular Biology, 6, 10.  
291. Lantz, P.G., Matsson, M., Wadström, T. & Rådström, P. (1997) Removal of PCR 
inhibitors from human faecal samples through the use of an aqueous two phase system for 
sample preparation prior to PCR. Journal of Microbiological Methods, 28,159–167. 
292. Lawes, J.R., Vidal, A., Clifton-Hadley, F.A., Sayers, R., Rodgers, J., Snow, L., Evans, 
S.J., Powell, L.F. (2012). Investigation of prevalence and risk factors for Campylobacter in 
broiler flocks at slaughter: results from a UK survey. Epidemiology and Infection, 140(10), 
1725-1737.  
293. Lawson, L.G., Jensen, J.D. & Lund, M. Cost of interventions against Campylobacter 
in the Danish broiler supply chain. Report no. 201. Copenhagen: Institute of Food and 
Resource Economics; 2009. [cited 2013 Jan 2]. Retrieved July 22, 2013, from 
http://www.foi.life.ku.dk/Publikationer/FOI_serier/Nummererede_rapporter.aspx#2009.  
Campylobacter Control in Poultry 
 
140 
 
294. Layton, S.L., Morgan, M.J., Cole, K., Kwon, Y.M., Donoghue, D.J., Hargis, B.M. & 
Pumford, N.R. (2011). Evaluation of Salmonella-vectored Campylobacter peptide epitopes 
for reduction of Campylobacter jejuni in broiler chickens. Clinical Vaccine Immunology, 
18(3), 449-454. 
295. Le Dréan, G., Mounier, J., Vasseur, V., Arzur, D., Habrylo, O. & Barbier, G. (2010) 
Quantification of Penicillium camemberti and P. roqueforti mycelium by real-time PCR to 
assess their growth dynamics during ripening cheese. International Journal of Food 
Microbiology, 138, 100–107. 
296. Leblanc-Maridor, M., Beaudeau, F., Seegers, H., Denis, M. & Belloc, C. (2011a) 
Rapid identification and quantification of Campylobacter coli and Campylobacter jejuni by 
real-time PCR in pure cultures and in complex samples. BMC Microbiology,11, 1–16.  
297. Leblanc-Maridor, M., Garénaux, A., Beaudeau, F., Chidaine, B., Seegers, H., Denis, 
M. & Belloc, C. (2011b). Quantification of Campylobacter spp. in pig feces by direct real-
time PCR with an internal control of extraction and amplification. Journal of 
Microbiological Methods, 85, 53–61.  
298. Lebuhn, M., Effenberger, M., Garces, G., Gronauer, A. & Wilderer, P.A. (2005) 
Hygienization by anaerobic digestion: comparison between evaluation by cultivation and 
quantitative real-time PCR. Water Science and Technology, 52 (1–2), 93–99. 
299. Lee, A., Smith, S. C. & Coloe, P. J. (1998). Survival and growth of Campylobacter 
jejuni after artificial inoculation onto chicken skin as a function of temperature and 
packaging conditions. Journal of Food Protection, 61, 1609-1614. 
300. Lee, L.H., Burg III, E., Baqar, S., Bourgeois, A.L., Burr, D.H., Ewing, C.P., Trust, 
T.J. & Guerry, P. (1999). Evaluation of a truncated recombinant flagellin subunit vaccine 
against Campylobacter jejuni. Infection and Immunology, 67, 5799–5805. 
301. Leong, D.T., Gupta, A., Bai, H.F., Wan, G., Yoong, L.F. & Too, H.P. (2007). 
Absolute quantification of gene expression in biomaterials research using real-time PCR. 
Biomaterials, 28, 203–210. 
302. Lesinski, G. B. & Westernick M. A. (2001). Vaccines against polysaccharide antigens. 
Currents in Drug Targets and Infectious Disorders, 1, 325–334.  
303. Levine, M.M., Kotloff, K.L., Barry, E.M., Pasetti, M.F. & Sztein, M.B. (2007). 
Clinical trials of Shigella vaccines: Two steps forward and one step back on a long, hard 
road. Nature Reviews Microbiology 5, 540–553. 
304. Li, X.,  Swaggerty, C.L.,  Kogut, M.H., Chiang, H., Wang, Y.,  Genovese, K.J., He, H.  
Stern, N.J.,  Pevzner, I.Y. & Zhou, H. (2008). The paternal effect of Campylobacter jejuni 
colonization in ceca in broilers. Poultry Science, 87, 1742-1747. 
305. Li, Y., Slavik, M. F., Walker, J. T. & Xiong, H. (1997). Prechill spray of chicken 
carcasses to reduce Salmonella typhimurium. Journal of Food Science, 62, 605–607. 
306. Lillard, H.S., Blankenship, L.C., Dickens, J.A., Craven, S.E. & Shackleford, A.D. 
(1987). Effect of acetic acid on the microbiological quality of scalded picked and unpicked 
broiler carcasses. Journal of Food Protection, 50, 112-114. 
307. Lin, J. (2009). Novel Approaches for Campylobacter Control in Poultry. Foodborne 
Pathogens and Disease, 6, 7. 
308. Lindblad, M., Hansson, I., Vågsholm, I. & Lindqvist, R. (2006). Postchill 
campylobacter prevalence on broiler carcasses in relation to slaughter group colonization 
level and chilling system. Journal of Food Protection, 69, 495-499. 
309. Lindqvist, R., Andersson, Y., Lindback, J., Wegscheider, M., Eriksson, Y., Tidestrom, 
L., Lagerqvist-Widh, A., Hedlund, K.O., Lofdahl, S., Svensson, L. & Norinder, A. (2001). 
Campylobacter Control in Poultry 
 
141 
 
A one-year study of foodborne illnesses in the municipality of Uppsala, Sweden. Emerging 
Infectious Diseases, 7, 588-592. 
310. Line, J.E. & Bailey, J.S. (2006). Effect of on-farm litter acidification treatments on 
Campylobacter and Salmonella populations in commercial broiler houses in northeast 
Georgia. Poultry Science, 85, 1529-1534. 
311. Line, J.E. (2001). Development of a selective differential agar for isolation and 
enumeration of Campylobacter spp. Journal of Food Protection 64(11), 1711‐1715. 
312. Line, J.E. (2002). Campylobacter and Salmonella populations associated with chicken 
raised on acidified litter. Poultry Science, 81(10), 1473-1477. 
313. Loc Carrillo, C., Atterbury, R.J., el-Shibiny, A., Connerton, P.L., Dillon, E., Scott, A. 
& Connerton, I.F. (2005). Bacteriophage therapy to reduce Campylobacter jejuni 
colonization of broiler chickens. Applied and Environmental Microbiology, 71(11), 6554–
6563. 
314. Löfström, C., Schelin, J., Norling, B., Vigre, H., Hoorfar, J. & Rådström, P. (2010). 
Culture independent quantification of Salmonella enterica in carcass gauze swabs by 
flotation prior to real-time PCR. International Journal of Food Microbiology, 145, S103–
109. 
315. Louis, V.R., Gillespie, I.A., O’Brien, S.J., Russek-Cohen, E., Pearson, A.D. & 
Colwell, R.R. (2005). Temperature-driven campylobacter seasonality in England and Wales. 
Applied and Environmental Microbiology, 71, 85-92. 
316. Lowman, R., Reiersen, J., Jónsson, Gunnarsson, A., Bisaillon, J.G. & Daoadottir, S.C. 
(2009). Iceland: 2008 pilot year fly netting ventilation inlets of 35 broiler houses to reduce 
flyborne transmission of Campylobacter spp. to flocks. In: Abstracts of the 15th 
International Workshop on Campylobacter, Helicobacter and related organisms; 2009 Sep 
2–5; Niigata, Japan. 2009. 
317. Lübeck, P.S., Wolfs, P., On, S.L.W., Ahrens, P., Rådström, P. & Hoorfar, J. (2003) 
Towards an International Standard for PCR-Based Detection of Food-Borne Thermotolerant 
Campylobacters. Assay Development and Analytical Validation 69, 5664–5669. 
318. Lucas, P.J.F., De Bruijn, N.C., Schurink, K. & Hoepelman, I.M. (2000). A 
probabilistic and decision-theoretic approach to the management of infectious disease at the 
ICU. Artificial Intelligence Medicine, 19(3), 251–279. 
319. Lund, M., Nordentoft, S., Pedersen, K. & Madsen, M. (2004) Detection of 
Campylobacter spp. in chicken fecal samples by realtime PCR. Journal of Clinical 
Microbiology, 42, 5125–5132. 
320. Lund, M., Welch, T.K., Griswold, K., Endres, J.B. & Shepherd, C. (2003).Occurrence 
of Campylobacter and Salmonella in broiler chickens raised in different production systems 
and fed organic and traditional feed. Food ProtectionTrends, 23, 252–256. 
321. Lütticken, D., Segers, R.P.A.M. & Visser, N. (2007).Veterinary vaccines for public 
health and prevention of viral and bacterial zoonotic diseases. Revue scientifique et 
technique (International Office of Epizootics), 26 (1), 165-177. 
322. Lyngstad, T.M., Jonsson, M.E., Hofshagen, M. & Heier, B.T. (2008). Risk factors 
associated with the presence of Campylobacter species in Norwegian broiler flocks. Poultry 
Science 87, 1987–1994. 
323. Madden, R.H., Moran, L. & Scates, P. (2000). Optimising recovery of Campylobacter 
spp. from the lower porcine gastrointestinal tract. Journal of Microbiological Methods, 42, 
115–119. 
324. Madsen, A.L., Karlsen, M., Barker, G.C., Garcia, A.B., Hoorfar, J. & Jensen, F. 
(2012). An Architecture For Web Deployment Of Decision Support Systems Based On 
Campylobacter Control in Poultry 
 
142 
 
Probabilistic Graphical Models With Applications. Tech Report TR-12-001 Department of 
Computer Science, Aalborg University, 2012. ISBN: 1601-0590. 
325. Malorny, B., Löfström, C., Wagner, M., Kramer, N. & Hoorfar, J. (2008). 
Enumeration of salmonella bacteria in food and feed samples by real-time PCR for 
quantitative microbial risk assessment. Applied and Environmental Microbiology, 74, 1299–
1304. 
326. Malsch, N.H. (2005). Biomedical Nanotechnology Washington, D.C.: CRC Press, 
2005. 
327. Martín, B., Jofré, A., Garriga, M., Pla, M. & Aymerich, T. (2006). Rapid quantitative 
detection of Lactobacillus sakei in meat and fermented sausages by real-time PCR. Applied 
and Environmental Microbiology, 72 (9), 6040–6048. 
328. Masco, L., Vanhoutte, T., Temmerman, R., Swings, J. & Huys, G. (2007). Evaluation 
of real-time PCR targeting the 16S rRNA and recA genes for the enumeration of 
bifidobacteria in probiotic products. International Journal of Food Microbiology, 113, 351–
357. 
329. McCarthy, N.D., Gillespie, I.A., Lawson, A.J., Richardson, J., Neal, K.R., Haxtin, 
P.R., Maiden, M.C. & O'Brien, S.J. (2012). Molecular epidemiology of human 
Campylobacter jejuni shows association between seasonal and interantional patterns of 
disease. Epidemiology and Infection, 140(12), 2247-2255. 
330. McCrea, B.A., Tonooka, K.H., VanWorth, C., Boggs, C.L., Atwill, E.R. & Schrader, 
J.S. (2006). Prevalence of Campylobacter and Salmonella species on farm, after transport, 
and at processing in specialty market poultry. Poultry Science, 85, 136–143. 
331. McDowell, S.W., Menzies, F.D., McBride, S.H., Oza, A.N., McKenna, J.P., Gordon, 
A.W. & Neill, S.D. (2008). Campylobacter spp. in conventional broiler flocks in Northern 
Ireland: epidemiology and risk factors. Preventive Veterinary Medicine, 84, 261–276. 
332. McGrogan, A., Madle, G.C., Seaman, H.E. & de Vries, C.S. (2009). The 
epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology, 32, 150–163.  
333. McKenna, J.P., Oza, A. & McDowell, S.W.J. (2001). The role of transport vehicles, 
modules and transport crates as potential sources of Campylobacter infection for broilers. 
International Journal of Medical Microbiology, 291,31- 38. 
334. McNicholas, A.M., Bates, M., Kiddle, E. & Wright, J. (1995). Is New Zealand's recent 
increase in campylobacteriosis due to changes in laboratory procedures? A survey of 69 
medical laboratories. New Zealand Medical Journal, 108, 459–461. 
335. Messens, W., Herman, L., De Zutter, L. & Heyndrickx, M. (2009). Multiple typing for 
the epidemiological study of contamination of broilers with thermotolerant Campylobacter. 
Veterinary Microbiology, 138, 120–131. 
336. Miller, G., Dunn, G.M., Smith-Palmer, A., Ogden, I.D. & Strachan, N.J. (2004). 
Human campylobacteriosis in Scotland: seasonality, regional trends and bursts of infection. 
Epidemiology and Infection, 132, 585–593 
337. Mills, A. & Phillips, C.A. (2003). Campylobacter jejuni and the human food chain: a 
possible source. Nutrition and Food Science, 33, 197–202. 
338. Monk, J.D., Beuchat, L.R. & Doyle, M.P. (1995). Irradiation inactivation of food-
borne microorganisms. Journal of Food Protection, 58, 197-208. 
339. Monteiro, M.A., Baqar, S., Hall, E.R., Chen, Y.-H., Porter, C.K., Bentzel, D.E., 
Applebee, L. & Guerry, P. (2009). A capsule polysaccharide conjugate vaccine against 
diarrheal disease caused by Campylobacter jejuni. Infection and Immunology, 77, 1128–
1136. 
Campylobacter Control in Poultry 
 
143 
 
340. Moore, J.E., Barton, M.D., Blair, I.S., Corcoran, D., Dooley, J.S., Fanning, S., Kempf, 
I., Lastovica, A.J., Lowery, C.J., Matsuda, M., McDowell, D.A., McMahon, A., Millar, 
B.C., Rao, J.R., Rooney, P.J., Seal, B.S., Snelling, W.J. & Tolba, O. (2006). The 
epidemiology of antibiotic resistance in Campylobacter. Microbes and Infection, 8(7),1955–
1966.  
341. Moore, J.E. & Madden, R.H. (1998). Occurrence of thermophilic Campylobacter spp. 
in porcine liver in Northern Ireland. Journal of Food Protection, 61, 409–413. 
342. Morishita, T.Y., Aye, P.P., Harr, B.S., Cobb, C.W., Clifford, J.R. (1997). Evaluation 
of an avian specific probiotic to reduce the colonization and shedding of Campylobacter 
jejuni in broilers. Avian Diseases, 41, 850-855. 
343. Mucchetti, G., Bonvini, B., Francolino, S., Neviani, E. & Carminati, D. (2008). Effect 
of washing with a high pressure water spray on removal of Listeria innocua from 
Gorgonzola cheese rind. Food Control 19, 521–525. 
344. Mughini Gras, L., Smid, J.H., Wagenaar, J.A., de Boer, A.G., Havelaar, A.H., 
Friesema, I.H.,French, N.P.,Busani, L. &van Pelt, W. (2012). Risk Factors for 
Campylobacteriosis of Chicken, Ruminant, and Environmental Origin: A Combined Case-
Control and Source Attribution Analysis. PLoS ONE 7(8), e42599.  
345. Mulder, R.W.A.W. (1999). Hygiene during transport, slaughter and processing. In: 
Poultry meat science (Edit. Richardson R.I., Mead G.C.) CABI Publishing, pp. 277-284. 
346. Muldoon, J., Shashkov, A.S., Moran, A.P., Ferris, J.A., Senchenkova, S.N. & Savage, 
A.V. (2002). Structures of two polysaccharides of Campylobacter jejuni 81116. 
Carbohydrate Research, 337, 2223–2229.  
347. Mullner, P., Jones, G., Noble, A., Spencer, S. E., Hathaway, S. & French N. P. (2009). 
Source attribution of food-borne zoonoses in New Zealand: a modified Hald model. Risk 
Analysis, 29, 970-984. 
348. Murphy, N.M., McLauchlin, J., Ohai, C. & Grant, K.A. (2007). Construction and 
evaluation of a microbiological positive process internal control for PCR-based examination 
of food samples for Listeria monocytogenes and Salmonella enterica. International Journal 
of Food Microbiology, 120, 110–9. 
349. Murphy, C., Carroll, C. & Jordan, K.N. (2006). Environmental survival mechanisms 
of the foodborne pathogen Campylobacter jejuni. Journal of Applied Microbiology, 100, 
623–632. 
350. Musgrove, M.T., Cason, J.A., Fletcher, D.L., Stern, N.J., Cox, N.A. & Bailey J.S. 
(1997). Effect of cloacal plugging on microbial recovery from partially processed broilers. 
Poultry Science, 76, 530-533. 
351. Nachamkin, I., Allos, B.M. & Ho, T. (1998). Campylobacter species and Guillain- 
Barré syndrome. Clinical Microbiology Reviews, 11, 555–67. 
352. Nachamkin, I. & Blaser, M.J. (2000). Campylobacter, 2nd edition. Washington: 
American Society for Microbiology,  2000. 
353. Nachamkin, I., Allos, B. M. & Ho, T.W. (2000). Campylobacter jejuni infection and 
the association with Guillain-Barré syndrome. In I. Nachamkin, M. J. Blaser (eds.), 
Campylobacter. ASM Press, Washington, DC. 
354. Nannapaneni, R., Chalova, V.I., Crandall, P.G., Rick, S.C., Johnson, M.G. & O'Bryan, 
C.A. (2009). Campylobacter and Arcobacter species sensitivity to commercial orange oil 
fractions. International Journal of Food Microbiology, 129, 43-49. 
355. Näther, G., Alter, T., Martin, A. & Ellerbroek, L. (2009). Analysis of risk factors for 
Campylobacter species infection in broiler flocks. Poultry Science, 88, 1299–1305. 
Campylobacter Control in Poultry 
 
144 
 
356. Nauta, M., Hill, A., Rosenquist, H., Brynestad, S., Fetsch, A., van der, L. P., Fazil, A., 
Christensen, B., Katsma, E., Borck, B. & Havelaar, A. (2009). A comparison of risk 
assessments on Campylobacter in broiler meat. International Journal of Food Microbiology, 
129, 107-123. 
357. Nauta, M., van der Fels-Klerx, I. & Havelaar, A. (2005). A poultry-processing model 
for quantitative microbiological risk assessment. Risk Analysis, 25(1), 85-98. 
358. Nechvatal, J.M., Ram, J.L., Basson, M.D., Namprachan, P., Niec, S.R., Badsha, K.Z., 
Matherly, L.H., Majumdar, A.P.N. & Kato, I. (2008). Fecal collection, ambient preservation, 
and DNA extraction for PCR amplification of bacterial and human markers from human 
feces. Journal of Microbiological Methods 72, 124-132. 
359. Neimann, J., Engberg, J., Molbak, K. & Wegener, H.C. (2003). A case-control study 
of risk factors for sporadic Campylobacter infections in Denmark. Epidemiology and 
Infection, 130, 353-366. 
360. Nelson, W. & Harris, B. (2006). Flies, fingers, fomites, and food. Campylobacteriosis 
in New Zealandefood-associated rather than food-borne. New Zealand Medical Journal, 
119, U2128. 
361. Neogen (2010).  Campy-blood free selective medium (CCDA) (7527) product 
information. Retrieved March 26, 2013, from 
http://www.neogen.com/Acumedia/pdf/ProdInfo/7527_PI.pdf  
362. Neubauer, C., Bibl, D., Szölgyenyi, W., Jauk, V., Schmid, M., Gabler, C. & Vasicek, 
L. (2005). Epidemiological investigation of Campylobacter spp. in Austrian broiler flocks: 
prevalence and risk factors. Wiener tierärztliche Monatsschrift, 92, 4–10. 
363. Newell, D.G. & Wagenaar, J.A. (2000). Poultry infections and their control at the 
farm level. In Campylobacter (I. Nachamkin & M.J. Blaser, eds), 2nd Ed. ASM Press, 
Washington, DC, 497-509. 
364. Newell, D.G., Elvers, K.T., Dopfer, D., Hansson, I., Jones, P., James, S., Gittins, J., 
Stern, N.J., Davies, R., Connerton, I., Pearson, D., Salvat, G. & Allen, V.M. (2011). 
Biosecurity-based interventions and strategies to reduce Campylobacter spp. on poultry 
farms. Applied and Environmental Microbiology, 77(24), 8605-8614.  
365. Newell, D.G. & Fearnley, C. (2003) Mini review. Sources of Campylobacter 
colonization in broiler chickens. Applied and Environmental Microbiology, 69 (8), 4343-
4351. 
366. Newell, DG. (2002).The ecology of Campylobacter jejuni in avian and human hosts 
and in the environment. International Journal of Infectious Diseases, 6, 3S16–3S21. 
367. Ng, L. K., Kingombe, C. I. B., Yan, W., Taylor, D. E., Hiratsuka, K., Malik, N. & 
Garcia M.M. (1997). Specific detection and confirmation of Campylobacter jejuni by DNA 
hybridization and PCR. Applied and Environmental Microbiology, 63, 4558-4563. 
368. Nguyen, V.T., Turner, M.S. & Dykes, G.A. (2011). Influence of cell surface 
hydrophobicity on attachment of Campylobacter to abiotic Surfaces. Food Microbiology, 
28, 942-950. 
369. Nichols, G.L., Richardson, J.F., Sheppard, S.K., Lane, C. & Sarran, C. (2012). 
Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and 
Wales between 1989 and 2011. BMJ Open, 2, e001179.  
370. Nichols, G.L. (2010). Disease transmission by non-biting hlies. In: Ayres JG, Harrison 
RM, Nichols GL, et al, eds. Environmental Medicine. London: Hodder Arnold,2010:434e46. 
371. Nichols, G.L. (2005). Fly transmission of campylobacter. Emerging Infectious 
Diseases, 11, 361e4. 
Campylobacter Control in Poultry 
 
145 
 
372. Nielsen, E.M., Fussing, V., Engberg, J., Nielsen, N.L. & Neimann, J. (2006). Most 
Campylobacter subtypes from sporadic infections can be found in retail poultry products and 
food animals. Epidemiology and Infection, 134, 758–767. 
373. Noble, R.T., Blackwood, A.D., Griffith, J.F., McGee, C.D. & Weisberg, S.B. (2010). 
Comparison of rapid quantitative PCR-based and conventional culture-based methods for 
enumeration of Enterococcus spp. and Escherichia coli in recreational waters. Applied and 
Environmental Microbiology, 76, 7437–7443. 
374. Nolan, T., Hands, R.E., Ogunkolade, W. & Bustin, S.A. (2006). SPUD: a quantitative 
PCR assay for the detection of inhibitors in nucleic acid preparations. Analytical 
Biochemisty, 351, 308–310. 
375. Noor, S.M., Husband, A.J. & Widders, P.R. (1995). In ovo oral vaccination with 
Campylobacter jejuni establishes early development of intestinal immunity in chickens. 
British Poultry Science, 36, 563–573. 
376. Nylen, G., Dunstan, F., Palmer, S.R., Andersson, Y., Bager, F., Cowden, J., Feierl, G., 
Galloway, Y., Kapperud, G., Mégraud, F., Molbak, K., Petersen, L.R. & Ruutu, P. (2002). 
The seasonal distribution of campylobacter infection in nine European countries and New 
Zealand. Epidemiology and Infection, 128(3), 383-390. 
377. Oberhelman, R.A. & Taylor, D.N. (2000). Campylobacter infections in developing 
countries. In: Nachamkin I, Blaser MJ, editors. Campylobacter, 2nd edition. Washington: 
American Society for Microbiology, p.139-53. 
378. O'Flaherty, S., Saulnier, D.M., Pot, B. & Versalovic, J. (2010). How can probiotics 
and prebiotics impact mucosal immunity? Gut Microbes, 1, 293–300. 
379. Ogden, I.D., Dallas, J.F., MacRae, M., Rotariu, O., Reay K.W., Leitch, M., Thomson, 
A.P., Sheppard, S.K., Maiden, M., Forbes, K.J. &Strachan, N.J. (2009). Campylobacter 
excreted into the environment by animal sources: prevalence, concentration shed, and host 
association. Foodborne Pathogens and Diseases, 6, 1161–1170. 
380. Okrend, A.J., Johnston, R.W & Moran, A.B. (1986). Effect of acetic acid on the death 
rates of 52°C of Salmonella newport, Salmonella typhimurium and Campylobacter jejuni in 
poultry scald water. Journal of Food Protection, 49, 500-503. 
381. Oliver, J.D. (2005). Viable but nonculturable bacteria in food environments. In P.M. 
Fratamico and A.K. Bhunia (eds.), Food Borne Pathogens: Microbiology and Molecular 
Biology. Horizon Scientific Press, Norfolk, U.K.  
382. O'Sullivan, N.A., Fallon, R., Carroll, C., Smith, T. & Maher, M. (2000). Detection and 
differentiation of Campylobacter jejuniCampylobacter jejuni and Campylobacter 
coliCampylobacter coli in broiler chicken samples with a PCR/DNA probe membrane based 
colorimetric detection assay. Molecular and Cellular Probes, 14, 7-16. 
383. Oyofo, B.A. & Rollins, D.M. (1993). Efficacy of filter types for detecting 
Campylobacter jejuni and Campylobacter coli in environmental water samples by 
polymerase chain reaction. Applied and Environmental Microbiology, 59, 4090–4095. 
384. Pancorbo, P.L., de Pablo, M.A., Ortega, E., Puertollano, M.A., Gallego, A.M. 
& Alvarez de Cienfuegos, G. (2001). Potential intervention of Campylobacter jejuni 
in the modulation of murine immune response. Currents in Microbiology, 43(3), 
209-14. 
385. Parkhill, J., Wren, B.W., Mungall, K., Ketley, J.M., Churcher, C., Basham, D., 
Chillingworth, T., Davies, R.M., Feltwell, T., Holroyd, S., Jagels, K., Karlyshev, A.V., 
Moule, S., Pallen, M.J., Penn, C.W., Quail, M.A., Rajandream, M.A., Rutherford, K.M., van 
Vliet, A.H., Whitehead, S. & Barrell, B.G. (2000).The genome sequence of the food-borne 
pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403, 665–668. 
Campylobacter Control in Poultry 
 
146 
 
386. Parrish, J.R., Yu, J., Liu, G., Hines, J.A., Chan, J.E., Mangiola, B.A., Zhang, H., 
Pacifico, S., Fotouhi, F., DiRita, V.J., Ideker, T., Andrews, P. & Finley, R.L. Jr. (2007). A 
proteome-wide protein interaction map for Campylobacter jejuni. Genome Biology, 8(7), 
R130. 
387. Partnership for Food Safety Education (2010). Safe food handling. Retrieved January 
9, 2013, from http://www.fightbac.org/safe-food-handling  
388. Patrick, M.E., Christiansen, L.E., Waino, M., Ethelberg, S., Madsen, H. & Wegener, 
H.C. (2004). Effects of climate on incidence of Campylobacter spp. in humans and 
prevalence in broiler flocks in Denmark. Applied and Environmental Microbiology, 70, 
7474-7480. 
389. Pearson, A. D., Greenwood, M.,  Healing, T.D., Rollins, D., Shahamat, M., 
Donaldson, J. &  Colwell, R.R. (1993). Colonization of broiler chickens by waterborne 
Campylobacter jejuni. Applied and Environmental Microbiology, 59, 987–996. 
390. Pebody, R.G., Ryan, M.J. & Wall, P.G. (1997). Outbreaks of Campylobacter 
infection: rare events for a common pathogen. Communicable Disease Report 7, R33-37. 
391. Pennacchia, C., Ercolini, D. & Villani, F. (2009). Development of a Real-Time PCR 
assay for the specific detection of Brochothrix thermosphacta in fresh and spoiled raw meat. 
International Journal of Food Microbiology, 134 (3), 230–236. 
392. Perch-Nielsen, I.R., Bang, D.D., Poulsen, C.R., El-Ali, J. & Wolff, A. (2003). 
Removal of PCR inhibitors using dielectrophoresis as a selective filter in a microsystem.  
Lab Chip 3:212–216. 
393. Perko-Mäkelä, P., Isohanni, P., Katzav, M., Lund, M., Hänninen, M.L. & Lyhs, U. 
(2009). A longitudinal study of Campylobacter distribution in a turkey production chain. 
Acta Veterinaria Scandinavica, 51, 18-28. 
394. Permin, A. & Detmer, A. (2007). Improvement of Management and Biosecurity 
Practices in smallholder poultry producers. Retrieved September 17, 2012, from 
http://www.fao.org/docs/eims//upload/228410/biosecurity_en.pdf  
395. Petersen, L., Nielsen, E.M. & On, S. L. (2001). Serotype and genotype diversity and 
hatchery transmission of Campylobacter jejuni in commercial poultry flocks. Veterinary 
Microbiology, 82, 141–154. 
396. Peyrat, M.B., Soumet, C., Maris, P. & Sanders, P. (2008). Recovery of Campylobacter 
jejuni from surfaces of poultry slaughterhouses after cleaning and disinfection procedures: 
Analysis of a potential source of carcass contamination. International Journal of Food 
Microbiology, 124, 188-194. 
397. Phalipon, A., Mulard, L.A. & Sansonetti, P.J. (2008). Vaccination against shigellosis: 
is it the path that is difficult or is it the difficult that is the path? Microbes Infection 10(9), 
1057-1062.  
398. Piskernik, S., Klančnik, A., Riedel, C.T., Brøndsted, L. & Možina, S.S. (2011). 
Reduction of Campylobacter jejuni by natural antimicrobials in chicken meat-related 
conditions. Food Control, 22, 718-724. 
399. Postollec, F., Falentin, H., Pavan, S., Combrisson, J. & Sohier, D. (2011) Recent 
advances in quantitative PCR (qPCR) applications in food microbiology. Food 
Microbiology, 28, 848–861. 
400. Prendergast, M.M., Tribble, D.R., Baqar, S., Scott, D.A., Ferris, J.A., Walker, R.I. & 
Moran, A.P. (2004). In vivo phase variation and serologic response to lipooligosaccharide of 
Campylobacter jejuni in experimental human infection. Infection and Immunology, 72, 916–
922. 
Campylobacter Control in Poultry 
 
147 
 
401. Pritchard, J., Stephens, M. & Donnelly, P. (2000). Inference of Population Structure 
using Multilocus Genotype Data. Genetics 155, 945-959. 
402. Prokhorova, T.A., Nielsen, P.N., Petersen, J., Kofoed, T., Crawford, J.S., Morsczeck, 
C., Boysen, A. & Schrotz-King, P. (2006). Novel surface polypeptides of Campylobacter 
jejuni as traveller’s diarrhoea vaccine candidates discovered by proteomics. Vaccine 24, 
6446–6455. 
403. Pujol, M., Badosa, E., Manceau, C. & Montesinos, E. (2006). Assessment of the 
environmental fate of the biological control agent of fire blight, Pseudomonas fluorescens 
EPS62e, on apple by culture and real-time PCR methods. Applied and Environmental 
Microbiology 72 (4), 2421–2427. 
404. Purnell, G., Mattick, K. & Humphrey, T. (2004). The use of 'hot wash' treatments to 
reduce the number of patogenic and spoilage bacteria on raw retail poultry. Journal of Food 
Engineering, 62, 29-36. 
405. Puterflam, J., Bouvarel, I., Ragot, O. & Drouet, M. (2005). Contamination of broiler 
breeder farms by Campylobacter: is this inevitable? Avian Science and Technology 12, 12–
19. 
406. Qiagen (2013). DNA Protocols & Applications. Retrieved May18, 2012, from 
http://www.qiagen.com/Knowledge-and-Support/Spotlight/Protocols-and-Applications-
Guide/DNA/#Storage of DNA. 
407. R Development Core Team (2008). R: A language and environment for statistical 
computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, 
URL. Retrieved February 9, 2013, from http://www.R-project.org.  
408. Rådström, P., Knutsson, R., Wolffs, P., Dahlenborg, M. & Löfström, C. (2003). Pre-
PCR processing of samples. Methods in Molecular Biology, 216, 31-50.  
409. Rådström, P., Knutsson, R., Wolffs, P., Lövenklev, M. & Löfström, C. (2004) Pre-
PCR processing: strategies to generate PCR-compatible samples. Molecular Biotechnology, 
26, 133–146. 
410. Ramabu, S.S., Boxall, N.S., Madie, P. & Fenwick, S.G. (2004). Some potential 
sources for transmission of Campylobacter jejuni to broiler chickens. Letters in Applied 
Microbiology, 39, 252-256. 
411. Rasschaert, G., Houf, K. & De Zutter, L. (2007). External contamination of 
Campylobacter-free flocks after transport in cleaned and disinfected containers. Journal of 
Food Protection, 70, 40–46. 
412. Rattanachaikunsopon, P. & Phumkhachorn, P. (2010). Potential of Coriander 
(Coriandrum sativum) Oil as a Natural Antimicrobial Compound in Controlling 
Campylobacter jejuni in Raw Meat. Bioscience, Biotechnology, and Biochemistry, 74, 31-
35. 
413. Refregier-Petton, J., Rose, N., Denis, M. & Salvat, G. (2001). Risk factors for 
Campylobacter spp. contamination in French broiler-chicken flocks at the end of the rearing 
period. Preventive Veterinary Medicine, 50, 89–100. 
414. Reich, F., Atanassova, V., Haunhorst, E. & Klein, G. (2008). The effects of 
Campylobacter numbers in caeca on the contamination of broiler carcasses with 
Campylobacter. International Journal of Food Microbiology, 127, 116-120. 
415. Reichert-Schwillinsky, F., Pin, C., Dzieciol, M., Wagner, M. & Hein, I. (2009). 
Stress- and growth rate-related differences between plate count and real-time PCR data 
during growth of Listeria monocytogenes. Applied and Environmental Microbiology, 75, 
(7):2132–2138. 
Campylobacter Control in Poultry 
 
148 
 
416. Renooij, S. (2001). Probability elicitation for belief network: issues to consider. The 
Knowledge Engineering Review, 16:3, 255-269. 
417. Rice, B.E., Rollins, D.M., Mallinson, N.E.T., Carr, L. & Joseph, S.W. (1997). 
Campylobacter jejuni in broiler chickens: colonization and humoral immunity following 
oral vaccination and experimental infection. Vaccine 15, 1922–1932. 
418. Ridley, A.M., Toszeghy, M.J., Cawthraw, S.A., Wassenaar, T.M. & Newell D.G. 
(2008a). Genetic instability is associated with changes in the colonization potential of 
Campylobacter jejuni in the avian intestine. Journal of Applied Microbiology, 105, 95–104. 
419. Ridley, A.M., Morris, V.K., Cawthraw, S.A., Ellis-Iversen, J., Harris, J.A., Kennedy, 
E.M., Newell, D.G. & Allen, V.M. (2011b). Longitudinal molecular epidemiological study 
of thermophilic campylobacters on one conventional broiler chicken farm. Applied and 
Environmental Microbiology, 77, 98–107. 
420. Ridley, A.M., Allen, V.M., Sharma, M., Harris, J. A. & Newell, D.G. (2008b). Real-
time PCR approach for detection of environmental sources of Campylobacter strains 
colonizing broiler flocks. Applied and Environmental Microbiology, 74, 2492–2504. 
421. Ridley, A., Morris, V., Gittins, J., Cawthraw, S., Harris, J., Edge, S. & Allen, V. 
(2011a). Potential sources of Campylobacter infection on chicken farms: contamination and 
control of broiler-harvesting equipment, vehicles and personnel. Journal of Applied 
Microbiology, 111, 233–244. 
422. Riley, L.W. (2004). Molecular Epidemiology of Infectious Diseases - Principles and 
Practices. Washington, DC, ASM Press. 
423. Ring, M., Zychowska, M. A. & Stephan, R. (2005). Dynamics of Campylobacter spp. 
spread investigated in 14 broiler flocks in Switzerland. Avian Diseases, 49, 390–396. 
424. Ringoir, D.D. & Korolik, V. (2003). Colonisation phenotype and colonization 
differences in Campylobacter jejuni strains in chickens before and after passage in vivo. 
Veterinary Microbiology, 92, 225–235. 
425. Rivoal, K., Ragimbeau, C., Salvat, G., Colin, P. & Ermel, G. (2005). Genomic 
diversity of Campylobacter coli and Campylobacter jejuni isolates recovered from free-
range broilers farms and comparison with isolates of various origins. Applied and 
Environmental Microbiology, 71, 6216-6227. 
426. Rivoal, K., Denis, M., Salvat, G., Colin, P. & Ermel, G. (1999) Molecular 
characterization of the diversity of Campylobacter spp. isolates collected from a poultry 
slaughterhouse: analysis of cross-contamination. Letters in Applied Microbiology, 29, 370–
374.  
427. Rodrigues, L.C., Cowden, J.M., Wheeler, J.G., Sethi, D., Wall, P.G., Cumberland, P., 
Tompkins, D.S., Hudson, M.J., Roberts, J.A. & Roderick, P.J. (2001).The study of 
infectious intestinal disease in England: risk factors for cases of infectious intestinal disease 
with Campylobacter jejuni infection. Epidemiology and Infection 127, 185–193. 
428. Roesler, U., Heller, P., Waldmann, K.H., Truyen, U., Hensel, A. (2006). 
Immunization of sows in an integrated pig-breeding herd using a homologous inactivated 
Salmonella vaccine decreases the prevalence of Salmonella typhimurium infection in the 
offspring. Journal of Veterinary Medicine B 53, 224-228. 
429. Rollins, D.M. & Colwell, R.R. (1986). Viable but nonculturable stage of 
Campylobacter jejuni and its role in survival in the natural aquatic environment. Applied 
and Environmental Microbiology, 52, 531–538. 
430. Rollwagen, F.M., Pacheco, N.D., Clements, J.D., Pavlovskis, O., Rollins, D.M. & 
Walker, R.I. (1993). Killed Campylobacter elicits immune response and protection when 
administered with an oral adjuvant. Vaccine11, 1316–1320. 
Campylobacter Control in Poultry 
 
149 
 
431. Rosef, O. & Kapperud, G. (1983). House flies (Musca domestica) as possible vectors 
of Campylobacter fetus subsp. jejuni. Applied and Environmental Microbiology, 45, 381–3. 
432. Rosenquist, H., Sommer, H.M., Nielsen, N.L. & Christensen, B.B. (2006). The effect 
of slaughter operations on the contamination of chicken carcasses with thermotolerant 
Campylobacter. International Journal of Food Microbiology, 108, 226-232. 
433. Rosenquist, H., Boysen, L., Galliano, C., Nordentoft, S., Ethelberg, S., Borck, B. 
(2009). Danish strategies to control Campylobacter in broilers and broiler meat: facts and 
effects. Epidemiology and Infection, 137, 1742-1750. 
434. Rosenquist, H., Nielsen N. L., Sommer H. M., Norrung B. & Christensen B.B. (2003). 
Quantitative risk assessment of human campylobacteriosis associated with thermophilic 
Campylobacter species in chickens. International Journal of Food Microbiology 83(1), 87-
103. 
435. Rothrock, M.J. Jr., Cook, K.L. & Bolster, C.H. (2009). Comparative quantification of 
Campylobacter jejuni from environmental samples using traditional and molecular 
biological techniques. Canadian Journal of Microbiology, 55(6), 633-641 
436. Rothrock, M. J., Jr., Cook, K. L., Warren, J. G. & Sistani, K. (2008). The effect of 
alum addition on microbial communities in poultry litter. Poultry Science, 87, 1493–1503. 
437. Roussel, Y., Wilks, M., Harris, A., Mein, C. & Tabaqchali, S. (2005) Evaluation of 
DNA extraction methods from mouse stomachs for the quantification of H. pylori by real-
time PCR. Journal of Microbiological Methods 62, 71–81. 
438. Rudi, K., Hoidal, H.K., Katla, T., Johansen, B.K., Nordal, J. & Jakobsen, K.S. (2004). 
Direct real-time PCR quantification of Campylobacter jejuni in chicken fecal and cecal 
samples by integrated cell concentration and DNA purification. Applied and Environmental 
Microbiology, 70, 790-797. 
439. Rushton, S.P., Humbhrey, T.J., Shirley, M.D., Bull, S. & Jorgensen, F. (2009). 
Campylobacter in housed broiler chickens: A longtudinal study of risk factors. 
Epidemiology and Infection, 86, 14-29. 
440. Russa, A.D., Bouma, A., Vernooij, J.C., Jacobs-Reitsma, W. & Stegeman, J.A. 
(2005). No association between partial depopulation and Campylobacter spp. colonization 
of Dutch broiler flocks. Letters in Applied Microbiology, 41, 280–285. 
441. Sagarzazu, N., Cebrián, G., Pagán, R., Condón, S. & Mañas, P. (2010). Resistance of 
Campylobacter jejuni to heat and to pulsed electric fields. Innovative Food Science and 
Emerging Technologies, 11, 283-289. 
442. Sahin, O., Morishita, T.Y. & Zhang, Q. (2002). Campylobacter colonization in 
poultry: sources of infection and modes of transmission. Animal health Research Reviews 3, 
95-105. 
443. Sails, A.D., Fox, A.J., Bolton, F.J., Wareing, D.R. & Greenway, D.L. (2003) Real-
time PCR assay for the detection of Campylobacter jejuni in foods after enrichment culture. 
Applied and Environmental Microbiology, 69, 1383–1390. 
444. Sampers, I., Habib, I., De Zutter, L., Dumoulin, A. & Uyttendaele, M. (2010). 
Survival of Campylobacter spp. in poultry meat preparations subjected to freezing, 
refrigeration, minor salt concentration, and heat treatment. International Journal of Food 
Microbiology, 137, 147-153. 
445. Samuel, M.C., Vugia, D.J., Shallow, S., Marcus, R., Segler, S., McGivern, T., 
Kassenborg, H., Reilly, K., Kennedy, M., Angulo, F. & Tauxe, R.V. (2004). Epidemiology 
of sporadic Campylobacter infection in the United States and declining trend in incidence, 
FoodNet 1996-1999. Clinical Infectious Diseases, 38, S165-174. 
Campylobacter Control in Poultry 
 
150 
 
446. Sanchez-Gonzalez, L., Cháfer, M., Hernández, M., Chiralt, A. & González-Martínez, 
C. (2011). Antimicrobial activity of polysaccharide films containing essentials oils. Food 
Control, 22(8), 1302-1310 
447. Sandberg, M., Hofshagen, M., Ostensvik, O., Skjerve, E. & Innocent, G. (2005). 
Survival of Campylobacter on frozen broiler carcasses as a function of time. Journal of 
Food Protection, 68, 1600-1605. 
448. Schnider, A., Overesch, G., Korczak, B.M. & Kuhnert, P. (2010). Comparison of real-
time PCR assays for detection, quantification, and differentiation of Campylobacter jejuni 
and Campylobacter coli in broiler neck skin samples. Journal of Food Protection, 73(6), 
1057-1063. 
449. Schoeni, J.L. & Wong, A.C. (1994). Inhibition of Campylobacter jejuni colonization 
in chicks by defined competitive exclusion bacteria. Applied and Environmental 
Microbiology, 60, 1191-1197. 
450.  Schrotz-King, P., Prokhorova, T.A., Nielsen, P.N., Crawford, J.S. & Morsczeck, C. 
(2007). Campylobacter jejuni proteomics for new travellers' diarrhoea vaccines. Travel 
Medicine and Infectious Diseases, 5(2), 106-109.  
451. Scott, D.A. & Tribble, D.R. (2000). Protection against Campylobacter infection and 
vaccine development. In: Campylobacter, 2nd edition. Nachamkin I, Blaser MJ (eds) 
Washington, DC: ASM Press, 303–319. 
452. Scott, D.A. (1997). Vaccines against Campylobacter jejuni. Journal of Infectious 
Diseases, 176, S183–S188.  
453. Sears, A., Baker, M.G., Wilson, N., Marshall, J., Muellner, P., Campbell, D.M., Lake, 
R.J. & French, N.P. (2011) Marked campylobacteriosis decline after interventions aimed at 
poultry, New Zealand. Emerging Infectious Diseases, 17, 6. 
454. Segal, Y. (2011). Farm Biosecurity for Better Performance and Higher Profit. 
Retrieved August 14, 2012, from 
http://www.thepoultrysite.com/focus/contents/ceva/OnlineBulletins/ob_2011/Article-no35-
Mar11.pdf  
455. Shahrizaila, N. & Yuki, N. (2011). Guillain-Barré Syndrome Animal Model: The First 
Proof of Molecular Mimicry in Human Autoimmune Disorder.  Journal of Biomedicine and 
Biotechnology, Article ID 829129, 5 pages. 
456. Shames, B., Fox, J.G., Dewhirst, F., Yan, L., Shen, Z. & Taylor, N.S. (1995). 
Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse 
colonies by culture and PCR assay. Journal of Clinical Microbiology, 33, 2968–2972. 
457. Shane, S.M., Montrose, M.S. & Harrington, K.S. (1985). Transmission of 
Campylobacter jejuni by the housefly (Musca domestica). Avian Diseases, 29, 384–391.  
458. Sheppard, S.K., Dallas, J.F., MacRae, M., McCarthy, N.D., Sproston, E.L., Gormley, 
F.J., Strachan, N.J., Ogden, I.D., Maiden, M.C. & Forbes, K.J. (2009a). Campylobacter 
genotypes from food animals, environmental sources and clinical disease in Scotland 
2005/6. International Journal of Food Microbiology, 134, 96-103. 
459. Sheppard, S.K., Dallas, J.F., Strachan, N.J., MacRae, M., McCarthy, N.D., Wilson, 
D.J., Gormley, F.J., Falush, D., Ogden, I.D., Maiden, M.C. & Forbes, K.J. (2009b). 
Campylobacter genotyping to determine the source of human infection. Clinical Infectious 
Diseases, 48, 1072- 1078. 
460. Shibata, T., Solo-Gabriele, H.M., Sinigalliano, C.D., Gidley, M.L., Plano, L.R., 
Fleisher, J.M., Wang, J.D., Elmir, S.M., He, G., Wright, M.E., Abdelzaher, A.M., Ortega, 
C., Wanless, D., Garza, A.C., Kish, J., Scott, T., Hollenbeck, J., Backer, L.C. & Fleming, 
L.E. (2010). Evaluation of conventional and alternative monitoring methods for a 
Campylobacter Control in Poultry 
 
151 
 
recreational marine beach with non-point source of fecal contamination. Environment and 
Science Technology, 44, 8175–8181. 
461. Shoaf-Sweeney, K.D., Larson, C.L., Tang, X. & Konkel, M.E. (2008). Identification 
of Campylobacter jejuni proteins recognized by chicken maternal antibodies.  Applied and 
Environmental Microbiology, 74, 6867-6875. 
462. Silkie, S.S. & Nelson, K.L. (2009) Concentrations of host-specific and generic fecal 
markers measured by quantitative PCR in raw sewage and fresh animal feces. Water 
Research, 43, 4860-4871. 
463. Sizemore, D.R., Warner, B., Lawrence, J., Jones, A. & Killeen, K.P. (2006). Live, 
attenuated Salmonella typhimurium vectoring Campylobacter antigens. Vaccine 24, 3793–
3803. 
464. Skånseng, B., Kaldhusdal, M., Moen, B., Gjevre, A.G., Johannessen, G.S., Sekelja, 
M., Trosvik, P. &  Rudi, K. (2010). Prevention of intestinal Campylobacter jejuni 
colonization in broilers by combinations of in-feed organic acids. Journal of Applied 
Microbiology, 109, 1265-1273. 
465. Slader, J., Domingue, G., Jorgensen, F., McAlpine, K., Owen, R. J., Bolton, F.J. & 
Humphrey T.J. (2002). Impact of transport crate reuse and of catching and processing on 
Campylobacter and Salmonella contamination of broiler chickens. Applied and 
Environmental Microbiology, 68, 713–719. 
466. Slorach, S.A., Maijala, R. & Belveze, H. (2002). Examples of comprehensive and 
integrated approaches to risk analysis in the food chain experiences and lessons learned. 
Pan-European conference on Fodd Safety and Quality. Budapest, Hungary. 
467. Smigic, N., Rajkovic, A., Nielsen, D.S., Arneborg, N., Siegumfeldt, H. & 
Devlieghere, F. (2010). Survival of lactic acid and chlorine dioxide treated Campylobacter 
jejuni under suboptimal conditions of pH, temperature and modified atmosphere. 
International Journal of Food Microbiology, 141, S140-S146. 
468. Smith, C.K., Kaiser, P., Rothwell, L., Humphrey, T., Barrow, P.A. & Jones, M.A. 
(2005). Campylobacter jejuni-induced cytokine responses in avian cells. Infection and 
Immunology, 73, 2094-2100. 
469. Snijders, T.A.B. (2005). Power and sample size in multilevel modeling. Encyclopedia 
of Statistics in Behavioral Science, 3, 1570-1573. 
470. Solis de los Santos, F.S., Donoghue, A.M., Venkitanarayanan, K., Dirain, M.L., 
Reyes-Herrera, I., Blore, P.J. & Donoghue, D.J. (2008). Caprylic acid supplemented in feed 
reduces enteric Campylobacter jejuni colonization in ten-day-old broiler chickens. Poultry 
Science, 87, 800- 804. 
471. Solow, B.T., Cloak, O.M. & Fratamico, P.M. (2003). Effect of temperature on 
viability of Campylobacter jejuni and Campylobacter coli on raw chicken or pork skin. 
Journal of Food Protection, 66, 2023-2031. 
472. Sopwith, W., Birtles, A., Matthews, M., Fox, A., Gee, S., Painter, M., Regan, M., 
Syed, Q. & Bolton, E. (2006). Campylobacter jejuni multilocus sequence types in humans, 
northwest England, 2003-2004. Emerging Infectious Diseases 12, 1500-1507. 
473. Sopwith, W., Birtles, A., Matthews, M., Fox, A., Gee, S., Painter, M., Regan, M., 
Syed, Q. & Bolton, E. (2008). Identification of potential environmentally adapted 
Campylobacter jejuni strain, United Kingdom. Emerging Infectious Diseases, 14, 1769. 
474. Sörquist, S. (1989). Heat resistance of Campylobacter and Yersinia strains by three 
methods. Journal of Applied Bacteriology, 67, 543-549. 
475. Sparks, N.H.C. (2009).The role of the water supply system in the infection and control 
of Campylobacter in chicken. World's Poultry Science Journal, 65, 459-474. 
Campylobacter Control in Poultry 
 
152 
 
476. Spratt, B.G., Hanage, W.P., Li, B., Aanensen, D.M. & Feil, E.J. (2004). Displaying 
the relatedness among isolates of bacterial species - the eBURST approach. FEMS 
Microbiology Letters, 241(2), 129-134. 
477. Stafford, R.J., Schluter, P., Kirk, M., Wilson, A., Unicomb, L., Ashbolt, R., Gregory, 
J. & OzFoodNet Working Group. (2007) A multi-centre prospective case-control study of 
campylobacter infection in persons aged 5 years and older in Australia. Epidemiology and 
Infection, 135, 978–988. 
478. Stafford, R.J., Schluter, P.J., Wilson, A.J., Kirk, M.D., Hall, G., Unicomb, L. & 
OzFoodNet Working Group. (2008). Population-attributable risk estimates for risk factors 
associated with Campylobacter infection, Australia. Emerging Infectious Diseases, 14, 895–
901. 
479. Stas, T., Jordan, F.T.W. & Woldehiwet, Z. (1999). Experimental infection of chickens 
with Campylobacter jejuni: strains differ in their capacity to colonize the intestine. Avian 
Pathology, 28, 61–64.  
480. Stemke, J. (2001).  Developing an integrated enterprise-wide knowledge architecture. 
Presentation from the APQC Conference - Next Generation KM, 2001. Retrieved March 17, 
2012, from eos.gsfc.nasa.gov/eos-ll/references/Developing-Integrated-Architecture.ppt 
481. Stern, N.J., Cox, N.A., Musgrove, M.T. & Park, C.M. (2001). Incidence and levels of 
Campylobacter in broilers after exposure to an inoculated seeder bird. Journal of Applied 
Poultry Research, 10, 315-318. 
482. Stern, N.J., Bailey, J.S., Blankenship, L.C., Cox, N.A. & McHan, F. (1988). 
Colonization characteristics of Campylobacter jejuni in chick ceca. Avian Diseases, 32, 330-
334. 
483. Stern, N.J., Georgsson, F., Lowman, R., Bisaillon, J.R., Reiersen, J., Callicott, K.A., 
Geirsdóttir, M., Hrolfsdóttir, R., Hiett, K.L. & Campy-on-Ice Consortium. (2007). 
Frequency and enumeration of Campylobacter species from processed broiler carcasses by 
weep and rinse samples. Poultry Science 86, 394-399. 
484. Stern, N.J., Hiett, K.L., Alfredsson, G.A., Kristinsson, K.G., Reiersen, J., Hardardottir, 
H., Briem, H., Gunnarsson, E., Georgsson, F., Lowman, R., Berndtson, E., Lammerding, 
A.M., Paoli, G.M. & Musgrove, M.T. (2003). Campylobacter spp. in Icelandic poultry 
operations and human disease. Epidemiology and Infection, 130, 23-32. 
485. Stern, N.J., Meinersmann, R.J., Cox, N.A., Bailey, J.S. & Blankenship, L.C. (1990). 
Influence of host lineage on cecal colonization by Campylobacter jejuni in chickens. Avian 
Diseases, 34, 602-606. 
486. Stern, N.J. & Robach, M.C. (2003). Enumeration of Campylobacter spp. in broiler 
feces and in corresponding processed carcasses. Journal of Food Protection, 66, 1557-1563. 
487. Stern, N. J. (1992). Reservoirs for Campylobacter jejuni and approaches for 
intervention in poultry, p. 49–60. In I. Nachamkin, M. J. Blaser, and L. S. Tompkins (ed.), 
Campylobacter jejuni: current status and future trends. American Society for Microbiology, 
Washington, DC. 
488. Stern, N. J., Myszewski, M. A., Barnhart, H. M. & Dreesen, D. W. (1997) Flagellin A 
gene restriction fragment length polymorphism patterns of Campylobacter spp. Isolates from 
broiler production sources. Avian Diseases, 32, 899–905.  
489. Stern, N., Eruslanov, B., Pokhilenko, V., Kovalev, Y., Volodina, L., Perelygin, V., 
Mitsevich, E., Mitsevich, I., Borzenkov, V., Levchuk, V., Svetoch, O., Stepanshin, Y. & 
Svetoch, E. (2008). Bacteriocins Reduce Campylobacter jejuni colonization while bacteria 
producing bacteriocins are ineffective. Microbial Ecology in Health and Disease, 20, 74-79. 
Campylobacter Control in Poultry 
 
153 
 
490. Stevens, K.A. & Jaykus, L.A. (2004) Bacterial separation and concentration from 
complex sample matrices: a review. Critical Reviews in Microbiology, 30, 7–24. 
491. Stratagene (2004). An introduction to Quantitative PCR. Stratagene, La Jolla, CA. 
Retrieved July 22, 2012, from 
http://qcbs.ca/wiki/_media/stratagene_introduction_to_quantitative_pcr_methods_and_appli
cation_guide.pdf   
492. Strus, M., Brzychczy-Wloch, M., Gosiewski, T., Kochan, P. & Heczko, P.B. (2006). 
The in vitro effect of hydrogen peroxide on vaginal microbial communities. FEMS 
Immunology and Medical Microbiology, 48, 56-63. 
493. Studahl, A. & Andersson, Y. (2000). Risk factors for indigenous campylobacter 
infection: a Swedish case-control study. Epidemiology and Infection, 125 (2), 269-275. 
494. Sunen, E., Casas, N., Moreno, B. & Zigorraga, C. (2004) Comparison of two methods 
for the detection of hepatitis A virus in clam samples (Tapes spp.) by reverse transcription-
nested PCR. International Journal of Food Microbiology, 91, 147–154. 
495. Svetoch, E.A. & Stern, N.J. (2010). Bacteriocins to control Campylobacter spp. in 
poultry – a review. Poultry Science, 89, 1763-1768. 
496. Svetoch, E.A., Stern, N., Eruslanov, B., Kovalev, Y., Volodina, L., Perelygin, V., 
Mitsevich, E., Mitsevich, I., Pokhilenko, V. & Borzenkov, V. (2005). Isolation of Bacillus 
circulans and Paenibacillus polymyxa strains inhibitory to Campylobacter jejuni and 
characterization of associated bacteriocins. Journal of Food Protection, 68(1), 11-17. 
497. Swaggerty, C.L., Pevzner, I.Y., He, H., Genovese, K.J., Nisbet, D.J., Kaiser, P. & 
Kogut, M.H. (2009). Selection of broilers with improved innate immune responsiveness to 
reduce on farm infection by foodborne pathogens. Foodborne Pathogens and Diseases, 6, 
777-783. 
498. Takahashi, R., Shahada, F., Chuma, T. & Okamoto, K. (2006). Analysis of 
Campylobacter spp. contamination in broilers from the farm to the final meat cuts by 
using restriction fragment length polymorphism of the polymerase chain reaction 
products. International Journal of Food Microbiology 110, 240 - 245. 
499. Tam, C.C., Higgins, C.D., Neal, K.R., Rodrigues, L.C., Millership, S.E. & O'Brien, 
S.J. (2009). Chicken consumption and use of acid-suppressing medications as risk factors 
for Campylobacter enteritis, England. Emerging Infectious Diseases, 15, 1402–1408. 
500. Tam, C.C., O’Brien, S.J., Adak, G.K., Meakins, S.M.  & Frost, J.A. (2003). 
Campylobacter coli - an important foodborne pathogen. Journal of Infection, 47, 28-32. 
501. Tam, C.C., Rodrigues, L.C., O’Brien, S.J. & Hajat, S. (2006). Temperature 
dependence of reported Campylobacter infection in England, 1989-1999. Epidemiology and 
Infection, 134, 119-125. 
502. Tamblyn, K.C., Conner, D.E. & Bilgili, S.F. (1997). Utilization of the skin attachment 
model to determine the efficacy of potential carcass treatments. Poultry Science, 76, 1318-
1323.  
503. Tang, J., Zeng, Z., Wang, H., Yang, T., Zhang, P., Li, Y., Zhang, A., Fan, W., Zhang, 
Y., Yang, X., Zhao, S., Tian, G. & Zou, L. (2008). An effective method for isolation of 
DNA from pig faeces and comparison of five different methods. Journal of Microbiological 
Methods, 75, 432-436. 
504. Tassou, C., Drosinos, E.H. & Nychas, G.J.E. (1995). Effects of essential oil from mint 
(Mentha piperita) on Salmonella enteritidis and Listeria monocytogenes in model food 
systems at 4ºC and 10ºC. Journal of Applied Bacteriology, 78, 593-600. 
Campylobacter Control in Poultry 
 
154 
 
505. Taylor, M.R. & Hoffmann, S.A. (2001).Redesigning Food Safety: Using Risk Analysis 
to Build a Better Food Safety System. Retrieved May 27, 2013, from 
http://www.rff.org/documents/RFF-DP-01-24.pdf  
506. The CamVac project (2012). Campylobacter vaccination of poultry. Retrieved 
September 21, 2012, from http://www.camvac.dk/  
507. Theoret, J.R., Cooper, K.K., Zekarias, B., Roland, K.L., Law, B.F., Curtiss, R. 3rd & 
Joens, L.A. (2012). The Campylobacter jejuni Dps homologue is important for in vitro 
biofilm formation and cecal colonization of poultry and may serve as a protective antigen 
for vaccination. Clinical Vaccine and Immunology, 19(9), 1426-1431. 
508. Thormar, H. & Hilmarsson, H. (2010). Killing of Campylobacter on contaminated 
plastic and wooden cutting boards by glycerol monocaprate (monocaprin). Letters in 
Applied Microbiology, 51(3), 319-24.  
509. Thormar, H., Hilmarsson, H. & Bergsson, G. (2006). Stable concentrated emulsions of 
the 1-monoglyceride of capric acid (monocaprin) with microbicidal activities against the 
foodborne bacteria Campylobacter jejuni, Salmonella spp., and Escherichia coli. Applied 
and Environmental Microbiology, 72, 522-526. 
510. Thornton, C.G. & Passen, S. (2004). Inhibition of PCR amplification by phytic acid, 
and treatment of bovine fecal specimens with phytase to reduce inhibition. Journal of 
Microbiological Methods 59, 43–52. 
511. Tichopad, A., Bar, T., Pecen, L., Kitchen, R.R., Kubista, M. & Pfaffl, M.W. (2010). 
Quality control for quantitative PCR based on amplification compatibility test. Methods 50, 
308-312. 
512. Tichopad, A., Didier, A. & Pfaffl, M.W. (2004). Inhibition of real-time RT-PCR 
quantification due to tissue-specific contaminants. Molecular and Cellular Probes 18, 45–
50. 
513. Tinker, D. B., Burton, C. H. & Allen, V.M. (2005). Catching, transporting and lairage 
of live poultry, p. 153–173. In G. C. Mead (ed.), Food safety control in the poultry industry. 
Woodhead Publishing, Cambridge, United Kingdom. 
514. Toplak, N., Kovač, M., Piskernik, S., Smole Možina, S., Jeršek, B. (2012).. Detection 
and quantification of Campylobacter jejuni and Campylobacter coli using real-time 
multiplex PCR. Journal of Applied Microbiology, 112 (4), 752–764. 
515. Townsend, JC. (2006). Use of a scald additive to reduce levels of salmonella during 
poultry processing. Master of Science Thesis, December 15, 2006. Retrieved January 8, 
2013, from 
http://etd.auburn.edu/etd/bitstream/handle/10415/547/TOWNSEND_JULIE_8.pdf  
516. Toze, S. (1999) PCR and the detection of microbial pathogens in water and 
wastewater. Water Research, 33, 3545–56. 
517. Tsubokura, K., Berndtson, E., Bogstedt, A., Kaijser, B., Kim, M., Ozeki, M. & 
Hammarstrom, L. (1997). Oral administration of antibodies as prophylaxis and therapy in 
Campylobacter jejuni-infected chickens. Clinical and Exploratory Immunology, 108, 451-
455. 
518. Tustin, J., Laberge, K., Michel, P., Reiersen, J., Dadadottir, S., Briem, H., 
Hardardottir, H., Kristinsson, K., Gunnarsson, E., Fridriksdottir, V. & Georgsson F. (2011). 
A national epidemic of campylobacteriosis in Iceland, lessons learned. Zoonoses. Public 
Health, 58, 440-447. 
519. Udayamputhoor, R.S., Hariharan, H., Van Lunen, T.A., Lewis, P.J., Heaney, S., Price, 
L. & Woodward D. (2003). Effects of diet formulations containing proteins from different 
Campylobacter Control in Poultry 
 
155 
 
sources on intestinal colonization by Campylobacter jejuni in broiler chickens. Canadian 
Journal of Veterinary Research, 67, 204-212. 
520. United States Department of Agriculture, USDA. (1999). Generic HACCP Model for 
Poultry Slaughter. Retrieved January 8, 2013, from 
http://www.fsis.usda.gov/OPPDE/nis/outreach/models/haccp-5.pdf  
521. Uyttendaele, M., Baert, K., Ghafir, Y., Daube, G., De Zutter, L., Herman, L., Dierick, 
K., Pierard, D., Dubois, J.J., Horion, B. & Debevere, J. (2006). Quantitative risk assessment 
of Campylobacter spp. in poultry based meat preparations as one of the factors to support 
the development of risk-based microbiological criteria in Belgium. International Journal of 
Food Microbiology, 111, 149-163. 
522. Van de Giessen, A.W., Bloemberg, B.P., Ritmeester, W.S. & Tilburg J. J. (1996). 
Epidemiological study on risk factors and risk reducing measures for Campylobacter 
infections in Dutch broiler flocks. Epidemiology and Infection, 117, 245–250. 
523. Van de Giessen, A.W., Tilburg, J. J., Ritmeester, W. S., van der Plas, J. (1998). 
Reduction of Campylobacter infections in broiler flocks by application of hygiene measures. 
Epidemiology and Infection, 121, 57–66. 
524. Van de Giessen, A., Mazurier, S.I., Jacobs-Reitsma, W., Jansen, W., Berkers, P., 
Ritmeester, W. & Wernars, K. (1992). Study on the epidemiology and control of 
Campylobacter jejuni in poultry broiler flocks. Applied and Environmental Microbiology, 
58, 1913–1917. 
525. Van Deun, K., Pasmans, F., Ducatelle, R., Flahou, B., Vissenberg, K. K, Martel, A., 
Van den Broeck, W., Van Immerseel, F. & Haesebrouck, F. (2008). Colonization strategy of 
Campylobacter jejuni results in persistent infection of the chicken gut. Veterinary 
Microbiology, 130, 285–297. 
526. Van Doorn, P.A., Ruts, L. & Jacobs, B.C. (2008). Clinical features, pathogenesis, and 
treatment of Guillain-Barré syndrome.Lancet Neurology, 7, 939–950.  
527. Van Gerwe, T., Bouma, A., Klinkenberg, D., Wagenaar, J.A., Jacobs-Reitsma, W.F. 
& Stegeman, A. (2010). Medium chain fatty acid feed supplementation reduces the 
probability of Campylobacter jejuni colonization in broilers. Veterinary Microbiology, 143, 
314-318. 
528. Van Immerseel, F., Fievez, V., de Buck, J., Pasmans, F., Martel, A., Haesebrouck, F. 
& Ducatelle R. (2004). Microencapsulated short-chain fatty acids in feed modify 
colonization and invasion early after infection with Salmonella Enteritidis in young 
chickens. Poultry Science, 83, 69-74. 
529. Van, N.P., Mossel D.A. & Huis, V. (1995). Lactic acid decontamination of fresh pork 
carcasses: a pilot plant study. International Journal of Food Microbiology, 25, 1-9. 
530. Vellinga, A. & Van Loock, F. (2002). The dioxin crisis as experiment to determine 
poultry-related Campylobacter enteritis. Emerging Infectious Diseases, 8, 19-22. 
531. Velusamy, V., Arshak, K., Korostynska, O., Oliwa, K. & Adley, C. (2010). An 
overview of foodborne pathogen detection. Biotechnological Advances 28, 232–254. 
532. Venkatesan, M.M & Ranallo, R.T. (2006). Live-attenuated Shigella vaccines. Expert 
Reviews Vaccines, 5(5), 669–686. 
533. Waage, A.S., Varund, T., Lund, V. & Kapperud G. (1999). Detection of small 
numbers of Campylobacter jejuni and Campylobacter coli cells in environmental water, 
sewage, and food samples by a seminested PCR assay. Applied and Environmental 
Microbiology, 65, 1636-1643. 
Campylobacter Control in Poultry 
 
156 
 
534. Wagenaar, J.A., Mevius, D.J. & Havelaar, A.H. (2006). Campylobacter in primary 
animal production and control strategies to reduce the burden of human campylobacteriosis 
Revue scientifique et technique (International Office of Epizootics), 25 (2), 581-594. 
535. Wagenaar, J.A., Van Bergen, M.A., Mueller, M.A., Wassenaar, T.M. & Carlton, R.M. 
(2005). Phage therapy reduces Campylobacter jejuni colonization in broilers. Veterinary 
Microbiology, 109(3-4), 275-283. 
536. Waldenstrom, J., Broman, T., Carlsson, I., Hasselquist, D., Achterberg, R.P., 
Wagenaar, J.A. & Olsen B. (2002). Prevalence of Campylobacter jejuni, Campylobacter 
lari, and Campylobacter coli in different ecological guilds and taxa of migrating birds. 
Applied and Environmental Microbiology, 68 (12), 5911-5917. 
537. Walker, R.I. (2005). New vaccines against enteric bacteria for children in less 
developed countries. Expert Reviews Vaccines, 4(6), 807-812. 
538. Wallace, J., Stanley, K., Currie, J., Diggle, P. & Jones J. (1997). Seasonality of 
thermophilic Campylobacter populations in chickens. Journal of Applied Microbiology, 82, 
224–230. 
539. Wassenaar, T. M., Kist, M. & de Jong, A. (2007). Re-analysis of the risks attributed to 
ciprofloxacin-resistant Campylobacter jejuni infections. International Journal of 
Antimicrobial Agents, 30, 195–201. 
540. Wassenaar, T.M. (2011). Following an imaginary Campylobacter population from 
farm to fork and beyond: a bacterial perspective. Letters in Applied Microbiology, 53, 253–
263.  
541. Waterman, S. C. (1982). The heat-sensitivity of Campylobacter jejuni in milk. Journal 
of Hygiene 88, 529-533. 
542. Wedderkopp, A., Rattenborg, E. & Madsen, M. (2000). National surveillance of 
Campylobacter in broilers at slaughter in Denmark in 1998. Avian Diseases, 44, 993-999. 
543. Wesley, I. V., Rostagno, M., Hurd, H. S. & Trampel, D.W. (2009). Prevalence of 
Campylobacter jejuni and Campylobacter coli in market-weight turkeys on-farm and at 
slaughter. Journal of Food Protection, 72, 43–48. 
544. Wesley, I.V., Wells, S.J., Harmon, K.M., Green, A., Schroedertucker, L., Glover, M. 
& Siddique, I. (2000). Fecal Shedding of Campylobacter and Arcobacter spp. in dairy cattle. 
Applied and Environmental Microbiology, 66, 1994–2000. 
545. Whelan, J.A., Russel, N.B. & Whelan, M.A. (2003). A method for the absolute 
quantification of cDNA using real time PCR. Journal of Immunological Methods, 278, 261–
269. 
546. Whyte, P., McGill, K., Cowley, D., Madden, R.H., Moran, L., Scates, P., Carroll, C., 
O'Leary, A., Fanning, S., Collins, J.D., McNamara, E., Moore, J.E. & Cormican, M. (2004). 
Occurrence of Campylobacter in retail foods in Ireland. International Journal of Food 
Microbiology, 95, 111–118. 
547. Whyte, P., McGill, K. & Collins, J.D. (2003). An assessment of steam pasteurization 
and hot water immersion treatments for the microbiological decontamination of broiler 
carcasses. Food Microbiology, 20, 111-117. 
548. Wickramasinghe, N. & von Lubitz, D.K.J.E. Knowledge-Based Enterprise: Theories 
and Fundamentals. Hershey PA: Idea Group Pub, 2007. 
549. Widders, P.R., Perry, R., Muir, W.I., Husband, A.J. & Long, K.A. (1996). 
Immunisation of chickens to reduce intestinal colonisation with Campylobacter jejuni. 
British Poultry Science, 37, 765–778. 
Campylobacter Control in Poultry 
 
157 
 
550. Wilson, D. J., Gabriel, E., Leatherbarrow, A. J., Cheesbrough, J., Gee, S., Bolton, E., 
Fox, A., Fearnhead, P., Hart, C. A. & Diggle P. J. (2008). Tracing the source of 
campylobacteriosis. PLoS. Genetics, 4: e1000203. 
551. Wingstrand, A., Neimann, J., Engberg, J., Nielsen, E. M., Gerner-Smidt, P., Wegener, 
H. C. & Molbak, K. (2006). Fresh chicken as main risk factor for campylobacteriosis, 
Denmark. Emerging Infectious Diseases, 12, 280-285. 
552. Wittschier, N., Lengsfeld, C., Vorthems, S., Stratmann, U., Ernst, J.F., Verspohl, E.J. 
& Hensel, A. (2007). Large molecules as anti-adhesive compounds against pathogens. 
Journal of Pharmacy and Pharmacology, 59, 777-786. 
553. Wolffs, P., Grage, H., Hagberg, O. & Rådström, P. (2004) Impact of DNA 
polymerases and their buffer systems on quantitative real-time PCR. Journal of Clinical 
Microbiology, 42, 408–411. 
554. Wolffs, P., Norling, B. &  Rådström, P. (2005) Risk assessment of falsepositive 
quantitative real-time PCR results in food, due to detection of DNA originating from dead 
cells. Journal of Microbiological Methods 60, 315–323. 
555. World Health Organisation, WHO (2012). Prevention of foodborne disease: Five keys 
to safer food. Retrieved January 9, 2013, from 
http://www.who.int/foodsafety/consumer/5keys/en/  
556. World Health Organization (2007a). The world health report 2007-A safer future: 
global public health security in the 21st century. Geneva: World Health Organization. 
Retrieved May 9, 2013, from  http://www.who.int/whr/2007/en/index.html  
557. World Health Organization (2007b). Food safety and foodborne illness. Retrieved 
Februray 19, 2013, from 
http://www.who.int/entity/mediacentre/factsheets/fs237/en/index.html  
558. World Health Organization (2000). Expert Consultation: “WHO Global Principles for 
the Containment of Antimicrobial Resistance in Animals Intended for Food.” Retrieved 
January 21, 2013, from 
http://whqlibdoc.who.int/hq/2000/WHO_CDS_CSR_APH_2000.4.pdf 
559. Wyszynska, A., Raczko, A., Lis, M. & Jagusztyn-Krynicka, E.K. (2004). Oral 
immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 
72Dz/92 cjaA gene elicits specific humoral immune response associated with protection 
against challenge with wild-type Campylobacter. Vaccine, 22, 1379-1389. 
560. Xiong, H., Li, Y., Slavik, M. F. & Walker, J.T. (1998). Spraying chicken skin with 
selected chemicals to reduce attached Salmonella typhimurium. Journal of Food Protection, 
61, 272–275. 
561. Yang, C., Jiang, Y., Huang, K., Zhu, C. & Yin, Y. (2003) Application of real-time 
PCR for quantitative detection of Campylobacter jejuni in poultry, milk and environmental 
water. FEMS Immunology and Medical Microbiology, 38, 265–271. 
562. Yang, Z., Li, Y. & Slavik, M.F. (1998). Use of antimicrobial spray applied with an 
inside outside birdwasher to reduce bacterial contamination on prechilled chicken carcasses. 
Journal of Food Protection, 61, 829–832. 
563. Young, K.T., Davis, L.M. & Dirita, V.J. (2007). Campylobacter jejuni: molecular 
biology and pathogenesis. Nature Reviews in Microbiology, 5, 665–679. 
564. Yu, Z. & Morrison, M. (2004) Improved extraction of PCR-quality community DNA 
from digesta and fecal samples. Journal of Biotechnology, 36, 808-812. 
565. Zeitoun, A.A. M. & Debevere, J.M. (1992). Decontamination with lactic acid/sodium 
lactate buffer in combination with modified atmosphere packaging effects on the shelf life 
of fresh poultry. International Journal of Food Microbiology, 16, 89–98. 
Campylobacter Control in Poultry 
 
158 
 
566. Zeng, X.M., Xu, F.Z. & Lin, J. (2009). Molecular, antigenic, and functional 
characteristics of ferric enterobactin receptor CfrA in Campylobacter jejuni. Infection and 
Immunology, 77, 5437-5448. 
567. Zhao, P., Zhao, T., Doyle, M.P., Rubino, J.R. & Meng, J. (1998). Development of a 
model for evaluation of microbial cross-contamination in the kitchen. Journal of Food 
Protection, 61, 960-963. 
568. Zhu, J., Zhang, Y., Hua, X., Hou, J. & Jiang, Y. (2006). Antibiotic resistance in 
Campylobacter. Reviews in Medical Microbiology, 17, 107-121. 
569. Ziprin, R.L., Hume, M.E., Young, C.R. & Harvey, R.B. (2002). Inoculation of chicks 
with viable non-colonizing strains of Campylobacter jejuni: evaluation of protection against 
a colonizing strain. Currents in Microbiology, 44, 221–223. 
570. Zoetendal, E.G., Ben-Amor, K., Akkermans, A.D., Abee, T. & De Vos, W.M. (2001) 
DNA isolation protocols affect the detection limit of PCR approaches of bacteria in samples 
from the human gastrointestinal tract. Systems in Applied Microbiology, 24, 405-410. 
571. Zweifel, C., Scheu, K.D., Keel, M., Renggli, F. & Stephan, R. (2008). Occurrence and 
genotypes of Campylobacter in broiler flocks, other farm animals, and the environment 
during several rearing periods on selected poultry farms. International Journal of Food 
Microbiology, 125, 182-187. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Campylobacter Control in Poultry 
 
159 
 
12.  APPENDICES 
12.1 Appendix 1  
Tables 5 and 6 Descriptive statistics showing the results obtained in the clinical trial with 
commercial broilers. 
 
 
Table 5 Results from descriptive statistics (data related to placebo chickens). Table shows 
mean ± standard deviation and maximum/minimum log CFU per gram fecal or cecal mass. 
R= rotation and I= isolator number  
                        
   
Log CFU/g of fecal material 
from placebo chickens          
Log CFU/g of cecal 
content placebo chickens 
R I  Day 35   Day 38  Day 42     Day 42   
1 1  
No individual samples taken 
 8.52±0.37 8.00/9.08 
  2   8.20±0.70 6.63/8.80 
  3   8.40±0.61 7.51/9.26 
  4   8.12±0.27 7.63/8.43 
2 1  7.72±0.54   7.15/8.76    7.42±1.28 4.90/8.84     7.19±0.62       6.45/8.08    7.91±0.84 6.72/8.82 
  2  7.09±0.87 5.75/8.08 7.60±0.79 6.40/8,57 7.15±1.05 5.51/9.20    8.16±0.66 7.04/9.30 
  3  7.13±1.00 5.26/8.26 7.07±0.92 5.57/8.28 6.61±0.63 5.96/8.00    7.47±0.55 6.86/8.34 
  4  7.38±0.63 6.04/7.89 6.49±0.83 5.51/7.76 6.60±1.11 5.46/8.18    8.12±0.40 7.53/8.71 
3 1  6.58±0.40 6.15/7.20    7.05±0.74       5.79/7.86    7.24±0.46 6.54/7.84    8.16±0.51 7.30/8.81 
  2  7.06±0.81 6.20/8.15 6.94±0.43 6.26/7.32 7.46±0.52 6.81/8.15    8.41±0.32 8.00/8.87 
  3  8.20±0.88 7.32/9.41 7.84±0.59 7.18/8.58 7.29±0.21 7.00/7.49    8.48±0.34 8.18/8.95 
  4  *  *  *   *  
4 1  7.48±0.49 6.67/8.30 7.58±0.50 6.81/8.11 7.29±0.58 6.40/8.30  7.89±0.25 7.36/8.26 
  2  7.28±0.70 5.64/8.00 7.15±0.95 4.94/8.53 7.43±0.59 6.43/8.34  8.61±0.28 8.18/9.04 
  3  7.89±0.46 7.04/8.36 7.45±0.31 7.11/7.98 7.00±1.08 5.28/9.38  7.24±0.95 5.26/8.41 
  4   7.42±0.38 6.80/8.20 6.86±0.69 5.96/8.18 5.671.13 4.04/7.38   6.27±1.07 4.81/8.30 
              
* Birds from this isolator were not included due to a functional breakdown of the isolator 
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Table 6 Results from descriptive statistics (data related to vaccinated chickens). Table shows 
mean ± standard deviation and maximum/minimum log CFU per gram fecal or cecal mass. R= 
rotation and I= isolator number. 
 
1 1  
No individual samples taken 
 7.94±0.50 7.28/8.73 
  2   8.77±0.45 8.08/9.38 
  3   8.66±0.64 7.30/9.41 
  4   7.31±0.57 6.30/8.08 
2 1  7.94±0.87      6.63/9.11    8.07±1.04    6.15/9.52    7.35±1.02     6.32/9.51     8.68±0.86 6.95/9.81 
  2  7.17±0.58 6.28/7.88 7.51±0.55 6.79/8.32 7.31±0.93 6.08/8.38     8.16±0.36 7.77/8.72 
  3  7.36±0.43 6.54/7.81 7.27±0.46 6.57/7.91 7.14±0.61 6.48/8.00     7.94±0.38 7.30/8.46 
  4  7.12±0.92 6.08/9.08 6.65±0.73 5.32/7.71 6.72±0.58 5.77/7.52     8.33±0.40 7.69/9.04 
3 1  7.46±0.34 7.04/7.90    7.98±0.83      7.08/9.32    8.37±0.62        7.41/9.18   8.79±0.32 8.26/9.30 
  2  7.28±0.17 7.04/7.52 7.71±0.40 7.34/8.45 7.51±0.56 6.88/8.49     8.18±0.77 6.86/9.11 
  3  6.81±0.65 5.69/7.78 6.92±0.90 6.08/8.65 7.12±0.88 5.45/8.32     7.78±0.83 5.48/8.46 
  4  7.59±0.43 6.79/8.04 7.39±0.60 6.36/8.23 7.22±0.58 6.28/8.20     8.14±0.38 7.41/8.54 
4 1  7.46±0.57  5.76/7.98 7.43±0.36 6.82/8.08 7.07±0.94 4.83/8.20  7.63±0.33 7.20/8.04 
  2  7.17±0.40 6.34/7.58 7.62±0.62 6.15/8.30 7.45±0.66 6.26/8.36  8.08±0.56 6.95/8.85 
  3  6.98±0.43 5.88/7.74 6.86±0.46 5.79/7.61 7.14±0.69 6.11/8.18  8.10±0.47 6.97/8.83 
  4   7.60±0.76 6.52/9.30 7.02±0.60 5.97/7.71 6.97±0.78 5.34/7.92   7.86±0.61 7.11/8.97 
 
 
 
 
 
 
 
 
 
 
                       
   
Log CFU/g of fecal material 
from vaccinated chickens          
Log CFU/g of cecal content 
from vaccinated chickens 
R I  Day 35   Day 38    Day 42     Day 42   
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12.2 Appendix 2 
 
Amplification plots and standard curves generated from all DNA extraction methods tested. Each 
amplification curve and each point in the standard curves represent the average of biological and 
PCR replicates per Campylobacter concentration level (five replicates when using Easy-DNA and 
four replicates when using miniMAG). 
1) Easy-DNA Invitrogen 
 
 
 
 
 
 
 
 
Campylobacter Control in Poultry 
 
162 
 
 
 
 
Easy-DNA Invitrogen (standard curve) 
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2) MagneSil® KingFisher 
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3) NucliSENS® miniMAG 
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4) QIAamp Qiagen 
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5) NucleoSpin® Tissue 
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6) SureFood® PREP 
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